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Abstract 
Vision loss from diabetic retinopathy (DR), a common diabetes-related 
complication and leading cause of blindness for working-age adults worldwide, is 
preventable.  Retinal screening is the proven clinical pathway to early DR 
detection; risk of vision loss can be significantly reduced by timely, appropriate 
treatment thereafter. Young adults with type 2 diabetes (T2D, 18-39 years) are a 
burgeoning population at risk of early development and rapid progression of 
diabetes-related complications, experiencing considerable health burden by mid-
life. Younger-onset T2D (i.e. diagnosis before 40 years of age) is also an 
independent risk factor for development of DR, and low uptake of retinal 
screening, highlighting young adults with T2D as a priority population for 
targeted intervention. Despite this, there is a paucity of research exploring 
underlying factors impacting retinal screening behaviour, and no retinal 
screening promotion interventions specifically tailored to young adults with T2D.  
The aim of this program of PhD research was to develop a public health 
intervention to promote uptake of retinal screening among young adults with 
T2D.  Objectives were: 1) identify modifiable factors impacting retinal screening 
behaviour among young adults with T2D, 2) develop an individual-level, 
theoretically-grounded, psycho-educational retinal screening promotion 
intervention, tailored to this priority population, and 3) evaluate the 
effectiveness of the intervention in increasing self-reported uptake of retinal 
screening and improving modifiable behavioural determinants. A mixed-
methods needs assessment (literature review, in-depth interviews, nationally 
representative survey) identified facilitators, barriers, and modifiable 
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psychosocial determinants of retinal screening for this priority population. 
Utilising intervention mapping as a development framework, these factors were 
targeted via theoretically-grounded persuasive messages which were embedded 
in an engaging and contextually-appropriate format (leaflet) and piloted. The 
leaflet significantly increased knowledge of DR, an important retinal screening 
facilitator, but not other behavioural determinants. Reduced sample size and 
real-world constraints curtailed capacity to test intervention effect on the 
primary outcome. These findings provide an evidence base for clinicians and 
researchers focussing on young adults with T2D and a template for best-practice, 
print-based intervention development.  Furthermore, in an Australian context, 
the broad learnings from this program of PhD research lend support to calls for 
the introduction of a nationally coordinated retinal screening program. 
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Outline of Thesis 
The aim of this program of PhD research was to develop a public health 
intervention to promote uptake of retinal screening among young adults with 
type 2 diabetes (T2D, aged 18-39 years).  The objectives of this research were to: 
 identify modifiable factors impacting retinal screening behaviour among young 
adults with type 2 diabetes 
 develop an individual-level, theoretically-grounded, psycho-educational retinal 
screening promotion intervention, tailored to young adults with type 2 diabetes  
 evaluate the effectiveness of the intervention in increasing self-reported 
uptake of retinal screening and improving modifiable behavioural determinants. 
To achieve these objectives, mixed-methods needs assessment was 
conducted, comprising literature review, qualitative in-depth interview study and 
online quantitative survey. Intervention Mapping used as a framework to 
develop evidence-based, persuasive messages targeting determinants identified 
in the needs assessment, and embed them in an engaging and relevant retinal 
screening promotion intervention. Finally, a randomised controlled trial was 
conducted to evaluate the effectiveness of the intervention.  
This thesis comprises six chapters. Chapter 1 (Introduction) describes type 
2 diabetes and the unique clinical and self-management challenges faced by 
young adults living with the condition.  The chapter introduces diabetic 
retinopathy (DR), the vulnerability of young adults with type 2 diabetes to the 
condition, and the problem of low retinal screening uptake (a crucial pathway to 
early DR detection) for this priority population, providing a rationale for the 
program of research.  
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Chapter 2 (Literature Review) summarises and critiques the available 
evidence regarding: research on the priority population, modifiable factors 
impacting uptake of retinal screening, previous interventions to increase the rate 
of retinal screening, as well as providing an overview of current ‘best practice’ in 
developing high quality health behaviour change interventions.   
Chapter 3 presents the first empirical study of the thesis (Paper 1: What 
factors influence uptake of retinal screening among young adults with type 2 
diabetes? A qualitative study informed by the Theoretical Domains Framework). 
The chapter describes the in-depth exploration (via a semi-structured interview 
study) of individual-level barriers and facilitators to retinal screening behaviour 
for young adults with T2D, and a systematic comparison with an older-adult 
comparator group, in order to identify those of greatest salience to the priority 
population.  
Chapter 4 (Paper 2: A tailored intervention to promote uptake of retinal 
screening among young adults with type 2 diabetes - an intervention mapping 
approach) describes a mixed-methods study to develop an evidence-based 
intervention using Intervention Mapping as a development framework. It 
presents the needs assessment (summarising the literature review and above 
qualitative study and detailing the methods and findings of a national, online 
survey), which sought to identify modifiable determinants of retinal screening 
behaviour to be targeted in a subsequent individual-level retinal screening 
promotion intervention.  It then goes on to describes the process of intervention 
development: involving a range of key stakeholders throughout the process; 
consolidation of needs assessment findings; development of logic models and 
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selection of modifiable behavioural determinants; development of theoretically-
grounded intervention content using evidence-based processes; production of an 
engaging resource; comprehensive pilot and debriefing of the new resource; and, 
finally, plans for implementation and evaluation.   
Chapter 5 (Paper 3: What is the effect of a tailored leaflet intervention on 
diabetic retinopathy screening among young adults with type 2 diabetes? A 
randomised controlled trial) describes the evaluation of the evidence-based 
intervention in terms of primary and secondary outcomes.  Efforts to address 
recruitment and attrition challenges are discussed, and implications for future 
research, including the use of non-conventional evaluation designs are presented 
for the benefit of future researchers. 
Finally, Chapter 6 (Discussion) presents an overview of key findings and 
discusses the contribution of this thesis to current knowledge, in relation to the 
literature reviewed in Chapter 2. The strengths and limitations of this program of 
research are discussed, and recommendations made for the future direction of 
research and clinical practice. 
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CHAPTER 1. Introduction 
This chapter comprises six sections. The first section introduces type 2 
diabetes (T2D), followed by section two which focusses on young adults with T2D 
(aged 18-39 years), who are the priority population in this program of PhD 
research. Section three introduces diabetic retinopathy (DR), with a focus on the 
vulnerability of young adults with T2D to early-onset and rapid progression of 
this common microvascular complication.  Section four introduces retinal 
screening as a proven clinical pathway for early DR detection, presenting 
evidence of low uptake of retinal screening among young adults with T2D. 
Section five summarises the case for a tailored, psychosocial, retinal screening 
promotion intervention, followed by section six which presents a rationale for 
the program of PhD research.  
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1.1 Introducing Type 2 Diabetes 
Type 2 diabetes is projected to become the leading cause  
of disease burden by 2023.  
Australian Institute of Health and Welfare, 2010 
More than 415 million adults worldwide live with diabetes mellitus; a key 
focus of the World Health Organisation General Assembly on the prevention and 
control of non-communicable diseases (International Diabetes Federation, 2015; 
World Health Assembly, 2013). Characterised by high blood glucose levels 
(hyperglycaemia) and glucose intolerance, there are two main forms of this 
chronic condition. The first, Type 1 diabetes (T1D), is an auto-immune condition, 
characterised by the inability to produce insulin. T1D accounts for 7-12% of 
diabetes cases, about half of which are diagnosed in childhood / adolescence. 
The second form, known as type 2 diabetes (T2D), has both modifiable (e.g. 
obesity) and non-modifiable risk factors (e.g. ethnicity, age), and is characterised 
by insulin resistance and deficiency. More often diagnosed in adults over the age 
of 45 years, T2D accounts for 87-91% of diabetes. Other forms of diabetes, such 
as gestational (diagnosed during and limited to pregnancy), account for 1-3% of 
diabetes diagnoses (American Diabetes Association, 2014; Ogurtsova et al., 
2017).   
Persistent hyperglycaemia can lead to both macrovascular (large blood 
vessel) and microvascular (small blood vessel) complications.  The former include 
stroke, coronary and peripheral artery disease, while the latter includes 
nephropathy (kidney damage, which can lead to kidney failure), neuropathy 
(nerve damage, which can lead to amputation) and retinopathy (retinal damage, 
which can lead to vision loss).  A key aim of diabetes self-management is to 
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prevent or delay development of diabetes-related complications, and is achieved 
primarily via achieving and maintaining glycaemic targets, and other risk factors.  
Diabetes self-management activities include daily blood glucose testing, 
following a healthy diet, engaging in regular physical activity, daily foot 
examinations and pharmacological management (such as daily tablets or insulin 
injections as prescribed to help manage blood glucose levels).  Other self-
management behaviours which confer health benefits and protect the individual 
from risk or progression of diabetes complications include weight management 
and smoking cessation. 
Diabetes self-management is underpinned by coordinated and 
collaborative care from multiple health providers, and periodic screening 
examinations, such as those conducted for the early detection of eye and foot 
complications (Victorian Government Department of Human Services, 2007).  
However, diabetes self-management behaviours can be onerous and 
unremitting, and an individual’s decision to initiate or maintain them is 
influenced by many factors including: degree of personal engagement and 
motivation, level of healthcare support and access, individual, familial, social and 
cultural factors (Crosby, Kegler, & DiClemente, 2002).    
1.1.1 Prevalence of diabetes. Diabetes prevalence has been increasing 
in recent years, driven by increasing incidence of T2D and closely linked to an 
ageing population and rise in obesity (Jaacks, Siegel, Gujral, & Narayan, 2016; 
Mokdad et al., 2000; Ng et al., 2014). Currently 9% of the world’s population (415 
million) live with diabetes worldwide; projected to rise to 10% (642 million) by 
2040 (Ogurtsova et al., 2017).  There are 1.25 million Australians living with 
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diagnosed diabetes (5% of the population), with T2D representing 86% of all 
cases (National Diabetes Services Scheme, 2017); in line with global estimates, 
this proportion is predicted to increase to 10% by 2025 (Magliano et al., 2009).  
1.1.2 The economic and psychosocial burden of diabetes. Given the 
role of diabetes in the development of micro- and macrovascular complications, 
the condition is a major cause of morbidity and mortality (Leung, Pollack, Colditz, 
& Chang, 2015; Tancredi et al., 2015) and a source of considerable burden on 
individuals, their families and the health system worldwide (Huo et al., 2016). 
 The economic impact of diabetes treatment and related complications is 
significant, with a recent systematic review estimating 12% (US$673 billion) of all 
global health expenditure is dedicated to diabetes (International Diabetes 
Federation, 2015); this is already disproportionate to the prevalence of the 
condition, and is projected to increase to US$802 billion by 2040 (Ogurtsova, 
2017).  In Australia, the total annual cost of diabetes treatment was estimated to 
be $14.6 billion in 2010 with per-person healthcare costs reported to be 2.5 
times higher for those with diabetes-related complications versus those without 
(Lee et al., 2013).      
The major proportion of economic cost of diabetes is accounted for by 
T2D, and includes carer costs and lost workforce productivity, as people with 
diabetes who are of working-age lose their place in the workforce or retire early 
(Australian Institute of Health and Welfare, 2013). For example, a recent 
systematic review of 23 studies, reported that the number of days lost per 
annum to absenteeism were 5.4-18.1 for an employee with T2D, compared to 
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3.4-8.7 for an employee without (Breton et al., 2013), increasing the risk of social 
isolation and economic deprivation (Egede, 2004). 
In addition to the economic cost, the psychological burden of managing 
diabetes is considerable (Young-Hyman & Peyrot, 2012).  People living with T2D 
are twice as likely as those without diabetes to experience depressive symptoms 
(Ali, Stone, Peters, Davies, & Khunti, 2006), which have been associated with 
impaired self-management and health behaviours, such as less physical activity, 
unhealthy diet, not taking medication as prescribed, and smoking (Lin et al., 
2004). Further, over one-third (36%) of people with T2D live with diabetes-
specific emotional distress (‘diabetes distress’); which includes a range of 
emotions such as feeling overwhelmed by diabetes management, and fear of 
diabetes-related complications, the most common being that of vision loss and 
blindness (Cavan et al., 2017; Perrin, Davies, Robertson, Snoek, & Khunti, 2017; 
Strain et al., 2014).   
Psychological stressors such as depression and diabetes distress are 
negatively associated with glycaemic outcomes, self-management activities, risk 
of complications and mortality (Ahola & Groop, 2013; Egede, Ellis, & Grubaugh, 
2009; Gonzalez et al., 2008). Furthermore, emerging research has established 
that people with T2D perceive diabetes-related stigma and judgement from 
others, which may be negatively associated with psychological well-being, 
glycaemic  outcomes, perceived social support and participation in diabetes self-
management education programs (Browne, Ventura, Mosely, & Speight, 2013b; 
Schabert, Browne, Mosely, & Speight, 2013; Winkley et al., 2015).   
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1.2 Introducing Young Adults with Type 2 Diabetes 
The principal concern with diabetes diagnosed at a young age  
is the development of complications at an earlier stage of life. 
Song, 2015 
Although improved awareness and treatment of T2D have seen declining 
rates of diabetes-related complications in developed countries (Gregg et al., 
2014), the sheer number of people developing the condition, and changes in risk 
profile, led K.M. Venkat Narayan, an internationally recognised leader in diabetes 
research, to claim that policy makers are “winning the battle, but losing the war” 
(Narayan, 2016, p.653).  One of the concerns raised by this and other recent 
landmark papers is the increasing incidence and burgeoning public health burden 
of younger-onset T2D (i.e. diagnosis <40 years of age; Dabelea et al., 2017; Jaacks 
et al., 2016; Mayer-Davis et al., 2017; Nadeau et al., 2016; Viner, White, & 
Christie, 2017; Yeung et al., 2014; Zimmet, Magliano, Herman, & Shaw, 2014).   
Average age at diagnosis for most of those who develop younger-onset 
T2D is 25-35 years, dependent upon country of origin, (Al-Saeed et al., 2016; Li et 
al., 2015; Sosale et al., 2016; Yeung et al., 2014).  Young adults with T2D (aged 
18-39 years) are the priority population in this program of PhD research, and 
have a number of unique clinical and demographic characteristics. These include: 
long diabetes duration; a severe, progressive phenotype (Viner et al., 2017); 
greater likelihood of family history of T2D (Benhalima et al., 2011b; Browne, 
Scibilia, & Speight, 2013a); higher rates of obesity and other health comorbidities 
(Browne et al., 2013a; Paul et al., 2017); lower rates of clinically therapeutic 
treatment (Al-Saeed et al., 2016; Wong, Constantino, & Yue, 2015), and greater 
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ethnic diversity than the general T2D population (Chen, Magliano, & Zimmet, 
2012; Paul et al., 2017).   
Both incidence and severity of diabetes-related complications are greater 
for young adults with T2D in comparison to similar-age adults with T1D and older 
adults with T2D (aged 40+ years), reducing quality and quantity of life 
(Constantino et al., 2013; Dabelea et al., 2017; Gregg, Sattar, & Ali, 2016; 
Harding, Shaw, Peeters, Davidson, & Magliano, 2016; Luk et al., 2014; Song, 
2012; Wong et al., 2015).  Higher overall mortality rates for young adults with 
T2D have been confirmed in an Australian context by Wong and colleagues who 
reported double the mortality risk when compared with their age of onset-
matched T1D peers, and an average 15 years lower age at death when compared 
to those with older-onset T2D (Al-Saeed et al., 2016; Constantino et al., 2013).  
1.2.1 Prevalence of younger-onset type 2 diabetes and data 
limitations in an Australian context. Globally, there is an 
increasing trend of obesity and decrease in the age of T2D diagnosis (Chen et al., 
2012; Jaacks et al., 2016). Prevalence data for younger-onset T2D has typically 
focussed on paediatric and adolescent populations (Dabelea et al., 2014), with a 
recent systematic review reporting that, dependent upon study population, 
geographic region and ethnicity, prevalence rates for T2D in children and 
adolescents range from 0 - 5,300 per 100,000 population (Fazeli Farsani, van der 
Aa, van der Vorst, Knibbe, & de Boer, 2013).  In Australia, prevalence of T2D for 
young adults is reported at 3% of the overall Australian T2D population, 
representing more than 35,000 registrants on Australia’s National Diabetes 
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Services Scheme (NDSS, 2017)1. In contrast to global trends, a recent Australian 
Institute of Health and Welfare working paper on T2D in Australia’s children and 
young people (2014) reported no evidence of an increase in incidence of 
younger-onset T2D, but cautioned that the data, which are derived from a range 
of sources but predominantly from the NDSS, should be interpreted with caution 
and are likely to be an underestimate due to data source limitations. In contrast, 
12-year follow-up data from the Australian Diabetes, Obesity and Lifestyle study, 
a longitudinal population based study of over 11,000 adults (Tanamas et al., 
2012), provides evidence of a potential increase in incidence of younger-onset 
T2D in Australia. The study reported that younger people (aged 25-34), gained 
more weight than any other age group, and that people who were overweight or 
obese in the study were 2-5 times more likely to have diabetes.   An important 
limitation of Australian data on incidence and prevalence of younger-onset T2D, 
is that NDSS registration is not compulsory. Health professionals typically register 
people to enable them to access subsidised products.  As young adults with T2D 
are less likely to use insulin or take insulin injections as recommended (Browne, 
Nefs, Pouwer, & Speight, 2014; Browne et al., 2013a), benefits of registration 
may not be apparent. Further, with the relatively recent restriction of access to 
subsidised glucose monitoring supplies for those with non-insulin-treated T2D 
                                                     
1 The NDSS is an initiative of the Australian Government, administered with the 
assistance of Diabetes Australia. The NDSS provides subsidised access to products (e.g. 
syringes needles, blood glucose test strips, insulin pump consumables) and a range of 
free services (e.g. information, education and advice) to registrants. 
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(July 2016), this situation is likely to perpetuate and there is the very real 
possibility that Australian T2D prevalence data may become increasingly 
inaccurate over time. Nonetheless, with 86% of Australians with T2D having 
registered with the NDSS, the service remains the “best available” source to 
monitor young Australian adults with T2D (Australian Institute of Health and 
Welfare, 2014).   
1.2.2 Barriers to optimal self-management and glycaemic control 
faced by young adults with type 2 diabetes. Optimal diabetes 
self-management and glycaemic control are cornerstones in reducing risk of 
development, or progression, of diabetes-related complications and consequent 
poor health outcomes. Known clinical and psychosocial barriers to optimal 
diabetes self-management for young adults with T2D are presented below.  
1.2.2.1 Clinical barriers. Clinical barriers include: high rates of physical  
comorbidity, such as obesity, high blood pressure (hypertension) and high blood 
cholesterol (hyperlipidaemia) (Browne et al., 2013a; Chowdhury & Lasker, 2002; 
Koelmeyer, Dharmage, & English, 2016; Sillars, Davis, Kamber, & Davis, 2010); 
delay in diagnosis of T2D, estimated at twice that of their T1D counterparts 
(Crume et al., 2016), and misdiagnosis, due to the clinical complexity of younger-
onset T2D (Australian Institute of Health and Welfare, 2014; Song, 2012). 
Sub-optimal glycemic outcome is characteristic of young adults with T2D, 
irrespective of country (Benhalima et al., 2011b; Deconinck, Mathieu, & 
Benhalima, 2017; Hsieh et al., 2014; Quah, Liu, Luo, How, & Tay, 2013; Song & 
Hardisty, 2007, 2009; Wilmot et al., 2013). Unique barriers faced by young adults 
with T2D include: emerging adulthood and learning to navigate the health 
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system (Amutha et al., 2017), and lack of intensive therapeutic management by 
clinicians in accordance with evidence-based guidelines, known as clinical inertia 
(Al-Saeed et al., 2016; Amed et al., 2014; Benhalima et al., 2011a; Constantino et 
al., 2013; Gregg et al., 2016; Rosenberg, Friedman, & Gurland, 2011; Song, 2012).  
For women, T2D during pregnancy provides an additional diabetes self-
management challenge and has been associated with poor outcomes for both 
the mother and baby.   For example, T2D during pregnancy has been associated 
with increased risk of miscarriage or stillbirth, exacerbation of diabetic 
retinopathy, and a two-fold increase in risk of congenital abnormality (DCCT 
Research Group, 2000; Errera, Kohly, & da Cruz, 2013; Klingensmith et al., 2016; 
Singh, Murphy, Hendrieckx, Ritterband, & Speight, 2013; Song, 2012).  
1.2.2.2 Psychosocial barriers. Psychosocial factors play an integral role  
in diabetes self-management behaviour (Bennett, Conner, & Godin, 2004; 
Graffigna, Barello, Libreri, & Bosio, 2014; Nam, Chesla, Stotts, Kroon, & Janson, 
2011; Skinner et al., 2014). Young adults with T2D face a range of psychosocial 
barriers, all of which negatively affect optimal diabetes management and have 
the potential to translate into disengagement with services and loss to medical 
follow-up (Pyatak, Sequeira, Peters, Montoya, & Weigensberg, 2013).   
Compared to their older T2D counterparts, young adults with T2D are 
characterised by higher levels of diabetes distress and depression (Browne et al., 
2013a), lower diabetes self-efficacy (Hessler, Fisher, Mullan, Glasgow, & 
Masharani, 2011) and impaired quality of life (Sillars et al., 2010). Young adults 
with T2D report feeling shame and negative judgement for having a condition 
usually associated with older adulthood (Browne et al., 2013a; Browne et al., 
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2013b), preferring not to disclose their condition, impeding their ability to 
communicate with, and connect to, important support networks (Auslander, 
Sterzing, Zayas, & White, 2010; Brouwer et al., 2012). 
Young adults with T2D also face unique, stage of life barriers such as work 
and study commitments, separation from parental care, disrupted routine, lack 
of time, age-related optimistic bias and perceptions of invulnerability (Arnett, 
2000; Australian Institute of Health and Welfare, 2014; Diabetes Australia, 2006; 
Johnson, Scott-Sheldon, & Carey, 2010; Lapsley & Hill, 2010; Waitzfelder et al., 
2011).   Identifying obesity as their most important health issue (Nguyen et al., 
2014), young adults with T2D are characterised by lack of diabetes-related 
clinical complications, which typically manifest themselves after 10 years 
duration, (Dart et al., 2014), reducing the perceived imperative for diabetes self-
care.  
In an Australian context, the top diabetes self-management barriers cited 
by young adults with T2D are: lack of motivation or feeling ‘burned out’, lack of 
time, work/study commitments, denial of diabetes, fear of complications, 
dissatisfaction and disengagement with existing diabetes education and support 
services (which they see as catering for older adults), embarrassment about 
diabetes diagnosis, and lack of support (Browne et al., 2013a; Diabetes Australia, 
2006).  Importantly for this program of PhD research, psychosocial factors are 
considered the “most important” barriers for those with younger-onset T2D 
(McGavock, Dart, & Wicklow, 2015) and many are amenable to change.   
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1.3 Introducing Diabetic Retinopathy  
In patients with type 2 diabetes…duration of diabetes is 
independently associated with microvascular events and this 
effect is greater in the younger patients. 
Zoungas et al, 2014 
With increasing prevalence of T2D comes a concomitant increase in 
diabetes-related complications, the most common of which is diabetic 
retinopathy (DR, Dirani, 2013; Nentwich & Ulbig, 2015; Sivaprasad, Gupta, 
Crosby-Nwaobi, & Evans, 2012). Currently, the fifth most common cause of 
blindness worldwide, and the leading cause of vision loss in working-age adults 
(Flaxman et al., 2017; Leasher et al., 2016) the condition has significant 
economic , psychosocial and public health implications (Access Economics, 2004; 
Fenwick et al., 2012; Rees, Saw, Lamoureux, & Keeffe, 2007; Ting, Cheung, & 
Wong, 2016). 
At its simplest, DR can be classified as having two stages: an 
asymptomatic, early stage known as ‘background’ or non-proliferative DR 
(NPDR), which can progress to ‘proliferative’ or vision-threatening retinopathy 
(VTDR).  In the NPDR stage, chronic hyperglycaemia can damage the tiny blood 
vessels in the retina resulting in bleeding and leakage of fluids, usually without 
any visual symptoms.  In the second, VTDR stage, new blood vessels form on the 
surface of the retina and further haemorrhage occurs. The most common 
manifestation of VTDR is known as diabetic macular oedema; vision changes are 
experienced by the person with diabetes as blurriness, floaters or spots and 
inability to see central detail, increasing in severity to vision loss or blindness 
(Fowler, 2008; Stone, Ryan, & Sinclair, 2012).  
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1.3.1 Prevalence of diabetic retinopathy and major risk factors.  
1.3.1.1 General population. Current global prevalence estimates  
suggest that approximately 30-40% of people with T2D have DR, with rates 
varying from 10-61% dependent upon country and ethnic group (Cheung, 2010; 
International Diabetes Federation, 2015; Ruta et al., 2013; Yau et al., 2012).  
Development of DR is closely linked to three key risk factors: diabetes 
duration, blood glucose and blood pressure.  As evidence of the importance of 
the above three factors, prevalence of DR was mapped to each in a recent meta-
analysis of pooled data across 35 population-based studies, with a total sample 
of N=22,896 (Yau et al., 2012). The authors reported that greater prevalence of 
DR was associated with increased HbA1c (18% vs 51% for <7% vs >9%), and 
increased blood pressure (31% vs 40% for ≤140/90 vs >140/90), and increased 
diabetes duration (21% vs 76% for <10 vs ≥20 years).   
In Australia, National Health and Medical Research Council guidelines for 
the management of DR recommend tight management of the two key modifiable 
risk factors: blood glucose (target HbA1c <7% or <53mmol/mol)2 and blood 
pressure (target systolic blood pressure <130mmHg), (Mitchell & Foran, 2008).  
Duration of diabetes, a non-modifiable risk factor, has the greatest influence 
beyond 10 years, with DR prevalence estimated to increase to 60% and 90% at 20 
and 25 years, respectively (Bhavsar, 2002; Klein, Klein, Moss, Davis, & DeMets, 
1984; Wong et al., 2009).   
                                                     
2 HbA1c, or glycated haemoglobin is an indicator of an individual’s average blood 
glucose levels during the past 90-120 days. 
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Finally, other modifiable behavioural and psychosocial factors linked with 
development or progression of DR include depression (Nguyen et al., 2010), 
obesity, alcohol and tobacco use (Kohner et al., 1998; Tyrberg et al., 2017). 
1.3.1.2 Young adults with type 2 diabetes. Diabetic retinopathy confers a 
20% lifetime risk of blindness for those who develop T2D before 24 years of age 
(Zimmet et al., 2014), and is the leading cause of blindness in working-age adults 
(Yau et al., 2012).  There is a lack of diabetes-related research on young adults 
with T2D in general, and this paucity of data extends to ophthalmic research.  
A recent systematic review of 84 large, population-based eye studies 
reported that none specifically examined young adults, with most focussing on 
ocular conditions related to ageing (e.g. cataract, macular degeneration and 
glaucoma) and a substantial minority concentrating on paediatric eye conditions 
(Forward, Hewitt, & Mackey, 2012).  
Yet, there is emerging evidence of age-specific changes in eye disease 
necessitating a shift in focus toward young adults with T2D.  For example, a 
recent comparison of two cycles of United States (US) National Health and 
Nutrition Examination Survey data over two time periods (1999-2002 & 2005-
2008, N=10,489, aged 20+ years) revealed that the prevalence of non-refractive 
visual impairment over time increased by 21% (1.4% to 1.7%, p<0.05), with the 
greatest change noted in young adults (20-39 years, from 0.6% to 1.0%). Noting 
that prevalence of diabetes significantly increased over the same time period, 
the authors concluded that T2D was a likely contributor to non-refractive visual 
impairment among younger adults (Ko et al., 2012). 
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In a reflection of the nascent stage of research on young adults with T2D, 
population-level prevalence of DR at diagnosis is difficult to determine for those 
newly diagnosed with T2D, and existing studies often focus on clinical 
populations (Chowdhury & Lasker, 2002).  The existence of high quality medical 
record data has allowed for ascertainment of DR prevalence for young adults 
with T2D at 10 year’s duration, where it is largely equivalent to the general 
population rates reported in a review by Yau et al (34.6%, 2012). For example, a 
recent analysis of data for 354 Australian adults who had been diagnosed with 
younger-onset T2D (average age 40 years, average duration 12 years) reported 
prevalence of any DR at 37% (Constantino et al., 2013).  
Unfortunately however, prevalence and severity of DR increases for 
young adults with T2D from 10 years duration, impacting affected individuals 
during their busiest and most productive years.  For example, Song and Gray 
(2011), in their recent survey of a UK hospital diabetes register and retinal 
screening database (N=2,061), reported significantly higher progression to VTDR 
for the younger-onset T2D cohort (age <40 years) when compared to their older-
onset T2D counterparts.  Using 10 years duration of T2D as a reference point, the 
authors demonstrated a significant increase in VTDR at subsequent duration 
points of 10-20 years (67% vs 55%, p<0.05) and >20 years (84% vs 73%, p<0.05), 
concluding that the younger-onset T2D cohort were at risk of developing VTDR 
20 years earlier than their later onset counterparts (Song & Gray, 2011).  
In addition to vulnerability to the three principle DR risk factors noted 
above (long diabetes duration, suboptimal glycaemic outcomes and 
hypertension;  Okudaira, Yokoyama, Otani, Uchigata, & Iwamoto, 2000; Song & 
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Gray, 2011; Tikellis et al., 2008), young adults with T2D experience clustering of 
demographic, clinical, behavioural and psychosocial DR risk factors which may 
explain increased DR prevalence for this priority population. 
Demographic risk factors which characterise young adults with T2D 
include: ethnicity, particularly South Asian which is associated with higher DR 
prevalence (Cheung, 2010; Raymond et al., 2009; Yau et al., 2012); early age of 
onset, where younger age is positively associated with higher prevalence of DR  
independent of duration (Cai et al., 2014; Klein R, 1984; Porta et al., 2001; Wong, 
Molyneaux, Constantino, Twigg, & Yue, 2008) and pregnancy, which is associated 
with accelerating the development of DR, particularly if other risk factors are 
present (DCCT Research Group, 2000; Errera et al., 2013; Klein, Moss, & Klein, 
1990; Singh et al., 2013; Tarr, Kaul, Wolanska, Kohner, & Chibber, 2012).   
Clinical risk factors that characterise young adults with T2D include: 
hyperlipidaemia, which has been linked to higher prevalence of diabetic macular 
oedema (Cheung, 2010; Unnikrishnan et al., 2017; Yau et al., 2012); delay in 
diabetes diagnosis, which can extend time to DR diagnosis (Song, 2012), and lack 
of aggressive clinical diabetes management, of crucial importance due to 
aggressive nature of younger-onset T2D (Song & Hardisty, 2010).  
Behavioural and psychosocial DR risk factors which characterise the 
young adults with T2D priority population include: high rates of depression, 
which has been associated with retinal microvascular changes in young adults 
(Meier et al., 2014; Silverstein et al., 2015), and low uptake of retinal screening 
after diabetes diagnosis, which has been associated with higher rates of VTDR 
(Scanlon 2016). 
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1.3.2 The economic and psychosocial burden of diabetic retinopathy. 
In economic terms, vision loss and blindness exert considerable stress at all 
levels, with a recent systematic review of 22 studies reporting that people with 
vision impairment bear almost twice the hospital and care-related expenses 
annually than those without (Koberlein, Belfus, Schaffert, & Finger, 2013).  In an 
Australian context, economic costs related to vision disorders have been 
estimated at AUD$9.85 billion, placing vision impairment as the seventh most 
expensive disorder, ahead of coronary heart disease, diabetes and depression 
(Taylor, Pezzullo, & Keeffe, 2006).  Importantly for this program of PhD research, 
a recent analysis of US econometric data by Wittenborn and colleagues (2013) 
reported that the earlier vision loss develops, the greater the cost burden, with 
more than one-third (US$27 billion) of the total cost of vision loss and eye 
disorders in the US applied to people aged under 40 years, including US$21.6 
billion for young adults aged 18-39 years.   
In addition to economic burden, DR has recently been confirmed as an 
independent risk factor for symptoms of depression (Rees et al., 2016), which 
has a negative impact on self-management, treatment concordance and 
glycaemic outcomes (Evans, Fletcher, & Wormald, 2007; Gonzalez et al., 2008; 
Horowitz, 2004; Rotella & Mannucci, 2013).  Fenwick and colleagues summarised 
the impact of DR on health beliefs and quality of life factors, concluding that 
vision loss from DR has a negative impact on perceptions of diabetes, personal 
and romantic relationships, activities of daily living, social and emotional 
wellbeing, and employment (Fenwick et al., 2011; Fenwick et al., 2012; Rees et 
al., 2012).   
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1.4 Introducing Retinal Screening for the Early Detection of Diabetic 
Retinopathy 
The principal aim of diabetes management is to prevent 
complications and this is even more pertinent in early-onset 
subjects given the potential for longer disease duration and 
exposure to adverse risk factors. 
Song and Hardisty, 2009 
The purpose of screening is for the early detection of an abnormality in 
order gain a better health outcome than if the disease were diagnosed at a later 
stage (Cancer Council Australia, 2014).  Retinal screening is an effective clinical 
pathway for the early detection of DR; risk of vision loss can be significantly 
reduced by timely and appropriate treatment thereafter (Agardh, Agardh, & 
Hansson-Lundblad, 1993; Arun, Ngugi, Lovelock, & Taylor, 2003).  Retinal 
screening can be conducted via a range of (mostly non-invasive) methods 
including: direct ophthalmoscopy (examination of the back of the eye (fundus); 
slit-lamp bio microscopy (examination of the fundus using high-intensity light 
source in combination with a microscopy); retinal photography; and most 
recently, the introduction of remote assessment via tele-retinal and mobile 
retinal screening, which improves accessibility (Ting et al., 2016). Depending on 
the examination method, dilation drops (mydriasis) may or may not be needed to 
increase the field of view and examine the retina, optic nerve and associated 
blood vessels (Hutchinson et al., 2000).  In Australia, retinal screening is usually 
conducted by an optometrist, takes about 40 minutes, and is either free or costs 
approximately AUD$35 (dependent upon the billing model of the provider).   
Recommended retinal screening intervals vary by country, but in 
Australia, the National Health and Medical Research Council evidence-based 
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guidelines for the management of DR recommend screening uptake at diabetes 
diagnosis, followed by a minimum of every two years thereafter (Mitchell & 
Foran, 2008). This interval is less frequent than that prescribed for adults with 
T2D in the UK and US, (American Diabetes Association, 2017; National Institute 
for health and Care Excellence, 2015).   
If DR is detected, timely treatment thereafter, can prevent up to 98% of 
DR-related vision loss (Ferris, 1993), dependent upon the stage of the condition 
(Bloomgarden, 2007).  For example, the NPDR stage of the condition is often 
monitored by an ophthalmologist via more regular retinal screening, whereas the 
VTDR stage often involves laser photocoagulation (where laser burns arrest 
progression of blood or fluid leakage) or more serious haemorrhage treated with 
surgery (Tarr et al., 2012).   
Although the primary benefit of retinal screening is early detection of 
asymptomatic DR, early and regular retinal screening also confer a multitude of 
secondary benefits. For example, a recent systematic review of economic 
evidence reported that regular screening was effective in terms of years of sight 
preserved (Jones & Edwards, 2010).  Importantly for this program of PhD 
research, a second, earlier review noted that retinal screening was most cost-
effective for the youngest age T2D cohort (<35 years), who have the potential to 
gain the most quality adjusted life years (Raikou & McGuire, 2003).  Recent meta-
analyses have confirmed that presence of DR is likely to provide early indication 
of presence of other diabetes complications such as renal and cardiovascular 
disease (He, Xia, Wu, Yu, & Huang, 2013; Zhu et al., 2017), both of which are  
high risk for young adults with T2D (Constantino et al., 2013).  Finally, retinal 
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screening provides opportunity for eye health professionals to educate and 
motivate patients, with the potential to improving glycaemic outcomes and 
moderating concern about DR (Rees et al., 2013).    
1.4.1 Rates of retinal screening. 
1.4.1.1 General population. Retinal screening rates have increased in  
developed countries over the past two decades due to coordinated initiatives 
and improvements in technology, which have increased both awareness of the 
condition and screening accessibility (Wong et al., 2009). For example, in the UK, 
retinal screening rates two decades ago were less than 50% (National Health 
Service, 2014). However, following introduction of a national program, rates have 
risen to 83% (Scanlon, 2017), with DR no longer the leading cause of vision loss in 
UK working-age adults (Liew, Michaelides, & Bunce, 2014).   
Recent findings from the Diabetic Retinopathy Barometer Study, a large-
scale survey of 4,340 adults with diabetes, and 2,329 health professionals from 
41 countries, provide insight into global trends, with the authors reporting that 
79% of adult respondents had screened at least once for DR since being 
diagnosed with diabetes (Cavan et al., 2017).  In an Australian context, general 
diabetes population retinal screening rates have risen from a median of 48% at 
the turn of the century (Tapp, Svoboda, Fredericks, Jackson, & Taylor, 2015) to 
78% (Foreman et al., 2017), primarily as the result of retinal photography-based 
DR screening programs and awareness-raising initiatives (Lee et al., 2000; Tapp et 
al., 2015).    
However, high average retinal screening rates conceal pockets of low 
uptake, with considerable negative impact, as delays in, or non-attendance of, 
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eye examinations increase the risk of VTDR when screening is finally initiated 
(Forster et al., 2013).  Demographic groups at risk of low retinal screening include 
young people with diabetes aged less than 40 years (Moreton, Stratton, Chave, 
Lipinski, & Scanlon, 2017), Indigenous and minority ethnic groups (Anderson et 
al., 2003; Tapp et al., 2015). 
1.4.1.2 Young adults with type 2 diabetes. Younger age of onset of  
diabetes is an independent risk factor for uptake of retinal screening, irrespective 
of country and healthcare system (Bylsma, Le, Mukesh, Taylor, & McCarty, 2004; 
Gulliford et al., 2010; MacLennan, McGwin, Heckemeyer, & et al., 2014; Owens 
et al., 2008; Sachdeva, Stratton, Unwin, Moreton, & Scanlon, 2012; Scanlon et al., 
2016; Villarroel, Vahratian, & Ward, 2015). This was illustrated in a recent 
analysis of UK retinal screening programs (N=689,025, Scanlon et al., 2016) which 
demonstrated that young adults aged 18-34 took the longest time to reach the 
goal of 80% retinal screening coverage (2 years and 9 months after registration). 
Further, the authors demonstrated that time from diabetes diagnosis to retinal 
screening was a significant predictor of DR severity, with those who delayed 
screening beyond three years four times more likely to have VTDR when they did 
screen .  
Despite the growing incidence of younger-onset T2D and sub-optimal 
clinical outcomes this group, there is a lack of focussed research examining rates 
and correlates of retinal screening.  As a case in point, Australia’s first National 
Eye Health Survey which was completed in 2016, excluded all adults with 
diabetes aged less than 40 years (Foreman et al., 2016), despite prior research 
suggesting lower retinal screening rates for young adults with T2D. For example, 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
22 
 
a small survey of young Australian adults with T2D (N=49) revealed lower retinal 
screening rates, when compared to general population, during an equivalent 
reporting period (55% vs 77% respectively; Diabetes Australia, 2006; Tapp et al., 
2004).  Absence of contemporary population-level data on retinal screening rates 
and prevalence of DR for young Australian adults with T2D increases the risk that 
the needs of this priority population will be neglected in future policy initiatives 
(Lake, Browne, & Speight, 2018).  
It is difficult to report retinal screening rates for young adults with T2D, as 
data are often specific to ethnic groups, or combine data for young adults with 
T2D, with their T1D counterparts (Katulanda et al., 2014; MacLennan et al., 2014; 
Millett & Dodhia, 2006; Orton, Forbes-Haley, Tunbridge, & Cohen, 2013).   
However, two recent studies from the US and UK confirm that retinal screening 
rates for youth/young adults with T2D remain below those of their similar aged 
T1D counterparts and the general diabetes population.  
In the US, a comparison of 12,686 youth/young adults aged ≤21 years 
(57%, n=7,233 T2D) with health insurance (a screening enabler, Jiang et al., 2017) 
reported that only 42% of those with T2D had screened for DR in the six years 
since diabetes diagnosis, compared with 65% of their T1D counterparts (Wang et 
al., 2017).   Further, a UK-based analysis of 21,797 people with diabetes (aged 
≥12 years, diabetes type not specified), reported an overall retinal screening rate 
of 82.4%.  However, once stratified by age, uptake was significantly lower in the 
12-39 year age group (66.6%) than for any other age group (Moreton et al., 
2017).  
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1.5 The Case for Psychosocial Intervention to Promote Retinal Screening for 
Young Adults with Type 2 Diabetes 
Eye complications have a high prevalence in younger-onset 
type 2 diabetes. Evidence-based behavioural intervention is still 
lacking in this group and it is one of the most challenging 
aspects of medicine in my experience.  
Song, 2015, personal communication 
Globally, public health advocates and policy makers have acknowledged 
the clinical and psychosocial challenges faced by young adults with T2D. In the 
absence of suitable existing retinal screening programs (see Chapter 2 for more 
detail), there is a growing body of literature calling for development of age-
appropriate, culturally and contextually sensitive interventions designed to 
improve diabetes self-management for this priority population (Browne et al., 
2014; Delamater et al., 2001; Dunning & Savage, 2013; MacLennan et al., 2014; 
Marrero et al., 2013; Nadeau et al., 2016; Thanabalasingham & Owen, 2014; 
Wilmot & Idris, 2014).   
Recommendations include: targeted and aggressive clinical management; 
tailored service delivery, with an early intervention focus; and psychosocial and 
educational intervention, to assist with health behaviour change (Amed et al., 
2014; Quah et al., 2013; Song, 2014; Turner et al., 2015; Twigg & Wong, 2015; 
Viner et al., 2017; Wilmot & Idris, 2014; Zhang & Ning, 2014). More specifically, 
recommendations focussing on promoting retinal screening for young adults 
with T2D argue that in addition to improving knowledge, efforts should be 
tailored to the priority population and focus on increasing perception of personal 
risk, and motivation to screen (Leese, Boyle, Feng, Emslie-Smith, & Ellis, 2008; 
MacLennan et al., 2014; Millett & Dodhia, 2006; Sachdeva et al., 2012; Scanlon et 
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al., 2016).  These recommendations respond to earlier research which 
established that many of the barriers to optimal diabetes self-management for 
young adults with T2D are psychosocial in origin (Diabetes Australia, 2006; 
McGavock et al., 2015).  
To achieve desired health behaviour for a priority population, best-
practice interventions deliver psycho-educational and motivational messages 
which are comprised of theory-based behaviour change techniques (Michie et 
al., 2013), and which target previously identified behavioural determinants 
(Michie & Abraham, 2004). Therefore, before any tailored retinal screening 
interventions can be developed, a clear understanding of the priority population 
and the factors associated with retinal screening is required.   
A range of factors are attributed to optimal diabetes self-management, 
including knowledge, attitudes, beliefs, social support, cultural and contextual 
factors, health literacy and health comorbidities (Nam et al., 2011).  Despite 
evidence of the unique clinical and psychosocial characteristics of young adults 
with T2D, and the challenges faced by emerging adults with regard to diabetes 
self-management, prior exploration of barriers, facilitators and determinants to 
this activity have typically been on paediatric T2D (Hanman et al., 2014; St. 
George et al., 2017) or adults with T2D aged over 40 years (Duckworth  et al., 
2009; Miller, Pawelczyk, Cheavens, Fujita, & Moss, 2017). This, taken in 
combination with paucity of research on factors impacting retinal screening for 
young adults with T2D, highlights a considerable gap in the literature and an 
imperative for the proposed program of PhD research.  
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1.6 Conclusion and Objectives 
Lower uptake rates for DR screening among younger people … 
represent lost opportunity in limiting the progression of DR … 
Those individuals who are least likely to attend diabetic 
retinopathy screening appointments are those who are at 
highest risk of developing DR.  
Sachdeva et al, 2012 
In conclusion, young adults (aged 18-39 years) with T2D are increasing in 
prevalence worldwide and have distinct clinical and psychosocial needs and 
characteristics when compared to their older-onset T2D, or age-equivalent T1D 
counterparts.  Younger-onset T2D is an independent risk factor for development 
of DR.  As such, it is crucial to ensure early uptake of retinal screening, the 
proven clinical pathway to early DR detection and, therefore, prevention of vision 
loss. Younger age however, is also an independent risk factor for low retinal 
screening uptake, and young adults with T2D are less likely to screen for DR in a 
timely fashion post-diabetes diagnosis.  
Educational and psychosocial intervention is a recommended pathway to 
promotion of retinal screening uptake for young adults with T2D. However, there 
is a paucity of foundation-level data upon which to develop a retinal screening 
for this under-researched group.  Thus, the overall aim of this program of PhD 
research is to develop a public health intervention to promote uptake of retinal 
screening among young adults with T2D.  The objectives of this research are to: 
 identify modifiable factors impacting retinal screening behaviour among 
young adults with type 2 diabetes 
 develop an individual-level, theoretically-grounded, psycho-educational 
retinal screening promotion intervention, tailored to young adults with T2D  
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 evaluate the effectiveness of the intervention in increasing self-reported 
uptake of retinal screening and improving modifiable behavioural 
determinants 
Preferred modes of receiving diabetes self-management education 
materials targeting young adults with T2D have been explored and include print, 
web-based and telephone-based options (Dunning & Savage, 2013). However, 
reaching young adults with T2D in an Australian context is challenging, due to 
absence of a nationally coordinated retinal screening database and lack of 
dedicated services or hubs by which to contact this priority population 
(Australian Institute of Health and Welfare, 2014; Vision 2020 Australia, 2017).  
Chapter 2 (Literature Review) outlines the predetermined, real-world parameters 
impacting the current program of PhD research, and the pragmatic solutions to 
the challenges associated with promoting retinal screening for young adults with 
T2D.  
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CHAPTER 2. Literature review 
This chapter comprises five sections. The first section provides context, 
positioning this program of PhD research within broader vision and retinal 
screening promotion initiatives conducted nationally and internationally. The 
second section summarises current literature on the barriers and facilitators 
impacting retinal screening behaviour, with emphasis on modifiable, 
psychosocial factors known to impact young adults with type 2 diabetes (T2D). 
The third section reviews previous interventions to promote screening for 
diabetic retinopathy (DR), with an emphasis on those that were conducted 
within the predetermined parameters of this program of PhD research (i.e. print-
based, individual-level). The fourth section discusses evidence-based 
intervention design, with emphasis on a ‘best practice’ framework (Intervention 
Mapping, IM), and other theoretically-grounded models. The fifth section 
concludes with direction for this program of PhD research.  
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2.1 Context of this Program of PhD Research 
Two large-scale and far-reaching initiatives have influenced the direction 
and scope of this program of PhD research and literature review. 
2.1.1 Vision 2020 – The Right to Sight. In response to projected global  
increase in blindness and visual impairment, the World Health Organisation and 
partner organisations launched the ‘Vision 2020 – The Right to Sight’ initiative in 
1999, with the aim of eliminating avoidable blindness by 2020. In Australia, the 
federal government supported this initiative with a National Framework for 
Action to promote Eye Health and Prevent Avoidable Blindness and Vision Loss 
(Commonwealth of Australia, 2005).  In Victoria, the state government’s public 
health response was the ‘Vision Initiative’, coordinated by Vision 2020 Australia.  
Vision Initiative activities were multi-focussed, conducted concurrently at the 
patient/population, provider/practice and healthcare system levels within four 
pre-specified Victorian local government areas (LGAs), during the period 
November 2012 – June 2015.  Activities included targeted population and health 
practitioner eye health campaigns; health workforce education; improvement of 
referral pathways for vision and rehabilitation services, and development of 
sustainable partnerships with Victorian eye health and vision care providers.  
 The program of PhD research described in this thesis was funded by 
Vision 2020 Australia and was a designated Vision Initiative activity. Conducted in 
a real-world setting as one of a broader suite of initiatives, many study 
components were predetermined, including intervention focus, eligibility criteria, 
timeline, intervention format, and delivery medium.  Contractual obligations 
required that the resource be targeted at the individual-level (intervention 
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focus), be delivered to young adult National Diabetes Services Scheme (NDSS) 
registrants with T2D who had not previously screened (eligibility criteria) by June 
2015 (timeline: 2 years and 7 months).  As the NDSS database primarily records 
registrant postal addresses, the intervention was, by necessity, print-based 
(intervention format) in a size that could be posted to participants at their street 
address (delivery medium: leaflet/brochure size).  
Importantly for this program of PhD research, the potentially confounding 
effect of concurrent, multi-focussed eye health initiatives on evaluation 
outcomes was identified and addressed early, minimising risk of bias.  The 
development and evaluation components of this program of PhD research were 
conducted nationwide, with residents from the four target Vision Initiative LGAs 
(who had been exposed to concurrent Vision Initiative activities) excluded from 
study involvement.  Thus, although the study was part of a multicomponent 
program of eye health awareness raising activities, the intervention was 
developed and evaluated in a geographically separate location and, as such, this 
program of PhD research can be considered single-focus, targeted at the 
patient/population level.  Importantly, residents of the four target LGAs were not 
excluded from receiving the leaflet post-evaluation, as it was distributed state-
wide to all eligible NDSS registrants in a mail out timed to coincide with the 
culmination of Vision Initiative activities in July 2015. 
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2.1.2 UK National Institute for Health Research WIDeR-EyeS program.  
The National Institute for Health Research (NIHR) commissions research focussed 
on improving health and social care to improve outcomes and reduce costs 
within the UK National Health Service.  In 2015, the NIHR commissioned an 
evidence synthesis project titled ‘What Works to Increase Attendance for 
Diabetic Retinopathy Screening? An Evidence sYnthEsiS (WIDeR-EyeS)’ (National 
Institute for Health Research, 2015), with an anticipated completion date of 
March 2018.  The three-phase program of research, which is ongoing, includes:  
1. Systematic review of the effectiveness of interventions to increase 
attendance for retinal screening (Lawrenson et al., 2016). 
2. Systematic review of barriers and enablers to DR screening attendance 
(Graham-Rowe et al., 2016). 
3. Integration of findings and development of recommendations regarding the 
use of specific evidence and theory-based intervention components for 
future DR screening interventions.   
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2.2 Factors Impacting Retinal Screening Behaviour 
Identifying the expectations, reservations, and barriers of those 
who underutilize eye care services will help us to understand 
the needs of this population and better serve them.  
Elam & Lee, 2013 
Despite clear health and economic benefits, substantial numbers of 
people with diabetes do not screen for DR (Foreman et al., 2017; Scanlon et al., 
2016). Factors impacting retinal screening exist at the patient, provider and 
system level (Elam & Lee, 2013; Nsiah-Kumi, Ortmeier, & Brown, 2009). A 
number of studies have used in-depth interviews or focus groups to explore 
factors at an individual-level (i.e. experiences and practices for the general 
diabetes population). However, the average age, where reported, is 60 years, 
offering little insight into the barriers experienced by young adults (Al-Alawi, Al-
Hassan, Chauhan, Al-Futais, & Khandekar, 2016; Ellish, Royak-Schaler, Passmore, 
& Higginbotham, 2007; Hartnett, Key, Loyacano, Horswell, & DeSalvo, 2005; 
Hipwell et al., 2014; John, Cooper, & Serrant-Green, 2014; Lewis, Patel, Yorston, 
& Charteris, 2007).  
A systematic review of barriers and facilitators to DR screening 
attendance is underway (Graham-Rowe et al., 2016). In a reflection of advances 
in behaviour change theory, the authors aim to classify the identified 
determinants into 14 theoretical ‘domains’ from the Theoretical Domains 
Framework (Cane, O'Connor, & Michie, 2012).  A review of the literature, 
focusing on factors impacting screening behaviour was conducted in 2013 by the 
author, and maintained for the duration of the program of PhD research (see 
Section 4.8.1 for details and findings). In brief, there are currently no published 
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studies specifically investigating factors impacting retinal screening for young 
adults with T2D, although one in-depth, qualitative study explored barriers to 
eye examinations among young adults (aged 18-35 years) in the general 
population (Shickle et al., 2014).  
More broadly, a range of environmental, systemic, demographic, clinical, 
and psychosocial factors which impact retinal screening behaviour for the 
general adult diabetes population have been identified. Given the context for this 
program of PhD research, those factors that cannot be influenced by the 
proposed intervention (i.e. information leaflet for young adults with T2D) are not 
included in this review. These include the environmental, systemic and 
demographic factors.  
Examples of environmental retinal screening barriers include lack of 
transport and remote location/lack of access (Al-Alawi et al., 2016; Gibson, 2014; 
Kovarik et al., 2016; Lee et al., 2014). Systemic retinal screening barriers include 
practice management issues including miscommunication/outdated contact 
details (Lindenmeyer et al., 2014; Strutton, Du Chemin, Stratton, & Forster, 
2016), or poorly constructed care pathways (Cavan et al., 2017). Demographic 
factors negatively impacting retinal screening behaviour which are not included 
in this review include: younger age (Khan, 2010; Leese, Boyle, Feng, Emslie-
Smith, & Ellis, 2008; Maberley, Koushik, & Cruess, 2002; Millett & Dodhia, 2006; 
Orton, Forbes-Haley, Tunbridge, & Cohen, 2013; Sachdeva, Stratton, Unwin, 
Moreton, & Scanlon, 2012); socioeconomic status/social deprivation (Brechner et 
al., 1993; Hwang, Rudnisky, Bowen, & Johnson, 2015; Leese et al., 2008; Orton et 
al., 2013; Waqar et al., 2012), and low education (Tajunisah, Wong, Tan, Rokiah, 
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& Reddy, 2011). Conversely, examples of demographic factors facilitating retinal 
screening behaviour which are not included are: female gender (Mukamel, 
Bresnick, Wang, & Dickey, 1999); treatment modality (Moss, Klein, & Klein, 1995) 
and (in the US), health insurance (Hwang et al., 2015; Jiang et al., 2017; Paksin-
Hall, Dent, Dong, & Ablah, 2013).   
Clinical and psychosocial factors play a crucial role in retinal screening 
behaviour (Gibson, 2014; Sikivou, 2000). When asked, individuals often cite 
multiple clinical factors ranging from lack of DR symptoms to lack of clinician 
recommendation to screen for DR. Psychosocial factors include knowledge, 
attitudes, health beliefs, health engagement and mental health (Peyrot et al., 
2005; Simmons, Lillis, Swan, & Haar, 2007).   Common clinical and psychosocial 
retinal screening barriers are reported below, with facilitators viewed as the 
converse of the barrier unless stated otherwise.  Where possible, each factor is 
discussed in relation to young adults with T2D.   
2.2.1 Clinical factors. 
2.2.1.1 Clinicians’ recommendation to screen for DR. Eighty-five  
percent of adults with diabetes who participated in the Diabetic Retinopathy 
Barometer Study (DRBS), a large-scale survey of 4,340 adults with diabetes, and 
2,329 health professionals from 41 countries (Cavan et al., 2017), stated that 
healthcare professionals were their main source of information about diabetes. 
Similarly, general practitioner (GP) recommendation has been highlighted 
as a key retinal screening predictor (Dervan, Lillis, Flynn, Staines, & O'Shea, 
2008).  This finding was confirmed qualitatively for young people with T2D, who 
cited supportive relationships with their health professionals as the most 
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important factor in enabling diabetes self-management (Protudjer, Dumontet, & 
McGavock, 2014). Direct encouragement (e.g. provision of information on retinal 
screening and diabetes-related complications, and follow-up of referrals), is a 
commonly cited determinant of retinal screening (Al-Alawi et al., 2016; Hwang et 
al., 2015; John et al., 2014; Lee et al., 2000; Lewis et al., 2007).  Despite this, only 
50% of DRBS participants reported receiving information about DR from their GP 
(Cavan et al., 2017). 
Clinical inertia, defined as “health professional’s failure to act, or intensify 
treatment, when clinically indicated” (Osataphan, Chalermchai, & Ngaosuwan, 
2017, p.267) is a related concept, which impacts young adults with T2D who rely 
on GPs as a major source of diabetes management information (Browne, Scibilia, 
& Speight, 2013a; Diabetes Australia, 2006). Two recent cross-sectional surveys 
suggest that lack of GP knowledge or confidence may underlie lack of GP 
encouragement to initiate retinal screening.  A survey of 430 Australian GPs (Ting 
et al., 2011) reported that only 29% had read the National Health and Medical 
Research Council guidelines on management of DR (Mitchell & Foran, 2008), and 
75% did not routinely conduct retinal screening themselves; with 86% citing lack 
of confidence in their ability to detect DR. Despite this, a recent survey of 598 
GPs in the Australian state of Victoria found that only half (53%) of those 
surveyed referred patients to an eye care provider for DR screening at diagnosis 
of T2D, taking an average 3.1 years from time of diabetes diagnosis to do so 
(Papa, Fenwick, Rees, Lamoureux, & Finger, 2016).   
Researchers have suggested additional factors may contribute to a 
disproportionate level of clinical inertia for young adults with T2D, such as: 
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clinician lack of knowledge, or uncertainty regarding appropriate therapeutic 
management of younger-onset T2D (i.e. diagnosis before 40 years of age), and 
the misconception that young adults with T2D, aged 18-39 years, are at low risk 
of complications (Song, 2015; Zafar, Stone, Davies, & Khunti, 2014; Zou et al., 
2017).  Irrespective of the cause, the outcome (low retinal screening uptake) 
remains the same, with demonstrated adverse clinical outcomes (Al-Saeed et al., 
2016; Owen, 2016).  
2.2.1.2 Recent diabetes diagnosis. Recent diabetes diagnosis (or short  
diabetes duration) is often cited as a barrier to retinal screening, possibly due to 
demands of psychological and lifestyle adjustment (Beeney, Bakry, & Dunn, 1996; 
Gregg et al., 2010; Rubin & Peyrot, 2012; van Eijk, Blom, Gussekloo, Polak, & 
Groeneveld, 2012); conversely, longer duration of diabetes is a key predictor of 
retinal screening (Moss et al., 1995).  
Young adults are vulnerable to delay in retinal screening uptake as 
demonstrated in an analysis of age versus time from registration to first screen, 
recently conducted by  Scanlon et al. (2016).  In their assessment of 394,309 
people referred to seven UK-based DR screening programs, Scanlon and 
colleagues demonstrated that young adults (aged 18-34) are the least likely age 
group to initiate retinal screening in a timely manner, with 80% coverage not 
achieved for this age group until 2 years and 9 months post-registration (proxy 
for diabetes diagnosis). This is a considerable period considering that screening 
guidelines in the UK recommend retinal screening uptake from diabetes 
diagnosis (National Institute for health and Care Excellence, 2015). 
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2.2.1.3 Absence or presence of DR symptoms. The asymptomatic nature 
of early DR results in a lack of connection between the individual's physical 
experience and the clinical imperative to screen for DR, lowering perception of 
need and personal risk (Ellish et al., 2007; Klein & Klein, 2006; Lee et al., 2000; 
Moss et al., 1995; Murgatroyd, MacEwen, & Leese, 2006; van Eijk et al., 2012).  In 
an Australian context, lack of symptoms was the most highly cited reason for not 
engaging in retinal screening, closely followed by lack of knowledge (86% and 
83% respectively, Sikivou, 2000).  
The asymptomatic nature of early DR is particularly relevant for young 
adults with T2D as diabetes-related clinical complications typically manifest 
themselves after 10 years duration (Dart et al., 2014; Delamater, Jacquez, & 
Patino-Fernandez, 2009). Providing insight into the beliefs of young adults, 
Shickle et al. (2014) reported that a dominant view expressed by focus group 
participants (N=43, aged 18-35 years) was that eye disease was an issue for older 
people and that eye examinations were only necessary if symptoms appeared. 
Conversely, presence of DR or experience of vision loss are key retinal screening 
predictors (Dervan et al., 2008; Ellish et al., 2007; Hartnett et al., 2005; Saadine, 
Fong, & Yao, 2008), with 65% of optometrists who participated in the DRBS 
reporting that most individuals presented for retinal screening when visual 
problems had already occurred (Cavan et al., 2017).  
2.2.1.4 Competing health demands. Diabetes is a chronic condition and 
the presence of other, often chronic, medical comorbidities, can complicate and 
take precedence over diabetes self-care and engagement in screening (Kovarik et 
al., 2016; Lee et al., 2000).  Despite often being unaffected by diabetes-related 
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complications in the early stages of the condition (Dart et al., 2014), young adults 
with T2D are characterised by health comorbidities (of which obesity is generally 
the primary concern), and complex healthcare needs (Auslander, Sterzing, Zayas, 
& White, 2010; Nguyen et al., 2014; Sillars, Davis, Kamber, & Davis, 2010). For 
example, in their in-depth exploration of barriers to diabetes self-management 
for US adolescents with T2D (N=10, aged 14-19 years) and their parents, 
Auslander and colleagues (2010) reported that all participants had at least one 
health comorbidity, and that both parents and adolescents cited health 
comorbidities as a key barrier to optimal self-management, which is a predictor 
of DR risk (Auslander et al., 2010).   
In an Australian context, Koelmeyer, Dharmage, and English (2016) 
reported a range of statistically significant physical and health-related 
comorbidities correlated with diabetes diagnosis in their young adult male 
cohort (N=11,075, aged 18-49 years), including obesity, depression, anxiety, high 
cholesterol and high blood pressure.  The latter is of greatest concern as it is both 
an independent risk factor for DR and negative associated with retinal screening 
uptake (Sachdeva et al., 2012).  
2.2.2 Psychosocial factors. 
2.2.2.1 Knowledge. In general, most people living with diabetes know  
of the connection between diabetes and vision loss, and that eyes should be 
examined (Cavan et al., 2017; Hall, Hall, Kok, Mallya, & Courtright, 2016; Hussain 
et al., 2016; Kovarik et al., 2016). However, knowledge of two factors crucial to 
retinal screening behaviour (Zhang et al., 2007): DR (as a condition or 
complication of diabetes), and of the role of retinal screening as a prevention 
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and detection measure, is often lacking (Cavan et al., 2017; John et al., 2014; 
Moss et al., 1995).  These include lack of knowledge of the asymptomatic nature 
of early DR, confusion between screening for DR and a standard vision-related 
eye examination, and lack of awareness of DR status, all of which are important 
screening barriers (Dervan et al., 2008; Gibson, 2014; Hipwell et al., 2014; Klein & 
Klein, 2006; Lee et al., 2000; Peng, 2010; van Eijk et al., 2012).      
Two factors closely related to knowledge are: diabetes self-management 
education, and low health literacy (an individual’s ability to obtain, process, and 
act appropriately on basic health information; Mackert, Donovan, Mabry, 
Guadagno, & Stout, 2014). Participation in diabetes self-management education 
is an important retinal screening predictor (Elam & Lee, 2013; Lewis et al., 2007; 
Moss et al., 1995; Murray & Shah, 2016; van Eijk et al., 2012; Yamashita, Kart, & 
Noe, 2012). Despite this, participation is low overall for people with diabetes, 
and has been identified as significantly lower for younger adults (Li et al., 2014).  
Explanation given for low participation in structured diabetes education by 
almost two-thirds (63%) of 149 young adults with T2D surveyed by Browne et al. 
(2013a) and in qualitative studies, were that participants felt they had “different” 
healthcare needs from “older” adults, and that current education programs were 
not age-appropriate (Browne et al., 2013a; Diabetes Australia, 2006; Savage, 
Dabkowski, & Dunning, 2009).  
Recent research has associated low health literacy with negative diabetes 
self-management outcomes (Bailey et al., 2014; Beard, Clark, Hurel, & Cooke, 
2010; Boren, 2009; Fransen, von Wagner, & Essink-Bot, 2012; Paduch et al., 
2017), and an important retinal screening barrier (Sikivou, 2000).   The issue of 
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health literacy is particularly important for people living with diabetes because of 
the need to adequately interpret clinical markers such as HbA1c and blood 
pressure readings (Williams, Baker, Parker, & Nurss, 1998), which are risk 
indicators for diabetes-related complications, including for DR.   
Young adults with T2D and those at high risk of the condition are 
characterised by low general and health literacy (Cha, Umpierrez, Kim, Bello, & 
Dunbar, 2013; Gregg, Sattar, & Ali, 2016).  An important step in addressing low 
health literacy involves ensuring appropriate readability and suitability of 
individual-level health information resources (Bartholomew Eldredge et al., 
2016). Despite this, many existing materials are written at literacy levels above 
the skills of the target population (Ryan et al., 2014).  Excessively complex textual 
content has been demonstrated to apply to eye health resources, with a recent 
review of readability of printed DR  information materials reporting an average 
Flesch-Kincaid readability score of 10.1 which is equivalent to a tenth-grade 
reading level (Muir & Lee, 2010), and well above the eighth-grade acceptability 
threshold (Doak, Doak, & Root, 1996).  
2.2.2.2 Anticipated regret. Anticipated regret, the belief about whether 
feelings of guilt or regret will result from inaction, has been demonstrated to 
moderate the intention-behaviour relationship (Abraham & Sheeran, 2003).  
Vision loss from DR is the diabetes complication of greatest concern to affected 
individuals (Strain et al., 2014) and fear of vision loss if screening was not 
conducted, has been cited as a facilitator by people living with diabetes (Hartnett 
et al., 2005).   
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2.2.2.3 Risk perception. In a recent systematic review of how people  
living with T2D perceive their risk of diabetes-related complications, the authors 
reported mixed findings, including: overestimation and underestimation of risk, 
or absence of correlation between perceived and actual risk, dependent upon 
population and diabetes-related complication (Rouyard, Kent, Baskerville, Leal, & 
Gray, 2017).  Once refined to studies which focussed on eye complications 
however, the authors reported underestimation of risk and higher optimistic 
bias. As both of these characteristics are disproportionately represented during 
young adulthood, there is strong likelihood of risk perception being an important 
retinal screening barrier for young adults with T2D (Lapsley & Hill, 2010; Nguyen 
et al., 2014; Reyes-Velazquez & Sealey-Potts, 2015; Turner et al., 2015).  
2.2.2.4 Fatalism. Young adults with T2D are more likely than their older-
onset T2D counterparts to have a family history of the T2D (Zeitler, Chou, 
Copeland, & Geffner, 2015).  Recent qualitative research with youth with T2D 
suggested that family history may contribute to a sense of fatalism regarding the 
inevitability of diabetes complications (Turner et al., 2015). Consequently, 
researchers have advocated for interventions to provide educational and 
psychosocial support and assist young adults to both appreciate and cope with 
the complication risk associated with T2D, including increasing the perception of 
need for retinal screening (Browne, Nefs, Pouwer, & Speight, 2014; MacLennan, 
McGwin, Heckemeyer, & et al., 2014; Turner et al., 2015; Zhang & Ning, 2014). 
2.2.2.5 Depression, diabetes-specific distress and stigma. Prevalence of 
depression among adults with T2D is almost twice as high as in the general 
population (Ali, Stone, Peters, Davies, & Khunti, 2006), and is associated with low 
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participation in diabetes self-care of which screening for DR is one aspect (Sumlin 
et al., 2014). Diabetes-specific distress, a separate psychological construct which 
entails a range of negative emotions specific to living with and managing 
diabetes (e.g. feeling overwhelmed by diabetes, fear for the future and risk of 
complications, guilt about getting ‘off-track’ with diabetes self-management), 
also impacts upon diabetes self-management and is associated with sub-optimal 
glycemic control (Ducat, Philipson, & Anderson, 2014).   
Younger age is independently associated with high rates of depressive 
symptoms and diabetes-specific distress (Anderson et al., 2011; Berge, Bauer, 
Eisenberg, Denny, & Neumark-Sztainer, 2013; Browne et al., 2014; Browne et al., 
2013a; Chittleborough, Winefield, Gill, Koster, & Taylor, 2011; Hessler, Fisher, 
Mullan, Glasgow, & Masharani, 2011; Stoop et al., 2014) and has been linked to 
greater emotional distress at diabetes diagnosis, when compared to older adults 
(Beeney et al., 1996). Despite this, only a small proportion of those with 
younger-onset T2D receive appropriate therapeutic intervention, (Silverstein et 
al., 2015) indicating that these (untreated) factors are likely to negatively impact  
diabetes self-care, and retinal screening behaviour to a greater extent among this 
priority population.  
Relatedly, people living with T2D report perceived and experienced 
stigma and fear of negative judgement (Browne, Ventura, Mosely, & Speight, 
2013b; Winkley et al., 2015), an emotion particularly pertinent for young adults 
with T2D who perceive additional burden for having a condition commonly 
associated with obesity and older adulthood (Browne et al., 2013a; Savage et al., 
2009).  
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
74 
 
Perception of stigma has been associated with low health literacy 
(Mackert et al., 2014) and reported as a barrier to non-attendance at diabetes 
self-management education (Winkley et al., 2015).  For example, in-depth 
interviews with youth/young adults living with T2D in Australia and overseas 
revealed a reluctance to disclose their condition, preventing opportunity to seek 
or receive peer and family support, self-management education, and adequate 
healthcare support (Browne et al., 2013b; Protudjer et al., 2014).   
2.2.2.6 Fear of DR screening, diagnosis and/or treatment.  Fear of the  
DR screening procedure (particularly consequences of pupil dilation drops), 
diagnosis, and/or of treatment are commonly cited screening barriers (Elam & 
Lee, 2013; Ellish et al., 2007; Lewis et al., 2007; Luckie et al., 2007; Murgatroyd et 
al., 2006; Strutton et al., 2016; Walker et al., 1997). The potential negative effects 
of fear arousal, including denial and avoidance, necessitate careful consideration 
when designing health behaviour interventions, in order to encourage people to 
consider acting to minimise the threat of DR, as opposed to message rejection 
(Ruiter & Kok, 2012).   
2.2.2.7 Engagement in diabetes self-care. Those most engaged in their  
diabetes self-care are also most likely to screen for DR (Ellish et al., 2007; Müller, 
Lamoureux, Bullen, & Keeffe, 2006). In their exploration of factors associated 
with never attending retinal screening, Strutton and colleagues (2016) 
highlighted denial of diabetes and disengagement with diabetes care as 
important considerations, particularly as those who had not screened for DR 
“represented a vulnerable group of patients” (Strutton et al., 2016, p.5).  Younger 
age has been associated both with fear of disclosure of T2D and consequent lack 
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of engagement with their diabetes self-management, with young adults with T2D 
reporting key barriers being lack of motivation and feeling “burned out” 
(Brouwer et al., 2012; Ellish et al., 2007; Müller et al., 2006; Nguyen et al., 2014; 
Savage et al., 2009; Wilmot & Idris, 2014). 
2.2.2.8 Practical obstacles. Practical obstacles (e.g. lack of time, cost,  
competing commitments) are commonly cited screening barriers for the general 
diabetes population (Ellish et al., 2007; Hartnett et al., 2005; Hipwell et al., 2014; 
John et al., 2014; Lewis et al., 2007; Lu et al., 2016) and have considerable impact 
on young adults with diabetes.  For example, Moss et al. (1995) compared 1,298 
people with diabetes (type not defined) stratified by age at diagnosis (n=765 <30 
years, n=533 ≥30 years). The authors reported that a higher proportion of the 
younger-onset group cited time and cost as reasons for not screening, compared 
to their older counterparts (23% vs 11% for lack of time, 30% vs 12% for cost), 
(Moss et al., 1995).   
Adults with diabetes who have never attended screening cited competing 
commitments, including work and childcare, as key reasons for non-attendance 
(Sachdeva et al., 2012; Strutton et al., 2016).  As lack of time and financial 
considerations are commonly cited life-stage factors known to impact diabetes 
self-management for young adults with T2D in Australia (Australian Institute of 
Health and Welfare, 2014; Diabetes Australia, 2006), it is reasonable to expect 
these factors to impact upon retinal screening uptake.  
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2.2.3 The importance of understanding context. The barriers cited  
above indicate that young adults with T2D are a high-need group facing multiple, 
complex clinical and psychosocial barriers to diabetes self-care, which are likely 
to also be relevant to the uptake of retinal screening for the early identification 
of DR.   
However, not all barriers may apply to retinal screening behaviour in a 
given priority population.  For example, a recent mixed-methods needs 
assessment conducted to identify barriers to DR screening for people living with 
diabetes in Sub-Saharan Africa (Hall et al., 2016), reported that adults with T2D 
from this region were not impacted by diabetes-related stigma, an emerging 
issue gaining credence as a barrier to diabetes self-management (Browne et al., 
2013b; Joachim & Acorn, 2000; Savage et al., 2009; Schabert, Browne, Mosely, & 
Speight, 2013; Winkley et al., 2015).   
This finding was contrary to expectations, and highlights the importance 
of exploring cultural and contextual factors for a given priority population. 
Drawing direct comparison with the Australian experience (Browne et al., 
2013b), Hall and colleagues (2016) reported that rather than conceal their 
diabetes diagnosis, participants wore identifying stickers with pride, observing 
that “in a continent with a high prevalence of a more stigmatising disease such as 
HIV/AIDS, it may be a relief to … have a more socially acceptable explanation for 
their chronic illness” (Hall et al., 2016, p.12). 
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2.3 Interventions to Promote Retinal Screening 
Our projections indicate a serious picture of the future national 
diabetes burden in youth … To prevent future human suffering 
and health care costs, effective interventions for the prevention 
of diabetes-related complications should be available to all 
youth with diabetes. 
Imperatore et al (2013) 
Interventions to promote retinal screening can be categorised broadly 
into three areas of focus: patient/population, practitioner/provider or healthcare 
system.  Patient/population-focussed interventions include programs to increase 
awareness of DR and promote self-management among people with diabetes, 
including the use of prompts/reminders. Provider-focussed interventions include 
educational programs designed to improve clinician adherence to clinical 
guidelines, as well as to improve the quality and flexibility of their clinical 
practice. Healthcare system-level interventions include programs designed to 
reduce barriers and improve access to healthcare delivery (e.g. telemedicine), as 
well as large-scale implementation of registration and recall systems.   
A systematic review of interventions to promote screening for DR 
identified 48 studies published between 1980 and May 2005 (Zhang et al., 2007). 
Of those, 10 targeted patient/population (Anderson et al., 2003; Basch, Walker, 
Howard, Shamoon, & Zybert, 1999; Clark, Snyder, Meek, Stutz, & Parkin, 2001; 
Gross, Cataruozolo, & Mitofsky, 1999; Halbert, Kwan-Moon, Nichol, & Legorreta, 
1999; Lafata, Baker, Divine, McCarthy, & Xi, 2002; Maliszewski, Dennis, & Coyd, 
1988; Prela, Smilie, McInerney, Harwell, & Helgerson, 2000; Varroud-Vial et al., 
1999; Vinker, Shpiz, Elhayany, & Nakar, 2003), four targeted 
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practitioner/providers, 19 targeted healthcare systems, and 15 were multi-
focussed3.   
A second systematic review of interventions to promote screening for DR 
is underway and a protocol has been published (Lawrenson et al., 2016). In a 
reflection of advances in intervention design theory and successful application in 
other health behaviour change areas (e.g. diet and physical activity; Greaves et 
al., 2011), the review protocol states that a key is to identify the specific 
components of existing retinal screening programs associated with intervention 
effectiveness. To achieve this, the authors propose to classify intervention 
content into theoretically-grounded “active ingredients” or behaviour change 
techniques (BCT), defined as “observable, replicable and irreducible 
component(s) of an intervention designed to alter or redirect causal processes 
that regulate behaviour” (Michie et al., 2013, p.82) 4.   
For this program of PhD research, a literature search was conducted to 
update the review by Zhang et al (i.e. from 2005 to 2017). Thirteen studies (9 
randomised controlled trials (RCT) and four non-randomised), and one 
companion paper (Jones, Walker, Schechter, & Blanco, 2010), were identified 
(see Additional file for search strategy and summary of findings).  Of the 13 
studies, nine targeted patient/population (Bush et al., 2014; Gabbay et al., 2006; 
                                                     
3 See Zhang et al 2007 for a list of non-patient/population level interventions, 
beyond the scope of this review. 
4 See Section 4.4.3.2 for detail on use of the same approach in this program of 
PhD research. 
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Judah et al., 2017; Lian et al., 2013; Murray & Shah, 2016; Pizzi et al., 2015; 
Walker, Schechter, Caban, & Basch, 2008; Weiss et al., 2015; Zangalli et al., 2016), 
two targeted practitioner/providers (Newman, Cummings, Doherty, & Patel, 
2012; Zwarenstein et al., 2014) and two targeted healthcare systems (Jani et al., 
2017; Olayiwola, Sobieraj, Kulowski, St.Hilaire, & Huang, 2011). Consistent with 
Zhang et al. (2007), relative risk (RR) with 95% confidence interval (CI) is used as 
a measure of effect for both randomised and non-randomised designs. In this 
review, RR was defined as the ratio of the probability of retinal screening 
occurring, and was calculated as screening rate post-intervention divided by 
screening rate at baseline (Deeks, 2002). 
2.3.1 Synthesis of study findings. Overall, most of the retinal screening  
promotion interventions achieved statistically significant increases in retinal 
screening, supporting the assertion by Zhang et al. (2007) that a variety of 
interventions are effective in promoting the behaviour.  Also consistent with the 
earlier systematic review, (Zhang et al., 2007), quality of studies varied with some 
missing key data such as length of follow-up, mean age of participants at 
baseline, clarity of participant screening status (i.e. whether the participants had 
never screened for DR, or instead, were overdue), and randomisation procedure 
(for RCTs). 
As the context of this program of PhD research is grounded at the 
patient/population level, the focus from here on is on the 19 studies targeting 
patients or populations (10 identified by Zhang et al 2007; 9 from the update 
review), Table 1. Of those, 16 studies reported a modest, statistically significant 
increase in retinal screening (11 RCT1-5,7,9-13, 5 five non-randomised      
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designs14,16-19)
5. Relative risk ranged from 1.02 (CI 0.94-1.10, Prela et al., 2000) to 
2.63 (CI 2.01-3.45, Gabbay et al., 2006) for RCTs, and 1.08 (CI 1.07-1.09, Murray 
& Shah, 2016) to 1.80 (CI 1.59-2.03, Vinker et al., 2003) for non-randomised 
designs.   
  
                                                     
5 Subscript numbers represent studies listed in Table 1 below  
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Table 1: Study characteristics, intervention effects and relative risk for patient-level retinal screening interventions 
Primary author 
(year) 
Sample 
size 
Intervention / Control conditions 
Length of 
follow up 
(weeks) 
Mean 
age at 
baseline 
Relative risk (95% 
confidence 
interval) 
Randomised controlled trial designs 
1. Anderson a  
    (2003) 
132 Intervention: letter and personalised follow up phone call.  
Control: letter only  
52 54.8 1.86 (1.28 -2.69) 
2. Basch a (1999) 280 Intervention: three part education program to increase 
knowledge of DR and personalised telephone outreach.  
Control: meal planning booklet 
26 54.7 2.01 (1.48 -2.73) 
3. Bushb (2014) 852 Intervention: letter plus encouraging and reminder 
telephone calls by multi-lingual link workers.  
Control: usual care (letter) 
52 N/R   2.55 (2.1 - 3.1) 
4. Gabbayb  
    (2006) 
332 Intervention: Nurse care management (BCT: self-
management education, goal setting, care planning). 
Control: usual care 
52 65 2.63 (2.01 - 3.45) 
5. Halbert a  
    (1999) 
19,523 Intervention: multiple educational material and reminders 
to increase awareness of retinal screening.  
Control: single reminder 
52 N/R 1.05 (1.01 - 1.08) 
6. Judahb (2017) 1,051 Intervention A: mailed invitation letter plus 10 pound 
voucher if attend retinal screening appointment  
Intervention B: mailed invitation letter with 1:100 chance 
to win £1,000.  
Control: usual care (mailed invitation letter) 
12 N/R Intervention A: 
0.70 (0.35 - 1.39) 
Intervention B: 
0.42 (0.18 - 0.98) 
Combined A&B: 
0.56 (0.34 - 0.92) 
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Table 1: Study characteristics, intervention effects and relative risk for patient-level retinal screening interventions (Cont.) 
Primary author 
(year) 
Sample 
size 
Intervention / Control conditions 
Length of 
follow up 
(weeks) 
Mean 
age at 
baseline 
Relative risk (95% 
confidence 
interval) 
Randomised controlled trial designs (Cont.) 
7. Lafata a (2002) 3,309 Intervention: mailed reminder packet (letter, self-care 
handbook, screening checklist). Control: usual care 
52 59.7 1.13 (1.04 - 1.23) 
8. Lianb (2013) 2,593 Intervention: small copayment (~£4.90). Control: no cost N/R 64 0.93 (0.90 – 0.96) 
9. Pizzib (2015) 356 Intervention A: mailed personalised letter with educational 
brochure; Intervention B: Int. A plus ≤ 3 phone calls.  
Control: usual care (standardised reminder letter) 
12 61 Intervention A: 
0.90 (0.63 – 1.28)                                           
Intervention B: 
1.41 (1.05 – 1.8) 
10. Prela a (2000) 6,546 Intervention: direct mail reminder. Control: no reminder 26 N/R 1.02 (0.94 - 1.10) 
11. Walkerb  
      (2008) 
598 Intervention: tailored educational and motivation phone 
intervention (≤7 phone calls). Control: 14-page booklet on 
preventing diabetes eye problems. 
26 57 1.74 (1.31 - 2.30) 
12. Weissb 
(2015) 
206 Intervention: BA: action planning, barrier identification, 
problem solving). Control: supportive therapy.  
26 73 2.58 (1.91-3.48) 
13. Zangallib 
(2016) 
521 Intervention: personalised letter, educational brochure and 
≤ 3 phone calls. Control: usual care (standard letter) 
12 61 1.57 (1.26 - 1.95) 
Other research designs  
14. Clark a (2001, 
pre-post) 
370 Comprehensive diabetes management education program 52 64 1.49 (1.29 - 3.64) 
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Table 1: Study characteristics, intervention effects and relative risk for patient-level retinal screening interventions (Cont.) 
Primary author 
(year) 
Sample 
size 
Intervention / Control conditions 
Length of 
follow up 
(weeks) 
Mean 
age at 
baseline 
Relative risk  
(95% confidence 
interval) 
Other research designs (Cont.) 
15. Gross a (1999, 
pre-post) 
100 Survey on receipt of preventive care from hospitalised 
patients 
26 N/R 0.32 (0.02 - 5.01) 
16. Maliszewski a 
(1988, pre-post) 
338 Education program to increase patient awareness of 
retinal screening 
52 N/R 1.78 (1.50 - 2.12) 
17. Varroud-Vial a 
(1999, pre-post) 
505 Cooperation program between healthcare specialists and 
patient feedback/education 
52 61.9 1.12 (1.02 - 1.22) 
18. Vinker a (2003, 
pre-post) 
420 Written reminder plus phone calls to increase patient 
awareness of retinal screening 
52 65.8 1.80 (1.59-2.03) 
19. Murrayb 
(2016, other) 
45,212 Attendance at any diabetes self-management education 
without assessment of content or quality 
N/A 76 1.08 (1.07-1.09) 
aStudies contained in Zhang et al systematic review (2007, n=10),  
bStudies post-Zhang et al systematic review (i.e. published 2005 onward, n=9).   
N/R: not reported, N/A: not applicable, BCT: behaviour change technique, BA: behavioural activation 
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2.3.1.1 Patient/population level interventions that achieved increased 
retinal screening. Interventions with largest effect were those that 
utilised the most resources (generally through personalised contact), although 
cost-effectiveness analyses were not reported. Examples of effective, intensive 
interventions include: 
 utilisation of multi-lingual link-workers for bookings, reminders and recall 
(Bush et al., 2014; RR 2.55, CI 2.1-3.1),  
 care planning and coordination by nurse case manager in conjunction with 
self-management education (Gabbay et al., 2006; RR 2.63, CI 2.01-3.45),  
 community health worker implementation of educational manuals designed 
to assist people with T2D to identify and address screening barriers and 
formulate action plans (Weiss et al., 2015; RR 2.58, CI 1.91-3.48), and  
 printed education materials combined with telephone outreach (Basch et al., 
1999; RR 2.01, 1.48-2.73).   
In contrast, studies that reported modest, but statistically significant 
increases in retinal screening did not include personalised contact.  Typically, 
such interventions comprised print-based reminders or educational brochures 
with RR ranging from 1.02 (CI 0.94-1.10) to 1.13 (CI 1.04-1.23), (Burnett et al., 
1998; Halbert et al., 1999; Lafata et al., 2002; Prela et al., 2000).  The study 
closest in design to the leaflet intervention proposed in this program of PhD 
research (due to the context of the project, see Section 2.1) involved a direct 
mail reminder, which was sent to US adults with diabetes, identified through 
medical claims data.  The authors reported a modest, statistically significant 
increase in eye examination medical claims by the intervention group in the 
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three months following receipt of the flyer (19.4% vs 17.2%; RR 1.13, CI 1.01-
1.26), (Prela et al., 2000). However, this was not sustained six months post-
intervention and did not influence eye examination rates in people who had not 
screened for DR in the previous two years.  However, it is likely that the didactic 
content of the letter (Figure 1) may not have tapped into the cognitive, 
psychosocial or contextual factors associated with the decision to screen.  
  
Figure 1: Direct mail interventions (L: Lafata et al, 2002; R: Prela et al, 2000) 
More broadly, although detail of text-based content was often sparse or 
non-existent in the literature, those printed interventions that were published 
were limited in scope (Lafata et al., 2002; Prela et al., 2000), as exemplified in 
Figure 1.  Descriptions provided in the remaining studies indicated that text-
based interventions were typically in the form of letters, brochures or leaflets. 
Content was didactic in nature, focusing almost completely on improving 
  Figure 1: Direct mail interventions (L: Lafata et al, 2002; R: Prela et al, 2000) 
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awareness and knowledge of DR to prompt the recipient to either initiate or 
reprise screening for DR.  For example, content ranged from appointment only 
information (Lafata et al., 2002) or directive prompts such as ‘Get regular eye 
exams’ (Anderson et al., 2003; Prela et al., 2000), to education-based content 
outlining the condition, the retinal screening process, or emphasising the 
importance of eye examinations (Pizzi et al., 2015).   
Importantly for this program of PhD research, the most effective, print-
based interventions relied on individuals to be registered on an existing 
database, either with an eye health practitioner, or with a centralised, system, 
such as the UK national screening program (Scanlon, 2017).  As young adults with 
T2D may not yet experience the age-related refractive changes that often prompt 
a first visit to an eye health practitioner, and no national retinal screening 
program exists in Australia, reliance on existing databases is not an option in this 
program of PhD research, necessitating utilisation of alternate data sources to 
optimise reach. 
2.3.1.2 Patient/population level interventions that did not achieve 
increased retinal screening. Of the four patient/population level studies  
that did not achieve statistically significant increases in screening rates for 
participants, three were RCTs6,8,9
6 and one had a non-randomised design15. 
Relative risk ranged from 0.32 (Gross et al., 1999; CI 0.02-5.01) to 0.93 (Lian et 
al., 2013; CI 0.90 0.96). Interestingly, two of the interventions explored the effect 
                                                     
6 Subscript numbers represent studies listed in Table 1. 
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of cost of screening as a facilitator/barrier, providing insight into the possible 
cognitive processes underlying the behaviour.  
For example, one study (evaluating the effect of two incentives: one small 
and fixed, i.e. guaranteed £10; one larger and probabilistic, i.e. 1:100 chance to 
win £1,000) on screening attendance reported that participants offered either 
incentive were less likely to screen than control participants who received an 
invitation letter only (RR 0.56, CI 0.34-0.92), (Judah et al., 2017). The authors 
concluded that, in this case, an extrinsic reward may reinforce the view that 
screening is unpleasant.   
Conversely, a Hong Kong study, which explored the impact of a small co-
payment by patients (~£4.90) on screening attendance, reported payment was 
also associated with lower screening uptake when compared to free access (RR 
0.93, CI 0.90–0.96), (Lian et al., 2013).  Notably, uptake for both groups was high 
(82.4% and 88.5%, respectively, p<.001) in a country where a small co-payment is 
typical. These findings suggest that financially-based incentive strategies 
(regardless of whether they are framed in terms of financial gain or loss) have 
the potential to discourage individuals from screening. Furthermore, there is 
little available evidence to support the use of incentives to promote retinal 
screening uptake in young adults with T2D.  
A recent systematic review by Yu et al. (2016), which examined the use of 
incentives in 26 studies, reported that the studies “almost exclusively” targeted 
discouraging unhealthy behaviours, and no studies which focussed on diabetes. 
As such, the authors were unable to determine the utility of incentives strategies 
encouraging uptake of positive health behaviours for young adults. 
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2.3.2 Factors impacting intervention effectiveness or interpretation. In  
their review, Zhang et al. (2007) reported a range of characteristics related to the 
effectiveness of interventions. For example, interventions were less likely to 
succeed if they were conducted outside metropolitan areas or with minority 
populations, and more likely to succeed if they were multi-focussed, involved 
multidisciplinary collaborations or were conducted in healthcare systems 
equipped with a computerised database.  However, given that most 
interventions were found to be effective in promoting retinal screening, three 
additional factors relevant to this program of PhD research, but not explicitly 
raised by Zhang et al. (2007), need to be considered, and are described below. 
2.3.2.1 Participant eligibility criteria: lapsed vs never screened. The  
first factor with the potential to impact intervention success is choice of target 
group eligibility criteria.  Although the 19 patient-level studies reviewed in this 
section shared the same assessable outcome (i.e. screening for DR), 13 studies 
employed broad eligibility criteria which included those who had previously 
screened, but who had not done so within a pre-defined interval, which was 
commonly 12 months (hereafter ‘lapsed’).  Only three studies specified use of 
the stricter eligibility criteria of never screened for DR since their diabetes 
diagnosis (Bush et al., 2014; Halbert et al., 1999; Judah et al., 2017); (eligibility 
criteria could not be determined for three studies; Clark et al., 2001; Murray & 
Shah, 2016; Vinker et al., 2003). 
Past behaviour is a strong predictor of future behaviour (Ouellette & 
Wood, 1998) and once initiated, screening is generally sustained (Lee et al., 
2000; Zhang et al., 2007). Consequently, retinal screening intervention 
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evaluations that include ‘lapsed’ participants risk inflation of intervention effect, 
as the lapsed participant may have always intended to screen for DR. Usage of 
the stricter criteria (i.e. only those who had never screened), although arguably 
of greater economic and social benefit to the population (Raikou & McGuire, 
2003), is likely to impact the study on multiple levels, from recruitment, through 
to evaluation, as those who have never screened, by definition, have not 
engaged with the behaviour and are likely to either be resistant to the behaviour, 
or face an accumulation of barriers which impede the behaviour (Moreton, 
Stratton, Chave, Lipinski, & Scanlon, 2017; Scanlon et al., 2016; Strutton et al., 
2016; Zhang et al., 2007). 
Interestingly, two of the three studies using the stricter criteria reported 
low or negative effect (Halbert et al., 1999; Judah et al., 2017). The third study, 
which employed healthcare staff from the same cultural and language 
background as the target group to encourage screening attendance, 
demonstrated significant improvements, reinforcing the finding that personalised 
interaction is a valuable contributor to intervention success, and an important 
imperative to address literacy, cultural and language retinal screening barriers 
faced by minority populations (Bush et al., 2014).    
2.3.2.2 Question-behaviour-effect. The second factor with the potential 
to impact intervention success is the potentially confounding effect of the pre-
intervention survey on screening behaviour. Known as Question-Behaviour-Effect 
(QBE), this phenomenon is supported by a body of literature, which posits that 
the act of asking questions and measuring intentions about a specific behaviour 
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influences the performance of that behaviour (Dholakia, 2010; Spangenberg et 
al., 2012).   
Considering that most interventions to promote screening for DR 
achieved statistically significant increases in retinal screening, and that QBE 
effects have been demonstrated in other socially desirable behaviours (Ayres et 
al., 2013; Conner, Godin, Norman, & Sheeran, 2011; Godin, Germain, Conner, 
Delage, & Sheeran, 2013; Godin, Sheeran, Conner, & Germain, 2008), it is 
interesting to note that only one study accounted for this phenomenon (Walker 
et al., 2008). They did so by using a Solomon group design, which assigns 
participants at random to a combination of four pre-test/intervention groups, 
and allows the examination of both the intervention and the interaction of pre-
test items (Solomon, 1949).  If pre-test sensitisation, or QBE, is present, the 
effect would be expected to be larger in the ‘pre-test plus intervention’ group 
than in the ‘no pre-test plus intervention’ group.  The study, which also cross-
validated self-report of retinal screening behaviour with medical records, 
reported no pre-intervention effect between those who completed and did not 
complete the pre-intervention questionnaire (RR 1.73 and 1.74, respectively, 
p=.97), with the authors concluding that QBE was not present (Walker et al., 
2008).  However, as all participants in this study had previously screened, the 
sensitivity of the study to detect a QBE may have been reduced, in comparison to 
effect of QBE on those who had never screened.  
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2.3.2.3 Standards of reporting and intervention design In the past  
decade, several clear, systematic intervention design and reporting frameworks 
have been proposed (Hoffmann et al., 2014; Moher et al., 2010). Despite this, 
sub-optimal intervention design and reporting continue to impact upon the 
quality and evaluation of DR screening interventions.  
The current literature review was impeded by a lack of published detail 
on whether screening barriers/facilitators relevant to the priority population 
were explored prior to intervention development, and whether those factors 
were targeted explicitly using theoretically-grounded BCT. For example, in their 
description of a successful education program to increase DR screening, Basch et 
al. (1999) did not report whether the resources in their tailored, multi-
component education intervention were based on an earlier, comprehensive 
exploration of barriers and facilitators within the priority population (Walker et 
al., 1997). Considering the proximity of publications and the similar 
characteristics of study participants (African Americans with diabetes enrolled 
from New York City medical centres), it is highly likely that this was the case, and 
clear specification of this prior needs assessment would have added to the 
strength of the study findings.  
Furthermore, some researchers do not appear to have incorporated 
advances in intervention design theory into their interventions. For example, a 
recent large-scale, cluster RCT involving 5,048 Canadian GPs and 179,833 people 
with diabetes reported that various printed educational messages targeting 
clinicians, and companion patient-targeted memos, were ineffective in increasing 
patient screening rates (Zwarenstein et al., 2014).  However, as acknowledged by 
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the authors, the lack of impact may reflect the fact that the message content was 
not evidence-based (i.e. “not based on a prior assessment of barriers to 
screening”, p.8), concluding that targeted barriers may not have been relevant to 
the study population. Indeed, examination of the published patient-targeted 
memo (Figure 2) shows it to be didactic in nature, focusing solely on commonly 
known barriers of knowledge and cost, rather than psychosocial, cognitive and 
contextual factors associated with screening behaviour among the target 
population. 
 
Figure 2: Patient memo (Zwarenstein et al, 2014) 
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In summary, a broad range of interventions have been successful in 
promoting DR screening, and patient-level, print-based materials generally 
report small-to-moderate positive effect.  However, there are several limitations 
of these studies, which are likely to have contributed to the success of these 
interventions. Importantly for this program of PhD research, none of the studies 
reviewed targeted young adults with T2D and the mean age of participants 
(where reported in Table 1) was 63 years (range 55 - 76 years). 
In contrast to ‘best practice’ health behaviour intervention development, 
none of the intervention studies reported investigating antecedent psychosocial 
and cognitive factors to inform the content of the intervention, and few targeted 
or assessed change in known screening determinants (e.g. beliefs, attitudes, risk 
perception or knowledge).  Further, only one of the studies described above 
(Judah et al., 2017) specifically nominated utilisation of theoretically-derived BCT 
as a behaviour change strategy, although many used commonly identifiable 
techniques, such as improving knowledge, goal setting and planning, and 
providing information about health consequences (Basch et al., 1999; Gabbay et 
al., 2006; Weiss et al., 2015).  Thus, it is expected that a text-based intervention 
containing tailored, evidence-based message content that reflects a thorough 
understanding of the target cohort (including existing barriers and determinants), 
and which addresses the above shortcomings, is likely to be more effective than 
earlier interventions in promoting uptake of DR screening. 
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2.4 Changing Health Behaviour 
 The evidence that behaviour is the dominant element in 
successful management of diabetes is so overwhelming that we 
tend to ignore it. 
Gale, 2004 
Health behaviours are defined as “behaviour patterns, actions and habits 
that relate to health maintenance, to health restoration and to health 
improvement” (Delamater et al., 2009, p.3). They have the capacity to impact an 
individual’s health positively or negatively (Abraham, Kelly, West, & Michie, 
2009).  At an individual level, modifiable determinants include knowledge, 
intention, risk perception, self-efficacy, perceived norms, health beliefs and 
attitudes (Abraham, Conner, Jones, & O'Connor, 2008).  Programs designed to 
change or enhance health-promoting behaviours and reduce the risk or impact 
of disease, are known as health behaviour change interventions. Evidence 
suggests that behaviour change interventions are effective across a broad range 
of health behaviours (Michie & Abraham, 2004a).  
2.4.1 The evolving use of social cognition models in health behaviour 
change intervention development. Health behaviour change  
interventions based on theory and theoretical constructs are, generally, more 
effective than those with no explicit theoretical basis (Gage et al., 2004; 
Hampson et al., 2000). Historically, a number of social cognition models (SCMs) 
have been used to account for variations in health behaviour and to inform and 
evaluate health behaviour change interventions (Serlachius & Sutton, 2009). In 
general, SCMs predict and explain health behaviour, specifying modifiable 
antecedents or determinants of behaviour change which can be targeted in a 
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behaviour change intervention.  Examples of application of such models within 
diabetes include: understanding perceptions of the role of self-monitoring of 
blood glucose for adults with T2D who had improved glycaemic control, via the 
Common Sense Model (Tanenbaum et al., 2015); identification of factors 
predicting concordance with retinal screening recommendations via the Health 
Belief Model (Sheppler, Lambert, Gardiner, Becker, & Mansberger, 2014); 
development of a physical activity promotion intervention for adults with T2D, 
informed by the Theory of Planned Behaviour (Avery et al., 2016), and 
development of a 5-week self-management program for adult with T2D based on 
Social Cognitive theory (Steed et al., 2005).  
However, in many instances, effect sizes are small (Hardeman et al., 2002; 
Johnson, Scott-Sheldon, & Carey, 2010).  For example, a recent meta-synthesis of 
62 meta-analyses of a diverse range of more than 1,000 behaviour change 
interventions reported a small-to-moderate effect size for the broad range of 
interventions (d=0.08-.045, 95% CI)7 and a moderate effect for those focussed on 
‘improving participation in health services’ (d=0.35, 95% CI), (Johnson et al., 
2010).  Of interest to this program of PhD research, is the conclusion by Johnson 
and colleagues that younger age is a risk factor for efficacy across a range of 
health behaviour change interventions, with the authors suggesting that 
increased risk-taking behaviour and perceptions of invulnerability underlie this 
phenomenon.  
                                                     
7d = weighted mean effect size (positive for improvements in the outcome studied and 
negative for impairments). 
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Although individual SCMs and the theoretical constructs that underpin 
them have guided research and intervention development, and formed the basis 
of numerous effective interventions, various conceptual and pragmatic 
limitations have been raised by scholars in the field. A common observation is 
that individual SCM models differ in the specification of mechanisms or pathways 
by which behaviour can be changed, and individual SCMs are restricted to the 
regulatory mechanisms that explain behaviour within their own paradigm 
(Ogden, 2003). For example, Abraham (2015) highlighted limitations of the 
Theory of Planned Behaviour (TPB) in intention formation and intervention 
development, arguing that TPB does not specify all processes by which intention 
can be influenced, and that TPB does not provide information on when and how 
to target specific mechanisms (Abraham, 2015). 
Real-world health behaviours are complex and nuanced, and use of one 
specific SCM may overlook or omit relevant regulatory processes or 
determinants that might have been included had another SCM been selected 
(Michie & Abraham, 2004b).  
2.4.1.1 Information-Motivation-Behavioural skills model. An alternate  
model proposed by leading scholars is an integrated approach which allows for 
identification of change mechanisms without reliance on any one specific 
psychological theory (Abraham, 2015; Bartholomew Eldredge et al., 2016).  The 
Information-Motivation-Behavioural skills (IMB) model, developed by Fisher and 
Fisher (1992), has utility for this purpose (Figure 3).  The IMB model posits that 
although information is a key element in changing behaviour, increasing 
knowledge and awareness of a behaviour is not sufficient in itself, and requires 
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the integration of motivational and skills elements to ensure behaviour change.  
In essence, an individual who is well-informed relevant to the target health 
behaviour, personally and socially motivated to perform the behaviour, and who 
has the appropriate behavioural skills, will be more likely to initiate and maintain 
the target health behaviour (Fisher, Fisher, & Harman, 2003).   
 
 
 
 
 
Figure 3: Information-Motivation-Behavioural skills model 
Use of the IMB model in behaviour change research requires 
identification of behavioural determinants in each of the three key areas, which 
can then be targeted in a subsequent intervention.  The model can be used as 
the foundation for quantitative surveys, with items based on each of the three 
categories.  
Increasingly used with chronic conditions, the IMB has been validated in a 
model of diabetes self-care behaviours (Osborn & Egede, 2010) and medication 
adherence (Mayberry & Osborn, 2014). Of particular interest to this program of 
PhD research is that greater diabetes knowledge, and higher personal and social 
motivation was associated with performing diabetes self-care behaviours in a 
sample of 130 adults with T2D from a US medical clinic (Osborn & Egede, 2010).  
Unfortunately, the lack of consideration of behavioural skills in the study limits 
our understanding of the application of the IMB model in a diabetes context.  
More recently, Mayberry & Osborn (2014) demonstrated that IMB elements 
Motivation 
Behavioural 
Skills 
Behaviour 
Information 
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explained 41% of the variance in diabetes medication adherence, identifying 
modifiable determinants for future interventions. 
IMB studies among young adults have identified determinants of the 
uptake of sexual health and screening behaviours such as human papillomavirus 
vaccination (Perez, Cruess, & Strauss, 2016), HIV self-testing (Brown, Carballo-
Diéguez, John, & Schnall, 2016), condom use (Camilleri, Kohut, & Fisher, 2015), 
and breast cancer screening (Wells, Shon, McGowan, & James, 2017).  
Considering that studies focussing on correlates to health promoting behaviours 
for young people have found that knowledge is a weaker correlate than social 
cognitive determinants, such as attitudes, self-efficacy, risk perception and 
intentions (Abraham, Krahe, Dominic, & Fritsche, 2002; Bengel, Belz-merk, & 
Farin, 1996; DiClemente, 1991), identification of motivational and skill factors are 
an important issue for the priority population (Browne et al., 2013a), and an 
important element for this program of PhD research. 
2.4.2 Guidance for health behaviour change intervention 
development, implementation, and reporting. In response to 
acknowledged deficiencies in descriptions of existing health behaviour change 
interventions and evaluations, guidance has been published on ‘best practice’ 
development, piloting, implementation, and standardised reporting.  For 
example, Davidson et al. (2003) augmented the CONsolidated Standards of 
Reporting Trials (CONSORT) statement to include consideration of components 
unique to behavioural medicine research and, similarly, the TREND group 
published guidelines for Transparent Reporting of Evaluations with Non-
randomised designs (Des Jarlais, Lyles, Crepaz, & Group, 2004).  Both initiatives 
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were supported by scientific reporting guidance for authors (Hoffmann et al., 
2014) and journal editors (Albrecht, Archibald, Arseneau, & Scott, 2013) 
developed by consensus by expert workgroups formed in response to an 
identified need. 
More broadly, Craig et al. (2008) updated UK Medical Research Council 
(MRC) guidance on developing and evaluating complex health behaviour change 
interventions, outlining core intervention processes and components.  These 
include: use of good quality evidence from a range of sources, use of 
psychological theory to identify modifiable behavioural determinants and to 
select appropriate BCT; use of causal modelling to understand the pathways 
between the behavioural determinants, the intervention and the desired 
outcome; and selection of evaluation design appropriate to priority population 
characteristics and context.  
Health behaviour change intervention development theory and practice 
have also advanced with regard to classification of intervention content and 
utilisation of systematic frameworks to identify and target underlying 
psychological mechanisms of a specific health behaviours. 
2.4.2.1 Classification of intervention content: establishing a common 
language. A welcome advance in the health behaviour change field,  
which addresses some of the limitations noted in Section 2.4.1, was the 
development of a 26-item classification system or behaviour change taxonomy, 
providing standardised descriptions of intervention content. Twenty-six theory-
based behaviour change techniques (BCT) used in health behaviour change 
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interventions were identified, synthesised from six SCM and theoretical 
frameworks (Abraham & Michie, 2008).  
In their influential work, the authors argued that use of commonly 
defined, theory-linked BCTs in future interventions would establish a common 
language and understanding of intervention content, providing opportunity for 
comparison across interventions, behavioural domains and research teams, as 
well as enhancing effectiveness and intervention fidelity. Since publication, the 
taxonomy has been used widely in intervention design, reporting, and evidence 
synthesis (Michie et al., 2011a).  However, as noted by the authors, the original 
26-item taxonomy was not exhaustive and since then, behaviour-specific BCT 
taxonomies (e.g. smoking cessation and physical activity; Michie et al., 2011b; 
Michie, Hyder, Walia, & West, 2011c) and a cross-behaviour 93-item taxonomy of 
BCT have been developed, expanding scope and application (Michie et al., 2013).  
Shared classification of content via theory-based BCTs (including for 
interventions to increase attendance for DR screening, Lawrenson et al., 2016), 
are fundamental to the science of health behaviour change, and prospective 
inclusion of BCTs are recommended for diabetes-related interventions (Presseau 
et al., 2015). However it must be noted that the development of BCT taxonomies 
are is still evolving, with a recent analysis of 40 published interventions reporting 
that 80 of the 93 BCTs were identified in each intervention, suggesting that, in 
the interest of parsimony, further refinement of the 80 frequently observed BCTs 
was warranted (Abraham et al., 2015).   
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2.4.2.2 Intervention Mapping: a systematic framework for health 
behaviour change intervention development. Encompassing the MRC  
elements noted above, Bartholomew and colleagues (1998; 2001) developed a 
formal, systematic process for building interventions known as Intervention 
Mapping (IM), to assist program developers to apply ‘best practice’ guidance to 
the development of real-world health behaviour change problems. Using this 
framework, program developers were encouraged to adopt a problem-solving 
approach, using a theory-informed, in-depth needs assessment to explore 
underlying behavioural determinants specific to the problem, population and 
context, to be systematically targeted in an intervention tailored to the 
characteristics and context of the priority population (Bartholomew Eldredge et 
al., 2016).  In order to ensure that a wide range of change mechanisms were 
considered, program developers using IM were advised to draw upon a range of 
theoretical constructs in preference to utilisation of a specific SCM; an approach 
recommended by leading scholars (Abraham, 2015; Davis, Campbell, Hildon, 
Hobbs, & Michie, 2015), with the challenge being to find “the best theory or 
combination of theoretical constructs” to address the problem at hand 
(Bartholomew Eldredge et al., 2016). 
The IM framework comprises six iterative steps (Figure 4). Core activities 
in Step 1 include the formation of a multidisciplinary project planning team, 
detailed needs assessment to explore and identify individual-level behavioural 
(e.g. attitudes, knowledge, self-efficacy, cultural beliefs) and environmental 
determinants, development of a causal logic model of the problem depicting the 
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proposed relationship between problem and determinants, and clear statement 
of program goals.    
In Step 2, the program planner specifies expected outcomes and 
Performance Objectives for the desired behaviour, develops a causal logic model 
of change depicting the proposed relationship between the determinants, the 
change methods and desired outcome, and constructs matrices of Change 
Objectives (CO) comprising determinants (columns) and Performance Objectives 
(PO, rows). Step 3 involves all aspects of program design, including development 
of program themes and components in collaboration with members of the 
priority population, selection of theory and evidence-based change methods and 
selection of practical intervention delivery application. Step 4 focuses on 
program production, including planning and drafting all content, pre-testing and 
refinement of the program with broad stakeholder input.  Planning and design 
for program implementation is conducted in Step 5, starting with program 
adoption, planning for implementation and ensuring program maintenance. 
Finally, the program is evaluated in Step 6, including assessment of program 
fidelity, outcome, process and economic evaluation.  
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 Step 1: Logic 
model of the 
problem 
 
 Establish and work with a planning group 
 Conduct a needs assessment to create a 
logic model of the problem  
 Describe context for the intervention 
including the population, setting, and 
community 
 State program goals 
 Step 2: Program 
outcomes and 
objectives; logic 
model of change 
 State expected outcomes for behaviour 
and environment 
 Specify Performance Objectives for 
behavioural and environmental outcomes 
 Select determinants for behavioural and 
environmental outcomes  
 Construct matrices of Change Objectives 
 Create logic model of change  
 Step 3: Program 
design 
 
 Generate program themes, components, 
scope and sequence 
 Choose theory- and evidence-based 
change methods 
 Select or design practical applications to 
deliver change methods 
 Step 4: Program 
production 
 Refine program structure and organisation 
 Prepare plans for program materials 
 Draft message, materials and protocols 
 Pre-test, refine and produce materials 
 Step 5: Program 
implementation 
plan 
 Identify potential program users 
(implementers, adopters and maintainers) 
 State outcomes and Performance 
Objectives for program use 
 Construct matrices of Change Objectives 
for program use 
 Design implementation interventions 
  Step 6: Evaluation 
plan 
 Write effect and process evaluation 
questions 
 Develop indicators and measures for 
assessment 
 Specify the evaluation design 
 Complete evaluation plan 
    www.interventionmapping.com 
Figure 4: The six steps of Intervention Mapping   
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
104 
 
Intervention mapping has been used widely to guide the development of 
health behaviour change interventions at the patient/population, 
practitioner/provider and healthcare system levels, in a variety of contexts and 
with a range of populations (Bartholomew Eldredge et al, 2016).  A core IM 
process cited as a major strength is the involvement of stakeholders (particularly 
the priority population and public involvement), which facilitates production of 
an intervention which is tailored and therefore relevant to the needs and 
characteristics of the priority population (Fernandez et al., 2009; Greaves et al., 
2016; Willems et al., 2017; Wolfers, de Zwart, & Kok, 2012).  This feature of IM is 
particularly important to this program of PhD research, as a recent meta-analytic 
review of text-based health behaviour change interventions, demonstrated that 
(in comparison to control conditions) tailored interventions, which match 
content to previously identified theoretically-grounded determinants from a 
behaviour change theory or model, have a greater impact on the target health 
behaviour (Noar, Benac, & Harris, 2007).   
Previous IM-based interventions promoting screening uptake at the 
patient/population level have focussed on: breast and cervical cancer (Byrd et al., 
2012; Fernandez, Gonzales, Tortolero-Luna, Partida, & Bartholomew, 2005; 
Highfield et al., 2015; Hou, Fernandez, Baumler, & Parcel, 2002; Vernon et al., 
2008), colorectal cancer (Vernon et al., 2011), hepatitis B (Van Der Veen, Van 
Empelen, & Richardus, 2012) and utilisation of sexual health service by young 
people (Newby et al., 2017; Theunissen et al., 2013; Wolfers et al., 2012).  
Although IM is a widely-used, positive advance in the development of 
health behaviour change interventions and the multitude of studies using the 
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framework appears to endorse its utility, the framework has been critiqued for a 
lack of guidance on how to apply BCT and behaviour change methods for 
complex interventions in a coherent format (Lloyd, Logan, Greaves, & Wyatt, 
2011).  In addition, there exist a number of limitations to formulation of 
evidence-based conclusions of the overall effectiveness.  
The first is lack of published evidence of the effectiveness of IM-based 
interventions.  This was highlighted in a recent systematic review of evaluation 
trials of IM-based disease prevention interventions, which identified 168 IM-
based studies describing the development of health promotion or disease 
prevention interventions, but only 22 studies evaluating such interventions 
(Garba & Gadanya, 2017).  
The second limitation is poor quality of reporting of existing evaluation 
studies.  Although each of the 22 studies successfully identified determinants of 
the uptake of the target behaviours, only five compared the IM-based program 
to control groups, with each reporting statistically significant increases in 
percentage uptake of the target disease prevention behaviour, including for 
screening (range: 9%-28%, p≤0.005; Garba & Gadanya, 2017).  However, of the 
five noted above, an effect size was reported in just one study (Looijmans-van 
den Akker et al., 2010), impeding interpretation and comparison.  
Using a combination of two objective quality assessment tools, Garba and 
Gadanya (2017) rated 15 of the 22 studies as being of low methodological 
quality, observing that the majority did not report study design, data collection 
methods or statistical analysis; essential components of health behaviour change 
reports, noted earlier.  Both barriers highlight a need for further development of 
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Step 6 of the IM framework, to include more explicit guidance for program users, 
and greater emphasis that intervention evaluation findings should be 
disseminated to the wider community irrespective of outcome, to contribute to 
IM knowledge base.  More broadly, an additional issue which could not be ruled 
out by Garba and Gadanya (2017) was potential for publication bias, where 
manuscripts with null findings are less likely to be accepted for publication in 
preference to those with positive results (Jadad & Enkin, 2008) impacting the 
number of IM evaluations published. 
Overall, IM provides an important and necessary bridge between 
intervention development theory and real-world practice, evidenced by the wide 
adoption of the framework in a multitude of contexts.  Despite the evidence base 
being limited by lack of published evaluations and inconsistent quality of 
reporting, Garba and Gadanya (2017), conclude that IM-based studies are 
successful in identifying modifiable behavioural determinants and increasing 
uptake of disease prevention interventions, including screening behaviours, thus 
supporting the use of the IM framework in this program of PhD research.  
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2.5 Conclusion 
In conclusion, DR is detectable via screening and effective treatments are 
available to slow its progression. Although lack of knowledge is a key retinal 
screening barrier, it does not fully explain low screening rates because most 
people living with diabetes know of a connection between diabetes and vision 
loss, and that eyes should be examined.   
In the absence of DR symptoms, social cognitive factors such as attitudes, 
beliefs and self-efficacy, play an important role in motivating retinal screening 
and as such, a psychosocial approach is warranted. For example, the belief by 
young adults that eye examinations are only necessary for older people, or if 
symptoms are present (Shickle et al., 2014), and lack of age-appropriate diabetes 
education programs or resources identified in earlier studies (Browne et al., 
2013a), are likely to be prominent factors.  
To date however, paucity of research into the modifiable factors 
impacting retinal screening for young adults with T2D impedes the development 
of age-appropriate and evidence-based intervention materials which target 
determinants to screening behaviour.  No qualitative studies have explored the 
nature of barriers or other factors contributing to low retinal screening rates 
among young adults with T2D, nor are there any retinal screening promotion 
interventions tailored to this priority population. 
This literature review has drawn on existing evidence to demonstrate a 
theoretical understanding of the psychosocial determinants likely to impact 
retinal screening behaviour for young adults. A broad range of interventions are 
effective in promoting DR screening among adults with diabetes, including text-
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based materials (such as leaflets and reminders), although their effectiveness has 
been limited.  In contrast to current ‘best practice’, the content of earlier text-
based intervention materials was generally didactic in nature, focussed primarily 
on mitigating lack of knowledge or awareness of DR.  The absence of 
theoretically-derived, evidence-based persuasive messages, tailored to the 
contextual characteristics of the target group, may explain the limited 
effectiveness of earlier retinal screening interventions and lack of sustained 
impact.  
Despite demonstrated low DR screening uptake, vulnerability to DR and 
disengagement with current diabetes services, and suboptimal health outcomes 
among young adults with T2D, there is a paucity of research exploring the factors 
impacting screening in this priority population, and no evidence-based 
interventions tailored specifically to their unmet needs.  IM offers a suitable 
framework for development of a theoretically-grounded and evidence-based 
retinal screening intervention tailored to this priority population.    
A vital first step in this process involves exploring and identifying 
individual-level barriers and facilitators, and modifiable behavioural 
determinants to screening behaviour for this priority population. The IMB model 
offers a suitable foundation upon which to base elicitation of DR screening 
determinants, enabling an evidence-based understanding of behaviour change, 
through which theory-based BCT can be matched to the identified mechanisms. 
Using the IM approach, intervention resources can be developed with the 
involvement of key stakeholders, including members of the priority population.   
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2.7 Additional file 1: Literature Search Strategy and Summary of Findings 
Population, Intervention, Control and Outcome.(PICO)  
 Population: all adults with diabetes who were eligible for screening but were 
either overdue (i.e. ‘lapsed’) or who had not initiated screening.  Exclusion 
criteria: pediatric (<18 years)  
 Intervention: all interventions designed to promote retinal screening. 
Studies were included if they were randomised controlled trials (RCTs), or 
non-randomised trials, of interventions. Cohort, observational, survey and 
qualitative studies were excluded.  
 Control or comparison groups: classified as those who did not receive the 
intervention. 
 Outcome: retinal screen for DR within a specified time frame. 
Search strategy 
1. Search terms were derived from Lawrenson et al. (2016) and Zhang et al. 
(2007), see Table 2 below. 
2. Scoping of the PsychINFO database (via EBSCOHOST) found that 300 of the 
309 papers were not relevant.  
3. Search terms were refined, adding additional keyword limiters, and the 
search was repeated. As search terms were identifying RCTs of DR screening 
interventions, the search was repeated with key databases and double-
checked results via Scopus and personal Endnote library (see Table 3 below). 
4. Titles and abstracts (published in peer-reviewed journals in the English 
language from January 2005 to August 2017) were screened in relation to the 
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inclusion/exclusion criteria above, and full text retrieved for all potentially 
relevant studies.  
5. Of the 28 abstracts screened, nine patient-level interventions were included 
in the review Table 1 (Section 2.3.1); reference lists were scanned for 
additional studies not identified in the search.   
Table 2:  Literature search terms 
Concepts Search terms 
1: the condition “diabetic 
retinopathy” 
“eye 
health” 
vision ophthalmic 
2: the behaviour screen* exam* behaviour* behavior* 
3: the method intervention tailor* target* program* 
4: the outcome uptake compliance utili?at* adherence 
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Summary of Findings 
Table 3: Databases, literature search terms, and returned abstracts 
Database Limiters Abstracts^ 
Psychinfo via 
EBSCOHOST 
"diabetic retinopathy" OR "diabetic retinopathy 
screening" OR eye OR vision 
screen or screening or test OR exam* 
intervention or program* or strategy 
uptake OR attend* OR utili?at* OR promot* 
9/309 
 
Medline 
complete via 
EBSCOHOST 
“diabetic retinopathy” OR “eye health” OR vision 
OR ophthal* 
screen* or exam* or behavio?r* 
intervention or tailor* or target* or program* 
uptake or compliance or utili?at* or adherence 
14/198 
CINAHL via 
EBSCOHOST 
“diabetic retinopathy” OR “eye health” OR vision 
OR ophthal* 
screen* or exam* or behavio?r* 
intervention or tailor* or target* or program* 
uptake or compliance or utili?at* or adherence 
2/47 
Embase “diabetic retinopathy” OR “eye health” OR vision 
OR ophthal* 
screen* or exam* or behavio?r* 
intervention or tailor* or target* or program* 
uptake or compliance or utili?at* or adherence 
4/78 
Scopus* ("diabetic retinopathy") AND (screen* or exam*) 
and (intervention or program*) and (uptake or 
compliance or utili?at* or adherence) ABSTRACT 
ONLY 
1/39 
Scopus Added in ‘evaluation’ 0/50 
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CHAPTER 3. What Factors Influence Uptake of Retinal Screening Among 
Young Adults with type 2 Diabetes? A Qualitative Study Informed By the 
Theoretical Domains Framework8.  
                                                     
8 This manuscript was published in Journal of Diabetes and its Complications, 31: 997-
1006. The chapter has been formatted in APA style, to maintain consistency of structure 
and referencing throughout the thesis. Text content is identical to the published 
manuscript. 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
149 
 
3.1  Authorship statement  
1.  Details of publication and executive author 
Title of Publication Publication details 
What factors influence uptake of retinal screening 
among young adults with type 2 diabetes? A 
qualitative study informed by the Theoretical 
Domains Framework. 
Journal of Diabetes and its 
Complications, 31 (6): 
997-1006. 
Name of executive 
author 
School/Institute/Division 
if based at Deakin; 
Organisation and 
address if non-Deakin 
Email or phone 
Amelia J. Lake Australian Centre for 
Behavioural Research in 
Diabetes; School of 
Psychology 
alake@acbrd.org.au 
 
2. Inclusion of publication in a thesis 
Is it intended to include this publication in 
a higher degree by research (HDR) thesis? 
Yes 
 
If Yes, please complete 
Section 3. If No, go straight 
to Section 4. 
3.  HDR thesis author’s declaration 
Name of HDR thesis 
author if different from 
above. (If the same, 
write “as above”) 
School/Institute/Division if 
based at Deakin 
Thesis title 
As above 
 
Australian Centre for 
Behavioural Research in 
Diabetes; School of 
Psychology 
Reducing risk of vision 
loss for young adults with 
type 2 diabetes  
If there are multiple authors, give a full description of HDR thesis author’s 
contribution to the publication (for example, how much did you contribute to 
the conception of the project, the design of methodology or experimental 
protocol, data collection, analysis, drafting the manuscript, revising it critically 
for important intellectual content, etc.) 
The thesis author managed the study, including contributing to the study 
methodology, design and development of the interview guide, planning and 
coordination of participant recruitment, ethics application, conduct of the 
interview guide validation activity and conduct of all participant interviews (data 
collection).  The thesis author led the process of quality checking transcripts, 
data analysis and interpretation, including determination of coding themes and 
data coding (NVivo).  The thesis author prepared the first and subsequent drafts 
of the manuscript 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
150 
 
I declare that the above is an accurate 
description of my contribution to this 
paper, and the contributions of other 
authors are as described below. 
Signature 
and date: 
  
20 November 2017 
 
4.  Description of all author contributions 
Name and affiliation of author  Contribution(s) (for example, conception of 
the project, design of methodology or 
experimental protocol, data collection, 
analysis, drafting the manuscript, revising it 
critically for important intellectual content, 
etc.) 
Dr. Jessica L. Browne  
School of Psychology, Deakin 
University, Geelong, VIC 
Australia; The Australian Centre 
for Behavioural Research in 
Diabetes, Diabetes Victoria, 
Melbourne, VIC Australia 
Provided substantial input into the study 
methodology, design and development of 
interview guide.  
Substantial input into collaboratively 
reviewing coding decisions and 
determination of initial coding themes, data 
analysis and interpretation. Provided 
substantial intellectual input through 
reviewing the first and subsequent drafts of 
the manuscript. 
Dr. Gwyneth Rees 
Centre for Eye Research 
Australia, Royal Victorian Eye and 
Ear Hospital, Melbourne, VIC 
Australia; Ophthalmology, 
Department of Surgery, 
University of Melbourne, 
Melbourne, VIC Australia 
Provided substantial input into the study 
methodology, design and development of 
interview guide, including introduction to 
the theoretical domains framework 
Professor Jane Speight 
School of Psychology, Deakin 
University, Geelong, VIC 
Australia; The Australian Centre 
for Behavioural Research in 
Diabetes, Diabetes Victoria, 
Melbourne, VIC Australia; AHP 
Research, Hornchurch, UK 
Provided substantial input into the study 
methodology, design and development of 
interview guide. Substantial input into 
determination of coding themes, data 
analysis and interpretation. Provided 
substantial intellectual input through 
reviewing the first and subsequent drafts of 
the manuscript. 
 
 
 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
151 
 
5.  Author Declarations 
I agree to be named as one of the authors of this work, and confirm:  
i. that I have met the authorship criteria set out in the Deakin University Research 
Conduct Policy, 
ii. that there are no other authors according to these criteria, 
iii. that the description in Section 4 of my contribution(s) to this publication is accurate,  
iv. that the data on which these findings are based are stored as set out in Section 7 
below. 
v. If this work is to form part of an HDR thesis as described in Sections 2 and 3, I further 
consent to the incorporation of the publication into the candidate’s HDR thesis 
submitted to Deakin University and, if the higher degree is awarded, the subsequent 
publication of the thesis by the university (subject to relevant Copyright provisions).   
Name of author Signature* Date 
Dr. Jessica L. Browne  
 
23 October 2017 
Dr. Gwyneth Rees 
 
19 October 2017 
Professor Jane Speight 
 
19 October 2017 
6.  Other contributor declarations 
I agree to be named as a non-author contributor to this work. 
Name and affiliation of 
contributor 
Contribution Signature* and 
date 
 
Not applicable 
  
* If an author or contributor is unavailable or otherwise unable to sign the 
statement of authorship, the Head of Academic Unit may sign on their behalf, 
noting the reason for their unavailability, provided there is no evidence to 
suggest that the person would object to being named as author. 
7.  Data storage 
The original data for this project are stored in the following locations. (The 
locations must be within an appropriate institutional setting. If the executive 
author is a Deakin staff member and data are stored outside Deakin University, 
permission for this must be given by the Head of Academic Unit within which the 
executive author is based.) 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
152 
 
Data format Storage Location Date lodged Name of custodian 
if other than the 
executive author 
Data files 
are stored in 
electronic 
format 
Deakin University secure 
network 
N/A Professor Jane 
Speight 
Paper copies 
of consent 
forms 
The Australian Centre for 
Behavioural Research in 
Diabetes, Melbourne, VIC 
N/A Professor Jane 
Speight 
If the publication is to be included as part of an HDR thesis, a copy of this form 
must be included in the thesis with the publication. 
 
 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
153 
 
3.2 Abstract 
Aims: Young adults with type 2 diabetes (T2D, 18-39 years) face increased 
risk of vision loss from diabetic retinopathy (DR).  Retinal screening is essential to 
detect DR, yet screening rates for this group are low and little is known about the 
underlying factors influencing this important behaviour. Using the Theoretical 
Domains Framework (TDF) to guide data collection and analysis, we explored 
screening barriers and facilitators, contrasting them with a comparator group of 
older adults with T2D (40+ years). Methods: Thirty semi-structured telephone 
interviews (10 younger, 20 older adults) were conducted. Data were coded into 
TDF domains with salience identified by “frequency” of reference. Screening 
facilitators and barriers were systematically compared between groups. Results: 
Although many screening facilitators and barriers were shared by younger and 
older adults, additional factors highly relevant to the former included: social 
comparison with others (‘social influences’); concern for the impact on the family 
unit, unrealistic optimism and perceived invulnerability (‘beliefs about 
consequences’); lack of time and financial resources (‘environmental context and 
resources’), and DR misconceptions (‘knowledge’). Conclusions: This study 
demonstrated that young adult retinal screening behaviour was influenced by 
additional social cognitive factors compared to older adults, providing a first-step 
evidence base for clinicians and other health professionals, and potential targets 
for future eye health and retinal screening interventions.  
Keywords: type 2 diabetes, diabetic retinopathy, theoretical domains framework, 
qualitative research, young adults. 
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3.3 Introduction 
Prevalence of young-onset type 2 diabetes (T2D), defined as a diagnosis 
before 40 years of age, is increasing worldwide, predisposing individuals to 
significant complication burden by the time they reach mid-life (Yeung et al., 
2014). One such complication is diabetic retinopathy (DR), a leading cause of 
vision loss and blindness in working-age adults (Fong et al., 2004).  
Retinal screening (henceforth ‘screening’) is key to the early detection of 
asymptomatic DR, with timely treatment significantly reducing risk of vision loss 
and blindness (Klein & Klein, 1997). Australian National guidelines recommend 
initiation of screening at diabetes diagnosis, and at least every two years 
thereafter, more often for those at higher risk (Mitchell & Foran, 2008).  
Screening usually involves dilation of pupils with mydriasis drops, and slit lamp 
biomicroscopy or ophthalmoscope to detect presence and severity of DR. It is 
conducted by an optometrist or ophthalmologist in community settings, takes 
about 20 min and costs the individual about AUD$30.  
Despite clear health benefits, some people with diabetes do not engage 
in screening. Common screening barriers for the general T2D population include 
lack of knowledge (e.g. DR, symptoms, confusion between screening and 
standard eye check), and practical obstacles (e.g. cost, time, access), (Al-Alawi, 
Al-Hassan, Chauhan, Al-Futais, & Khandekar, 2016; Ellish, Royak-Schaler, 
Passmore, & Higginbotham, 2007; Hartnett, Key, Loyacano, Horswell, & DeSalvo, 
2005; Hipwell et al., 2014; John, Cooper, & Serrant-Green, 2014; Lewis, Patel, 
Yorston, & Charteris, 2007). Despite recognition of the crucial role that 
psychosocial factors play in diabetes self-management activities (Peyrot et al., 
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2005), few studies have focussed specifically on exploring in-depth their impact 
on screening behaviour. Those that have, report that key barriers include lowered 
perception of risk, fear of outcome, and guilt with regard to suboptimal blood 
glucose management (Al-Alawi et al., 2016; Hipwell et al., 2014; Lewis et al., 
2007).   
Similarly, despite their value in promoting DR screening behaviour, few 
studies have specifically explored facilitating factors, beyond the assumption that 
they are the opposite of identified barriers.  Those that have, report common 
screening facilitators as knowledge of DR, recommendation by GP, and social 
support (Ellish et al., 2007; Hartnett et al., 2005; John et al., 2014).  Notably, the 
average age of participants with T2D in the above studies (where reported) was 
60 years and most studies did not distinguish between diabetes types.   
Although data are sparse, screening rates for young adults are low, 
despite high risk of early-onset and rapid progression of DR (Hanman et al., 2014; 
Li et al., 2015; Rajalakshmi et al., 2014; Song & Gray, 2011; Tryggestad & Willi, 
2015).  In Australia, a small survey of 16-35 year olds with T2D (average age 29 
years) reported a 55% screening rate (Diabetes Australia, 2006), while a larger, 
population-based study conducted at a similar time reported that 77% of adults 
with T2D (average age 64 years) had engaged in retinal screening in the past two 
years (Tapp et al., 2004).   
Young adults with T2D differ clinically, physiologically and psychosocially 
from older adults with T2D, and young adults with T1D (Browne, Nefs, Pouwer, & 
Speight, 2014; Gregg, Sattar, & Ali, 2016; Song, 2012).  Previous research has 
established that young adults with T2D face unique barriers to diabetes self-
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management, report dissatisfaction and disengagement with existing diabetes 
support programmes and services, and have specific unmet psychosocial and 
information needs (Browne, Scibilia, & Speight, 2013; Savage, Dabkowski, & 
Dunning, 2009).  Despite increasing calls for concerted and targeted intervention 
to reduce the risk of long-term complications (Amutha & Mohan, 2016; 
Benhalima et al., 2011; Browne et al., 2014; Li et al., 2015; MacLennan, McGwin, 
Heckemeyer, & et al., 2014; Tryggestad & Willi, 2015; Wilmot & Idris, 2014), no 
studies, to our knowledge, have focussed specifically on the facilitators and 
barriers influencing screening behaviour in young adults with T2D.   
Facilitators of, and barriers to, screening behaviour can be identified 
systematically using the Theoretical Domains Framework (TDF, Table 4).  
Focusing on individual-level determinants, the TDF comprises fourteen domains, 
derived from 33 behaviour change theories and 128 theoretical constructs (Cane, 
O'Connor, & Michie, 2012). Each domain comprises multiple, related but distinct 
component constructs. For example, the TDF domain ‘knowledge’ (defined as ‘an 
awareness of the existence of something’), comprises ‘knowledge of condition’, 
‘scientific rationale’, and ‘procedural knowledge’. Participant information 
captured for this domain would include knowledge of DR risk factors, an 
understanding of the reasons for screening, and how to arrange the procedure. 
See Table 4 for definitions of each TDF domain and component constructs 
associated with the target behaviour. 
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Table 4: Definition of TDF domains and component constructs associated with retinal screening behaviour 
TDF domain and definition 
Component constructs and additional behaviour specific beliefs used in 
coding framework 
Knowledge: Awareness of the existence of something   Knowledge, procedural knowledge: Absence/presence of knowledge of: 
connection between diabetes and eye health, DR prevention activities 
and risk factors, DR symptoms, rationale for screening. Eye health 
misconceptions. When to initiation screening, and relevant intervals. 
Skills: Ability or proficiency acquired through practice Skills, competence: Ability to attend screening (including viewing 
screening as 'routine'). 
Social professional role and identity: A coherent set of 
behaviours and displayed personal qualities of an 
individual in a social or work setting 
Social and group identity: How the individual views screening behaviour 
relative to their identity (e.g. What kind of person has eye exams?).  
Beliefs about capabilities: Acceptance of the truth/reality 
about or validity of an ability, talent or facility that a 
person can put to constructive use 
Self-confidence, perceived competence, perceived behavioural control, 
self-efficacy: The extent to which the individual believes they are able to 
influence their eye health and attend screening. 
Optimism: Confidence that things will happen for the 
best or that desired goals will be attained 
Optimism, pessimism, unrealistic optimism: regarding susceptibility to 
DR or vision loss 
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Table 4: Definition of TDF domains and component constructs associated with retinal screening behaviour (Cont.) 
TDF domain and definition 
Component constructs and additional behaviour specific beliefs used in 
coding framework 
Beliefs about consequences: Acceptance of the 
truth/reality about or validity of outcomes of a behaviour 
in a given situation 
Beliefs, outcome expectancies, consequents: Emotional expressions of 
regret or concern about the consequences of not attending screening or 
of vision loss.  Beliefs regarding utility, effectiveness or value of 
screening.  Anticipated outcomes of not participating in screening; 
anticipated or experienced outcomes of screening (positive or negative). 
 
Reinforcement: Increasing the probability of a response 
by arranging a dependent relationship, or contingency, 
between the response and a given stimulus 
Reinforcement, consequents: Screening to avoid or remove negative 
outcomes, screening to gain positive outcome.  
Intentions: Conscious decisions to perform a behaviour or 
a resolve to act in a certain way 
 
Stability of intentions, statement of intention: to engage in or maintain 
screening (or otherwise). 
Goals: Mental representations of outcomes or end states 
that an individual wants to achieve 
 
Goal priority, goals: for eye health and preservation of vision. 
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Table 4: Definition of TDF domains and component constructs associated with retinal screening behaviour (Cont.) 
TDF domain and definition 
Component constructs and additional behaviour specific beliefs used in 
coding framework 
Memory attention decision processes: Ability to retain 
information, focus selectively on aspects of the 
environment and choose between two or more 
alternatives 
Memory, attention control, decision making, cognitive overload: The 
role of memory and act of remembering to ensure that screening is done 
(cognitive component only; behavioural component is linked to Action 
Planning).  Feelings of being overwhelmed by diabetes 
diagnosis/management or life stresses (which may limit attention control 
with respect to screening behaviour). 
Environmental context and resources: Any circumstance 
of a person’s situation or environment that discourages or 
encourages the development of skills and abilities, 
independence, social competence, and adaptive 
behaviour  
Environmental stressors, resources, salient events, and person x 
environment interaction: Environmental constructs include stressors 
such as cost, lack of time, illness and the experience of mydriasis.  
Facilitators may include ease and accessibility of screening. 
 
Social influences: Interpersonal processes that can cause 
individuals to change their thoughts, feelings or behaviors 
Social pressure, social norms, social comparison, social support: Belief 
in authority of healthcare professionals; experience of professional and 
personal influence (including clinical inertia), experience of social 
support (positive or negative) 
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Table 4: Definition of TDF domains and component constructs associated with retinal screening behaviour (Cont.) 
TDF domain and definition 
Component constructs and additional behaviour specific beliefs used in 
coding framework 
Emotion: A complex reaction pattern, involving 
experiential, behavioural and physiological elements, by 
which the individual attempts to deal with a personally 
significant matter or event 
 
Positive/negative affect, fear, anxiety, stress: Negative emotions may 
include expressions of fear, anxiety or sadness at the prospect of vision 
loss/DR diagnosis. Positive emotions may include relief/reassurance 
following screening. 
Behavioral regulation: Anything aimed at managing or 
changing objectively observed or measured actions 
Action planning: Steps taken to ensure that screening is remembered 
and conducted (includes absence of planning). 
DR: diabetic retinopathy 
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Predominantly focussed on implementation challenges within healthcare 
systems and/or clinician behaviour, the TDF has been used increasingly to 
understand patient-level uptake of health behaviours (Burgess et al., 2015; Gray-
Burrows et al., 2016) and, even in well-researched areas, has elicited previously 
unidentified psychosocial factors impacting the target behaviour (Dyson, Lawton, 
Jackson, & Cheater, 2011).  A major benefit to using a framework such as the TDF 
is the systematic assessment of health behaviour implementation problems, 
allowing identification of key influencing domains and targets for intervention.   
Thus, the aim of this study was to explore facilitators and barriers 
associated with retinal screening among young adults with T2D.  In order 
determine the relative influence of factors; we systematically compared young 
adults with a parallel group of older adults with T2D (for whom the majority of 
existing management guidelines, services and resources are developed).  
Following this method, we aimed to highlight key differences between the two 
groups, thereby contributing to clinician’s knowledge of the burgeoning young 
adults with T2D population and identifying cohort-specific targets for 
intervention.  
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3.4  Subjects, Materials and Methods 
3.4.1 Study design.Semi-structured telephone interviews were  
conducted using an interview guide developed and validated specifically for this 
study. 
3.4.2 Participants. Younger adults (YA, aged 18-39 years) and older  
adults (OA, aged 40+ years) with T2D were eligible to participate. Exclusion 
criteria were: non-English speaking, other diabetes types (e.g. type 1, 
gestational) and evidence of cognitive impairment. 
In anticipation of YA recruitment challenges (Savage et al., 2009; Turner et 
al., 2015), the study was advertised widely online (diabetes advocacy websites, 
social media, young adult support groups) and in community settings, as well as 
via postal invitations to members of a leading state-based diabetes consumer 
and advocacy organisation.  
During the initial recruitment period, only two YA registered interest, 
necessitating a revision of the incentive (upgraded from a $20 department store 
voucher to a chance to win an iPad Mini) and timeline (extended by an additional 
three months). 
3.4.3 Development and validation of interview guide. A 34-item, semi-
structured interview guide was developed to explore screening facilitators and 
barriers, with items informed by published TDF-based interview guides (Burgess 
et al., 2015; Curran et al., 2013). To ensure that items accurately represented TDF 
domains, an online validation activity was conducted anonymously with 16 
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volunteer clinicians/researchers from health/clinical psychology or health service 
backgrounds.   
Each expert matched randomised items with clearly defined TDF 
domains. Concordance between nominated and intended domains was 
acceptable for 26 of the original 34 items (average 76%). The remaining eight 
items were revised, and five more added in response to reviewer feedback.  The 
final interview guide (Appendix C) comprised 39 TDF-based questions, which 
were ordered to minimise the potential for introducing a knowledge bias to 
subsequent items.  Sample questions for each of the 14 TDF domains are 
presented in Table 5. 
Table 5: Example topic guide items by TDF domain 
Topic guide items 
1. Knowledge: Are you aware of a connection between diabetes and eye health?  
Do you know of anything that a person can do to reduce their risk of getting 
retinopathy, or of slowing its progress?       
2. Skills Can you please describe how you would go about getting an eye 
examination? 
3. Social professional role and identity: What does having eye examinations 
mean to you? (Prompt: what kind of person are they?) 
4. Beliefs about capabilities: One a scale of 0 –10, where 0 is ‘not at all 
confident’ and 10 is ‘very confident’, how confident are you that you can talk to 
your GP or diabetes educator about eye examinations?  What makes it 
easy/hard?  What do you think would help you to overcome these problems? 
5. Optimism: Do you think that you are likely to experience vision problems due 
to diabetes? 
6. Beliefs about consequences: What are the positive benefits to having eye 
exams?  Are there are any negatives or ‘down sides’ to having eye exams? What 
do you expect will happen if you don’t have regular eye examinations? 
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Table 5 : Example topic guide items by TDF domain (Cont.) 
Topic guide items (Cont.) 
7. Reinforcement: (If previous eye exam) Did the experience of having an eye 
examination make it more or less likely that you would have another one in the 
future? 
8. Intentions: Considering your other competing priorities…how likely is it for 
you to have eye examinations when they are next due? What are higher 
priorities and why? 
9. Goals: Considering your other priorities…how important is it for you to 
maintain your current vision? What are higher priorities and why 
10. Memory attention decision processes: Have you ever forgotten, or delayed, 
an eye examination when it was due? Do you know why? 
11. Environmental context and resources: Sometimes our plans are hindered by 
things outside of our control. What things, outside of your control, could make it 
harder for you to have regular eye exams? What things could make it easier? 
12. Social influences: Have you been prompted by someone to have an eye 
examination? If Y, who? Has anyone you know had an eye examination for DR? 
13. Emotion: Can you please imagine/think back to when you are having an eye 
examination, what thoughts or feelings would you/did you, have?   
14. Behavioural regulation: Eye examinations don’t have to be done as often as 
other diabetes self-care tasks.  If you want to have an eye examination, how do 
you think you will remember/remind yourself)?        
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3.4.4 Procedure. Semi-structured telephone interviews were conducted 
by an experienced interviewer with post-graduate training in health psychology 
(AL), (average length: 55 min, range: 31-106 min).  All interviews were recorded, 
professionally transcribed, and de-identified.  Demographic data were collected 
to describe the sample. 
3.4.5 Data handling and analysis 
3.4.5.1  Development of coding framework.As young adults with T2D are 
a sub-group of adults with T2D, we anticipated that differences between young 
adults and their older adult counterparts were likely to emerge at a component 
construct level, rather than a domain level. A coding framework was developed 
deductively by AL and JB, using the TDF domains and all component constructs as 
the foundation.  Some of the component constructs were subsequently excluded 
because they were irrelevant, not evident in the data, or overlapped closely with 
similar constructs. For example, ‘knowledge of task environment’ and 
‘procedural knowledge’ (both component constructs within the ‘knowledge’ 
domain) were indiscernible in the data and so the former was collapsed into the 
latter code.  At this point, we found that the component constructs within some 
domains did not adequately provide the level of detail required to facilitate 
interpretation of our data, particularly when comparing young adults with T2D 
with their older adult counterparts. In these instances, we followed the example 
of other TDF-based studies and inductively generated additional sub-theme 
labels, which represented a belief statement specific to the target behaviour 
(Birken, Presseau, Ellis, Gerstel, & Mayer, 2014; Newlands et al., 2016).  Using 
‘Knowledge’ as an example, an additional sub-theme was ‘misconceptions about 
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eye health’, which in turn, was a barrier to retinal screening (see Table 4 for 
description of component constructs and behaviour specific sub-themes used in 
coding framework). Once the framework and coding strategy was finalised, AL 
and JB independently coded 20% of transcripts.  Inter-rater agreement was high 
(99.4%) with minor discrepancies resolved through discussion.  The remaining 
transcripts were coded by AL.  
3.4.5.2 Data coding and analysis. The primary coder (AL) conducted 
extensive data familiarisation of interview transcripts and kept notes in a 
reflective diary to ensure a clear overview of the material. All interview 
transcripts were checked for accuracy and imported into NVivo10 (QSR 
International Pty Ltd, Doncaster, VIC., Australia, 2012). Each participant utterance 
was coded for the relevant component construct or theme within a TDF 
domain(s), and again as either ‘facilitator’ or ‘barrier’ dependent upon the 
context in which the participant made the utterance. For example, responses to 
the question “do you know of anything that a person can do to reduce their risk 
of getting retinopathy, or of slowing its progress?” were coded as ‘knowledge of 
condition’ within the TDF ‘Knowledge’ domain.  Correct responses, such as 
“keeping blood sugars under control and definitely having regular eye checks” 
(ID06_OA) were coded as a ‘facilitator’; incorrect description or utterances 
expressing lack of knowledge, such as “No, I don’t know how I can avoid it” 
(ID41_YA), were coded as ‘barrier’.  Further, the same utterances would have 
been coded under a component construct or theme within the ‘Social influence’ 
TDF domain if they made direct reference to the presence (or absence) of 
recommendation from their GP. 
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Using a common approach (Birken et al., 2014; Bussieres et al., 2012), 
TDF domains were judged for relevance based on the relative frequency of 
coding for each TDF domain, which had been aggregated from all component 
constructs and behaviour-specific belief statements within that domain.  TDF 
domains were then rank-ordered according to the relative frequency of coding 
(we interpreted higher frequency of utterance to indicate higher salience).  Data 
analysis was conducted separately for facilitators and barriers and results were 
reported for each group.  As a final step, the facilitators/barriers and those TDF 
domains most frequently coded for each group were systematically compared 
between YA and OA, to identify and contrast those of greatest salience to each 
group. 
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3.5 Results 
3.5.1 Participant characteristics. Forty-nine people (14 YA, 35 OA) 
expressed interest in the study and were screened for eligibility by telephone.  All 
YA were eligible and were mailed study information; 10 YA returned signed 
consent forms, the remaining four could not be contacted.  Of the 10 YA, five 
reported no previous screen, and a sixth was overdue.  Of the 35 OA, two were 
ineligible (one did not have T2D, one showed evidence of cognitive impairment). 
We purposively selected 20 OA to ensure representation in a range of 
demographic factors.  Each was mailed study information and all returned signed 
consent forms.  All of the 20 OA had previously engaged in retinal screening and 
none were overdue.  Participant characteristics are presented in Table 6. 
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Table 6:  Participants’ demographic and self-reported clinical characteristics by age 
group  
Demographic characteristics Young  adults (N=10) Older adults (N=20) 
Age, years  32.6 (32.0-34.8)  62.5 (55.9-72.8) 
Women 5 (50) 10 (50) 
Geographic locationa 
      Major metropolitan 
      Inner regional  
      Outer regional 
 
8 (80) 
2 (20) 
0 (0) 
 
6 (30) 
10 (50) 
4 (20) 
Place of birth 
      Australia                       
      UK 
      Asia (incl India, Sri Lanka) 
      Africa 
 
6 (60) 
0 (0) 
3 (30) 
1 (10) 
 
14 (70) 
6 (30) 
0 (0) 
0 (0) 
Age at diabetes diagnosis, years  30.5 (28.2-32.0)  51.5 (47.5-60.5) 
Duration of diabetes, years  1.45 (0.3-4.5)  13.0 (2.8-15.3) 
Previous retinal screenb 5 (50) 20 (100) 
Diagnosis of diabetic retinopathyb 0 (0) 5 (25) 
Data are median (interquartile range) or number (%),  
a Australian Standard Geographical Classification (ASGC) remoteness index 
b Self-report data 
 
Median age was 33 years for YA and 63 years for OA and median diabetes 
duration was 1.5 and 13 years, respectively.  Gender was distributed equally in 
both groups, although geographic location was not, with 20% OA residing in 
outer regional areas compared to no YA. The majority of YA and OA participants 
were Australian-born.  
3.5.2 Facilitators of and barriers to screening. More than 80% of all 
facilitator references for both YA and OA were captured by the same six TDF 
domains: ‘social influences’, ‘beliefs about consequences’, ‘reinforcement’, 
‘intentions’, ‘emotion’, and ‘knowledge’.  Similarly, more than 80% of all barrier 
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references for YA and OA were accounted for by five domains, the first four of 
which were shared: ‘environmental context and resources’, ‘knowledge’, ‘social 
influences’, and ‘beliefs about consequences’.  The fifth barrier domain was 
cohort-specific: ‘emotion’ for YA, and ‘behavioural regulation’ for OA 
participants. All further description of study results focuses on the above TDF 
domains. 
Overall, each YA and OA participant made a similar number of references 
to screening facilitators (averaging 26 and 29, respectively).  In contrast, YA made 
more references to screening barriers than their OA counterparts (averaging 19 
and 6, respectively).  A summary of facilitator and barrier TDF domains, including 
relative rank and frequency of reference are presented in Table 7. 
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Table 7: Summary of facilitator and barrier TDF domains for younger and older adults 
TDF domain 
Younger adults (N=10) Older adults (N=20) 
Rank 
order 
Freq. of 
utterance 
% of total 
utterance 
Rank 
order 
Freq. of 
utterance 
% of total 
utterance 
Facilitators to retinal screening*  
Social influences 1 58 22 1 114 20 
Belief about conseq. 2 46 18 3 101 18 
Reinforcement 3 34 13 2 109 19 
Intentions  4 28 11 4 62 11 
Emotion 5 27 10 5 45 8 
Knowledge 6 23 9 6 43 7 
Env. context/resources 7 14 5 10 16 3 
Goals 8 9 3 9 17 3 
Belief about capability 9 7 3 11 15 3 
Social professional 
role and identity 9 7 3 12 12 2 
Behaviour regulation 10 3 1 7 24 4 
Skills 10 3 1 8 21 4 
Memory, attention & 
decision making 11 2 1 13 3 1 
Optimism N/A 0 0 14 2 1 
Total  261 100  584 100 
Av. utterance per participant 26  29 
* The TDF domains accounting for the top 80% of all utterances in either the facilitator or barrier 
categories are presented above the double line 
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Table 7: Summary of facilitator and barrier TDF domains for younger and older 
adults (Cont.) 
TDF domain 
Younger adults (N=10) Older adults (N=20) 
Rank 
order 
Freq. of 
utterance 
% of total 
utterance 
Rank 
order 
Freq. of 
utterance 
% of total 
utterance 
Barriers to retinal screening*  
Env. context/resources 1 63 34 1 61 48 
Social Influences 2 28 15 3 13 10 
Knowledge 3 26 14 2 18 14 
Belief about conseq. 4 18 10 4 10 8 
Emotion 5 17 9 7 5 4 
Behaviour regulation 8 7 4 5 8 6 
Belief about capability 6 14 7 8 3 2 
Optimism 7 8 4 9 1 1 
Memory, attention & 
decision making 8 7 4 6 7 6 
Social professional 
role and identity 
N
N/A 0 0 
N
N/A 0 0 
Reinforcement N/A 0 0 N/A 0 0 
Intention N/A 0 0 N/A 0 0 
Goals N/A 0 0 N/A 0 0 
Skills N/A 0 0 N/A 0 0 
Total   188 100  126 100 
Av. utterance per participant 19  6 
* The TDF domains accounting for the top 80% of all utterances in either the facilitator or barrier 
categories are presented above the double line 
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Although YA and OA participants shared the majority of facilitator and 
barrier domains (with slight differences in relative rank), considerable differences 
were observed with respect to component constructs and key beliefs once the 
data were analysed qualitatively; illustrative quotes are presented in Table 8 and 
Table 9 below. 
3.5.2.1 Facilitators 
3.5.2.1.1  Social influences. The influence of others, particularly health 
professionals, was noted as a screening facilitator for both YA and OA.  
Participants indicated that they placed high value on advice from their GP, with a 
common view being “if a GP says get a test, I get a test” (ID38_YA), while others 
screened to “keep my doctor and endocrinologist happy” (ID39_YA).  Individuals 
who were advised by their GP to have an eye examination, or were referred to an 
eye specialist for screening at diagnosis, reported initiating screening in a timely 
manner. Participants also indicated that when it came to screening, they were 
reminded by family members and friends, who were “the ones that care about 
me the most, and want me to be around for as long as possible” (ID36_YA).   
Among YA only, social comparison was a strong facilitator of screening. 
When asked who would influence their uptake of screening, a common response 
was “another diabetic patient who had the same control as myself but had some 
eye problems” (ID33_YA). 
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3.5.2.1.2 Beliefs about consequences The overwhelming belief expressed by YA 
and OA participants was that the benefits of screening, such as early detection of 
DR and feeling reassured, outweighed the negatives.  Description of common 
barriers or disadvantages, such as cost or discomfort due to mydriasis, were 
commonly followed by counteracting views, such as screening is a “wise spend” 
(ID32_YA) and “the stinging is not for long” (ID20_OA). 
Although most participants understood that screening was undertaken 
for the early detection of DR, YA and OA participants expressed optimism that 
there “shouldn’t be any problems with [my] eyesight” (ID33_YA).   
Shared too, were the beliefs regarding consequences if screening was 
missed.  Both YA and OA anticipated feelings of regret and expectations of a poor 
outcome, such as vision loss. However, YA regularly focussed on the impact this 
would have on their family, summed up by one single mother who explained 
“ultimately if I lose my vision, it’s going to affect everybody, so I had to make it 
[screening] a high priority” (ID32_YA).  
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3.5.2.1.3 Reinforcement. Participants cited rewards associated with screening 
(i.e. positive reinforcement) when receiving an all-clear screening result as an 
important facilitator.  A positive screening outcome was often subsequently 
interpreted by the participant as an indicator that they were “managing my 
diabetes well” (ID12_OA).  Having an eye examination in order to avoid negative 
outcomes (i.e. negative reinforcement), where “the eyes might deteriorate 
without being detected” (ID04_OA) was also a strong shared facilitator.  This was 
particularly true of OA who commonly stated that they engaged in screening to 
preserve their independence, including their “driving licence, which is very 
precious” (ID07_OA). 
3.5.2.1.4 Intentions. The majority of YA and OA participants indicated high 
screening intention, including YA who had not screened: “I need to get my eyes 
checked soon, just to know” (ID38_YA). Older adults rarely had their good 
intentions thwarted by barriers, with one stating “it couldn’t be any easier” 
(ID20_OA).  In contrast, YA intention statements were often followed by a list of 
barriers. For example, one YA who was overdue for screening, stated: “I’ve…a 
building project happening, I had to go overseas, I had to go home for about 
three months… [we’re] expecting another child…life is hectic” (ID34_YA). 
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3.5.2.1.5 Emotion. Young adult and OA participants who engaged in screening 
reported feeling “comfortable and positive” (ID33_YA) about the behaviour, 
indicating feelings of “assurance [and] peace of mind” (ID08_OA). Many 
described positive emotions such as “relief when [the optometrist] says that 
everything is fine” (ID14_OA), leaving the examination “feeling in a good mood” 
(ID40_YA) with “absolute evidence that things are great” (ID15_OA). An 
additional emotion facilitating ongoing screening was enjoyment of the 
experience itself: “the really exciting thing is you can actually see your eyes and 
your vessels” (ID15_OA).  
3.5.2.1.6 Knowledge. Young adults and OA demonstrated basic knowledge 
about the connection between diabetes and eye health, and the steps required 
to undergo screening, but detailed knowledge was lacking.  When asked to list 
anything that a person could do to reduce their risk of getting DR, or of slowing 
its progress, most participants were unable to specify more detail beyond “trying 
to keep your blood sugars at ... normal level” (ID04_OA).  Similarly, although most 
participants understood that regular screening was necessary, they were unable 
to articulate clearly when to initiate and how often to attend, with no differences 
between YA and OA. 
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Table 8: Illustrative quotes for main facilitators of screening (TDF domains and constructs) for younger and older adultsa 
Younger adults (N=10) Older adults (N=20) 
Social Influences 
a. Professional influence. 
“I had got a few reading materials from NDSS when I was 
signed up, and I found it was advised in that that I should get 
an annual eye checkups, so I thought I should go ahead with 
it.” ID37 
“When I first got diagnosed…they sent me to the optometrist.  I 
said ‘Why am I going to an optometrist?’ and he [GP] explained 
that this is what could happen and I said ‘Ok, I’ll go’.” ID05 
b. Personal influence from family/friends 
“My wife…she’s always encouraging me, she always reminds 
me. She’s always asking ‘Are you due for an eye check.  Have 
you done your eye check’?” ID34  
“My daughter would nag me.  She is very bossy and intelligent and 
has my best interest at heart. My husband would tell me to have 
an eye exam because he worries that I won’t be able to look after 
him.” ID06 
c. Social norms 
“Someone that’s informed and responsible would have an 
eye exam…I think you would have to be pretty negligent to 
leave it.” ID32 
“They're taking responsibility for their actions and for their 
medical state…if you didn't have an eye examination you'd be an 
absolute idiot.” ID02 
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Table 8: Illustrative quotes for main facilitators of screening (TDF domains and constructs) for younger and older adultsa (Cont.) 
Younger adults (N=10) Older adults (N=20) 
Social Influences (Cont.)  
d. Comparison with others. “I was talking to a friend before my 
exam yesterday and she’s now got it [DR] in both eyes...I 
have empathy for [her], but then I think ‘Gee, I’m glad it’s 
not me’…this is why I go and get my eyes tested every year”. 
ID40 
 
 
Beliefs about Consequences 
a.Beliefs about the value of screening 
“I think at least having [screening] every two years is…vital 
to ensure good eye health.” ID39 
“[Eye examinations] are an important part of regular health 
monitoring, so they are a good thing.” ID11 
b.Expectations of a positive outcome 
“I have confidence when I go there, my sugar is under 
control, so I generally expect good results.”  ID33 
 
“I just expect to get an all clear.  That’s my expectation.  I go in 
there expecting everything to be looking pretty good and I expect 
something from the optometrist to say ‘Look, it’s all great, it’s on 
track, nothing is happening’…It’s just that well-being feeling that 
you’re okay.” ID15 
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Table 8: Illustrative quotes for main facilitators of screening (TDF domains and constructs) for younger and older adultsa (Cont.) 
Younger adults (N=10) Older adults (N=20) 
Beliefs about Consequences (Cont.) 
c.Anticipated regret 
“[If I don’t have screening] I’ll be under mental torture.  I’ll 
be thinking about it, ‘Oh my gosh, is something wrong with 
my eyes’? So, I’d rather go and get it done then, go ahead, 
even with the discomfort [otherwise] the rest of the days I’d 
be thinking something is wrong with my eyes.” ID37 
“I need to go so I can get it checked out.  There’s no other way I 
can really put it...if you have a problem and it builds up, you might 
not know until it’s too late.  And then you end up blind, don’t 
you?” ID17 
d.Impact of vision loss on family. “I drive, going to work, 
coming back home and on the weekend I’m driving family 
around…I need my eyes to do all these things.” ID34 
 
Reinforcement 
a. Positive reinforcement (screening to gain a positive outcome) 
“I think if I can keep my doctor and endocrinologist happy its 
good.” ID39 
“I’ll always have [screening]...just to make sure my eyes remain 
healthy.” ID07 
b. Negative reinforcement (screening to avoid a negative outcome) 
“I always think if I don’t go, I won’t know; but then I really 
want to know because then it would be worse next time.” 
ID40 
“Just to make sure that my eyes are being looked after, and if 
there was a problem starting, then hopefully it can be rectified 
before it gets too bad.”  ID20 
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Table 8: Illustrative quotes for main facilitators of screening (TDF domains and constructs) for younger and older adultsa (Cont.) 
Younger adults (N=10) Older adults (N=20) 
Reinforcement (Cont.)  
c. Avoiding vision loss – preservation of independence “You need your sight to be able to get around.  It would mean a 
loss of independence, having to rely on people to do things for 
you, take you places.  I would find that difficult because I’m an 
independent person.” ID14 
Intentions 
Intention to commence or maintain screening 
“I’ve been in Australia probably six years now and I always 
did it [screening].” ID33 
“I’d come back from holidays to have one.  How’s that!” ID08 
Emotion 
Positive emotions related to screening 
“I was having a ball...’the chair is going up, the chair is going 
down.’ I’ve had orange dye put in my eyes, which I just 
loved...it was actually nice to relax and not have to worry 
about the kids.” ID32 
“Well, straight after the last time, the optometrist said ‘You’re 
eyes are fine, no problems whatsoever’ and I’m like ‘What, so 
there’s no damage?’ and he goes ‘No, you’re doing really good’ 
and it’s just a sigh of relief.” ID05 
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Table 8: Illustrative quotes for main facilitators of screening (TDF domains and constructs) for younger and older adultsa (Cont.) 
Younger adults (N=10) Older adults (N=20) 
Knowledge 
a.Knowledge of the connection between diabetes and eye health 
“[The] moment you don’t keep your blood pressure in target 
then you are going to have those blood vessels leaking...and 
if you don’t go for regular examinations you don’t know if 
there is damage happening to you.” ID34 
“I got onto the internet and learnt about [diabetes]. I knew that I 
had to watch my eyes and the circulation around my feet.” ID01 
b.Knowledge of the purpose of screening 
“Going once a year to get your eyes checked, to make sure 
that there’s no issues with the eyes.  You can’t just look at 
someone’s eye and go ‘yep, you’re okay’, you need to take 
that… photo of the back of the retina of the eye.” ID 39 
“I always understand that eyes and feet are so important in 
diabetes and that’s why I think it’s important that you have the 
eye test annually.” ID08 
a 
Blank cells indicate that the facilitator or component construct was not frequently discussed by that group 
 NDSS: National Diabetes Service Scheme, GP: General Practitioner 
 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
182 
 
3.5.2.2 Barrier. 
3.5.2.2.1 Environmental context and resources.  Older adults  
mentioned the cost of screening, but commonly indicated: “I can afford that” 
(ID06_OA).  In contrast, cost was a prominent barrier for YA, some of whom 
reported experiencing “financial stress” (ID38_YA). Furthermore, application of 
mydriasis drops resulted in a period of time where participants “can’t see 
properly for a bit” (ID38_YA), or in some cases “hours and hours” (ID20_OA). 
Time-related barriers were more salient for YA than their OA counterparts, with 
YA commenting that specialist appointments were often conducted only “within 
work hours” (ID36_YA). The main barriers anticipated to impede screening for OA 
participants were “health issues” (ID04_OA) or being “on holiday” (ID15_OA). 
3.5.2.2.2 Social influences.  Many participants who had not been 
advised to have screening by their GP indicated that they “didn’t immediately go 
to the optician” (ID01_OA) once they became aware that screening was required.  
Comments from some YA suggested that their GPs were reluctant to 
acknowledge the seriousness of young-onset T2D, reflected in a comment by one 
YA who felt her GP “played down” (ID41_YA) her T2D diagnosis.  The GP 
neglected to recommend screening, instead advising the YA to “go and book the 
appointment with the educator and ask all of your questions then” (ID41_YA). 
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3.5.2.2.3 Knowledge. Both YA and OA participants lacked knowledge of 
screening guidelines and relied on “what the eye doctor says” (ID01_OA) 
regarding screening.  Although broader knowledge deficits, such as lack of 
knowledge of DR symptoms and risk factors, did not seem to impede screening 
uptake for OA, they appeared to perpetuate health misconceptions for YA 
participants; including the view that DR was only a concern for older people.  
When asked if they were likely to experience vision problems, a common 
response was “No ... [I have] never had any complications, no sight problems or 
anything” (ID33_YA).  Lack of symptoms, combined with perceptions of 
invulnerability and unrealistic optimism also contributed to lack of engagement 
with DR screening among YA participants: “I put [screening] off because ... my 
vision is quite good and just my age … [32 years]” (ID36_YA). 
3.5.2.2.4  Beliefs about consequences. Much of the participant 
commentary around negative consequences of screening focussed on the 
discomfort of mydriasis, such as “oh, not that dye again” (ID08_OA).  The time 
taken to recover and the need to “hang around for a while” (ID32_YA) impacted 
participants, although none of the YA or OA participants indicated that this 
would prevent them from screening. 
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3.5.2.2.5  Emotion (YA only).   Younger adults expressed negative 
emotions and fear about their diabetes diagnosis, noting that “when I read about 
diabetes, I get really stressed out” (ID38_YA).  Others reported being afraid of 
screening due to concerns about losing their freedoms (e.g. driving license), 
vision, or being told they have DR.  Further, the knowledge that they had 
developed diabetes at “quite an early age, so I know it’s going to go on for some 
time…it’s going to build up” (ID37_YA) generated distress.  Rather than acting to 
reduce their DR risk, some YA response to the potential threat of vision loss was 
“just total denial” (ID32_YA), “blocking it all out and not dealing with it” 
(ID38_YA). 
3.5.2.2.6 Behaviour regulation (OA only). Older adults reported 
primarily relying on receiving screening reminders from eye health specialists.  
Such reliance resulted in an absence of behaviour regulation strategies, and in 
appointments that were missed or forgotten.  However, once the omission was 
discovered, participants reported that they “got in as quick as I could” (ID09_OA). 
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Table 9: Illustrative quotes for main barriers to screening (TDF domains and constructs) for younger and older adultsa 
Younger adults (N=10) Older adults (N=20) 
Environmental Context and Resources 
a.Cost of procedure 
 “I thought it should be covered by Medicare but he said this 
particular picture it’s not going to be covered so I had to pay 
out of my pocket there.” ID38 
 
b.Lack of time 
“I put off [screening] for a while because I kept thinking ‘I 
need to make sure that my kids are taken care of.  I won’t be 
right for the afternoon.  I’ll have to have a lift to get in there 
and a lift to get out or I’ll have to get a taxi’.” ID32 
 
c.Deteriorating health  
 
I can look after [screening] OK at the moment, but I’ve got a lot of 
things wrong with me, and if I get any worse I may not be able 
to.” ID13 
Social Influences 
a.Lack of clinician recommendation 
“If he [GP] had told me that sometimes even before the 
diagnosis there could be retinopathy that would definitely 
have an influence.” ID31 
Interviewer: Were you advised to have your eyes checked at 
diabetes diagnosis? “Um, no…it wasn't until…the endocrinologist 
that I saw [6 years later], said ‘you should go and see this eye 
doctor’.” ID21 
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Table 9: Illustrative quotes for main barriers to screening (TDF domains and constructs) for younger and older adultsa (Cont.) 
Younger adults (N=10) Older adults (N=20) 
Social Influences (Cont.)  
b.Clinical inertia 
“[My GP] said ‘Look, for the moment, if you’re not feeling any 
pressure, you’ve got excellent eyesight at the moment anyway’ 
[and that], in the next six months, I would have to go and see an 
optometrist or an eye specialist.” ID32 
 
Knowledge 
a.Lack of knowledge about screening 
“As wonderful as [my GP] is, I wish that I had have known from 
word go just how important [screening] was.” ID32 
“The guideline is when I get the annual letter from the 
optometrist.” ID11 
b.Eye health misconceptions 
“[DR] is something that happens to elderly people; it’s not a 
concern for me.” ID32 
 
Beliefs about Consequences 
Consequences of mydriasis  
“The only that’s annoying for me is that...they dilate the 
pupils...and then you can’t see that clearly and that well for the 
next two to three hours until it wears off.” ID39 
 
“I think it’s [mydriasis] a necessary evil, but I don’t think you’d 
neglect it [screening] for it.” ID07 
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Table 9: Illustrative quotes for main barriers to screening (TDF domains and constructs) for younger and older adultsa (Cont.) 
Younger adults (N=10) Older adults (N=20) 
Emotion  
Fear of DR diagnosis  
“I was afraid.  Everything was coming in at the same time.  I 
was diagnosed with diabetes...and I thought ‘now, this [DR] is 
going to be the last thing, it’s going to be the topping of the 
cake’.  There was going to be something wrong with my 
eyesight.” ID37 
  
Behaviour Regulation  
Absence of planning “I am a calendar person.  But two years, no, I don't keep that 
calendar.  I suppose really I do rely on the [reminder] letter 
coming.” ID18 
a Blank cells indicate that the barrier or component construct was not frequently discussed by that group 
 GP: General Practitioner, DR: diabetic retinopathy 
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3.6 Discussion 
3.6.1 Summary of findings. This is the first in-depth exploration of the  
factors which influence screening behaviour among young adults with T2D who 
are at high risk of complication burden from diabetes, including vision loss from 
DR (Yeung et al., 2014).   The study was conducted in response to an urgent need 
for behavioural and ophthalmic research focussed on the needs of this group 
(Forward, Hewitt, & Mackey, 2012; Shickle et al., 2014).   
We identified seven behaviour change domains associated with screening 
among both younger and older adults with T2D: ‘social influences’, ‘beliefs about 
consequences’, ‘reinforcement’, ‘intentions’, ‘emotion’, ‘knowledge’, and 
‘environmental context and resources’.  Within those domains, we identified 
component constructs that were of greater salience to the young adult cohort, 
and which are consistent with constructs identified in the broader qualitative 
literature on healthcare engagement for youth and young adults.  For example, 
social normative factors (which include social influence, an important screening 
facilitator in the current study), have been demonstrated to be more strongly 
correlated with health promoting behaviours than knowledge-based factors for 
young people (Bengel, Belz-merk, & Farin, 1996; DiClemente, 1991).  Similarly, 
screening barriers identified to be of greater salience to young adults with T2D in 
this study, such as stage of life constraints, low perceived personal risk and 
unrealistic optimism have previously been reported to impact perception of T2D 
risk and utilisation of eye care services (MacLennan et al., 2014; Reyes-Velazquez 
& Sealey-Potts, 2015; Turner et al., 2015).   Our study also suggests that the 
distress associated with having a chronic condition usually associated with older 
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adults, and fear of the possibility of serious complications, which was previously 
reported by Browne et al. (2013), negatively impacts screening behaviour, with 
some participants avoiding screening altogether.    
By utilising a known comparator group, we were able to demonstrate that 
the young adult participants made a high number of barrier references 
compared to the older adult participants.  High frequency of barriers was made 
irrespective of screening behaviour, suggesting that even those young adults who 
had engaged in DR screening had overcome more barriers to do so than their 
older counterparts.   These findings support the assertion by earlier studies that 
accumulation of barriers, rather than any specific one, may explain lower 
screening rates (Lindenmeyer et al., 2014; Waqar et al., 2012).   
 
3.6.2 Implications for policy and practice. Retinal screening initiatives 
that focus on high-risk sub-groups, such as young adults with T2D, benefit from 
using educational materials tailored to the target group (Noar, Benac, & Harris, 
2007; Zhang et al., 2007).  We have identified individual-level contextual and 
motivational factors which impact screening behaviour for young adults with 
T2D, many of which may be amenable to change.  In order to assist clinicians and 
those involved with supporting young adults with T2D, we recommend the 
development of tailored message content which targets the potentially 
modifiable factors.  Considering the challenges associated with reaching and 
engaging young adults with T2D in their diabetes care (Browne et al., 2013; 
COAG Reform Council, 2014), we recommend that tailored messages be 
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incorporated into individual-level eye health resources, such as a leaflet, and 
embedded within both provider and system-level initiatives.  
At a provider level, research demonstrates that GPs are the primary 
information source for the majority of younger adults living with T2D (Browne et 
al., 2013; Diabetes Australia, 2006), and important facilitators of screening, as 
identified in this and other qualitative studies (Lindenmeyer et al., 2014; van Eijk, 
Blom, Gussekloo, Polak, & Groeneveld, 2012).  The current study confirmed that 
some GPs may not be actively promoting retinal screening at diabetes diagnosis 
for young adults, or reinforcing it thereafter.  This is a form of clinical inertia, a 
phenomenon demonstrated to have a much larger impact on young adults with 
T2D than on their older counterparts in clinical settings (Al-Saeed et al., 2016; 
Rosenberg, Friedman, & Gurland, 2011). The introduction of quality 
improvement strategies (e.g. GPs providing evidence-based, targeted resources 
to emphasise the importance of screening alongside reminders to prompt 
screening behaviour) may ensure that young adults’ interactions with the health 
system facilitate uptake and maintenance of this crucial vision-loss prevention 
activity. 
Recently, it has been shown that young adults with T2D are the least 
likely to initiate screening promptly after diabetes diagnosis, exposing them to 
high risk of severe DR at their first screen (Scanlon et al., 2016).  Thus, at an 
Australian health system level, we recommend targeting young adults with T2D 
via the National Diabetes Services Scheme (NDSS). The NDSS is an initiative of 
the Australian Government, which provides subsidised supplies (e.g. needles, 
blood glucose testing strips) and programs and services (e.g. information, 
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education and advice), to registrants. With approximately 86% of people with 
T2D registered on the NDSS, it is considered to be the “best available source to 
monitor type 2 diabetes in children and young people in Australia” (p.36, 
Australian Institute of Health and Welfare, 2014).  Each new registrant receives a 
diabetes management information booklet, which could include eye health 
resources tailored to this group.  The use of the NDSS as a vehicle for targeted 
mail-outs of eye health messages appears to have been successful in an earlier 
community-based screening program, with anecdotal reports of an increase in 
enquiries after each mail campaign (Lee et al., 2000). 
3.6.3 Strengths and limitations.  This study has a number of strengths.  
It is the first in-depth exploration of factors impacting screening for young adults 
with T2D, an under-researched group at high risk for vision loss and blindness 
from DR.  Although small, the sample of young adults with T2D included a 
diverse group of participants, with respect to key demographic factors (e.g. 
gender, country of birth), and screening behaviour. The systematic comparison of 
facilitators and barriers with a known comparator group (older adults with T2D, 
aged 40+ years) permitted identification of salient factors likely to influence 
young adult screening behaviour which can now be targeted by health care 
professionals and those developing tailored resources for this group.  Finally, this 
is the first study to use the TDF, a theoretically-driven behaviour change 
framework, to systematically identify facilitators and barriers to screening 
behaviour.  The key benefit of this novel approach is that the behavioural 
determinants and key differences, which were systematically identified in this 
study, can be matched to evidence-based behaviour change techniques in a 
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future eye health intervention (Cane, Richardson, Johnston, Ladha, & Michie, 
2014), providing clear justification for intervention content. 
This study also has some important limitations.  We experienced 
recruitment challenges specific to each group, which limit the interpretability 
and generalisability of the findings.  Firstly, despite doubling the recruitment 
period to six months, and introducing a technology-based incentive, we were 
unable to recruit young adults with T2D in sufficient numbers to confirm data 
saturation.  Although diverse in gender and screening behaviour, there was a 
recruitment bias toward the upper age range (average age 33 years).  This can be 
understood in the context of the skewed nature of the demographic (Australian 
Institute of Health and Welfare, 2014), but nevertheless means that the views 
and experiences of the youngest members of the young adult group are not well 
represented in our data.   
While we were able to recruit sufficient numbers of older adults, the 
challenge focussed on engaging those who had not attended retinal screening.  
In contrast to the young adults with T2D, all the older adults who volunteered to 
participate had previously engaged in screening. Although this may be a 
reflection of a genuine disparity in screening behaviour, the 100% screening rate 
of our older adults sample is higher than recently reported general population 
rates (78%, Foreman et al., 2016), raising the strong possibility of self-selection 
bias (Chou et al., 2013).  Absence of older adults who had not attended screening 
compromises the interpretability of the barrier findings because we do not know 
if the barriers cited by the young adults with T2D also apply to older adults who 
had not screened, or indeed, whether they face different barriers altogether.  
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However, as a first step towards understanding the barriers and facilitators of 
retinal screening amongst young adults with T2D, our study still makes a 
meaningful contribution to the existing literature.   
Finally, despite our comprehensive validation exercise, we faced coding 
challenges due to conceptually overlapping constructs from different TDF 
domains (e.g. ‘reinforcement’/’beliefs about consequences’, ‘behaviour 
regulation’/’memory, attention and decision processes’).  Although we addressed 
this challenge by always exploring the context of the utterance to inform coding 
decisions, the issue of discriminant validity of questionnaire items has been 
raised by other TDF-studies (Birken et al., 2014; Bussieres et al., 2012) and 
remains a work in progress for the TDF framework. 
3.6.4 Future research. The findings of this study suggest that there are 
facilitators and barriers to retinal screening that are of greater salience to young 
adults with T2D than older adults, indicating that tailored resources are 
warranted in order to promote screening uptake in this group.  As this study was 
descriptive and exploratory in nature, a logical next step is to confirm them in a 
larger, quantitative survey.  Subsequently, identified deficits can be targeted in a 
future eye health intervention, using content mapped to specific behaviour 
change techniques. Additional efforts to boost recruitment and minimise self-
selection bias will be important for any future studies with this target group on 
this topic.  
3.6.5 Conclusion. Our study has identified a number of attitudinal and 
motivational factors associated with retinal screening behaviour among young 
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adults with T2D.  Some of these factors appear to differ from those reported by 
older adults who, given their majority, are the target group for most diabetes 
self-management resources and services. As many of the identified factors, such 
as social influence and knowledge, are modifiable, this study is an important first 
step in establishing an evidence base for tailored resources and greater 
understanding among clinicians and other health professionals of the issues 
associated with retinal screening uptake among young adults with T2D.   
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CHAPTER 4. A Tailored Intervention to Promote Uptake of Retinal 
Screening among Young Adults with Type 2 Diabetes - an Intervention 
Mapping Approach9  
  
                                                     
9 This manuscript is under review in BMC Health Services Research. The chapter has 
been formatted in APA style, to maintain consistency of structure and referencing 
throughout the thesis. Text content is identical to the submitted manuscript. 
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4.2 Abstract 
Background: Young adults (18-39 years) with type 2 diabetes are at risk of 
early development and rapid progression of diabetic retinopathy, a leading cause of 
vision loss and blindness in working-age adults. Retinal screening is key to the early 
detection of diabetic retinopathy, with risk of vision loss significantly reduced by 
timely treatment thereafter. Despite this, retinal screening rates are low among this 
at-risk group. The objective of this study was to develop a theoretically-grounded, 
evidence-based retinal screening promotion leaflet, tailored to young adults with 
type 2 diabetes. Methods: Utilising the six steps of Intervention Mapping, our 
multidisciplinary planning team conducted a mixed-methods needs assessment 
(Step 1); identified modifiable behavioural determinants of screening behaviour and 
constructed a matrix of change objectives (Step 2); designed, reviewed and 
debriefed leaflet content with stakeholders (Steps 3 and 4); and developed program 
implementation and evaluation plans (Steps 5 and 6). Results: Step 1 included in-
depth qualitative interviews (N=10) and an online survey that recruited a nationally-
representative sample (N=227), both informed by literature review. The needs 
assessment highlighted the crucial roles of knowledge (about diabetic retinopathy 
and screening), perception of personal risk, awareness of the approval of significant 
others and engagement with healthcare team, on retinal screening intentions and 
uptake. In Step 2, we selected five modifiable behavioural determinants to be 
targeted: knowledge, attitudes, normative beliefs, intention, and behavioural skills. 
In Steps 3 and 4, the "Who is looking after your eyes?" leaflet was developed, 
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containing persuasive messages targeting each determinant and utilising engaging, 
cohort-appropriate imagery. In Steps 5 and 6, we planned Statewide implementation 
and designed a randomised controlled trial to evaluate the leaflet. Conclusions: This 
research provides an example of a systematic, evidence-based approach to the 
development of a simple health intervention designed to promote uptake of 
screening in accordance with national guidelines. The methods and findings 
illustrate how Intervention Mapping can be employed to develop tailored retinal 
screening promotion materials for specific priority populations. This paper has 
implications for future program planners and is intended to assist those wishing to 
use Intervention Mapping to create similar theoretically-driven, tailored resources. 
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4.3 Background 
Worldwide increase in the prevalence of type 2 diabetes (T2D) in young 
adults (<40 years), with its associated considerable morbidity and mortality, is a 
burgeoning public health concern (Chan et al., 2014; Constantino et al., 2013; 
Harding, Shaw, Peeters, Davidson, & Magliano, 2016; Tancredi et al., 2015; Zimmet, 
Magliano, Herman, & Shaw, 2014).  Adverse phenotype (Song & Hardisty, 2009), sub-
optimal glycemic (blood glucose) control and long diabetes duration expose young 
adults with T2D to a high lifetime risk of diabetes-related complications (Al-Saeed et 
al., 2016; Dart et al., 2014). One of the most common is diabetic retinopathy (DR), 
which is a leading cause of vision loss and blindness in working age adults (Leasher 
et al., 2016; Wong, Molyneaux, Constantino, Twigg, & Yue, 2008).   
Early detection of DR via retinal screening (‘screening’), followed by timely 
treatment, are crucial factors in preventing vision loss (Ferris, 1993).  Australian 
national Guidelines for the Management of Diabetic Retinopathy recommend 
screening uptake at diabetes diagnosis, repeated at least every two years thereafter 
(Mitchell & Foran, 2008), an interval less frequent than that prescribed for adults 
with T2D in the United States (US) and United Kingdom (UK) (American Diabetes 
Association, 2017; National Institute for health and Care Excellence, 2015).  
Unfortunately however, young adults (aged 18-39 years) are the least likely to 
initiate retinal screening in accordance with national guidelines and have lower 
overall screening rates than older adults (aged ≥40 years) or young adults with type 
1 diabetes (Scanlon et al., 2016; Villarroel, Vahratian, & Ward, 2015; Wang et al., 
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2017). In addition to their low engagement with existing diabetes services (Savage, 
Dabkowski, & Dunning, 2009), additional communication challenges exist due to the 
lack of dedicated programs, hubs or services for young adults with T2D. Thus, there 
is need for the development of tailored, evidence-based health promotion 
resources, using an application appropriate to the culture and context, in order to 
encourage screening uptake among this priority population (Browne, Scibilia, & 
Speight, 2013; Forward, Hewitt, & Mackey, 2012; MacLennan, McGwin, Heckemeyer, 
& et al., 2014; Song, 2015; Wilmot & Idris, 2014).   
Best-practice development of health promotion resources targets modifiable 
behavioural determinants for a clearly specified health behaviour.  The UK Medical 
Research Council (MRC) framework for the design and evaluation of complex 
interventions recommends use of good quality evidence from a range of sources, 
strong theoretical underpinnings, causal modelling and a well-designed evaluation 
(Craig et al., 2008). Intervention mapping (IM) is a six-step protocol encompassing 
MRC elements, which provides an effective and useful framework for this purpose 
(Bartholomew Eldredge et al., 2016). Key activities are: 1) detailed needs 
assessment, developing causal logic model of the problem, 2) stating program 
outcomes and performance objectives, developing logic model of change, 3) utilising 
theory and evidence-based change methods, designing program to target identified 
behavioural determinants, 4) producing, pre-testing and refining program with 
broad stakeholder input, 5) planning for program implementation, and 6) planning 
for evaluation ("Intervention mapping,"). Intervention mapping has been widely 
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used by intervention planners to guide the development of effective health 
promotion materials in a variety of contexts and populations (Ball, Mushquash, 
Keaschuk, Ambler, & Newton, 2017; Gray-Burrows et al., 2016; Hurley et al., 2016; 
Newby et al., 2017; Song, Choi, Kim, Seo, & Lee, 2015) and has been shown to be 
effective both in identifying determinants and increasing uptake for a range of 
disease prevention interventions (Garba & Gadanya, 2017).  Utilising IM, the aim of 
the current study was to identify determinants of screening behaviour for young 
adults with T2D, and develop an engaging psycho-educational resource to target 
these factors, designed to promote screening uptake.   
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4.4 Method and Results 
In this section, IM steps 1-4 are presented in detail, followed by summaries of Steps 
5 and 6. Method and results are reported separately for each step, including 
illustrative examples of key IM activities (with full detail provided in Additional files). 
Table 10 provides an overview of each IM step as it was applied to this project.  
 
Table 10: Overview of IM steps and activities applied to the current leaflet development 
program 
IM steps IM activities 
Step 1: Logic model of 
the problem 
 
 Establish and work with a planning group 
 Conduct mixed-methods needs assessment 
 Create logic model of the problem  
 Describe context of the intervention and state program 
goals 
Step 2: Program 
outcomes and 
objectives; logic 
model of change 
 State expected behavioural outcomes and Performance 
Objectives (PO) 
 Create logic model of change  
 Create matrix of Change Objectives 
Step 3: Program 
design 
 
 Generate program themes, components, scope and 
sequence 
 Choose theory and evidence-based change methods 
Step 4: Program 
production 
 Draft persuasive message content and leaflet 
 Pre-test, refine and produce leaflet 
Step 5: Program 
implementation 
 Identify program implementers, adopters and 
maintainers 
 Design implementation and liaise with program 
implementers 
Step 6: Program 
evaluation 
 Write effect and process evaluation questions 
 Develop measures for assessment 
 Specify and complete evaluation plan 
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4.4.1 Logic model of the problem. 
4.4.1.1 Establish and work with a planning group. A six-person 
multidisciplinary planning team was convened comprising representatives from The 
Australian Centre for Behavioural Research in Diabetes (AJL, JLB, JS); Centre for Eye 
Research Australia (GR); Diabetes Victoria (CH); and Vision 2020 Australia (DT).  
Combined, the planning team provided expertise in psychosocial and clinical aspects 
of diabetes and vision loss, health promotion, behaviour change research 
methodologies and intervention development.  Monthly meetings (chaired by JS) 
were held throughout the project, with additional meetings held as-needed and 
quarterly progress reports provided to the funding body.  Throughout the study, the 
planning team consulted a practicing health psychologist (CA) with expertise in IM 
and a track record of developing and analysing evidence-based health promotion 
leaflets (Abraham, Southby, Quandte, Krahé, & ven der Sluijs, 2007; Elliott, White, 
Taylor, & Abraham, 2016; Hill & Abraham, 2008; Krahé, Abraham, & Scheinberger-
Olwig, 2005). Additional expert input was provided by representatives from key 
stakeholder organisations, such as the National Diabetes Services Scheme (NDSS, an 
initiative of the Australian Government, which provides free or subsidised self-
management supplies and services to registrants), Optometry Australia and key units 
within Diabetes Victoria.    
Patient and public involvement (PPI) is essential for the development of high-
quality health behaviour change interventions (Stewart, Wilson, Selby, & Darbyshire, 
2011) and is recommended specifically as a strategy for engaging groups at high risk 
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of underutilsation of eye healthcare services (Elam & Lee, 2013).  In this study, five 
young adults with T2D were involved, providing feedback on all study 
documentation, piloting the quantitative survey and providing detailed review of the 
eye health leaflet.  
4.4.1.2 Conduct mixed methods needs assessment.  Our study of the 
literature (summarised in Additional file 1) revealed that, while there was a paucity 
of research in this specific area, sub-optimal diabetes self-management (in general) 
among young people is likely driven by low socioeconomic status (Koelmeyer, 
Dharmage, & English, 2016), low general and health literacy (Koelmeyer et al., 2016), 
low engagement with diabetes self-management education (Browne, Nefs, Pouwer, 
& Speight, 2014; Browne et al., 2013; Hessler, Fisher, Mullan, Glasgow, & Masharani, 
2011; Koelmeyer et al., 2016), cultural diversity of the priority population (Tuomi et 
al., 2014), optimistic bias and low risk perception (Reyes-Velazquez & Sealey-Potts, 
2015), life-stage demands (Lake, Browne, Rees, & Speight, 2017), high rates of 
diabetes-related distress (Browne et al., 2014) and complex healthcare needs 
(Owen, 2016).  
In our empirical needs assessment studies, we sought to determine the 
relevance of these factors to DR screening specifically, and to identify any additional 
factors that may facilitate or impede this target behaviour. As other researchers have 
found it challenging to recruit young adults with T2D to research studies (Nguyen et 
al., 2014; Zeitler, Chou, Copeland, & Geffner, 2015), several steps were taken to 
boost recruitment in the mixed-methods needs assessment. These included: giving 
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priority to ease of participant access; distribution of engaging, cohort-appropriate 
recruitment invitations with an NDSS and Diabetes Australia branded cover letter 
introducing the study; reminder invitation after four weeks; age-appropriate 
incentives (e.g. entry to a technology-based prize draw), and extension of 
recruitment periods until participant registration visibly flagged.  
 
4.4.1.2.1 In-depth qualitative interviews. 
Qualitative interview procedure: Detailed description of the study methods 
and findings, including the participants, procedure, interview guide and analysis, are 
published elsewhere (Lake et al., 2017), see Appendix C for interview guide. In brief, 
we conducted in-depth semi-structured interviews to explore factors affecting 
screening behaviour for young adults with T2D, with an emphasis on those that were 
individual-level and modifiable. The study was advertised widely online and in 
community settings, and recruitment invitations were mailed to eligible members of 
a leading state diabetes consumer advocacy organisation.  All interviews were 
conducted via telephone by an experienced interviewer (AJL), audio-recorded and 
transcribed verbatim.  All transcripts were checked for accuracy and imported into 
NVivo10 (QSR International Pty Ltd, Doncaster, VIC., Australia, 2012). Transcripts 
were subjected to content analysis (by AJL), with each participant utterance coded 
for behavioural determinants (using an a priori coding framework informed by the 
literature (Cane, O'Connor, & Michie, 2012)), and again as either ‘facilitator’ or 
‘barrier’ dependent upon the context. Twenty percent of transcripts were double-
coded (by JLB), with high inter-rater reliability of 99%.  Screening determinants were 
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rank-ordered by frequency of coding (higher frequency of utterances interpreted to 
indicate higher salience).   
Qualitative interview findings: In brief, ten young adults with T2D (50% 
women, aged 29-37 years) were interviewed (average length: 55 min, range: 31-106 
min).  Fifty percent had not attended retinal screening previously.  Although young 
adults with T2D knew of a link between diabetes and vision loss, they did not have a 
comprehensive understanding of DR or screening (e.g. symptoms, risk factors, 
screening guidelines, distinction between screening and standard vision checks).  
Participants reported distress related to having a condition stereotypically associated 
with older people, and many did not know others of similar age with T2D.  
Participants indicated that absence of social influence (e.g. prompting from 
significant others, social comparison with others), and low DR risk perception, 
combined with life-stage barriers (e.g. lack of time and finances), negatively 
impacted screening uptake.  Concerned about negative judgment by others, and 
fearing a DR diagnosis, participants reported that they did not always disclose their 
diabetes diagnosis or proactively seek healthcare or social support, thus losing 
crucial pathways to timely screening uptake.  Irrespective of their screening history, 
young adults with T2D identified a range of screening barriers, suggesting that a 
cumulation of factors may impact uptake, thus highlighting the need to acknowledge 
and address a broad range of barriers in a tailored intervention. 
Screening facilitators were often conceptualised by participants as the 
opposite of the barriers (e.g. improved, as opposed to inadequate, knowledge or 
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access to social support). However, the study also highlighted other screening 
facilitators: participants compared themselves with others experiencing diabetes-
related vision loss, and were thus influenced to engage in screening due to concerns 
about the impact that vision loss would have on their lives, including anticipated 
regret at the potential impact on their spouses and/or children.  For those who 
previously attended screening, feelings of relief and reassurance facilitated repeat 
screening behaviour, with participants expressing intent to sustain the behaviour 
and expectation of a positive outcome (i.e. no DR diagnosis).  
4.4.1.2.2 National online survey. 
Online survey procedure 
Survey development. Using the Information-Motivation-Behavioural skills 
(IMB) model (Fisher, Fisher, & Harman, 2003) as a foundation, the planning team 
developed a survey designed to identify modifiable behavioural determinants for 
screening. The IMB model posits that although information is a key element in 
changing behaviour, increasing knowledge and awareness of a behaviour is not 
sufficient in itself, and requires the integration of motivational and skills elements to 
ensure behaviour change.  Use of the IMB model in behaviour change research 
requires identification of deficits in each of the three key areas, to be addressed in a 
subsequent intervention.  The IMB model has been effective both as a framework 
for intervention design (Fisher, Fisher, Bryan, & Misovich, 2002) and as a predictive 
model for health-related screening behaviours, such as breast self-examination 
(Misovich, Martinez, Fisher, Bryan, & Catapano, 2003).   
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Increasingly used with chronic conditions, the IMB model has been validated 
recently in a model of diabetes self-care behaviours (Osborn & Egede, 2010) and 
medication adherence (Mayberry & Osborn, 2014).  Survey items were based on 
IMB-based questionnaires previously validated for diabetes self-management 
(Mayberry & Osborn, 2014; Osborn & Egede, 2010), the widely-used Theory of 
Planned Behaviour (Fishbein & Ajzen, 2010), and cognitive constructs shown to be 
relevant to young adults with T2D (e.g. optimism/fatalism, social support, risk 
perception, anticipated regret, self-efficacy) (Reyes-Velazquez & Sealey-Potts, 2015; 
Turner et al., 2015).  
In brief, the survey comprised 54 items assessing information/knowledge, 
motivation and behavioural skills (see Additional file 2 for individual items). 
Information: 16 items assessed knowledge of the link between diabetes and vision 
loss, diabetic retinopathy and retinal screening. Responses scored dichotomously 
(incorrect / correct).  Motivation: 21 items collectively assessed three attitudinal 
constructs (attitudes toward screening for DR, perception of personal risk, and 
anticipated regret); three items assessed normative beliefs and three items assessed 
intention.  Behavioural skills: 11 items collectively assessed two behavioural skills 
constructs (perceived control over screening and overcoming barriers).   
Unless otherwise noted, each item was rated on a 7-point Likert scale 
(“strongly disagree” to “strongly agree”). Individual items were aggregated to 
provide a composite score for each construct, with good internal consistency (see 
Additional file 3).  For each, higher scores indicated greater endorsement of the 
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construct measured (e.g. stronger intentions, more positive attitudes).  In addition, 
we collected socio-demographic data to describe the sample at baseline. The survey 
was piloted with young adult PPI members and representatives from selected 
stakeholder organisations, who also commented on readability, format, accessibility 
and content; no substantive changes were required.   
Data collection and participants. The survey was conducted nationwide and 
hosted via a secure online survey platform, QualtricsTM (Provo, UT, 2014-2015).  In 
Australia, the majority of people with a confirmed diagnosis of diabetes are 
registered by their health professional with the NDSS (Australian Institute of Health 
and Welfare, 2014). All young adults with T2D who had been registered on the NDSS 
in the previous three years (registration date was used as a proxy for diagnosis date), 
and who had consented to be contacted for research (N=5,354) were invited to 
participate. Exclusion criteria included non-English speaking; those aged 40+ years, 
and diagnosis of another type of diabetes. Study invitations were managed by the 
NDSS in order to preserve registrant confidentiality, but purposive sampling of those 
who had not previously screened for DR was not possible, due to lack of available 
data on retinal screening status of NDSS registrants. Recruitment to the online 
survey continued for seven weeks. 
Statistical analyses. Statistical analyses were conducted using SPSS version 
22 (SPSS Inc., Chicago IL, USA). Univariate analyses (chi-square and independent 
measures t-tests, two-sided) were conducted to explore between-group (previous 
retinal screen: yes/no) differences on demographic variables and modifiable 
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behavioural determinants at the item level (to inform specific intervention message 
content). Given the large number of analyses, a conservative p<0.01 was considered 
statistically significant.  
Online survey findings: Overall, 129 participants (2% of eligible population) 
completed the full survey, and their sociodemographic characteristics are presented 
in Table 11. Sixty percent were women, average age 34±5 years (range: 19-39 years), 
and 74% had previously screened for DR.  No significant differences in 
sociodemographic characteristics were found between screening groups.  
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Table 11: Sociodemographic characteristics by screening behaviour (N=129) 
Sociodemographic characteristics 
Retinal screen 
p 
No (n=33) Yes (n=96) 
Age, years  34.39 (33, 37) 34.04 (32, 37) .697 
Duration, years 1.00 (1.84) 1.69 (1.97) .081 
Gender: women 15 (45) 62 (65) .084 
Primary diabetes management:  
  Lifestyle only 
  Medication (not insulin)  
  Insulin 
 
5 (15) 
23 (70) 
5 (15) 
 
21 (22) 
64 (67) 
11 (11) 
 
 
.652 
Country of birth: Australian born 18 (55) 66 (69) .206 
Main language spoken at home: 
English 
27 (82) 81 (84) .944 
Employment status: employed 20 (61) 57 (59) 1.000 
Socioeconomic statusa 984.55 (83.52) 991.48 (57.11) .660 
Family history of T2Db 22 (67) 72 (75) .483 
≥1 comorbid health conditionb 25 (76) 75 (79) .891 
Depression (PHQ-2)c  2.94 (2.48) 2.12 (2.07) .102 
Data are number (%), mean (SD), or median (IQR); p-value is Pearson’s chi-square or 
independent t-tests (two-sided); statistical significance p<0.05.   
aIndex of Relative Socio-economic Advantage and Disadvantage: lower score 
indicates relatively greater disadvantage, range 300-1250. 
bMissing data (average 6%, range 2-11%) 
cPHQ-2 range 0-6: ≥3 indicating likely depression 
 
Behavioural determinants of screening. Selected findings for information 
(knowledge), motivation and behavioural skills items are detailed in Table 12 (full 
detail and construct-level findings provided in Additional file 3).  
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Table 12: Selected behavioural determinant items by retinal screen (N=129)  
Modifiable behavioural determinants 
Retinal screen 
p No 
(n=33) 
Yes 
(n=96) 
INFORMATION (KNOWLEDGE) ITEMS 
Diabetes can lead to vision loss   30 (91) 93 (97) .174 
All people with diabetes are at risk of DR 26 (79) 89 (93) .004 
Recommended target HbA1ca 17 (53) 81 (87) <.001 
Initiate eye examinations ‘at diabetes 
diagnosis’ 
5 (15) 42 (45) .004 
Screen ‘at least every 2 years’ if no DR present 0 (0) 18 (19) .003 
MOTIVATION ITEMSb                                      An eye health check for DR would be...c 
  ...(not) ‘unpleasant’ 3.71 (0.94) 3.86 (1.07) .500 
  ...reassuring 3.94 (0.96) 4.63 (0.61) <.001 
  ...important 4.06 (1.06) 4.89 (0.35) <.001 
  …empowering 3.10 (1.19) 3.73 (0.97) .004 
  ...comfortable 3.26 (1.15) 3.68 (1.10) .073 
I believe I will develop DR due to my diabetesd 4.03 (1.45) 4.14 (1.62) .734 
Expect to be diagnosed with DR at next  
eye checkd 
2.97 (1.47) 2.43 (1.66) .114 
Can reduce risk of vision problems…d 2.32 (1.44) 1.43 (0.79) .002 
If I did NOT have an eye health check for DR, I would feel…d 
  ...concerned 5.03 (1.70) 5.88 (1.40) .007 
  ...fearful  4.48 (1.79) 5.13 (1.70) .073 
  ...worried 4.65 (1.80) 5.53 (1.47) .007 
My family/close friends would approve…d 5.94 (1.69) 6.82 (0.80) .008 
I plan to attend an eye health check…d 4.26 (2.32) 6.76 (0.77) <.001 
I intend to have an eye health check…d 4.42 (2.32) 6.74 (0.77) <.001 
BEHAVIOURAL SKILLS ITEMSb,e                       How confident are you that you... 
…know steps to reduce the risk of  
developing DR 
2.39 (1.17) 3.06 (1.29) .012 
…will remember to have an eye health check… 2.68 (1.35) 4.36 (0.90) <.001 
…can talk to your doctor about your eye health 3.39 (1.28) 4.17 (1.03) .001 
…can find the time to attend an eye health 
check 
2.74 (1.37) 4.55 (0.75) <.001 
…can afford to pay for the eye health check… 2.68 (1.49) 3.52 (1.48) .008 
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Legend: DR: diabetic retinopathy. Data are number (%) of participants who 
answered each item correctly (Knowledge items); mean (SD) Motivation and 
Behavioural skills items.  p-value is Pearson’s Chi-Square (or Fisher’s exact test if 
expected cell count<5), or Independent-samples t-test (two-sided); statistical 
significance p<0.01. aGlycated haemoglobin (measure of average blood glucose over 
the past 8-12 weeks, and indicator of DR risk). bValid n: 121 (motivation items), 120 
(behavioural skills items). Item response range: c1 (Strongly disagree) to 5 (Strongly 
agree), d1 (Strongly disagree) to 7 (Strongly agree), e1 (Not at all confident) to 5 
(Extremely confident). 
______________________________________________________________ 
Almost all participants (irrespective of previous screening behaviour) knew of 
a link between diabetes and vision loss. However, compared to their non-screening 
counterparts, those who had previously screened knew that all people with diabetes 
were at risk of DR, the clinically-recommended HbA1c (average blood glucose) target 
for DR prevention, when to initiate screening and recommended screening intervals.   
Overall, participants who had screened indicated more positive attitudes 
towards the behaviour (e.g. empowering, reassuring and important) than those who 
had not screened. No differences were observed between groups on how pleasant 
or comfortable the eye check was perceived to be, although scores were lower for 
all participants compared to other attitude items. Perception of personal risk of 
vision problems and DR were moderate for all participants with low expectations of 
a DR diagnosis in the short term. Although all participants believed they could not 
reduce their risk of vision problems, those who had screened held this belief more 
strongly. All participants reported negative emotions when thinking about not 
screening, including fear, which was high for both groups.  Compared to their non-
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screening counterparts, those who had previously screened reported greater 
concern and worry at the prospect of not screening.   Participants who had 
previously screened were significantly more likely to agree that significant others 
(i.e. family/friends, healthcare team) would approve of screening.  Intention to 
screen was high among all participants but significantly higher for those who had 
previously screened compared to those who had not.  
Those who had screened previously reported significantly greater confidence 
on all aspects of behavioural control over screening (e.g. how to make an 
appointment for screening, ability to screen regularly, remember and attend an 
appointment). No differences were observed between groups on confidence in 
knowing the steps that can be taken to reduce the risk of DR, although scores were 
lower for all participants compared to other behavioural control items. Those who 
had screened also reported significantly higher confidence in overcoming common 
screening barriers (including time and cost, and discussing diabetes and DR with 
healthcare professionals).   
4.4.1.2.3 Summary of key learnings from needs assessment. Key learnings 
from the literature review, qualitative interviews and quantitative survey are 
summarised in Table 13 below. 
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Table 13: Key lessons learned from needs assessment 
1. Compared to their older adult counterparts, young adults with T2D have 
different psychosocial and information needs.  
2. There is a lack of behavioural interventions focused on encouraging screening 
uptake among young adults with T2D, indicating that development of a tailored 
intervention is warranted.   
3. Perceived barriers to and facilitators of screening (which are modifiable and 
within the scope of the current intervention) include: 
 Knowledge: diabetic retinopathy (awareness of asymptomatic nature of DR 
high personal DR risk, modifiable risk factors), screening (consequences of 
not screening, role of screening in early detection of DR and subsequent 
benefit of timely treatment, distinction between standard eye check and 
retinal screen) 
 Attitudes: low perception of personal risk, recognition of the benefit of 
screening 
 Normative beliefs: awareness of screening approval by significant others, 
and screening approval and behaviour of similar others 
 Intention: low prioritisation of target behaviour  
 Behavioural skills: self-efficacy in overcoming common screening barriers to 
ensure screening attendance (e.g. lack of time or resources), engagement 
with healthcare (sharing diabetes diagnosis, participation in diabetes self-
management behaviours) 
 
The survey identified that compared to their non-screening counterparts, 
those who had previously attended screening reported: significantly higher 
knowledge of both DR and retinal screening; more positive attitudes towards 
screening; stronger agreement that significant others would approve of the 
behaviour; higher intention to screen; greater perceived behavioural control (i.e. 
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confidence that they could arrange and attend screening when due), and greater 
confidence in addressing common screening barriers. 
The findings suggest that messages highlighting the prevalence of DR and link 
between DR and diabetes duration are warranted to prompt reassessment of 
personal risk.  Information on modifiable DR risk factors (blood glucose, blood 
pressure and cholesterol), asymptomatic nature of the condition and screening 
guidelines are needed to encourage individuals to both reduce DR risk and initiate 
screening.  
Messages designed to highlight the health and material consequences of 
screening, including likely positive emotional consequences, are warranted in order 
to promote positive screening attitudes. Findings suggesting that all participants 
perceived screening as potentially ‘unpleasant’, ‘uncomfortable’ and disruptive to 
normal activities are realistic considering that many people experienced discomfort 
and delay from pupil dilation (mydriasis) drops.  Consequently, positive messages 
should be balanced by acknowledgement of the potential for negative consequences 
related to mydriasis in order to maintain credibility.   
Although moderately high levels of distress in the priority population mean 
that it is important to avoid direct ‘fear appeal’ messages, low anticipated regret 
scores for those who had not screened reinforce the need for messages which 
emphasise personal susceptibility and describe the likely consequences of not 
screening. Similarly, responses to risk perception items point to a possible unrealistic 
level of optimism, highlighting the need to emphasise personal susceptibility while 
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providing information-based content on steps that can be taken to reduce DR risk.   
As with many other preventive behaviours, awareness of the potential effectiveness 
of screening followed by subsequent protective action did not necessarily result in 
intention formation or prioritisation of preventive intentions. Cognitive dissonance 
induction techniques have been found to have generally positive effects on changing 
attitudes, motivations and health-related behaviour patterns (Freijy & Kothe, 2013). 
Consequently, we selected dissonance reduction as a technique that could promote 
screening motivation. 
Responses to normative behaviour items suggest that messages that provide 
information about significant others’ approval are warranted.  The findings suggest 
that inclusion of procedural information and messages to promote confidence in 
knowing steps that can be taken to reduce DR risk including how to book and 
remember a retinal screen, as well as overcoming common barriers are warranted.  
Emphasis is required to minimise misconceptions about some barriers (e.g. inclusion 
of messages which accurately describe the cost and time taken for the procedure).   
4.4.1.3 Logic model of the problem.  Giving consideration to both the 
qualitative and quantitative needs assessments, we synthesised our findings into a 
logic model for DR screening.  The aim of the logic model was to identify the 
pathways of problem causation moving from determinants, to low screening rates 
and consequent impact on health and quality of life (Figure 5). 
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    DR: diabetic retinopathy, GP: general practitioner, HCP: healthcare practitioner, T2D: type 2 diabetes.  
    *Identified in the needs assessment but cannot be modified by the current intervention. 
 
Figure 5: Logic model of the problem 
 
Personal determinants 
(at-risk group) 
Modifiable 
• Knowledge 
• Attitudes 
• Normative beliefs 
• Intention 
• Behavioural skills 
Behaviour and Environmental factors 
Behaviour (at-risk group) 
Delay or failure to initiate uptake of DR 
screening after diabetes diagnosis 
• Failure to detect DR at the early,  
   asymptomatic stage 
• Lack of timely DR treatment 
• DR leading cause of vision loss in  
   working age adults 
Health problem 
Impact of vision loss: quality of life 
• Restricted lifestyle, social isolation 
• Loss of independence 
• Risk of injury (falls) 
• Loss of employment, economic  
   impact 
• Relationship stress, depression  
   and adjustment/coping issues 
Non-modifiable environmental factors* 
Organisational 
• Model of care not suited to needs of    
   target groups (incl. lack of support  
   networks) 
• Clinical inertia 
• Workplace inflexibility 
Community 
• Cost of retinal screening 
• Access to eye care specialists 
Society 
• Diabetes-related stigma 
Non-modifiable* 
• Socioeconomic status 
• General and health literacy  
• Cultural diversity 
• Life stage demands 
• Multimorbidity 
• Complex treatment regimen 
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4.4.1.4 Context of the intervention and program goals. The intervention was 
to be evaluated and implemented in a real-world setting where intervention format 
and delivery medium were dictated by broader policy-level initiatives and a fixed 
delivery timeline.  The intervention was funded by Vision 2020 Australia and 
grounded within a suite of Vision Initiative projects collectively designed to achieve 
the aims of the Commonwealth government ‘National Framework for Action to 
Promote Eye Health and Prevent Avoidable Blindness and Vision Loss’ 
(Commonwealth of Australia, 2005). Vision Initiative policy required that the 
resource be targeted at the individual-level and delivered directly to eligible young 
adults with T2D (NDSS registrants). As such, it was determined by the planning team 
members who were involved in conception of the study, that the most efficient, 
cost-effective way to meet these criteria was for the intervention to take the form of 
a leaflet, to be posted to eligible NDSS registrants. Furthermore, this enabled the 
leaflet to be included in future ‘NDSS starter packs’ for new registrants, and to be 
made available online. This decision was supported by previous research, which 
showed that printed materials are acceptable to young adults with T2D, who give 
preference to consistent, centralised information over format, and who specifically 
state that the NDSS ‘starter pack’ is a useful resource . 
 With 86% of Australians with T2D registered, the NDSS is considered the 
“best available source to monitor type 2 diabetes in children and young people in 
Australia” (p.36, 2014).  However, the NDSS database primarily records registrant 
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postal addresses, which necessitated the use of a print-based intervention tool that 
could be posted to registrants.  
Overall, the purpose of the intervention was to promote uptake of screening 
among young adults with T2D.  Accounting for real-world logistical considerations, 
the program goal was to develop a leaflet intervention that: could be delivered by 
post, was tailored to young adults with T2D, and included persuasive messaging 
targeting behavioural determinants of the target behaviour.  
4.4.2 Program outcomes and objectives; logic model of change. 
4.4.2.1 Expected behavioural outcomes and Performance Objectives. The 
multidisciplinary planning team defined a single, measurable primary outcome when 
planning for the subsequent evaluation (uptake of screening for those young adults 
with T2D who had not previously screened for DR), and multiple secondary 
outcomes (i.e. change in nominated modifiable behavioural screening 
determinants). 
Working from the designated program outcomes, and informed by the 
findings of the needs assessment, the planning team established the foundation for 
the intervention by defining four Performance Objectives (PO, Table 14). We 
increased the specificity of each Performance Objective by defining sub-objectives, 
each identifying a behaviour or cognitive process that would promote screening 
uptake. 
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Table 14: Performance Objectives (e.g. PO.1) & sub-objectives (e.g. PO.1.1, PO.1.2..) 
Young adults with type 2 diabetes will… 
PO.1. … demonstrate a clear understanding of diabetic retinopathy (DR) 
PO.1.1 Modifiable and non-modifiable DR risk factors  
PO.1.2 Clinical targets for reducing risk of DR 
PO.1.3 Symptoms of DR  
PO.1.4 Role of DR in vision loss  
PO.1.5 Prevalence of DR 
PO.2. …demonstrate clear understanding of retinal screening 
PO.2.1 Role in detecting DR and reducing vision loss 
PO.2.2 Screening procedure and experience 
PO.2.3 Booking and examination procedure 
PO.3. …be motivated to engage in retinal screening 
PO.3.1. Prioritise retinal screening  
PO.3.2. Understand personal risk of DR 
PO.3.3. Identify personal barriers to retinal screening 
PO.3.4. Perceive personal responsibility to engage in screening  
PO.4. …proactively engage with the healthcare system and their healthcare team 
PO.4.1 Discuss diabetes and eye health with healthcare professionals 
PO.4.2 Understand treatment benefits and options 
PO.4.3 Seek more information about diabetes and eye health 
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4.4.2.2 Create logic model of change. We developed a logic model of change 
(Figure 6) to depict the hypothetical causal pathway from the intervention to 
program outcomes, and anticipated health and quality of life improvements. 
Commencing with the intervention, we outlined the five modifiable behavioural 
determinants (from Figure 5) and four Performance Objectives (Table 14), which 
were expected to change the measurable behavioural outcome. The planning team 
also acknowledged external factors that may affect screening behaviour (i.e. factors 
that cannot be changed through an individual-level intervention) in the logic model, 
even though these were beyond the scope of our intervention. 
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Behavioural  
Determinants  
 
• Knowledge 
• Attitudes  
• Normative  
   beliefs 
• Intention 
• Behavioural skills 
Long term impact 
Health problem 
• Reduce risk of DR by managing 
modifiable risk factors 
• Prevent vision loss from DR by 
early detection and timely 
treatment 
Quality of life 
• Maintain independence, 
workforce participation, family 
functioning 
              
Leaflet 
intervention 
tailored to 
young 
adults with 
T2D 
Intervention 
Outcome 
 
Uptake of 
screening for 
young adults with 
T2D who had not 
screened for DR 
since diabetes 
diagnosis 
Other factors (e.g. economic, access, language and cultural) 
Identified in the needs assessment but cannot be modified by the current intervention 
Performance 
Objectives 
 
• Understand DR  
• Understand retinal  
  screening 
• Motivated to screen 
• Engage with  
  healthcare 
                                 T2D: type 2 diabetes, DR: diabetic retinopathy, GP: general practitioner 
 
Figure 6: Logic model of change 
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4.4.2.3 Create matrix of Change Objectives.  Once the health behaviours, 
Performance Objectives and determinants were defined, Change Objectives were 
developed. Change Objectives are integral to intervention content because they 
represent the behaviour or cognition being targeted.  A sub-group of the planning 
team generated Change Objectives by creating a matrix, with modifiable behavioural 
determinants (in columns) and sub-objectives (in rows).   
Table 15 presents a matrix of Change Objectives for Performance Objective 3 
(Young adults with type 2 diabetes will be motivated to engage in retinal screening). 
To illustrate, two Change Objectives were generated for sub-objective 3.2 
(Understand personal risk of DR), at the intersection with two determinants 
(knowledge and attitudes). The first (K.3.2) sought to improve knowledge that risk of 
DR increases over time, and the second (A.3.2) sought to change attitudes regarding 
personal risk and susceptibility to DR. See Table 20 (Additional files) for a complete 
matrix of Change Objectives. 
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Table 15:  Illustrative matrix of Change Objectives for Performance Objective 3 (PO.3) - Young adults with type 2 diabetes will be 
motivated to engage in retinal screening* 
Sub-objectives^ 
Modifiable behavioural determinants 
Knowledge Attitudes Normative beliefs Intention Behavioural skills 
PO.3.1 Prioritise 
retinal screening  
  NB.3.1 Recognise 
that similar others 
have overcome 
screening barriers 
I.3.1 Form an 
intention to 
prioritise retinal 
screening 
 
PO.3.2 
Understand 
personal risk  
of DR 
K.3.2 Know that DR 
risk increases over 
time 
A.3.2 Perceive 
high personal risk 
and susceptibility 
to DR 
   
PO.3.3  Identify 
personal barriers 
to retinal 
screening 
 A.3.3 Believe that 
attending 
screening will 
relieve fear and 
guilt and be a 
positive 
experience 
NB.3.3 See that 
similar others face 
screening barriers 
(e.g. cost, fear of 
adverse effects) 
 BS.3.3 Be confident 
in one’s ability to 
identify and 
overcome common 
screening barriers  
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Table 15:  Illustrative matrix of Change Objectives for Performance Objective 3 (PO.3) - Young adults with type 2 diabetes will  
                           be motivated to engage in retinal screening* (Cont.) 
Sub-objectives^ 
Modifiable behavioural determinants 
Knowledge Attitudes Normative beliefs Intention Behavioural skills 
PO.3.4 Perceive 
personal 
responsibility  
to engage in 
screening  
K.3.4 Know that 
they can take steps 
to protect eye 
health 
A.3.4 Adopt 
personal 
responsibility for 
retinal screening 
NB.3.4 Believe that 
similar others take 
responsibility for 
their own eye health 
 BS.3.4 Be confident 
they have the tools 
to act on personal 
responsibility 
^See Table 14 for full list of Performance Objectives and sub-objectives 
*Full matrix of Change Objectives for every Performance Objective is provided in Additional file 3 
PO=performance objective, DR=diabetic retinopathy, GP=general practitioner.  
Determinants: K=Knowledge, A=Attitudes, NB=Normative Beliefs, I=Intention, BS=Behavioural Skills 
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4.4.3 Intervention design. 
4.4.3.1 Intervention themes, components, scope and sequence.  Ensuring 
that all components of the intervention reflected the needs and preferences of 
young adults with T2D was a crucial consideration for the planning team.  The health 
behaviour change and health communication literature provided ample foundation 
on best practice presentation of message content (Abraham & Kools, 2012; Bailey et 
al., 2014; Bartholomew Eldredge et al., 2016; Beard, Clark, Hurel, & Cooke, 2010; 
Browne et al., 2014; Browne et al., 2013; Cialdini & Goldstein, 2004; Muller et al., 
2014; Werrij, Ruiter, van't Riet, & de Vries, 2012). Informed by this evidence and the 
findings of the needs assessment, we developed seven guiding principles for leaflet 
intervention design (Table 16). Consultation with young adult PPI members and 
experts from key stakeholder groups confirmed that these were appropriate guiding 
principles from their perspective.  
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Table 16: Guiding principles for retinal screening leaflet intervention design 
Readability and comprehension: content to be written to acceptable (health) 
literacy standards, with minimal technical or medical terminology (Bailey et 
al., 2014; Beard et al., 2010). 
Scope: the scope of intervention messages to be restricted to targeting individual-
level, modifiable behavioural determinants. 
Framing: despite long term benefit, retinal screening can be considered a high-risk 
behaviour due to the potential for immediate DR diagnosis (Werrij et al., 
2012).  Loss-framed messages are effective in promoting engagement with 
high-risk behaviours and will be used in this leaflet (Bartholomew Eldredge 
et al., 2016).  The majority of headings to be framed as questions to engage 
the reader while minimising any potentially defensive reaction (Muller et al., 
2014).   
Sequence: content to follow the logical order of reading. In order to balance loss-
framed messages against the high levels of diabetes-related distress and 
anxiety experienced by young adults with T2D (Browne et al., 2014; Browne 
et al., 2013), potentially threatening content to be immediately followed by 
an empowering or reassuring statement.   
Use of quotes: in recognition of the subtle aspects of social influence, where an 
individual’s’ beliefs are influenced by those accepted and encouraged by the 
majority (Cialdini & Goldstein, 2004), quotes from similar others to be used 
to reinforce key persuasive messages.  All quotes to be sourced verbatim 
from interview study with descriptors (age and diabetes duration) included 
to reinforce group membership. 
Credibility: quote descriptors within the leaflet to reflect demographic 
characteristics of the priority population to prompt identification with a 
credible source.  Similarly, logos of leading diabetes and eye health 
organisations that had contributed to the content to be included to enhance 
credibility of information.  Important yet necessary negative information 
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(e.g. discomfort associated with mydriasis, time required to recover clear 
vision) to be included to provide balance. 
Graphics and imagery: to reflect the demographic characteristics of the priority 
population (e.g. young adults from a range of ethnicities, with and without 
children).  National interpreter symbol to indicate availability of language 
assistance services to those with limited English proficiency (Abraham & 
Kools, 2012). 
 
4.4.3.2 Choose theory and evidence-based behaviour change methods. 
Having established guiding principles, the planning team selected types of theory-
based psychological change techniques (or change strategies) (Abraham, 2012; 
Abraham & Michie, 2008) grouped into six broad change mechanisms designed to 
‘boost motivation and prompt action’ (Abraham, 2012, p.104). The constituent 
techniques (or practical methods) included in the leaflet focused on: i) changing 
beliefs about the benefits of screening (e.g. providing general information on 
behaviour-health links, describing likely consequences of behaviour); ii) changing 
risk perception (e.g. emphasising personal susceptibility to negative consequences, 
prompting recipients to assess own risk); iii) changing attitudes associated with 
screening uptake (e.g. describing likely emotional or affective consequences, 
potentially inducing cognitive dissonance among those not intending to act in the 
face of negative consequences); iv) changing (normative) beliefs about others’ 
behaviour (e.g. emphasising significant others’ approval of screening behaviour, 
providing information about others’ screening behaviour); v) fostering a positive 
screening identity (e.g. providing a positive group identity for those engaging in 
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screening); and vi) enhancing self-efficacy (e.g. using persuasive argument to bolster 
self-efficacy, providing instruction, prompting barrier identification and planning in 
relation to anticipated barriers, prompting goal setting). 
4.4.4 Intervention development. 
4.4.4.1 Draft persuasive message content and leaflet.  
Develop message content: Working from the matrix of Change Objectives, 
the guiding principles, and theory and evidence-based intervention strategies noted 
above, a pool of more than 60 persuasive messages was developed.  From this pool, 
specific change techniques or practical methods were selected to encourage 
screening.  For example, to achieve Change Objective A.3.4 (View retinal screening 
as a personal responsibility), four potential leaflet heading messages were 
developed: ‘Eyes: they’re important any way you look at it’, ‘The only way to know is 
to go…’ (verbatim quote), ‘Who is looking after your eyes?’, and ‘Looking at the 
facts’.  All messages were reviewed by the planning team, and a sub-set selected 
based on the perceived capacity of the message to achieve program goals, target 
individual Change Objectives, and satisfy the leaflet guiding principles.  Thus, in the 
above example, the third option (‘Who is looking after your eyes?’) was selected 
because it was phrased as an engaging question, promoting personal responsibility 
with potential to reduce defensive reaction while motivating screening.   
A selected example, linking leaflet content to Performance Objective 3, is 
presented in Table 17. Full intervention map detail for all Performance and Change 
Objectives is provided in Table 21 (Additional files).  
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Table 17: Illustrative intervention map linking leaflet content directly back to Performance Objective 3 (PO.3: Young adults with T2D 
will be motivated to engage in retinal screening) 
Sub-objective (i.e. 3.1) and 
related Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
number* 
PO.3.1 Prioritise retinal screening 
 NB.3.1 Recognise that similar 
others have overcome 
screening barriers 
(Jenny’s story: before and after the eye health check) 
“I was scared.  I was scared of what damage was done…of confronting the fact that  
my eyesight could be damaged, and of going through the exam and being  
confronted with what’s there.” 
7 
 I.3.1 Form an intention to 
prioritise retinal screening 
(What can I do to protect myself from DR and prevention vision loss?)  
1. Have a diabetes eye health check. 
(Note: eye health check listed as Step 1, highest priority) 
5 
PO.3.2 Understand personal risk of DR 
 K.3.2 Know that DR risk 
increases over time  
The longer you have diabetes the more at risk you are of DR. 
1 
 A.3.2 Perceive high personal 
risk and susceptibility to DR 
 
 
 
 
Image: mother and daughter smiling. Child holding hands over mother’s eyes 
But I'm still young.  Am I at risk of DR?  
Yes you are.  Anyone with diabetes can develop DR, which is the leading cause of  
vision loss for people under 60 years. 
There are over 34,000 Australians with type 2 diabetes who are under 40 years of age.  
More than 8,500 will already have DR. 
The longer you have diabetes the more at risk you are of DR. 
 (Lucas, aged 34, diagnosed with type 2 diabetes 2 years ago) 
 
1 
1 
 
1 
 
1 
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Sub-objective (i.e. 3.1) and 
related Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
number* 
"I didn't know that I was at risk."  
 (Jane 25 years, diagnosed with type 2 diabetes 3 years ago) 
"You might have good vision, you might think that your eyes are absolutely brilliant  
and there's no issue.  But in the back of your eye, there could be a problem with  
those little tiny veins that you don't realise." 
1 
 
 
4 
PO.3.3 Identify personal barriers to retinal screening 
 A.3.3 Believe that attending 
screening will relieve fear and 
guilt and be a positive 
experience 
(Jenny’s story: before and after the eye health check) 
“It was actually quite fun; I don’t know why I put it off. I was really scared going in  
there, but definitely not now – I’m not fazed by it at all.” 
 
 
7 
 NB.3.3 See that similar others 
face screening barriers (e.g. 
cost, fear of adverse effects) 
(Jenny’s story: before and after the eye health check) 
“The eye drops were a bit uncomfortable and there was a small cost – but I think it’s  
a wise spend considering what you’re preventing.”   
 
7 
 BS.3.3 Be confident  
in one’s ability to identify and 
overcome common screening 
barriers  
(What else do I need to know?) A diabetes eye health check takes about 30 minutes.  
(What else do I need to know?) It may be free (bulk-billed) or there may be a small fee.   
 
(What else do I need to know?) Your optometrist may use eye drops which helps them to 
see the back of your eye.  If you do have eye drops, they may be a little uncomfortable.  
The drops will also leave you sensitive to light, so bring your sunglasses and be prepared to 
wait a while for your vision to return to normal. 
 
 
 
6 
6 
 
6 
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Sub-objective (i.e. 3.1) and 
related Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
number* 
PO.3.4 Perceive personal responsibility to engage in screening 
 K.3.4 Know that they can take 
steps to protect eye health 
What can I do to protect myself from DR and prevent vision loss? 5 
 A.3.4 Adopt personal 
responsibility for retinal 
screening  
"I'm a busy person and my family depend on me.”  
 
Leaflet heading: Who is looking after your eyes? 
1 
 
3 
 NB.3.4 Believe that similar 
others take responsibility for 
their own eye health 
Images: mother and daughter, smiling couple selfie, young man  
of indeterminate cultural origin, Asian female (a.k.a. ‘Jenny’) 
1,3,5,8 
 BS.3.4 Be confident they have 
the tools to act on personal 
responsibility 
Leaflet sub-heading: Your guide to preventing vision loss from diabetes eye disease 
Protect your sight for life 
3 
2 
Complete intervention map for all Performance and Change Objectives is provided in Additional file 5.  
PO=Performance Objective (in bold), DR=diabetic retinopathy. ^See Table 15 for illustrative matrix of Change Objectives and 
Additional file 3 for complete matrix.   
*See Figure 7 for leaflet panels.   
Determinants: K=knowledge, A=attitudes, NB=normative behaviour, I=intention, BS=behavioural skills. 
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Assessing readability and suitability: The leaflet was assessed using a 
combination of an online readability consensus calculator and the Suitability 
Assessment of Materials (SAM) test, consistent with best practice (Ryan et al., 2014).  
The consensus calculator reports synthesised results from seven assessment tools 
(e.g. Flesch Reading Ease formula, Flesch-Kincaid Grade), to provide two composite 
scores by grade (range: 4-9) and reading level (range: 0-29 ‘very confusing’ to 90-100 
‘very easy’) (Scott, 2016). The SAM test uses six evaluation criteria (content, literacy 
demand, graphics, layout and type, learning stimulation and motivation, cultural 
appropriateness) to determine overall suitability (Doak, Doak, & Root, 1996), with 
scores summed and converted to a percentage score and classified as ‘not suitable’ 
(0-39%), ‘adequate’ (40-69%), or ‘superior’ (70-100%).   
We excluded the front and back panels of the ‘Who is looking after your 
eyes?’ leaflet from assessment, as they included minimal text. For the remaining 
panels, the median readability consensus grade was 6; median reading ease level 
was 75.6 (fairly easy), and SAM test outcome was 75% (superior).  
Draft intervention materials: The planning team selected an 8-panel leaflet 
design, with panels opening outward from the centre, which could fit into a standard 
DL-size envelope.  A range of leaflet design options were created in close 
consultation with a graphic designer who had expertise in producing health 
promotion materials for people with diabetes.  The designs varied in structure, 
imagery and organisation, but all adhered to the guiding principles and included 
consistent messaging.   
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4.4.4.2 Pre-test, refine and produce leaflet.  
Validation and pilot testing: The draft leaflet was reviewed by the planning 
team and representatives from key stakeholder organisations to confirm that all 
content was factually accurate and clinically appropriate, and that the resource was 
likely to meet the project objective.  Young adult PPI members participated in a 
thorough piloting process to determine whether: the images and quotes were 
culturally relevant and resonated with the reader; participants perceived the leaflet 
would have met their information needs at the time of their T2D diagnosis; and 
there were any unintended adverse effects in the messaging, imagery or format.  
Each young adult PPI member received the draft leaflet by post and, after reviewing 
it, participated in a telephone interview during which they commented on the 
leaflet’s suitability, responding to questions based on the SAM criteria (Doak et al., 
1996).   
Feedback from stakeholder reviewers was positive, with minimal critique 
offered. Young adult PPI members gave more considered commentary on what they 
found useful and what could be improved (Table 18). Where appropriate, the leaflet 
was revised to improve content, imagery, readability and cultural acceptability. Once 
finalised, leaflet printing was managed by Diabetes Victoria (the state agent of the 
NDSS). 
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Table 18: Suitability Assessment Materials (SAM) evaluation criteria, young adults’ feedback and changes made to leaflet 
Sample pilot questions Young adults’ feedback Changes to leaflet 
Content: Do you think that this leaflet 
achieves the purpose of the project? 
 Did you learn anything new?   
 
“Key information came through really clearly. I didn’t know 
that early DR doesn’t have any symptoms…the doctors tend 
to focus on blood glucose, so I knew the 7% (HbA1c) but I 
didn’t know what the cholesterol target and normal blood 
pressures were.” ID32 
“This leaflet improved my intentions. (DR) is not something 
you would think could happen to young people.” ID32 
"’Protect your sight for life’ is a powerful statement. “ ID36 
 
Make ’Protect your 
sight for life’ a stand-
alone statement and 
place at top of panel 2, 
which signposts 
location of more 
information 
Literacy demand: Was the length of the 
leaflet acceptable to you?  
 How about the number of words? 
 How easy was it to read and understand 
the information in the leaflet?  
 Are the words used simple, clear and 
informal?  
 Were medical terms defined 
adequately? 
“It only took about 5 minutes to read.” ID33 
“Language is pretty relaxed which is good for young people.” 
ID40 
“The only thing that caught me was ‘DR’.  Did you mean 
‘doctor’ or ‘diabetic retinopathy’? I think you should bold it 
when it is first defined.”  ID32 
  
Discuss whether to 
include ‘DR’ in leaflet.  
By consensus, a 
decision was made to 
include it, but to bold 
initial definition of 
diabetic retinopathy 
and DR acronym at top 
of panel 4. 
 
Graphics: What do you think of the front 
panel image? 
“Very professional.  Looks like it's targeted at my 
demographic.”   ID36 
Bold text ‘When 
diabetes is first 
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Sample pilot questions Young adults’ feedback Changes to leaflet 
 Are the other images and graphics 
‘friendly’ and relevant? 
“Maybe bold ‘When diabetes is first diagnosed’ so that you 
hammer home that it’s never too early to have an eye 
check.”  ID32 
“I’ve never really looked at a graph in a pamphlet. It might 
appeal to some people, but I don’t know…” ID40 
 
diagnosed’ in panel 5. 
Remove graph, which 
depicted rate of DR 
progression over time. 
Layout and typography: What do you 
think of the sequence of information? 
 Is the text type size and font easy to 
read, or could it be easier?  
 Is the information in the leaflet well-
spaced, or does it appear cluttered or 
confusing?  
“Main headings need to be in a larger sized font and bold, 
and sub-headings in smaller font.  Keep the blue colouring.” 
ID39 
“Is there a way that you can make more white space? The 
different colours are more attractive.” ID33 
 
Learning stimulation, motivation: 
Thinking back to when you first were told 
that you had diabetes or when you learnt 
that diabetes could affect the eyes – 
would the leaflet have met your 
information needs at that time? 
 Do you feel that the leaflet is friendly or 
formal? 
 Do you feel like you want to read it now 
or later?  Why? 
“Jenny’s story is a good thing to have in there.  Including 
name, age and diabetes duration makes the quotes more 
meaningful.” ID39 
“Wow, that looks awesome…I didn’t expect to see two 
smiling faces on the front because most diabetes things are 
all doom and gloom, they’re so terrifying and then you don’t 
want to read them.  Whereas, I read this and thought, this 
was a reminder for me to book in for my eye check.”ID40 
“I loved the ‘What happens if I had DR’ section.  I kept putting 
off an eye check because I was scared of what would happen. 
Revisit Performance 
Objectives to include 
understanding the 
treatment options 
(PO.4.2), populating 
this through the matrix 
of Change Objectives 
and into the leaflet 
content.  Add more 
treatment detail to 
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Sample pilot questions Young adults’ feedback Changes to leaflet 
Can you add more about what the treatment is?” ID32 panel 8. 
Cultural appropriateness: Do the quotes 
represent key emotions or experiences 
that you have felt about eye 
examinations? Was the language used 
throughout the leaflet familiar and 
culturally appropriate to you? 
 Were there any sections that you found 
confusing or were unsure about? 
“I love the pictures; they speak to different cultural 
backgrounds.” ID32 
“English is not my first language, but I didn’t have any 
problem reading the leaflet.” ID33 
 
Retain multicultural 
imagery. 
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4.4.5 Intervention implementation. Planning for program adoption and 
implementation started at study commencement and was heavily influenced by 
contractual obligations with the funder. These included a one-off statewide 
distribution of the leaflet to all eligible NDSS registrants, timed to coincide with 
Vision 2020 Australia public awareness campaign.   
To protect registrants’ privacy, the NDSS distributed the final leaflet 
(presented in Figure 7) directly to members of the priority population, on behalf of 
the planning team.  Plans are underway for a revision of the NDSS ‘starter pack’ to 
include the eye health leaflet for young adults with T2D, ensuring long-term 
sustainability of the intervention. Further, to enhance reach, an electronic copy of 
the leaflet was made freely available via Diabetes Victoria and Vision 2020 Australia 
(Diabetes Victoria; Vision 2020 Australia, 2017) and promoted to healthcare 
professionals and members of the priority population. 
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 Figure 7: ‘Who is looking after your eyes?’ tailored leaflet                                 © Vision 2020 Australia, 2017. All rights reserved. 
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Figure 7: ‘Who is looking after your eyes?’ tailored leaflet                                 © Vision 2020 Australia, 2017. All rights reserved. 
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4.4.6 Planning for intervention evaluation. Similarly, evaluation planning 
started at study commencement. The planning group determined that the best 
method of evaluation of the leaflet intervention was a two-arm, wait-list 
randomised controlled trial with screening uptake as the primary outcome and 
change in modifiable behavioural determinant constructs as secondary outcomes.  
The trial, registered with the Australian and New Zealand Clinical Trials Registry 
(ACTRN12614001110673), is now complete, and a manuscript is in preparation.  
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4.5 Discussion 
Uptake of retinal screening from diabetes diagnosis is crucial for the early 
identification of DR. In this study, we undertook the systematic development of an 
evidence-based health behaviour change intervention tailored to the needs of a 
priority population, young adults with T2D, who are at risk of low retinal screening 
uptake and vision loss from DR.  
To date, lack of information on the determinants of retinal screening 
behaviour among young adults with T2D, and on the elements of individual-level DR 
screening interventions (Lawrenson et al., 2016), has hampered development of 
effective, targeted intervention strategies for this priority population.  Further, 
previous print-based retinal screening interventions have been limited in focus, 
aiming primarily to increase knowledge and awareness of DR, and of retinal 
screening, and neglecting to target other behavioural determinants, such as social 
norms and intentions (Lawrenson et al., 2016; Zhang et al., 2007), despite the 
acknowledged role of psychosocial factors in health behaviour (Michie & Abraham, 
2004).  
The needs assessment described here is the first large-scale, mixed-method 
exploration of modifiable behavioural factors impacting retinal screening behaviour 
among young adults with T2D. The findings highlighted that many of clinical and 
psychosocial barriers to diabetes self-management faced by young adults with T2D 
more broadly (Auslander, Sterzing, Zayas, & White, 2010; Brouwer et al., 2012; 
Browne et al., 2014; Browne et al., 2013; Hessler et al., 2011; Savage et al., 2009; 
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Sillars, Davis, Kamber, & Davis, 2010; Waitzfelder et al., 2011), also apply to retinal 
screening.  Importantly, when compared to older adults with T2D, young adults with 
T2D face both an accumulation of barriers to retinal screening, and a number of 
uniquely salient barriers and facilitators (Lake et al., 2017), warranting tailored 
intervention.  
Combined with consensus-driven selection of Performance Objectives, 
theoretically-grounded change methods and comprehensive pilot and review, IM 
provided the means by which to develop a retinal screening promotion intervention 
that was both evidence-based and sensitive to the needs and characteristics of 
young adults with T2D.  However, despite this being a relatively simple, single-focus 
intervention, we shared the experience of other programmes, which reported the 
IM process to be both resource and time-intensive (Gray-Burrows et al., 2016; 
Greaves et al., 2016; Hurley et al., 2016).  In particular, we found the high degree of 
process documentation time-consuming, although we acknowledge that this activity 
was crucial for transparency of reporting, and conforms to key items in the Template 
for Intervention Description and Replication (TIDieR) checklist and guidance 
(Hoffmann et al., 2014).   
4.5.1 Strengths and limitations. The key strengths of this work relate to the 
use of the IM, which combines both innovative and traditional intervention 
development activities into an organised, systematic process, and which is 
consistent with the UK MRC framework for the design and evaluation of complex 
interventions (Craig et al., 2008).  In the face of limited existing evidence, the 
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empirical needs assessment, complemented by contribution from the 
multidisciplinary planning team, key stakeholders and the young adults with T2D PPI 
group, enabled comprehensive exploration of the problem, providing a robust 
foundation to the intervention. Further, the use of sound theoretical underpinnings, 
causal modelling, and detailed pilot and review, provided assurance as to the validity 
of the outcome.  As such, the ‘Who is looking after your eyes?’ leaflet was both 
evidence-based and sensitive to the needs and characteristics of young adults with 
T2D. 
Nonetheless, this study was subject to several limitations.  First, the vast 
majority of studies targeting youth and young adults with T2D face recruitment 
challenges (Browne et al., 2013; Nguyen et al., 2014; Speight, Browne, Holmes-
Truscott, Hendrieckx, & Pouwer, 2012), and our empirical studies were no different 
in this respect. Despite numerous steps taken to improve recruitment, only 10 young 
adults with T2D participated in the qualitative study and only 2% of the eligible 
population completed the quantitative online study.   
It is likely that recruitment was impacted by a range of challenges typically 
specific to young adults with T2D, such as social disadvantage, disengagement with 
existing services, and complex psychosocial and health needs (Lake et al., 2017; 
Nadeau et al., 2016; Nguyen et al., 2014; Zeitler et al., 2015). Furthermore, the 
needs assessment studies were conducted concurrent with a number of other 
research projects managed by the NDSS, which may have contributed to study 
‘fatigue’ for this already small population (personal communication, D. Rae, National 
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Inventory Manager, NDSS). Although low sample size potentially impacted the 
generalisability of the needs assessment findings, the response rate for the national 
survey was larger than any other conducted to date with this priority population.  
Second, this study was limited to one priority population where in fact, 
several populations have been identified as at-risk for low retinal screening and 
vision loss from DR. These include young adults with T1D, those living in socio-
economically deprived areas or from minority ethnic and Indigenous populations 
(Foreman et al., 2017; Moreton, Stratton, Chave, Lipinski, & Scanlon, 2017; Paksin-
Hall, Dent, Dong, & Ablah, 2013; Shi, Zhao, Fonseca, Krousel-Wood, & Shi, 2014), 
each of which warrant targeted evidence-based intervention, informed by 
population-specific needs assessments.    
Finally, many key contextual elements (e.g. intervention level, delivery 
medium and format) were externally prescribed within a broader sphere of real-
world logistic and contractual limitations.  Although unavoidable, this limitation 
meant that our intervention was unable to address external factors known to impact 
screening behaviour, such as the cultural diversity of young adults with T2D, low 
socioeconomic status and lack of English language proficiency, potentially limiting 
effectiveness. Given that NDSS database strictures limited the intervention to a 
format suited to postal delivery, the leaflet design was suited to the stated purpose 
for state-wide implementation.  Diabetes Victoria has ensured sustainability and 
reach of the intervention by regularly updating their resources and making an 
electronic version of the leaflet freely available on its website (Diabetes Victoria).  
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4.5.2 Future directions. Recent research suggests that an individual’s 
beliefs about diabetes and self-management, are most likely to be influenced early 
in their diabetes trajectory (Skinner et al., 2014). Certainly, this appears to be the 
case for retinal screening where, once initiated, the behaviour is generally sustained 
(Zhang et al., 2007). Thus, we recommend targeting individuals recently diagnosed 
with T2D via the NDSS, with registration date considered a proxy for date of diabetes 
diagnosis. The leaflet could be used to promote national retinal screening 
programmes in this age group and would be of greatest benefit if translated into 
additional languages. Further, this process could be utilised to produce tailored 
resources designed to increase awareness and screening for other populations at 
high-risk of DR (such as young adults with T1D), or for other diabetes-related 
complications which impact young adults with T2D (such as nephropathy and 
cardiovascular disease (Tryggestad & Willi, 2015)).   
Our experience of the time and resource-intensive nature of IM reinforces 
that expressed by others and we suggest that undertaking the full IM methodology 
may not be suitable for all situations.  As such, we recommend that future 
programme planners explore alternative options where possible, such as adapting 
an existing, effective intervention to their target population. This can be enabled by 
use of a simplified process (IM Adapt), which guides decisions regarding selection of 
appropriate intervention, and components, to adapt (Highfield et al., 2015). 
4.5.3 Conclusions. In conclusion, our mixed method needs assessment has 
highlighted salient challenges faced by young adults with T2D and we have 
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demonstrated that IM is a feasible and worthwhile approach to use for the 
development of an evidence-based, engaging resource to promote retinal screening 
to young adults with T2D.  This detailed illustration will enable researchers and 
health promotion specialists to adopt IM methods when developing interventions 
tailored to high-risk groups. Meanwhile, preliminary evaluation of the ‘Who is 
looking after your eyes?’ leaflet shows it meets the needs of young adults with T2D 
and its effectiveness in promoting uptake of retinal screening can now be evaluated 
in a fully-powered RCT.   
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4.8 Additional files 
4.8.1 Literature study 
Literature study procedure. We conducted a preliminary literature search 
(see box), which focused on screening facilitators and barriers, effective elements of 
existing individual-level screening interventions, and health information-seeking 
preferences and behaviours of the priority population.  The literature study was 
maintained throughout the project via regular updates from search alerts; search 
terms were reviewed annually.  
 
 Literature study findings.  
Screening facilitators and barriers: Although barriers and facilitators to 
screening varied across countries, healthcare systems and population groups, shared 
themes were identified. For example, screening uptake depended on population 
awareness of health risk (Strutton, Du Chemin, Stratton, & Forster, 2016), health 
consequences (MacLennan, McGwin, Heckemeyer, & et al., 2014) and treatment 
benefits following identification through screening (Hua, Cao, Cui, Maberley, & 
Search engines and key databases: Cochrane Reviews, EBSCOhost, ProQuest, Scopus, 
Psychlit, Medline, PubMed and CINAHL 
Publication period: 10 years prior to February 2013.   
Search terms: ‘young-onset’, ‘early-onset’, ‘young adult’, ‘type 2 diabet*’), in 
combination with terms associated with eye health and retinal screening uptake 
(‘barrier’, ‘challenge’, ‘facilitator’, ‘enabler’, ‘diabetic retinopathy’, ‘uptake’, ‘retinal 
screening‘, ‘eye health’, ‘ophthalmic’) and terms associated, more broadly, with 
screening and health behaviours of importance to young adults (e.g. ‘prevention’, 
‘health promotion’, ‘colorectal cancer’, ‘cervical screening’, ‘breast screen, ‘sexual 
health’, ‘condoms’).   
The search was supplemented by scanning reference lists of articles identified by our 
search strategy and grey literature (e.g. academic theses, government publications).   
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Matsubara, 2013).  Common awareness-related barriers included lack of awareness 
of DR, asymptomatic nature of early-stage DR, confusion between screening for DR 
and a standard vision-related eye check, absence of clinician recommendation and 
lack of diabetes self-management education (Al-Alawi, Al-Hassan, Chauhan, Al-
Futais, & Khandekar, 2016; Ellish, Royak-Schaler, Passmore, & Higginbotham, 2007; 
Hartnett, Key, Loyacano, Horswell, & DeSalvo, 2005; Hipwell et al., 2014; John, 
Cooper, & Serrant-Green, 2014; Klein & Klein, 2006; Lewis, Patel, Yorston, & 
Charteris, 2007; Livingston et al., 1998; Müller, Lamoureux, Bullen, & Keeffe, 2006; 
Peng, 2010). Conversely, improvements in the above were common facilitators of 
screening (John et al., 2014; van Eijk, Blom, Gussekloo, Polak, & Groeneveld, 2012; 
Walker et al., 1997).  In addition to lack of awareness, common screening barriers 
included low perceived personal risk; fear of screening or of a DR diagnosis if 
screening was undertaken, and denial of diabetes.  Common screening facilitators 
included anticipated regret at not screening (e.g. undetected eye damage), clinician 
referral, social support from family, and social comparison (Ellish et al., 2007; Hipwell 
et al., 2014; Lewis et al., 2007; Strutton et al., 2016).  
The evidence base specific to young adults with T2D was scant, with the majority of 
information either from pediatric-focused population-based studies or clinical trials 
(Hanman et al., 2014; TODAY study group, 2013), or from retrospective medical 
record data (Al-Saeed et al., 2016; Wong, Molyneaux, Constantino, Twigg, & Yue, 
2008).  Younger age (under 40 years) was often controlled or excluded in adult-
focused T2D and ophthalmic studies (Forward, Hewitt, & Mackey, 2012; Hessler, 
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Fisher, Mullan, Glasgow, & Masharani, 2011), and the few available studies targeted 
specific ethnic or cultural groups, limiting generalisability (Al-Alawi et al., 2016; Hall, 
Hall, Kok, Mallya, & Courtright, 2016).  More broadly, the review identified 
modifiable factors impacting young adults’ health behaviours, including elevated 
rates of psychological distress (Anderson et al., 2011; Berge, Bauer, Eisenberg, 
Denny, & Neumark-Sztainer, 2013; Chittleborough, Winefield, Gill, Koster, & Taylor, 
2011; Hessler et al., 2011), perceptions of invulnerability leading to lowered 
perceived risk (Lapsley & Hill, 2010; Nguyen et al., 2014), and disengagement with 
healthcare (including diabetes-specific) services (Müller et al., 2006; Nguyen et al., 
2014; Savage, Dabkowski, & Dunning, 2009).  Such factors are likely to have 
relevance for screening uptake among young adults with T2D. The need to target a 
range of behavioural determinants was reinforced by studies focusing specifically on 
populations at high risk of vision loss (e.g. low socio-economic status, suboptimal 
glycemic control), which singled out perception of personal risk (MacLennan et al., 
2014), cultural appropriateness, and literacy levels of patient education materials 
(Elam & Lee, 2013), as important screening barriers and consequently, 
considerations for intervention.   
Effective elements of existing individual-level screening interventions. A 
systematic review by Zhang of the effectiveness of interventions to promote retinal 
screening (Zhang et al., 2007), reported that most interventions significantly 
increased screening rates, suggesting that a range of methodologies were effective. 
However, the lack of specificity of the effective elements of screening interventions 
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(Lawrenson et al., 2016), combined with lack of interventions specifically targeting 
young adults with T2D, highlight considerable gaps in the evidence base.  Research 
suggests that screening interventions with the highest degree of effectiveness 
involve raising knowledge and awareness of DR, and/or involved ‘registration, 
reminder and recall’ (i.e. where a patient registered on a database received regular 
screening prompts) (Halbert, Kwan-Moon, Nichol, & Legorreta, 1999; Zhang et al., 
2007). The former (increasing knowledge and awareness) is an achievable 
intervention target in an Australian context. However, the reminder/recall is not 
because, currently, Australia does not have a nationally coordinated DR screening 
programme, such as that offered in the United Kingdom where people with diabetes 
are registered and automatically receive a screening invitation (Scanlon, 2008).   
Health information-seeking preferences and behaviours. The information 
needs of people living with diabetes change over time dependent upon life stage 
and progress of the condition (Beeney, Bakry, & Dunn, 1996). Young adults with T2D 
nominated their primary sources of diabetes-related information as: parents/family, 
healthcare practitioners, the national diabetes advocacy organisation, and the 
internet (Diabetes Australia, 2006; Dunning & Savage, 2013; Greene, Choudhry, 
Kilabuk, & Shrank, 2011), with credibility of information given priority over delivery 
medium (Kumah-Crystal et al., 2015; Savage et al., 2009).   
Literature focusing more broadly on young adult health behaviours demonstrated 
that knowledge is a weaker correlate of preventative health behaviour compared to 
other modifiable factors, such as subjective norms, self-efficacy and risk perception 
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(Abraham, Krahe, Dominic, & Fritsche, 2002; Bengel, Belz-merk, & Farin, 1996; 
DiClemente, 1991). This highlights the importance of including motivation and skills, 
as well as knowledge, as behaviour change targets for this group. 
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Table 19: Additional file 2 – Modifiable behavioural determinants by baseline retinal screen  
Modifiable behavioural determinants 
Retinal screen 
p 
No (n=33) Yes (n=96) 
INFORMATION (KNOWLEDGE) ITEMS 
Diabetes can lead to vision loss   30 (91) 93 (97) .174 
All people with diabetes are at risk of DR 26 (79) 89 (93) .004 
Approximately 1 in 4 people with T2D have DR 8 (24) 38 (40) .164 
DR can cause vision loss or blindness 29 (91) 92 (99) .051 
DR can develop without symptoms 15 (47) 56 (61) .268 
DR is influenced by high blood pressure 10 (31) 44 (47) .167 
DR is influenced by high cholesterol 7 (22) 29 (31) .437 
DR is treatable if detected early via an eye health check  21 (66) 65 (70) .819 
DR is more likely to develop the longer you have diabetes 21 (66) 68 (73) .561 
DR is influenced by high blood glucose 23 (72) 83 (89) .025 
Early DR is asymptomatic 4 (12) 9 (9) .738 
Recommended target HbA1ca 17 (53) 81 (87) <.001 
Recommended target blood pressure 21 (66) 67 (72) .644 
Optometrist most likely to conduct DR examination 31 (94) 89 (96) .652 
Initiate eye examinations ‘at diabetes diagnosis’ 5 (15) 42 (45) .004 
Screen ‘at least every 2 years’ if no DR present 0 (0) 18 (19) .003 
MOTIVATION ITEMSb 
Attitudes to retinal screeningc:               An eye health check for DR would be... 
  ...a good idea 4.19 (1.14) 4.94 (0.23) .001 
  ...(not) ‘unpleasant’ 3.71 (0.94) 3.86 (1.07) .500 
  ...wise 4.29 (0.97) 4.86 (0.44) .004 
  ...(not) ‘difficult’ 3.10 (1.17) 4.02 (0.96) <.001 
  ...(not) ‘frightening’ 3.52 (1.06) 4.07 (1.13) .019 
  ...(not) ‘unnecessary’ 3.52 (1.18) 4.50 (0.62) <.001 
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Modifiable behavioural determinants 
Retinal screen 
p 
No (n=33) Yes (n=96) 
  ...reassuring 3.94 (0.96) 4.63 (0.61) <.001 
  ...important 4.06 (1.06) 4.89 (0.35) <.001 
  ...beneficial 4.03 (0.95) 4.86 (0.38) <.001 
  ...comfortable 3.26 (1.15) 3.68 (1.10) .073 
  ...empowering 3.10 (1.19) 3.73 (0.97) .004 
11 items (range: 11-55, α=.86) 40.71 (8.42) 48.03 (4.26) <.001 
Attitudes: risk perceptiond 
 I believe I will develop DR due to my diabetes 4.03 (1.45) 4.14 (1.62) .734 
 I expect to be diagnosed with DR at my next eye   health check 2.97 (1.47) 2.43 (1.66) .114 
 I believe I can reduce my risk of vision problems  if I manage my diabetes well 2.32 (1.44) 1.43 (0.79) .002 
 I believe I will develop vision problems due to  diabetes 4.26 (1.69) 4.49 (1.68) .511 
4 items (range: 4-28, α=.70) 13.58 (4.46) 12.50 (4.34) .238 
 Attitudes: anticipated regretd            If I did NOT have an eye health check for DR, I would feel… 
  ...indifferent  3.65 (1.64) 3.24 (1.89) .295 
  ...concerned 5.03 (1.70) 5.88 (1.40) .007 
  ...fearful  4.48 (1.79) 5.13 (1.70) .073 
  ...worried 4.65 (1.80) 5.53 (1.47) .007 
  ...regretful 4.81 (1.68) 5.54 (1.49) .023 
  ...guilty 4.58 (1.75) 5.47 (1.57) .010 
6 items (range: 6-42, α=.87) 22.61 (7.02) 25.33 (6.04) .040 
Normative beliefsd  
Subjective norms 
  My family/close friends would approve of me attending an eye health check 5.94 (1.69) 6.82 (0.80) .008 
  My health professionals would approve of me attending an eye health check 5.84 (1.75) 6.94 (0.28) .001 
2 items (range: 2-14; α=.93, r=.87) 11.77 (3.43) 13.77 (1.02) .003 
Descriptive norms 
  Most people I know with diabetes have regular eye health checks 4.55 (1.57) 5.07 (1.42) .091 
Intentiond  
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Modifiable behavioural determinants 
Retinal screen 
p 
No (n=33) Yes (n=96) 
  I plan to attend an eye health check… 4.26 (2.32) 6.76 (0.77) <.001 
  I will make an effort to have an eye health check… 4.55 (2.42) 6.74 (0.87) <.001 
  I intend to have an eye health check… 4.42 (2.32) 6.74 (0.77) <.001 
3 items (range: 3-21, α=.98) 13.22 (6.97) 20.24 (2.16) <.001 
BEHAVIOURAL SKILLS ITEMSb,e 
Perceived control               How confident are you that you...  
  …know what steps you can take to reduce the risk of developing DR? 2.39 (1.17) 3.06 (1.29) .012 
  …will have regular eye health checks? 3.16 (1.16) 4.43 (0.87) <.001 
  …know how to make the appointment for an eye      check? 3.35 (1.36) 4.54 (0.83) <.001 
  …will remember to have an eye health check in the next 4 weeks OR next due? 2.68 (1.35) 4.36 (0.90) <.001 
  …will attend the eye health check that you have booked? 3.84 (1.16) 4.67 (0.60) <.001 
  …can reschedule the eye health check to a different time or day if needed? (n=119) 3.45 (1.15) 4.61 (0.67) <.001 
6 items (range: 6-30, α=.87)   18.87 (5.44) 25.63 (3.75) <.001 
 Overcoming barriers          How confident are you that you…   
  …can talk to your doctor about your eye health? 3.39 (1.28) 4.17 (1.03) .001 
  …can find the time to attend an eye health check in the next 4 weeks or when next due? 2.74 (1.37) 4.55 (0.75) <.001 
  …will mention you have diabetes when you make the eye check appointment? 3.68 (1.25) 4.65 (0.62) <.001 
  …can resume your normal activities immediately after the eye health check? 3.55 (1.26) 3.91 (1.25) .169 
  …can afford to pay for the eye health check, if there is a charge? 2.68 (1.49) 3.52 (1.48) .008 
5 items (range: 5-25, α=.76) 16.03 (4.88) 20.80 (3.49) <.001 
DR: diabetic retinopathy.  Data are number (%) of participants who answered each item correctly (Knowledge items); mean (SD) 
Motivation and Behavioural skills items. p-value is Pearson’s Chi-Square (or Fisher’s exact test if expected cell count<5), or 
Independent-samples t-test (two-sided); statistical significance p<0.01. aGlycated haemoglobin (measure of average blood glucose 
over the past 8-12 weeks, and indicator of DR risk). bMinimal missing data (average 6%, range 2-11%). Valid n: 121 (motivation 
items), 120 (behavioural skills items, unless noted otherwise). Cronbach’s alpha noted (plus Pearson’s r for 2-item constructs). Some 
items responses reverse coded where required. 
Item response range: c1 (Strongly disagree) to 5 (Strongly agree), d1 (Strongly disagree) to 7 (Strongly agree), e1 (Not at all confident) 
to 5 (Extremely confident).
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Table 20: Additional file 3 - Matrix of Change Objectives 
Performance 
Objectives and 
sub-objectives^ 
Modifiable behavioural determinants 
Knowledge Attitudes Normative beliefs Intention Behavioural skills 
PO.1 Young adults with type 2 diabetes will demonstrate a clear understanding of diabetic retinopathy (DR) 
PO.1.1   
Modifiable and 
non-modifiable 
DR risk factors 
K.1.1 Understand 
DR and know key 
modifiable risk 
factors 
  I.1.1 Form a positive 
intention to actively 
manage modifiable DR 
risk factors 
BS.1.1 Identify and 
initiate the actions 
required to reduce risk 
of developing DR 
PO.1.2   
  Clinical targets  
  for reducing  
  risk of DR 
K.1.2 Know clinical 
targets for 
modifiable DR risk 
factors to prevent 
DR or slow 
progression 
   BS.1.2 Believe that 
they can avoid 
negative 
consequences 
PO.1.3  
Symptoms of DR  
K.1.3 Understand 
asymptomatic 
nature of early DR 
and explain 
symptoms 
    
PO.1.4   
  Role of DR in     
  vision loss 
K.1.4 Understand 
how DR affects the 
eye  
A.1.4 Perceive 
consequences for 
family unit/future 
family 
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Performance 
Objectives and 
sub-objectives^ 
Modifiable behavioural determinants 
Knowledge Attitudes Normative beliefs Intention Behavioural skills 
PO.1.5  
Prevalence   of 
DR  
K.1.5 Know that DR 
is a common 
complication of 
diabetes 
 NB.1.5 Believe that 
similar others are at 
risk of DR 
  
PO.2 Young adults with type 2 diabetes will demonstrate a clear understanding of retinal screening 
PO.2.1  
   Role in     
   detecting DR  
   and reducing  
   vision loss 
K.2.1 Know the 
role of retinal 
screening in 
reducing vision loss 
A.2.1 Explain the 
clinical benefit of 
retinal screening  
   
PO.2.2  Screening 
procedure and 
experience 
K.2.2 Know when 
to have first and 
subsequent retinal 
screen  
A.2.2 Believe that 
screening promotes 
positive feelings 
NB.2.2 Believe that 
similar others 
approve of, and 
would recommend 
screening 
 BS.2.2 Express 
confidence in retinal 
screening procedure 
(prepare reader for 
the experience) 
PO.2.3 Booking and 
examination 
procedure 
K.2.3 Know that 
retinal screening 
can be self-referred 
  I.2.3 Form an 
intention to book first 
screen soon 
BS.2.3 Be confident 
that they can get an 
eye health check 
PO.3 Young adults with type 2 diabetes will be motivated to engage in retinal screening 
PO.3.1  
   Prioritise retinal  
  NB.3.1 Recognise that 
similar others have 
I.3.1 Form an 
intention to prioritise 
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Performance 
Objectives and 
sub-objectives^ 
Modifiable behavioural determinants 
Knowledge Attitudes Normative beliefs Intention Behavioural skills 
   screening  overcome screening 
barriers 
retinal screening 
PO.3.2  Understand 
personal risk of DR 
K.3.2 Know that DR 
risk increases over 
time 
A.3.2 Perceive high 
personal risk and 
susceptibility to DR 
 
   
PO.3.3  Identify 
personal barriers to 
retinal screening 
 A.3.3 Believe that 
attending screening 
will relieve fear and 
guilt and be a positive 
experience 
NB.3.3 See that 
similar others face 
screening barriers 
(e.g. cost, fear of 
adverse effects) 
 BS.3.3 Be confident in 
one’s ability to 
identify and 
overcome common 
screening barriers  
PO.3.4 Perceive 
personal 
responsibility     to 
engage in screening  
K.3.4 Know that 
they can take steps 
to protect eye 
health 
A.3.4 Adopt personal 
responsibility for 
retinal screening 
NB.3.4 Believe that 
similar others take 
responsibility for their 
own eye health 
 BS.3.4 Be confident 
they have the tools to 
act on personal 
responsibility 
PO.4 Young adults with type 2 diabetes will proactively engage with the healthcare system and their healthcare team 
PO.4.1   
  Discuss diabetes     
  and eye health  
  with healthcare  
  professionals 
K.4.1a Know that 
GP should be 
involved in 
monitoring 
diabetes-related 
A.4.1 Anticipate a 
positive social and 
emotional experience 
NB.4.1 Believe that 
similar others 
approve of, and 
recommend, sharing 
their diabetes 
 BS.4.1a Prompt GP 
contact 
BS.4.1b Be confident 
in sharing diabetes 
diagnosis with 
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Performance 
Objectives and 
sub-objectives^ 
Modifiable behavioural determinants 
Knowledge Attitudes Normative beliefs Intention Behavioural skills 
eye health  
K.4.1b Know that 
an eye examination 
for DR is different 
to a standard eye 
check 
diagnosis with 
optometrist 
optometrist  
PO.4.2  Understand 
treatment benefits 
and options 
K.4.2 Know 
treatment 
trajectory 
A.4.2 Understand 
benefits of early 
treatment 
  BS.4.2 Know that they 
will receive expert 
advice 
PO.4.3  
  Seek more  
  information about  
  diabetes and eye  
  health 
K.4.3a Know how 
to find more 
information (e.g. 
optometrist, 
diabetes or DR) 
K.4.3b Know that 
information is 
available in other 
languages 
  I.4.3 Form intention 
to access credible 
information about DR 
and screening 
 
PO=Performance Objective, DR=diabetic retinopathy, GP=general practitioner.  
Determinants: K=Knowledge, A=Attitudes, NB=Normative Beliefs, I=Intention, BS=Behavioural Skills 
^See Table 5 for full list of Performance Objectives and sub-objectives 
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Table 21: Additional file 4 - Intervention map linking leaflet content directly back to Performance Objectives and Change Objectives 
Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
PO.1 YOUNG ADULTS WITH T2D WILL DEMONSTRATE A CLEAR UNDERSTANDING OF DIABETIC RETINOPATHY (DR) 
  PO.1.1 Modifiable and non-modifiable DR risk factors 
 
 K.1.1 Understand DR 
and know key 
modifiable risk factors 
What is diabetes eye disease? 
Diabetes eye disease is also called Diabetic Retinopathy (DR).  
It is caused by having high blood glucose levels over a long time.  Other things that increase 
your risk of DR are high blood pressure and high cholesterol. 
4 
 I.1.1 Form a positive 
intention to actively 
manage modifiable DR 
risk factors 
 
(What can I do to protect myself from DR and prevent vision loss?)  
3. Follow your diabetes treatment plan which includes the diabetes ABCs 
 
5 
 BS.1.1 Identify and 
initiate the actions 
required to reduce risk 
of developing DR 
(What happens if I have DR?) 
You can slow progression of DR by keeping your blood glucose, blood pressure and 
cholesterol as close to target as possible. 
 
8 
  PO.1.2 Clinical targets for reducing risk of DR 
 K.1.2 Know clinical 
targets for modifiable 
DR risk factors to 
prevent DR or slow 
progression 
A  Average blood glucose (HbA1c) below 7% (53mmol/mol)  
     Every 1% (11mmol/mol) decrease in HbA1c lowers your risk of developing DR  
     by 30–40%.   
B  Blood pressure below 130/80 mm Hg  
     Keeping your blood pressure at target slows progression of DR 
C  Cholesterol at target  
     LDL cholesterol less than 2.0 mmol/L, triglycerides less than 2.0 mmol/L) 
5 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 302 of 470 
Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
 BS.1.2 Believe that they 
can avoid negative 
consequences 
(The good news is) there are things you can do to reduce your risk 
 
(The good news is) this leaflet provides the information you need to help prevent vision loss 
from DR. 
1 
 
4 
  PO.1.3 Symptoms of DR  
 K.1.3 Understand 
asymptomatic nature of 
early DR and explain 
symptoms 
Will I know if I have DR?  
You may not know. In the early stages, DR has no symptoms at all.  In the later stages, you 
my notice blurred, hazy or double vision or you may have sudden loss of vision. 
 
4 
  PO.1.4 Role of DR in vision loss 
 K.1.4 Understand how 
DR affects the eye 
(What is diabetes eye disease?) DR damages the tiny blood vessels in the back of your eye.  If 
left untreated, your vision can be affected. 
 
(Jane 25 years, diagnosed with type 2 diabetes 3 years ago) "You might have good vision, you 
might think that your eyes are absolutely brilliant and there's no issue.  But in the back of 
your eye, there could be a problem with those little tiny veins that you don't realise." 
4 
 
 
4 
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Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
 A.1.4 Perceive 
consequences for 
family unit / future 
family 
Image: mother and daughter smiling. Child holding hands over mother’s eyes 
 
(Lucas, aged 34, diagnosed with type 2 diabetes 2 years ago) "I'm a busy person and my 
family depend on me. “I know I can’t do all the things I do without my sight." 
 
(Jenny’s story: before and after the eye health check: “I was scared.  I was scared of what 
damage was done…of confronting the fact that my eyesight could be damaged, and of going 
through the exam and being confronted with what’s there.”) 
“But I want to take care of my kids; I want to be able to see their children one day.  I do want 
to be able to grow older and have my vision.” 
1 
 
1 
 
 
7 
  PO.1.5 Prevalence of DR 
 K.1.5 Know that  
DR is a common 
complication of 
diabetes 
 
There are over 34,000 Australians with type 2 diabetes who are under 40 years of age.   
More than 8,500 will already have DR. 
 
1 
 NB.1.5 Believe that 
similar others are  
at risk of DR 
But I'm still young.  Am I at risk of DR?  
Yes you are.  Anyone with diabetes can develop DR, which is the leading cause of vision loss 
for people under 60 years 
 
(Jane, 25 years, diagnosed with type 2 diabetes 3 years ago) "You might have good vision, 
you might think that your eyes are absolutely brilliant and there's no issue.  But in the back of 
your eye, there could be a problem with those little tiny veins that you don't realise." 
1 
 
 
 
4 
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Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
PO.2 YOUNG ADULTS WITH T2D WILL DEMONSTRATE A CLEAR UNDERSTANDING OF RETINAL SCREENING 
  PO.2.1 Role in detecting DR and reducing vision loss 
 K.2.1 Know the role  
of retinal screening in 
reducing vision loss 
 
 Having a diabetes eye health check and treating DR early can prevent severe vision    
    loss. 
 
1 
 A.2.1 Explain the clinical 
benefit of retinal 
screening 
  The only way to know if you have DR is to have a diabetes eye health check 4 
  PO.2.2 Screening procedure and experience 
 K.2.2 Know when to have 
first and subsequent 
retinal screen 
  Have a diabetes eye health check when diabetes is first diagnosed and then at least  
  every 2 years (more often if recommended by your optometrist) 
 
5 
 A.2.2 Believe that 
screening promotes 
positive feelings 
  (Jenny’s story: before and after the eye health check)   “Overall, it was worth it and the 
thought that I can control this gives me real peace of mind.” 
 
7 
 NB.2.2 Believe that 
similar others approve of, 
and would recommend, 
screening 
  (Jenny's advice to you)   "I suppose if I was telling someone that's just been diagnosed,   
  I would be saying to them 'Don't wait to be told and don't wait until you notice  
  changes - book an eye health check now’." 
 
 
8 
 BS.2.2 Express  
confidence in retinal 
screening procedure 
(prepare reader for  
  (What is a diabetes eye health check?) 
  It is usually done by an optometrist who will take a photo of the back of your eye.  
  Your optometrist will look at the photo to check the blood vessels at the back of your  
    eye for signs of diabetes-related eye damage 
6 
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Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
the experience) 
  PO.2.3 Booking and examination procedure 
 K.2.3 Know that  
retinal screening can be 
self-referred 
   (Getting a diabetes eye health check is easy) 
    You don’t need a referral from your GP. You can book an appointment directly with  
    an optometrist.   
 
6 
 I.2.3 Form an  
intention to book first 
screen soon 
  Book a diabetes eye health check now 
  Image: calendar  
 
2 
 BS.2.3 Be confident that 
they can get an eye 
health check 
  Getting a diabetes eye health check is easy. 6 
PO.3 YOUNG ADULTS WITH T2D WILL BE MOTIVATED TO ENGAGE IN RETINAL SCREENING 
  PO.3.1 Prioritise retinal screening 
 NB.3.1 Recognise that 
similar others have 
overcome screening 
barriers 
  (Jenny’s story: before and after the eye health check)  “I was scared.  I was scared of  
  what damage was done…of confronting the fact that my  eyesight could be damaged,  
  and of going through the exam and being confronted with what’s there.” 
7 
 I.3.1 Form an  
intention to prioritise  
retinal screening 
  (What can I do to protect myself from DR and prevention vision loss?)  
  1. Have a diabetes eye health check.  
  (Note: eye health check listed as Step 1, highest priority) 
5 
  PO.3.2 Understand personal risk of DR 
 K.3.2 Know that DR risk 
increases over time  
  The longer you have diabetes the more at risk you are of DR. 
 
1 
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Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
 A.3.2 Perceive high 
personal risk and 
susceptibility to DR 
  Image: mother and daughter smiling. Child holding hands over mother’s eyes 
  But I'm still young.  Am I at risk of DR?  
 
  Yes you are.  Anyone with diabetes can develop DR, which is the leading cause of    
  vision loss for people under 60 years. 
 
  There are over 34,000 Australians with type 2 diabetes who are under 40 years of age.     
  More than 8,500 will already have DR. 
 
  The longer you have diabetes the more at risk you are of DR. 
 
    (Lucas, aged 34, diagnosed with type 2 diabetes 2 years ago)  
  "I didn't know that I was at risk." 
 
   (Jane 25 years, diagnosed with type 2 diabetes 3 years ago)  "You might have good  
  vision, you might think that your eyes are absolutely brilliant and there's no issue.   
  But in the back of your eye, there could be a problem with those little tiny veins that  
you don't realise." 
1 
 
 
 
1 
 
 
 
1 
 
 
 
1 
 
 
1 
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Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
4 
  PO.3.3 Identify personal barriers to retinal screening 
 A.3.3 Believe that 
attending screening will 
relieve fear and guilt and 
be a positive experience 
  (Jenny’s story: before and after the eye health check)  “It was actually quite fun; I  
  don’t know why I put it off. I was really scared going in there, but definitely not now –  
  I’m not fazed by it at all.” 
 
7 
 NB.3.3 See that similar 
others face screening 
barriers (e.g. cost, fear of 
adverse effects) 
  (Jenny’s story: before and after the eye health check)   “The eye drops were a bit  
  uncomfortable and there was a small cost – but I think it’s a wise spend considering  
  what you’re preventing.”   
 
7 
 BS.3.3 Be confident in 
one’s ability to identify 
and overcome common 
screening barriers  
   (What else do I need to know?)  
 A diabetes eye health check takes about 30 minutes.   
  (What else do I need to know?) 
  It may be free (bulk-billed) or there may be a small fee.   
 
  (What else do I need to know?) 
  Your optometrist may use eye drops which helps them to see the back of your eye.   
  If you do have eye drops, they may be a little uncomfortable.  The drops will also leave  
  you sensitive to light, so bring your sunglasses and be prepared to wait a while for  
  your vision to return to normal 
6 
 
 
6 
6 
  PO.3.4 Perceive personal responsibility to engage in screening 
 K.3.4 Know that they can 
take steps to protect eye 
  What can I do to protect myself from DR and prevent vision loss? 5 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 308 of 470 
Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
health 
 
A.3.4 Adopt personal 
responsibility for retinal 
screening  
  (Lucas, aged 34, diagnosed with type 2 diabetes 2 years ago)  
  "I'm a busy person and my family depend on me.”  
 
  Leaflet heading: Who is looking after your eyes? 
13 
 NB.3.4 Believe that 
similar others take 
responsibility for their 
own eye health 
  Images: mother and daughter, smiling couple selfie, young man  
  of indeterminate cultural origin, Asian female (a.k.a. ‘Jenny’) 
 
1,3,5,8 
 BS.3.4 Be confident they 
have the tools to  
act on personal 
responsibility 
  Leaflet sub-heading: Your guide to preventing vision loss from diabetes eye disease 
 
  Protect your sight for life 
3 
 
2 
PO.4 YOUNG ADULTS WITH T2D WILL PROACTIVELY ENGAGE WITH THE HEALTHCARE SYSTEM AND THEIR HEALTHCARE TEAM 
  PO.4.1 Discuss diabetes and eye health with your healthcare professionals 
 K.4.1a Know that GP 
should be involved in 
monitoring diabetes-
related eye health 
  Either way, discuss your results with your GP or your diabetes specialist 
 
6 
 K.4.1b Know that an eye 
examination for DR is 
different to a standard 
eye check 
  (What is a diabetes eye health check?)  
It is different to a standard eye check because it specifically looks to see whether  
   diabetes is affecting your eyes. 
 
6 
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Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
 A.4.1 Anticipate a 
positive social and 
emotional experience 
 
  (Jenny’s advice to you) 
  "I had a lovely optometrist and she really put me at ease." 
 
8 
 NB.4.1 Believe that 
similar others approve of, 
and recommend, sharing 
their diabetes diagnosis 
with optometrist 
 
  (Jenny’s advice to you) 
  "Discuss with the optometrist what to expect, what you should be aware of and so    
    on.” 
 
8 
 BS.4.1a Prompt GP 
contact 
 
  Either way, discuss your results with your GP or your diabetes specialist 
 
6 
 BS.4.1b Be confident in 
sharing diabetes 
diagnosis with 
optometrist 
  (Getting a diabetes eye health check is easy. You don’t need a referral from your GP.    
  You can book an appointment directly with an optometrist.) 
  When you do, be sure to tell them you have diabetes. 
6 
  PO.4.2 Understand treatment benefits and options 
 K.4.2 Know treatment 
trajectory 
  What happens next?  
If they see any signs of damage to the back of your eye, your optometrist will either  
  monitor it or arrange treatment with an ophthalmologist (medical eye specialist). 
 
  (What happens if I have DR?) 
In the early stages, treatment may not be needed, but you may be asked to have eye  
6 
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Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
  health checks more frequently to monitor the DR. 
 
  (What happens if I have DR?) 
 If DR progresses, you may need to take tablets or have specialist treatment (usually  
  laser therapy) 
 
88 
 A.4.2 Understand 
benefits of early 
treatment 
 
  2. Treat DR early 
  Early treatment can prevent up to 98% of severe vision loss 
 
5 
 BS.4.2 Know that they 
will receive expert advice 
  What happens if I have DR?  
Your eye health professional will advise you of your treatment options 
8 
  PO.4.3 Seek more information about diabetes and eye health 
 K.4.3a Know how to find 
more information  
(e.g. optometrist, 
diabetes or DR) 
  To find an optometrist in your area  
Scan the QR code to download the free Diabetes Australia app  
 Visit Optometry Australia  
  www.optometry.org.au/find-an-optometrist/ 
 
  For more information on eye health and diabetes management 
Visit diabetesvic.org.au, or call the Info line on 1300 136 588 
Multilingual infoline 1300 801 164 multiculturalportal.ndss.com.au  
2 
 
 
2 
 K.4.3b Know that 
information is available in 
other languages 
 
  Image: national interpreter symbol 2 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 311 of 470 
Performance Objectives (PO) 
and Change Objectives^ 
Leaflet content (antecedent leaflet text in brackets illustrates context) 
Panel 
No.*  
 I.4.3 Form intention  
to access credible 
information about DR 
and screening 
  Images: smart phone, QR codes  
 ‘Proudly sponsored by [stakeholder logos]’ 
2 
2 
PO=Performance Objective, DR=diabetic retinopathy, GP=general practitioner.  *Panel number in Figure 3. 
^See Table 5 for full list of Performance Objectives and sub-objectives; see Additional file (Table 20) for complete list of Change Objectives. 
K=Knowledge, A=Attitudes, NB-Normative Behaviour, I=Intention, BS=Behavioural Skills 
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CHAPTER 5. What is the effect of a tailored leaflet intervention on diabetic 
retinopathy screening among young adults with type 2 diabetes?                 
A randomised controlled trial.10 
                                                     
10 This manuscript has been submitted to Journal of Diabetes and its Complications. The 
chapter has been formatted in APA style, to maintain consistency of structure and 
referencing throughout the thesis. Text content is identical to the submitted manuscript. 
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5.2 Abstract 
Aims: Diabetic retinopathy is the leading cause of blindness and vision 
loss in working-age adults.  Retinal screening is a crucial preventative measure, 
yet many young adults with type 2 diabetes (18-39 years) do not screen in a 
timely manner. We evaluated the effectiveness of a tailored, evidence-based 
leaflet designed to promote retinal screening uptake and improve identified 
modifiable behavioural determinants, using a randomised controlled trial (RCT, 
ACTRN1261400111067). Methods: Eligible participants were randomised to 
leaflet intervention or no-leaflet control, stratified by engagement with retinal 
screening (yes/no). Primary (screening uptake) and secondary (social cognitive) 
outcome data was collected pre-intervention and four weeks post-intervention.  
Results: A total of 129 young adults with type 2 diabetes (26% no retinal screen) 
provided baseline data; 101 completed follow-up.  A significant intervention 
effect was observed for knowledge of DR (p=.03) with moderate effect (2=.05); 
no other intervention effects were observed. Power to test intervention effect on 
the primary outcome was curtailed. Conclusions: This study confirms that a well-
designed retinal screening leaflet can increase knowledge of diabetic 
retinopathy, an important retinal screening predictor. Nonconventional 
alternatives to RCT designs should be considered for hard-to-reach populations. 
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5.3 Introduction  
Increasing incidence of type 2 diabetes (T2D) in young adults (aged 18-39 
years) and associated high morbidity and mortality has generated significant 
concern over the past decade (Yeung et al., 2014; Zimmet, Magliano, Herman, & 
Shaw, 2014).  Clinical and population-based studies highlight the aggressive 
nature of the condition, with affected individuals experiencing considerable 
diabetes-related complications by mid-life (Al-Saeed et al., 2016).  
The most common complication is diabetic retinopathy (DR), the leading 
cause of vision loss and blindness in working-age adults worldwide (Sivaprasad, 
Gupta, Crosby-Nwaobi, & Evans, 2012). Younger age of T2D onset is an 
independent risk factor for the development of DR (Wong, Molyneaux, 
Constantino, Twigg, & Yue, 2008).  Retinal screening (henceforth ‘screening’) is 
crucial for early detection of asymptomatic DR and timely treatment thereafter 
can significantly reduce risk of vision loss (Arun, Al-Bermani, Stannard, & Taylor, 
2009; Ferris, 1993). 
Australian guidelines recommend screening uptake at diagnosis of T2D, 
repeated a minimum of every two years thereafter (Mitchell & Foran, 2008).  
Once initiated, screening is generally sustained (Lee et al., 2000).  However, 
younger age is also an independent risk factor for low screening uptake 
(Sachdeva, Stratton, Unwin, Moreton, & Scanlon, 2012; Scanlon et al., 2016) with 
increased risk of vision-threatening retinopathy when screening is eventually 
initiated (Scanlon et al., 2016).  
Only 55% of young Australian adults with T2D report screening for DR 
(compared to 76% of young adults with type 1 diabetes, and 77% of the general 
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adult diabetes population, reported at around the same time), (Diabetes 
Australia, 2006; Tapp et al., 2004). Consequently, clinicians and policy makers 
have called for the development of early intervention strategies for this priority 
population (Dabelea et al., 2017; Wilmot & Idris, 2014). 
A systematic review of the effectiveness of interventions to promote 
retinal screening confirmed that a range of interventions targeting patients or 
populations are effective, and that the majority focussed on increasing 
knowledge and awareness of DR (Zhang et al., 2007).  However, lack of 
specification of the effective elements of many existing interventions has 
hindered implementation of strategies to promote screening uptake (Lawrenson 
et al., 2016).  
Effective interventions to promote health behaviour change, including for 
diabetes self-management, have shared elements: underpinned by theoretical 
constructs, grounded in evidence and data, targeting modifiable behavioural 
determinants associated with the behaviour (e.g. attitudes, normative beliefs, 
intentions), and tailoring to the priority population (Ayling, Brierley, Johnson, 
Heller, & Eiser, 2015; Bartholomew Eldredge et al., 2016). The Information-
Motivation-Behavioural skills (IMB) model, which cites three broad, underlying 
constructs, has utility for identification of modifiable behavioural determinants 
(Fisher, Fisher, & Harman, 2003). 
The IMB model posits information (knowledge) is a key determinant of 
behaviour change, but insufficient on its own, and requires the integration of 
motivational and behavioural skills elements In essence, an individual who is 
well-informed about their health risk(s) and the target health behaviour, 
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personally and socially motivated to perform the behaviour, and who has the 
appropriate behavioural skills, will be more likely to initiate and maintain the 
behaviour (Figure 8).  
 
 
 
 
 
 
 
Figure 8:  Information-Motivation-Behavioural skills model   
 
The IMB model has been validated in relation to diabetes for self-care 
behaviours and medication-taking (Mayberry & Osborn, 2014; Osborn & Egede, 
2010).  In the current study, the IMB model was used as a theoretical foundation 
for identification of modifiable behavioural determinants and as a framework for 
evaluating the effect of the leaflet on secondary outcome data.   
The aim of this study was to assess the effectiveness of a retinal screening 
promotion leaflet tailored to young adults with T2D.  Overall, the leaflet sought 
to promote screening uptake for those who had not previously engaged in the 
behaviour, and to improve modifiable behavioural determinants (associated with 
the behaviour) which had been identified in a comprehensive needs assessment 
(Lake et al., Unpublished results; Lake, Browne, Rees, & Speight, 2017).   
 
Motivation 
Behavioural skills Behaviour 
Information 
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 Participants, Materials and Methods 5.4
5.4.1 Study design and registration. This parallel-group randomised 
controlled trial (RCT) was retrospectively registered with the Australian New 
Zealand Clinical Trials Registry (ACTRN12614001110673, UTN No.: U1111-1161-
9803). Ethics approval was obtained from the Deakin University Human Research 
Ethics Committee (2014-156); all participants provided informed consent.   
5.4.1.2 Sample size and trial design considerations.  Informed by 
previous studies among young adults with T2D (Nguyen et al., 2014; Zeitler, 
Chou, Copeland, & Geffner, 2015), we anticipated low recruitment (10%; Browne, 
Nefs, Pouwer, & Speight, 2014) low screening rate (50%; Diabetes Australia, 
2006; Wang et al., 2017) and high attrition (40%; Nguyen et al., 2014).  
Initially, a four-group design was selected to account for anticipated bias 
(Solomon, 1949), but lower than expected recruitment (particularly of 
participants who had never screened for DR, henceforth ‘unengaged’), indicated 
high risk of lack of power at follow-up.  On advice from a senior biostatistician, 
the trial design was modified to a two-arm (intervention / control) RCT. 
Explanation of initial sample size calculation, number of recruitment invitations, 
and subsequent changes to methods after trial registration are provided in 5.8 
Additional information (Section 5.8.4). Using the revised design, 25 unengaged 
participants per condition were required to provide sufficient power at follow-up 
(80%, significance level 0.05, two-tailed).  
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5.4.2 Participants. Eligible participants were young adults with T2D (aged 
18-39 years), who had been registered with the National Diabetes Services 
Scheme (NDSS) in the previous three years (registration date was used as a proxy 
for diabetes diagnosis). The NDSS is an Australian Government initiative, which 
supports people with diabetes to self-manage their condition by providing 
subsidised access to products (e.g. needles, blood glucose testing strips) and 
services (e.g. information, education and advice). With approximately 86% of 
Australians with T2D registered, the NDSS is considered the “best available 
source to monitor type 2 diabetes in children and young people in Australia” 
(Australian Institute of Health and Welfare, 2014, p.36). Exclusion criteria were: 
non-proficiency in English, other diabetes types (e.g. type 1, gestational). 
Of the approximately 32,000 young adults with T2D registered on the 
NDSS, 36% (N=5,354) were eligible and had consented to be contacted for 
research purposes. To protect registrant confidentiality, the NDSS managed 
invitation mail-out, with one reminder posted four weeks later. Study 
recruitment was conducted over a 7-week period. Two incentives were offered; a 
chance to win one of three iPad minis at registration, and AUD$20 upon 
completion of follow-up questionnaire. In order to minimise the possibility of 
resistance from unengaged NDSS registrants (who may opt not to participate in a 
study specifically focussed on retinal screening), invitees were initially masked to 
the purpose of the study, which was advertised more broadly as research about 
“diabetes self-management”.  
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5.4.3 Procedure.  Data collection was managed via Qualtrics, a secure 
online survey platform (Qualtrics, 2014). 
5.4.3.1 Baseline data collection.. To ensure that private information 
(postal addresses) were only collected for intervention participants, baseline data 
was collected in two phases, with randomisation conducted in-between.   
Phase 1 (study registration): participants provided consent and 
demographic data (e.g. diabetes management, including screening status to 
provide an indication of the number of unengaged participants; family history of 
T2D, health comorbidities), see Appendix D for survey items. At the end of the 
recruitment period, participants were randomly allocated to one of two 
conditions (leaflet intervention, no-leaflet control) using an online random 
number generator (Dallal, 2008).  Unengaged participants were stratified in a 1:1 
ratio to ensure balanced representation into both conditions.  Phase 2: 
participants provided baseline social cognitive data (to assess secondary 
outcome) and retinal screening status (intended for primary outcome 
assessment to allow for the possibility that participants may have engaged in 
screening since phase 1 study registration). Those allocated to the leaflet 
intervention condition were also asked to provide their postal address so that 
they could be sent a “leaflet about diabetes self-management” (see Appendix E 
for survey items).   
5.4.3.2 Post-intervention data collection. Four weeks after the leaflet 
intervention mail-out (and six months after study commencement), all 
participants were invited to provide follow-up outcome data (screening status, 
modifiable behavioural determinants - Appendix E). To check assumptions 
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regarding the accessibility of optometry services, we conducted a nationwide 
dummy booking exercise.  Using the online Optometry Australia ‘find an 
optometrist’ service, we contacted 11 large and small-scale providers located in 
the same postcodes as leaflet intervention participants.  We called each provider, 
requesting an appointment for an eye check, stating that a diabetes diagnosis 
had been made.  We declined the first available appointment, asking instead for 
alternate appointment times including out of standard business hours.  All 
optometrists surveyed could offer appointments during business hours within 
five days, and most could offer out-of-hours appointments within seven days, 
confirming that the four-week timeframe between leaflet mail-out and follow-up 
data collection was appropriate.  At the end of the follow-up survey, control 
group participants were invited to receive the eye health leaflet. 
5.4.4 Summary of leaflet development. The aim of the leaflet was 
twofold: promote screening uptake for young adults with T2D, and improve 
modifiable behavioural determinants of screening behaviour. Leaflet 
development process is described in detail elsewhere (Lake et al., Unpublished 
results) and publicly available online (Diabetes Victoria; Vision 2020 Australia, 
2017).   
In brief, leaflet development was guided by intervention mapping (IM), a 
systematic framework for developing and evaluating behaviour change 
interventions specific to the needs and characteristics of a priority population 
(Bartholomew Eldredge et al., 2016). Following IM processes, leaflet design was 
informed by comprehensive needs assessment which highlighted five modifiable 
behavioural determinants associated with screening behaviour: knowledge, 
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attitudes, normative beliefs, intention and behavioural skills (Lake et al., 
Unpublished results; Lake et al., 2017).  A range of targeted, persuasive 
messaging was developed, written to recommended literacy standards and 
incorporated into a leaflet alongside engaging and appropriate imagery.  The 
leaflet was piloted and reviewed by a range of stakeholders, including five young 
adults with T2D who provided essential patient and public involvement (PPI) 
throughout. 
5.4.5 Outcomes. Primary and secondary outcome data were collected 
post-randomisation and at follow-up. The primary outcome was uptake of retinal 
screening for unengaged participants; secondary outcomes were change in the 
five modifiable behavioural determinants noted in Section 5.4.4. All data were 
collected via self-report online questionnaire which was pilot-tested online by 
PPI members (aged 29-37 years) prior to implementation.  
5.4.5.1 Primary outcome. Unengaged participants were asked if they had 
engaged in an “eye health check since you completed the last … questionnaire” 
at phase 2 baseline and at post-intervention data collection points.  The term 
“eye health check” was used in preference to “retinal screening”, informed by 
feedback from young adult PPI members. The following definition was used to 
minimise reported confusion between standard vision check and screening for 
DR (Hipwell et al., 2014):  
“An eye health check is usually done by an optometrist or eye specialist 
who will check the blood vessels at the back of your eye for signs of 
diabetes-related eye damage.  They do this by taking a photo or using a 
lamp and they may use eye drops to dilate your pupil”.   
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5.4.5.2 Secondary outcome. 54 items were developed in broad 
consultation with key stakeholders to assess the three IMB constructs, with 
wording derived from existing valid and reliable IMB-based questionnaires 
(Fishbein & Ajzen, 2010; Fishbein et al., 2001; Osborn, Amico, Fisher, Egede, & 
Fisher, 2010; Osborn & Egede, 2010).  Item categories are summarised below; 
related items were summed to create a composite score (full item detail 
provided in Table 24, Section 5.8.2 - 5.8.2 Supplementary materials, including 
item wording, score range and internal validity for composite scores; full 
questionnaire provided in Appendix E).  
Information: Information was assessed with 16 items across three 
categories: (i) link between diabetes and vision loss, (ii) knowledge of DR, and (iii) 
knowledge of retinal screening.  Responses were scored dichotomously (correct / 
incorrect).  Items were aggregated to form a composite score with higher scores 
indicating greater knowledge.  
Motivation: Motivation was assessed with 27 items across three 
behavioural determinant categories: (i) attitudes (e.g. towards retinal screening, 
risk perception and anticipated regret); (ii) normative beliefs (e.g. approval of 
others); (iii) intention to screen for DR. Responses were scored on either a 5- or 
7-point Likert scale, with higher scores representing stronger agreement (items 
reverse scored where necessary).  
Behavioural skills: Behavioural skills were assessed using 11 items across 
two behavioural determinant categories: (i) perceived control (e.g. ability to seek 
and attend retinal screening); (ii) overcoming barriers (e.g. ability to identify and 
address common environmental and psychosocial barriers). Responses were 
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scored on a 5-point Likert scale with higher scores representing greater 
confidence. 
5.4.5.3 Demographic data. Demographic data included: age, gender, 
country of birth, main language spoken at home, socio-economic status, 
employment, level of education and relationship status. Health information 
included: age at diagnosis of T2D, family history of T2D, primary diabetes 
management and health comorbidities.  To reduce the risk of overestimation due 
to social desirability bias (Hwang, Rudnisky, Bowen, & Johnson, 2015), the retinal 
screening item was embedded within a suite of six items which assessed 
engagement with healthcare: “Since you were diagnosed with diabetes, have you 
had your …(1) cholesterol, (2) blood pressure, (3) average blood glucose (HbA1c), 
(4) kidney function, (5) eye health, and (6) feet checked?”.    
5.4.6 Assessment of adverse effects. To determine any negative impact 
of the intervention on emotional well-being, participants completed a brief, 
validated depression screening tool, the Patient Health Questionnaire (PHQ-2; 
Kroenke, Spitzer, & Williams, 2003) at baseline and follow-up.  Using the PHQ-2, 
respondents rate how often, over the past two weeks, they had experienced 
“little interest or pleasure in doing things” and “feeling down, depressed or 
hopeless” on a 4-point scale (0=not at all to 3=nearly every day). Responses are 
summed (range: 0 - 6), with higher scores indicating more depressive symptoms. 
In addition, participants were invited to provide qualitative feedback. 
5.4.7 Intervention fidelity We included an item in the follow-up 
questionnaire asking intervention group participants whether they received the 
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leaflet, and if so, whether they had read it. 
5.4.8 Statistical analyses. We analysed data using the Statistical Package 
for Social Sciences (SPSS, IBM Corp, Armonk, NY; Ver.23, 2015).  To assess factors 
associated with loss to follow-up, chi-square and independent t-tests (two-tailed) 
were used to compare baseline demographic characteristics and scores on 
modifiable behavioural determinants between those who completed and did not 
complete the study.   
We were unable to perform inferential statistical analyses on the primary 
outcome, thus only descriptive statistics are reported for the numbers of 
participants in each study arm who were engaged versus unengaged pre- and 
post-intervention. To assess intervention effects on secondary outcomes, we 
created change scores by subtracting baseline score (pre-) from follow-up (post-) 
for each composite score. Then, we conducted independent samples t-tests 
(two-tailed) on the change scores to assess between-group differences, and 
paired-samples t-tests to assess within-group changes over time. Effect sizes are 
described with partial eta squared (2, range: 0-1); guidelines for interpretation 
are: 2=0.01 (small), 2=0.06 (moderate), and 2=0.14 (large effect), (Cohen, 
2013). 
Although intention-to-treat and per-protocol analyses were planned, 
unusually high attrition precluded reliable analysis. Consequently, we elected to 
exclude cases with missing secondary outcome data pairwise (there were no 
missing data on the primary outcome), restricting results to complete cases only 
for each individual behavioural determinants composite score.  Data are 
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presented as mean ± standard deviation (SD), median (interquartile range) or n 
(%), as appropriate.    
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5.5 Results 
5.5.1 Participant flow and timeline of study activities.  Of the 5,354 
young adults with T2D who were invited to participate, 273 (5%) visited the study 
website and completed eligibility screening.  Of those, 227 (4%) were eligible, 
consented to participate, completed phase 1 baseline questionnaire 
(demographic data), and were randomised. However, only 129 (57%) provided 
both phase 1 and 2 baseline data, and 101 (44% of original 227 registrants) 
provided follow-up data (Figure 9).   
There was considerable attrition over the course of the study, the 
majority of which occurred post-randomisation but before collection of phase 2 
baseline data (n=98, 45%). A further 22% of participants (n=28) did not complete 
the post-intervention, follow-up questionnaire.   Although there was no evidence 
of differential attrition between treatment groups (all p>.05), those who 
completed the study differed significantly from those who did not on four 
variables: country of birth, language spoken at home, number of health 
comorbidities and relationship status. Of those, country of birth was the only 
significant contributor to loss to follow-up at both of the stages noted above. 
Compared to non-completers, completers were significantly more likely to be 
Australian-born (65% vs 50%, p<.01 and 71% vs 43%, p<.05, respectively).   
Finally, the leaflet was received and read by the majority of intervention 
group participants (n=43, 86%); seven (four unengaged, three engaged) either 
did not receive, or did not read, the leaflet due to “lack of time” and were 
excluded from outcome analyses. The final sample comprised 94 participants 
(n=43 intervention; n=51 control). 
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Figure 9: CONSORT diagram detailing participant flow through the trial, and  
project timeline  
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c  Leaflet not received (n=5), leaflet received but not read (n=2)  
d Did not commence survey (n=12), withdrew (no reason given, n=1),  
  invalid email address (n=1), no postal address provided (n=2), other (n=1) 
e Did not commence survey (n=11) 
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5.5.2 Baseline characteristics.  The average age of the total study sample 
(N=227) was 34±4 years (range: 19-39 years), and more than half (n=126, 56%) 
were women. Most (n=177, 78%) spoke English at home, and more than half 
(n=131, 58%) were born in Australia, with a substantial minority (n=64, 29%) 
born in Asia. Participants reported short average duration of diabetes (1.6±2.5 
years). Two-thirds of participants (n=150, 66%) managed their diabetes with oral 
hypoglycaemic agents and a high proportion (197, 87%) reported having engaged 
with four or more diabetes-related health and complication checks since their 
diagnosis. Almost three-quarters (n=164, 72%) reported engagement with retinal 
screening since their diabetes diagnosis.  
One hundred and twenty-nine participants provided full baseline 
demographic and social cognitive data (Table 22). Overall, participants’ 
knowledge of an association between diabetes and vision loss was high 
(1.96±.20); but more detailed knowledge of DR and screening was low (6.46±2.12 
and 1.47±.63, respectively). Participants reported high baseline intention to 
engage in screening (18.45±5.01) and strong perceptions of others’ approval 
(normative beliefs, 13.26±2.12), but only moderate perception of personal risk 
and anticipated regret at missing screening (12.78±4.38 and 24.64±6.39, 
respectively).  Finally, participants reported moderately positive attitudes to 
screening at baseline (46.14±6.44), perceived control in attending screening and 
overcoming barriers (23.87±5.17 and 19.57±4.41, respectively). 
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Table 22:  Baseline demographic and behavioural determinants for total sample and by 
treatment group 
Variable name Total 
(N=129) 
Intervention  
(n=67) 
Control  
(n=62) 
p 
Demographic variables (range) 
Age, years  34.13 (4.46)  33.57 (4.58)  34.74 (4.28) .135 
Gender: women  77 (60)  40 (60)  37 (60) 1.00 
Australian born  84 (65)  41 (61)  43 (69) .431 
Main language spoken at home:     
   English 
108 (84)  57 (85)  51 (82) .846 
Relationship status:  
   In a relationship 
  83 (64)  44 (66)  39 (63) .885 
Level of education: .718 
    Secondary   28 (22)   13 (20)  15 (24)   
    Trade or certificate   49 (38)   25 (37)  24 (39)   
    Tertiary   52 (39)   29 (43)  23 (37)   
In paid employment   77 (60)   37 (55)  40 (65) .371 
Socioeconomic status:  
   SEIFA score^ 
989.71  
(64.6) 
981.7  
(7.38) 
998.4  
(68.3) 
.142 
T2D duration, years     1.51 (1.95)      1.53 (2.11)   1.48 (1.78) .877 
Primary diabetes management: .024 
    Lifestyle only   26 (20)  10 (15)  16 (26)  
    Oral medication   87 (67)  44 (66)  43 (69)  
    Insulin   16 (12)  13 (19)    3 (5)  
Family history of T2D   94 (73)  47 (70)  47 (76) .600 
Diabetes-related health  
check (range: 0-6) 
    4.63 (1.41)    4.67 (1.31)    4.60 (1.5) .762 
Engaged with retinal  
screening at baseline: yes 
 92 (71.3)  48 (72)  44 (71) 1.00 
Number of health 
comorbidities# 
   1.77 (1.38)    1.79 (1.33)    1.75 (1.45) .881 
Depressive symptoms:  
   PH-2 (range: 0-6)                   
   2.42 (2.08)    2.67 (2.15)    2.15 (1.98) .150 
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 Table 22: Baseline demographic and behavioural determinants for total sample 
and by treatment group (Cont.) 
Variable name Total 
(N=129) 
Intervention  
(n=67) 
Control  
(n=62) 
p 
 
 Social cognitive behavioural determinants (range)# 
Knowledge:   
   diabetes/vision link (range: 0-2) 
 
  1.96 (.20)   1.97 (.18)   1.94 (.23) .554 
   diabetic retinopathy (range: 0-11)   6.46 (2.12)   6.28 (2.20)   6.66 (2.03) .325 
   retinal screening (range: 0-3)   1.47 (.63)   1.46 (.56)   1.48 (.70) .902 
Attitudes:       
   retinal screening (range: 11-55) 
 
46.16 (6.44) 46.19 (5.62) 46.12 (7.31) .956 
   risk perception (range: 4-28) 12.78 (4.38) 13.23 (4.46) 12.26 (4.27) .225 
   anticipated regret (range: 6-42) 24.64 (6.39) 24.73 (6.19) 24.53 (6.65) .859 
Normative beliefs (range: 2-14) 13.26 (2.12) 13.41 (1.96) 13.09 (2.29) .411 
Intention (range: 3-21) 18.45 (5.01) 18.31 (4.78) 18.60 (5.29) .757 
Behavioural skills:  
   perceived control (range: 6-30) 
 
23.87 (5.17) 
 
23.58 (5.11) 
 
24.20 (5.27) 
 
.516 
   overcoming barriers (range: 5-55) 19.57 (4.41) 19.41 (4.25) 19.75 (4.61) .672 
#Some missing data: range 3-10 dependent upon variable. Data are number (%) 
or mean (SD). Chi-square and independent t-tests (two-sided); p<0.05.  
^Index of Relative Socio-economic Advantage and Disadvantage (IRSAD), 
www.abs.gov.au/websitedbs/censushome.nsf/home/seifa. 
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5.5.3 Primary and secondary outcomes at follow-up. Baseline, follow-up 
and change scores are presented for outcome variables, by treatment condition 
in Table 23.    
Table 23: Primary and secondary outcome variables at follow-up, by condition 
Variable name Time point 
Intervention 
(n=8) 
Control 
(n=12) 
Primary outcome variable:  
Retinal screening uptake 
since baseline for 
unengaged participants 
Baseline N/A N/A 
Follow-up 5 3 
% increase 63 25 
Secondary outcome variables (range)# 
Intervention  
(n=43) 
Control (n=51) 
Knowledge: diabetes/ 
vision link (0-2) 
Baseline 1.97 (.17) 1.96 (.21) 
Follow-up 1.97 (.17) 1.98 (.15) 
Change 0.00 0.02 
Knowledge:  diabetic 
retinopathy  
  (0-11) 
Baseline 6.43 (2.38) 6.78 (2.00) 
Follow-up 7.64 (1.97)b** 6.86 (2.10) 
Change 1.21a* 0.08 
Knowledge:  retinal 
screening  
  (0-3) 
Baseline 1.45 (.55) 1.42 (.70) 
Follow-up 1.70 (.72)b* 1.72 (.70)b** 
Change 0.25 0.30 
Attitudes:   retinal 
screening  (11-55) 
Baseline 46.29 (4.99) 46.28 (6.17) 
Follow-up 46.61 (5.70) 45.85 (5.4) 
Change 0.32 -0.43 
Attitudes:  risk perception  
   (4-28) 
Baseline 13.49 (4.24) 12.30 (4.08) 
Follow-up 13.64 (3.91) 12.17 (3.57) 
Change 0.15 -0.13 
Attitudes:  anticipated 
regret    (6-42) 
Baseline 24.62 (5.96) 24.79 (5.55) 
Follow-up 30.67 (5.85)b*** 29.40 (7.16)b* 
Change 6.05 4.62 
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Table 23: Primary and secondary outcome variables at follow-up (Cont). 
Secondary outcome variables (range)# 
Intervention  
(n=43) 
Control 
(n=51) 
Normative beliefs (2-14) Baseline 13.26 (2.28) 13.43 (1.44) 
Follow-up 13.10 (2.34) 13.02 (2.66) 
Change -0.15 -0.40 
Intention (3-21) Baseline 18.51 (4.61) 18.72 (5.22) 
Follow-up 18.46 (4.01) 18.83 (4.36) 
Change -0.05 0.11 
Behavioural skills:   
perceived control (6-30) 
Baseline 24.72 (4.10) 24.5 (4.38) 
Follow-up 25.28 (4.24) 24.11 (4.97) 
Change 0.56 -0.39 
Behavioural skills:   
overcoming barriers  
(5-25) 
Baseline 20.21 (3.27) 19.91 (4.08) 
Follow-up 20.08 (3.43) 19.15 (4.17) 
Change -0.13 -0.77 
PHQ-2 (0-6) Baseline 2.38 (2.42) 1.94 (1.96) 
Follow-up 2.05 (2.04) 2.00 (2.01) 
Change -0.33 0.06 
Primary outcome data: number who reported receiving and reading leaflet. 
Secondary outcome data: mean (standard deviation) 
Change score = follow-up score minus baseline score.  
# some missing data: range 3-10 dependent upon variable.   
a Significant between-condition difference in change scores;  
b Significant within-condition difference in change scores.  
*p<.05, ** p<.001, ***p<.001 
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5.5.3.1 Screening uptake for unengaged participants. Overall, an 
insufficient number of unengaged participants provided follow-up data (n=24, 
and 12 in each condition) and the study was underpowered to detect meaningful 
change on the primary outcome. Further, of the 24 unengaged participants who 
provided outcome data, four intervention group participants reported that they 
either did not receive, or did not read, the leaflet and were excluded from 
analysis. Among the remaining intervention group participants, there was a 
proportionally higher screening uptake than among those in the (no-leaflet) 
control group (n=5 and n=3 respectively).  
5.5.3.2 Social cognitive variables. At follow-up, the leaflet intervention 
group reported greater knowledge of DR relative to the control group (t(72)=-
2.213, p<.05; CI-2.14 to -.11), with moderate effect size (2=.05). There were no 
other significant between-group differences (all p>.05). Both groups reported a 
significant increase (from baseline to follow-up) in their knowledge of retinal 
screening and a significant increase in anticipated regret (all p<.05).    
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5.6 Discussion 
5.6.1 Summary of findings. This is the first randomised controlled trial to 
evaluate an evidence-based retinal screening promotion leaflet tailored to young 
adults with T2D. The leaflet targeted screening behaviour, as well as associated 
modifiable behavioural determinants identified in an earlier needs assessment 
(Lake et al., Unpublished results). Trends in the expected direction suggested that 
those unengaged participants who received the leaflet were more likely to 
initiate screening than those who did not, however caution is required in 
interpreting these findings given the small sample size, and in particular the 
smaller-than-anticipated number of unengaged participants.  The subsequent 
underpowered study precluded assessment of intervention effect on screening 
behaviour, the primary outcome. As such, no firm conclusions about the impact 
of the leaflet on screening uptake can be drawn.  
Effect of the leaflet on secondary outcomes was also promising. The 
intervention group demonstrated significantly greater improvement in 
knowledge of DR than the control group, an important retinal screening 
predictor associated with increase in screening in the general diabetes 
population (Zhang et al., 2007). The moderate effect size observed in the current 
study is consistent with effect sizes found in the behavioural sciences (Cohen, 
2013; Johnson, Scott-Sheldon, & Carey, 2010).  
Although the leaflet intervention did not independently impact other 
targeted social cognitive behavioural determinants, study involvement was 
associated with change in both knowledge (increased knowledge of retinal 
screening) and attitudes (increased anticipated regret). The latter is a likely 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 338 of 470 
artefact of question-behaviour effect (QBE), where answering questions about a 
specific behaviour can influence an individual’s related cognitions, emotions and 
behaviour (Spangenberg et al., 2012). Steps to address the potential for QBE had 
been incorporated into the originally planned 4-arm study design. Importantly 
though, evidence of QBE associated with retinal screening behaviour provides 
the potential for utilisation of this phenomenon as a simple, cost-effective 
pathway to promoting screening uptake; a strategy suggested for other health-
related behaviours, such as health check attendance and influenza vaccination 
(Conner, Godin, Norman, & Sheeran, 2011). 
5.6.2 Limitations. The key limitation was lack of power to detect change 
in the primary outcome.  Contributing factors were low recruitment, high 
baseline screening rate and high baseline scores (ceiling effect) for some of the 
behavioural determinant variables.  Despite careful planning, broad consultation 
and a nationwide recruitment program, only 4% of eligible NDSS registrants were 
recruited to the study.  It is likely that low recruitment resulted from a confluence 
of commonly reported barriers for this group (e.g. disproportionately high 
representation of ethnic/racial minorities, social disadvantage and complex 
psychosocial needs), (Lake et al., 2017; Nadeau et al., 2016; Nguyen et al., 2014; 
Zeitler et al., 2015).  Additional, context-specific barriers such as study ‘fatigue’ 
from high number of concurrent research opportunities (personal 
communication, D. Rae, National Inventory Manager, NDSS) may also have 
affected recruitment.   
The high participant baseline screening rate (72%) is lower than that the 
general (non-Indigenous) diabetes population in Australia’s first national eye 
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health survey (78%) (Foreman et al., 2017). However, reports from other sources 
indicate that the true young adult screening rate is likely to be closer to 50% 
(Diabetes Australia, 2006; Wang et al., 2017), indicating that the study may have 
missed recruiting the more disengaged members of the priority population.  The 
low average number of health comorbidities and high average number of 
diabetes-related health and complication checks despite earlier, contradictory 
findings (Browne et al., 2014),  support this assertion. 
Possible explanations for recruitment bias, which favours high self-
reported screening rates, include: self-selection bias, whereby those who choose 
to participate in research have higher self-efficacy and are more engaged in their 
diabetes care (Müller, Lamoureux, Bullen, & Keeffe, 2006), and social desirability 
and recall bias, both of which risk overestimation of retinal screening (Foreman 
et al., 2017).  Although self-report of retinal screening behaviour is commonly 
used as an outcome measure for intervention effectiveness, previous research 
has reported overestimation when compared with medical record data (Beckles 
et al., 2007; MacLennan, McGwin, Searcey, & Owsley, 2013).  
Despite efforts to conceal the true nature of the study, asking about self-
management behaviour from the outset may have elicited a social desirability 
bias, of which younger people are considered particularly susceptible (Johnson et 
al., 2010). Accuracy of self-report is also vulnerable to recall bias, particularly in 
the light of acknowledged confusion regarding the difference between screening 
for DR and a standard eye check (Hipwell et al., 2014). Future studies could 
overcome the threat of bias from these sources by not only including definition 
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of retinal screening (as was done in the current study), but also corroboration of 
self-report with medical record data.   
Finally, moderate-to-high baseline scores for many behavioural 
determinant variables indicated favorable retinal screening beliefs and attitudes 
in the priority population, prior to the intervention.  This ceiling effect was 
observed for variables within each of the three IMB constructs: Information 
(knowledge of diabetes/vision link); Motivational factors (attitudes, normative 
beliefs, and intentions) and Behavioural skills factors (perceived control, 
overcoming barriers).  Thus potential to detect treatment effect on the 
secondary outcome variables was limited.  Further, as we would expect to see 
the greatest change in those who had not previously screened for DR, low 
representation of unengaged young adults with T2D may have exacerbated this 
issue.   
Additional sources of bias included the inability to mask participants to 
the experimental condition (i.e. they either did or did not receive the leaflet) and 
high loss to follow-up.  Although inability to mask participants is a common issue 
for health behaviour change interventions (Tarquinio, Kivits, Minary, Coste, & 
Alla, 2015), possible consequences of this include performance or ascertainment 
bias, potentially affecting subjective reporting of study outcomes.  Further, we 
experienced considerable loss to follow-up, the majority of which occurred prior 
to intervention implementation. However, the majority of demographic 
characteristics of those lost to follow-up did not differ from those who 
completed the entire study with the important exception of country of birth.   
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5.6.3 Implications for future research. In addition to the need to 
redouble efforts to recruit and ensure retention of non-Australian born members 
of this cohort from the outset (possibly via collaboration with community-based 
organisations which represent culturally and linguistically diverse groups) as 
suggested by Zhang et al. (2007) in their systematic review of retinal screening 
promotion interventions, this study also highlights implications for the evaluation 
of retinal screening interventions.   
Considering that participant recruitment was conducted with the support 
and involvement of leading eye health and diabetes stakeholders, and that 
invitations were extended nationwide to over 5,000 eligible young adults with 
T2D, utilising an appropriate platform (NDSS database), our experience suggests 
that replication is not a practical option and that alternate evaluation designs 
should be considered.  
In recent years, clinical trials targeting youth/young adults with T2D have 
highlighted the challenges faced in the context of limited sample size and 
culturally diverse populations (Nadeau et al., 2016; Nguyen et al., 2014; Zeitler et 
al., 2015). Solutions proposed by those conducting large-scale trials include 
“realistic and efficient” study designs, development of collaborative networks, 
and a consortium approach to simultaneously evaluate medical treatments while 
sharing the one placebo arm (Nadeau et al., 2016; Zeitler et al., 2015).   
However, this may not be feasible for smaller-scale behavioural 
interventions, such as the current study. Instead, both MRC guidance and recent 
literature suggest alternatives to the conventional parallel-group randomised 
controlled trial.  Dependent upon a variety of factors (e.g. cost, time, priority 
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population characteristics, intervention setting and risk of selection bias), 
alternate evaluation approaches which maintain randomisation include dynamic 
wait-listed (DWL) and stepped wedge designs, while quasi-experimental designs 
include interrupted time-series (ITS) and regression point displacement (Craig et 
al., 2008; Fok, Henry, & Allen, 2015; Wyman, Henry, Knoblauch, & Brown, 2015). 
Despite improvements in study design, statistical and data measurement 
approaches which maximise efficiency and statistical power, each of the non-
conventional options cited above have inherent limitations, such as inflexibility 
due to time-limited parameters (DWL), long wait times (stepped-wedge), 
potential for high cost and participant burden (ITS), and potential for low power 
(regression point displacement), (Fok et al., 2015; Wyman et al., 2015).  
In their systematic review, Zhang and colleagues (2007) noted that retinal 
screening promotion intervention studies with non-RCT designs were conducted 
in more diverse populations than RCT designs. However, the benefits of the 
former need to be weighed against challenges with respect to achieving 
sufficient power, rigour and generalisability of findings.   Thus, in the context of 
future screening interventions for young adults with T2D, we recommend that 
researchers explore nonconventional alternatives to the traditional parallel 
groups RCT, while giving close consideration to the limitations noted above. 
However, if a conventional, gold standard RCT design is desired, we recommend 
use of a Solomon 4-group design to account for the likely presence of QBE. 
Furthermore, an RCT would need to overcome issues identified above, preferably 
via a highly proactive, community-based recruitment and engagement strategy.   
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5.6.4 Conclusion.Despite careful study design and proactive recruitment 
and implementation initiatives, we faced many of the challenges experienced in 
‘real-world’ health behaviour change intervention studies conducted with diverse 
or disadvantaged groups, including low recruitment from small population base, 
high loss to follow-up, and subsequent lack of statistical power. Notwithstanding 
its limitations, this study has made an important contribution by demonstrating 
that a tailored, evidence-based leaflet can improve knowledge of DR, a key 
screening facilitator, among young adults with T2D. A trend towards enhanced 
screening engagement as a result of the intervention was also observed, 
suggesting the leaflet has the potential to increase retinal screening rates among 
young adults with T2D.  
.   
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 344 of 470 
5.7 References 
Al-Saeed, A. H., Constantino, M. I., Molyneaux, L., D’Souza, M., Limacher-Gisler, 
F., Luo, C., . . . Wong, J. (2016). An inverse relationship between age of 
type 2 diabetes onset and complication risk and mortality: the impact of 
youth-onset type 2 diabetes. Diabetes Care, 39, 823-829. 
doi:10.2337/dc15-0991 
Arun, C. S., Al-Bermani, A., Stannard, K., & Taylor, R. (2009). Long-term impact of 
retinal screening on significant diabetes-related visual impairment in the 
working age population. Diabetic Medicine, 26(5), 489-492. 
doi:10.1111/j.1464-5491.2009.02718.x 
Australian Institute of Health and Welfare. (2014). Type 2 diabetes in Australia’s 
children and young people: a working paper. Diabetes Series No.21.  
Retrieved from http://www.aihw.gov.au/publication-
detail/?id=60129546361. Date accessed 22 August 2017. 
Ayling, K., Brierley, S., Johnson, B., Heller, S., & Eiser, C. (2015). Efficacy of 
theory-based interventions for young people with type 1 diabetes: A 
systematic review and meta-analysis. British Journal of Health 
Psychology, 20(2), 428-446. doi:10.1111/bjhp.12131 
Bartholomew Eldredge, L. K., Markham, C. M., Ruiter, R. A. C., Fernandez, M. E., 
Kok, G., & Parcel, G. S. (2016). Planning Health Promotion Programs : An 
Intervention Mapping Approach (4th ed.). San Francisco, CA: Jossey-Bass. 
Beckles, G. L., Williamson, D. F., Brown, A., F, Gregg, E. W., Karter, A. J., Kim, C., . 
. . Thompson, T., J. (2007). Agreement between self reports and medical 
records was only fair in a cross-sectional study of performance of annual 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 345 of 470 
eye examinations among adults with diabetes in managed care. Medical 
Care, 45(9), 9.  
Browne, J. L., Nefs, G., Pouwer, F., & Speight, J. (2014). Depression, anxiety and 
self-care behaviours of young adults with Type 2 diabetes: Results from 
the International Diabetes Management and Impact for Long-term 
Empowerment and Success (MILES) Study. Diabetic Medicine, 32(1), 133-
140. doi:10.1111/dme.12566 
Cohen, J. (2013). Statistical Power Analysis for the Behavioral Sciences: 
Burlington : Elsevier Science, 2013. 
Conner, M., Godin, G., Norman, P., & Sheeran, P. (2011). Using the question-
behavior effect to promote disease prevention behaviors: two 
randomized controlled trials. Health Psychology, 30(3), 300-309. 
doi:10.1037/a0023036 
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. 
(2008). Developing and evaluating complex interventions: the new 
Medical Research Council guidance. British Medical Journal, 337, a1655. 
doi:10.1136/bmj.a1655 
Dabelea, D., Stafford, J. M., Mayer-Davis, E. J., D'Agostino, R., Jr., Dolan, L., 
Imperatore, G., . . . Group, S. f. D. i. Y. R. (2017). Association of Type 1 
Diabetes vs Type 2 Diabetes Diagnosed During Childhood and 
Adolescence With Complications During Teenage Years and Young 
Adulthood. Journal of the American Medical Association, 317(8), 825-835. 
doi:10.1001/jama.2017.0686 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 346 of 470 
Dallal, G. E. (2008). Randomization.com.   Retrieved from 
http://www.randomization.com/. Date accessed 26 June 2017. 
Diabetes Australia. (2006). Young Adults With Diabetes Needs Analysis.   
Retrieved from 
http://static.diabetesaustralia.com.au/s/fileassets/diabetes-
australia/6321f173-1642-42ed-8501-e95dc1ffa189.pdf. Date accessed 22 
August 2017. 
Diabetes Victoria. Who is looking after your eyes? Your guide to preventing 
vision loss from diabetic retinopathy.   Retrieved from https://s3-ap-
southeast-2.amazonaws.com/dv-
resources/OrchestraCMS/a1f90000004k5XkAAI.pdf. Date accessed 22 
August 2017. 
Ferris, F. L. (1993). How effective are treatments for diabetic retinopathy? 
Journal of the American Medical Association, 269(10), 1290-1291.  
Fishbein, M., & Ajzen, I. (2010). Predicting and changing behaviour: the reasoned 
action approach. New York: Psychology Press. 
Fishbein, M., Hennessy, M., Kamb, M., Bolan, G. A., Hoxworth, T., Iatesta, M., . . . 
Zenilman, J. M. (2001). Using Intervention Theory to Model Factors 
Influencing Behavior Change: Project Respect. Evaluation & the Health 
Professions, 24(4), 363-384. doi:10.1177/01632780122034966 
Fisher, W. A., Fisher, J. D., & Harman, J. (2003). The Information–Motivation–
Behavioral Skills model: a general social psychological approach to 
understanding and promoting health behavior. In J. Sulls & K. A. Walston 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 347 of 470 
(Eds.), Social psychological foundations of health and illness (pp. 82-106). 
Oxford, UK: Blackwell Publishing Ltd. 
Fok, C. C., Henry, D., & Allen, J. (2015). Research Designs for Intervention 
Research with Small Samples II: Stepped Wedge and Interrupted Time-
Series Designs. Prevention Science, 16(7), 967-977. doi:10.1007/s11121-
015-0569-4 
Foreman, J., Keel, S., Xie, J., Van Wijngaarden, P., Taylor, H. R., & Dirani, M. 
(2017). Adherence to diabetic eye examination guidelines in Australia: 
the National Eye Health Survey. Medical Journal of Australia, 206(9), 402-
406.  
Hipwell, A. E., Sturt, J., Lindenmeyer, A., Stratton, I., Gadsby, R., O'Hare, P. O., & 
Scanlon, P. H. (2014). Attitudes, access and anguish: a qualitative 
interview study of staff and patients’ experiences of diabetic retinopathy 
screening. BMJ Open, 4(12), e005498. doi:10.1136/bmjopen-2014-
005498 
Hwang, J., Rudnisky, C., Bowen, S., & Johnson, J. A. (2015). Socioeconomic 
factors associated with visual impairment and ophthalmic care utilization 
in patients with type II diabetes. Canadian Journal of Ophthalmology, 
50(2), 119-126. doi:10.1016/j.jcjo.2014.11.014 
Johnson, B. T., Scott-Sheldon, L. A. J., & Carey, M. P. (2010). Meta-synthesis of 
health behavior change meta-analyses. American Journal of Public 
Health, 100(11), 2193-2198. doi:10.2105/AJPH.2008.155200 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 348 of 470 
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003). The Patient Health 
Questionnaire-2: Validity of a Two-Item Depression Screener. Medical 
Care, 41(11), 1284-1292.  
Lake, A. J., Browne, J. L., Abraham, C., Tumino, D., Hines, C., Rees, G., & Speight, 
J. (Unpublished results). A tailored intervention to promote uptake of 
retinal screening among young adults with type 2 diabetes - an 
intervention mapping approach   
Lake, A. J., Browne, J. L., Rees, G., & Speight, J. (2017). What factors influence 
uptake of retinal screening among young adults with type 2 diabetes? A 
qualitative study informed by the Theoretical Domains Framework. 
Journal of Diabetes and its Complications, 31(6), 997-1006. 
doi:http://dx.doi.org/10.1016/j.jdiacomp.2017.02.020 
Lawrenson, J. G., Graham-Rowe, E., Lorencatto, F., Presseau, J., Burr, J., Ivers, N., 
. . . Vale, L. (2016). Interventions to increase attendance for diabetic 
retinopathy screening (Protocol). Cochrane Database of Systematic 
Reviews(1). doi:10.1002/14651858.CD012054.pub2 
Lee, S. J., Sicari, C., Harper, C. A., Livingston, P. M., McCarty, C. A., Taylor, H., & 
Keeffe, J. E. (2000). Examination compliance and screening for diabetic 
retinopathy: a 2-year follow-up study. Clinical and Experimental 
Ophthalmology, 28(3), 149-152. doi:10.1046/j.1442-9071.2000.00302.x 
MacLennan, P., McGwin, G., Searcey, K., & Owsley, C. (2013). Medical Record 
Validation of Self-Reported Eye Diseases and Eye Care Utilization Among 
Older Adults. Current Eye Research, 38(1), 1-8. 
doi:10.3109/02713683.2012.733054 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 349 of 470 
Mayberry, L. S., & Osborn, C. Y. (2014). Empirical validation of the Information-
Motivation-Behavioral skills model of diabetes medication adherence: a 
framework for intervention. Diabetes Care, 37(5), 1246-1253. 
doi:10.2337/dc13-1828 
Mitchell, P., & Foran, S. (2008). Guidelines for the Management of Diabetic 
Retinopathy.   Retrieved from 
https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/di15
.pdf. Date accessed 22 August 2017. 
Müller, A., Lamoureux, E., Bullen, C., & Keeffe, J. E. (2006). Factors associated 
with regular eye examinations in people with diabetes: Results from the 
Victorian Population Health Survey. Optometry and Vision Science, 83(2), 
96-101. doi:10.1097/01.opx.0000200678.77515.2e 
Nadeau, K. J., Anderson, B. J., Berg, E. G., Chiang, J. L., Chou, H., Copeland, K. C., . 
. . Zeitler, P. (2016). Youth-Onset Type 2 Diabetes Consensus Report: 
Current Status, Challenges, and Priorities. Diabetes Care, 39(9), 1635-
1642. doi:10.2337/dc16-1066 
Nguyen, T. T., Jayadeva, V., Cizza, G., Brown, R. J., Nandagopal, R., Rodriguez, L. 
M., & Rother, K. I. (2014). Challenging recruitment of youth with type 2 
diabetes into clinical trials. Journal of Adolescent Health, 54(3), 247-254. 
doi:10.1016/j.jadohealth.2013.08.017 
Osborn, C. Y., Amico, K. R., Fisher, W. A., Egede, L. E., & Fisher, J. D. (2010). An 
Information-Motivation-Behavioral Skills Analysis of Diet and Exercise 
Behavior in Puerto Ricans with Diabetes. Journal of Health Psychology, 
15(8), 1201-1213. doi:10.1177/1359105310364173 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 350 of 470 
Osborn, C. Y., & Egede, L. E. (2010). Validation of an Information-Motivation-
Behavioral Skills model of diabetes self-care (IMB-DSC). Patient Education 
and Counseling, 79(1), 49-54. doi:10.1016/j.pec.2009.07.016 
Qualtrics. (2014).   Retrieved from https://www.qualtrics.com/. Date accessed 26 
June 2017. 
Sachdeva, A., Stratton, I. M., Unwin, J., Moreton, R., & Scanlon, P. H. (2012). 
Diabetic retinopathy screening: Study to determine risk factors for non-
attendance. Diabetes & Primary Care, 14(5), 308-316.  
Scanlon, P. H., Stratton, I. M., Leese, G. P., Bachmann, M. O., Land, M., Jones, C., 
. . . Four Nations Diabetic Retinopathy Screening Study Group. (2016). 
Screening attendance, age group and diabetic retinopathy level at first 
screen. Diabetic Medicine, 33(7), 904-911. doi:10.1111/dme.12957 
Sivaprasad, S., Gupta, B., Crosby-Nwaobi, R., & Evans, J. (2012). Prevalence of 
Diabetic Retinopathy in Various Ethnic Groups: A Worldwide Perspective. 
Survey of Ophthalmology, 57(4), 347-370. 
doi:10.1016/j.survophthal.2012.01.004 
Solomon, R. L. (1949). An extension of control group design. Psychological 
Bulletin, 46(2), 14.  
Spangenberg, E. R., Sprott, D. E., Knuff, D. C., Smith, R. J., Obermiller, C., & 
Greenwald, A. G. (2012). Process evidence for the question–behavior 
effect: Influencing socially normative behaviors. Social Influence, 7(3), 
211-228. doi:10.1080/15534510.2012.694024 
Tapp, R. J., Zimmet, P. Z., Harper, C. A., de Courten, M. P., Balkau, B., McCarty, D. 
J., . . . Shaw, J. E. (2004). Diabetes care in an Australian population: 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 351 of 470 
frequency of screening examinations for eye and foot complications of 
diabetes. Diabetes Care, 27(3), 688-693.  
Tarquinio, C., Kivits, J., Minary, L., Coste, J., & Alla, F. (2015). Evaluating complex 
interventions: Perspectives and issues for health behaviour change 
interventions. Psychology and Health, 30(1), 35-51. 
doi:10.1080/08870446.2014.953530 
Vision 2020 Australia. (2017). Who is looking after your eyes? Your guide to 
preventing vision loss from diabetic retinopathy.   Retrieved from 
http://www.visioninitiative.org.au/uploads/assets/files/infosheets/ACBR
D_DR%20Age%20under%2040.pdf. Date accessed 22 August 2017. 
Wang, S. Y., Andrews, C. A., Gardner, T. W., Wood, M., Singer, K., & Stein, J. D. 
(2017). Ophthalmic screening patterns among youths with diabetes 
enrolled in a large US managed care network. JAMA Ophthalmology, 
35(5), 432-438. doi:10.1001/jamaophthalmol.2017.0089 
Wilmot, E., & Idris, I. (2014). Early onset type 2 diabetes: risk factors, clinical 
impact and management. Therapeutic Advances in Chronic Disease, 5(6), 
11. doi:10.1177/2040622314548679 
Wong, J., Molyneaux, L., Constantino, M., Twigg, S. M., & Yue, D. K. (2008). 
Timing is everything: age of onset influences long-term retinopathy risk in 
Type 2 diabetes, independent of traditional risk factors. Diabetes Care, 
31(10), 1985-1991. doi:10.2337/dc08-0580 
Wyman, P. A., Henry, D., Knoblauch, S., & Brown, C. H. (2015). Designs for 
Testing Group-Based Interventions with Limited Numbers of Social Units: 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 352 of 470 
The Dynamic Wait-Listed and Regression Point Displacement Designs. 
Prevention Science, 16(7), 956-966. doi:10.1007/s11121-014-0535-6 
Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K. H., . . . Chan, J. 
C. N. (2014). Metabolic profiles and treatment gaps in young-onset type 2 
diabetes in Asia (the JADE programme): a cross-sectional study of a 
prospective cohort. The Lancet Diabetes & Endocrinology, 2(12), 935-943. 
doi:10.1016/S2213-8587 
Zeitler, P., Chou, H. S., Copeland, K. C., & Geffner, M. (2015). Clinical trials in 
youth-onset type 2 diabetes: needs, barriers, and options. Current 
Diabetes Reports, 15(5), 1-8. doi:10.1007/s11892-015-0597-2 
Zhang, X., Norris, S. L., Saadine, J., Chowdhury, F. M., Horsley, T., Kanjilal, S., . . . 
Buhrmann, R. (2007). Effectiveness of interventions to promote screening 
for diabetic retinopathy. Am J Prev Med, 33(4), 318-335. 
doi:10.1016/j.amepre.2007.05.002 
Zimmet, P., Magliano, D. J., Herman, W., & Shaw, J. (2014). Diabetes: a 21st 
century challenge. The Lancet Diabetes & Endocrinology, 2(1), 56-64. 
doi:10.1016/s2213-8587(13)70112-8 
 
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 353 of 470 
5.8 Additional information 
5.8.1 Acknowledgements. We thank the study participants for their 
contribution, insights and experiences. For their professional input, we thank: 
Carolyn Hines (Diabetes Education Manager, Diabetes Victoria) and Dee Tumino 
(Vision Initiative Manager, Vision 2020 Australia). For advice on QBE and  the 
Solomon 4-group trial design, we thank Prof Charles Abraham (Exeter University, 
UK). For advice on website development, we thank Dr Steve Trawley (ACBRD). 
For their statistical advice, we thank Dr Elizabeth Holmes-Truscott (ACBRD) and 
Deakin University Faculty of Health biostatistics team (Dr Lucy Busija, Assoc Prof 
Liliana Orellana, Dr Mohammadreza Mohebbi).  
Finally, we thank Mr. Darren Rae, National Operations Manager and staff 
at the NDSS for their advice and guidance, registration statistics and for 
managing participant recruitment. 
  
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 354 of 470 
5.8.2 Supplementary materials 
Table 24: Supplementary materials - questionnaire items assessing modifiable 
behavioural determinants associated with retinal screening 
VARIABLE NAME 
No. of 
items 
Range 
INFORMATIONa   
Knowledge: diabetes/vision loss link 2 0-2 
Diabetes can lead to vision loss     
All people with diabetes are at risk of DR   
Knowledge: diabetic retinopathy (DR) 11 0-11 
Prevalence rates of DR amongst people with diabetes   
DR can cause vision loss or blindness   
DR can develop without symptoms   
DR is influenced by high blood pressure   
DR is influenced by high cholesterol   
DR is treatable if detected early via an eye health check    
DR is more likely to develop the longer you have 
   diabetes 
  
DR is influenced by high blood glucose   
Early DR is asymptomatic   
Recommended target HbA1c*   
Recommended target blood pressure   
Knowledge: retinal screening 3 0-3 
Which health professional would you most likely to see 
    for a DR examination?  
  
When should a person with diabetes have their first eye 
   examination? 
  
Recommended eye examination frequency if no DR 
   present? 
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Table 24: Questionnaire items assessing modifiable behavioural determinants 
           associated with retinal screening (Cont.) 
VARIABLE NAME 
No. of 
items 
Range 
MOTIVATIONb,c   
Attitudes: retinal screeningc  (α=.86) ~ 11 11-55 
For me to have an eye health check for DR would...   
...be a good idea   
...(not)# be ‘unpleasant’   
...be wise   
...(not)# be ‘difficult’   
...(not)# be ‘frightening’   
...(not)# be ‘unnecessary’   
...be reassuring   
...be important   
...be beneficial   
...be comfortable   
...be empowering   
Attitudes: risk perceptionb (α=.70)  4 4-28 
I believe I will develop DR due to my diabetes   
I expect to be diagnosed with DR at my next eye check   
I believe I can reduce my risk of vision problems if  
   I manage my diabetes well 
  
I believe I will develop vision problems due to diabetes   
Attitudes: anticipated regretb (α=.87) 6 6-42 
If I did NOT have an eye health check for DR, I would feel...                                   
...indifferent    
...concerned   
...fearful    
...worried   
...regretful   
...guilty   
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Table 24: Questionnaire items assessing modifiable behavioural determinants  
            associated with retinal screening (Cont.) 
VARIABLE NAME 
No. of 
items 
Range 
MOTIVATIONb,c (Cont.)   
Normative beliefsb (α=.93, Pearson’s r=.87) 2 2-14 
My family/close friends would approve of me attending 
   an eye health check… 
  
My health professionals would approve of me attending 
   an eye health check… 
  
Additional item: Most people I know with diabetes have 
   regular eye health checksb 
1 0-7 
Intentionb (α=.98) 3 3-21 
I plan to attend an eye health check…   
I will make an effort to have an eye health check…   
I intend to have an eye health check…   
BEHAVIOURAL SKILLS   
Perceived controld (α=.87)  6 6-30 
How confident are you that you...   
…know what steps you can take to reduce the risk of  
   developing DR? 
  
…will have regular eye health checks?   
…know how to make the appointment for an eye  
   check? 
  
…will remember to have an eye health check in the next  
   four weeks OR when it is next due? 
  
…will attend the eye health check that you have  
   booked? 
  
…can reschedule the eye health check to a different  
   time or day if needed? 
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Table 24: Questionnaire items assessing modifiable behavioural determinants  
            associated with retinal screening (Cont.) 
VARIABLE NAME 
No. of 
items 
Range 
Overcoming barriersd (α=.76)         5 5-25 
How confident are you that you…   
…can talk to your doctor about your eye health?   
…can find the time to attend an eye health check in the  
   next four weeks OR when it is next due? 
  
…will mention you have diabetes when you make the  
   eye check appointment? 
  
…can resume your normal activities immediately after  
   the eye health check? 
  
…can afford to pay for the eye health check, if there is a  
   charge? 
  
~Cronbach’s alpha was generated for all motivational and behavioural skills 
constructs; Pearson’s r generated for 2-item construct.  
*Indicator of glycaemic control (measure of average blood glucose levels over the 
past 8-12 weeks). 
DR: diabetic retinopathy, #responses reverse coded.  
Scoring for individual items:  
a incorrect / correct;  
b 1 (Strongly disagree) to 7 (Strongly agree),  
c 1 (Strongly disagree) to 5 (Strongly agree),  
d 1 (Not at all confident) to 5 (Extremely confident).  
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5.8.3 Trial registration. Australian and New Zealand Clinical Trials registry 
ACTRN12614001110673 
5.8.4 Changes to methods after trial commencement. Based on 
experience from an earlier qualitative study (Lake, Browne, Rees, & Speight, 
2017), the original design for this project addressed a potential source of bias 
known as question-behaviour effect (QBE).  Common to socially desirable 
behaviours, QBE is a phenomenon whereby answering questions about a specific 
behaviour can influence an individual’s cognitions, emotions and subsequent 
behaviour (Spangenberg et al., 2012). QBE has been detected in relation to a 
range of health-related behaviours, including blood donation, cervical screening, 
uptake of influenza vaccination and health checks (Conner, Godin, Norman, & 
Sheeran, 2011; Godin, Germain, Conner, Delage, & Sheeran, 2013; Sandberg & 
Conner, 2009). 
Researchers have highlighted QBE as a source of bias in health behaviour 
change interventions (McCambridge, 2015), urging caution in the use of pre-test 
measures (Sandberg & Conner, 2009). In an attempt to account for QBE, we 
originally selected a Solomon 4-group study design (Solomon, 1949), which 
randomly assigns participants to a combination of four pre-test/intervention 
groups in a 2x2 factorial design.  In a Solomon 4-group design, half of all 
participants within each condition receive baseline questionnaires and the other 
half do not, permitting assessment of both the intervention and the interaction 
of pre-test items. If pre-test sensitisation, or QBE, is present, the effect would be 
expected to be larger than ‘no pre-test plus intervention’.   
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Informed by previous studies among young adults with T2D (Nguyen et 
al., 2014; Zeitler, Chou, Copeland, & Geffner, 2015), we anticipated low 
recruitment (10%) (Browne, Nefs, Pouwer, & Speight, 2014; Johnson, Niles, & 
Mori, 2015) estimated a low previous retinal screening rate (50%) (Diabetes 
Australia, 2006; Wang et al., 2017) and high attrition (40%) (Nguyen et al., 2014). 
Sample size calculation was computed using input parameter of an effect size of 
0.3 (Johnson, Scott-Sheldon, & Carey, 2010), which required 200 participants not 
engaged with screening (50 per condition in the 4-group design) at follow-up for 
80% power, using a significance level of 0.05 (two-tailed).   
To fulfil this requirement, it was estimated that we would need to mail 
recruitment invitations to 3,400 eligible NDSS registrants. However, subsequent 
discussions with representatives from the NDSS suggested that recruitment rates 
would be lower than reported in the literature due to a high number of 
invitations to concurrent research opportunities being disseminated by the NDSS.  
Consequently, the planning team agreed to send recruitment invitations to all 
eligible NDSS registrants who had consented to be contacted for research 
(N=5,354).   
At the end of the seven-week recruitment period, and after an additional 
reminder invitation was mailed, only 63 unengaged young adults had registered 
for the study; below the required minimum sample size. A senior biostatistician 
reviewed the study design and advised to replace the Solomon 4-group design 
with a standard 2-group RCT design (leaflet intervention vs no-leaflet control).  A 
second power analysis confirmed that the effect of the leaflet on the primary 
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outcome could be assessed with a sample size of 50 per condition (including 25 
‘unengaged’ per condition); power and significance levels remained the same.  
The RCT design modification received Deakin University Human Research 
Ethics Committee approval in November 2014 and was added to trial registration 
ACTRN12614001110673. 
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CHAPTER 6: Discussion 
The overall aim of this program of PhD research was to develop a public 
health intervention to promote uptake of retinal screening among young adults 
with type 2 diabetes (T2D).  To achieve this aim, three objectives were defined: i) 
identify modifiable factors impacting retinal screening behaviour among young 
adults with T2D; ii) develop an individual-level, theoretically-grounded, psycho-
educational retinal screening promotion intervention, tailored to this priority 
population; and iii) evaluate the effectiveness of the intervention in increasing 
self-reported uptake of retinal screening and changing modifiable behavioural 
determinants in a fully powered randomised controlled trial (RCT). 
This chapter comprises five sections. The first summarises key findings by 
objective, and discusses the original contribution of this program of PhD research 
to existing knowledge. The second section discusses study implications, 
particularly with regard to clinical practice and a proposed nationally coordinated 
retinal screening program in Australia. Section three discusses implications for 
future research, such as utilisation of the leaflet as a foundation for similar 
resources, and lessons learned for future research.  Strengths and limitations are 
discussed in Section four, followed by a brief conclusion (Section five). 
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6.1 Overview of Key Findings and Contribution to Current Knowledge 
Although younger age is an independent risk factor for both diabetic 
retinopathy (DR) and low retinal screening uptake (Scanlon et al., 2016; Zoungas 
et al., 2014), no study has previously explored in-depth, the underlying, 
individual-level factors impacting retinal screening uptake among young adults 
with T2D (Forward, Hewitt, & Mackey, 2012; Hessler, Fisher, Mullan, Glasgow, & 
Masharani, 2011).  Furthermore, no previous studies have developed a retinal 
screening promotion intervention tailored to this priority population. 
6.1.1 Objective 1: Identify modifiable factors impacting retinal 
screening behaviour among young adults with type 2 diabetes. 
Previous research has demonstrated that young adults with T2D face a range of 
clinical and psychosocial barriers to diabetes self-management (Auslander, 
Sterzing, Zayas, & White, 2010; Brouwer et al., 2012; Browne, Nefs, Pouwer, & 
Speight, 2014; Browne, Scibilia, & Speight, 2013a; Hessler et al., 2011; Savage, 
Dabkowski, & Dunning, 2009; Sillars, Davis, Kamber, & Davis, 2010; Waitzfelder et 
al., 2011). Chapters 3 and 4 of this thesis report the conduct and findings of a 
mixed-methods needs assessment, which confirmed that young adults with T2D 
experience multiple barriers and facilitators to retinal screening, and identified 
key behavioural determinants of this important behaviour.  
Using the Theoretical Domains Framework (TDF) as a theoretical 
foundation to data collection and interpretation (Cane, O'Connor, & Michie, 
2012), the qualitative in-depth interview study (described in Chapter 3) 
demonstrated that many barriers and facilitators experienced by young adults 
with T2D are shared with their older adult T2D counterparts for whom the 
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majority of existing self-management resources are designed. Shared barriers 
include lack of knowledge of DR and retinal screening guidelines (see Section 
3.5.2 for more detail).  However, the study also identified factors of greater 
salience to young adults with T2D, including lack of financial and time resources, 
and lack of engagement with existing diabetes information and support services, 
highlighting the need for tailored retinal screening promotion materials.  To 
illustrate, members of the older adult comparator group commonly stated that 
they engaged in retinal screening to preserve their independence, while those 
young adults with T2D who had screened for DR commonly reported fear of the 
impact of vision loss on the family unit as a motivating factor. 
Using the Information-Motivation-Behavioural skills model as a 
framework for data collection and interpretation (Fisher, Fisher, & Harman, 
2003), the nationally-conducted online quantitative survey (described in Section 
4.4.1.2.2), further explored barriers and facilitators, and highlighted multiple 
modifiable behavioural retinal screening determinants to be targeted in the 
intervention, including several key differences between the young adults with 
T2D who had and had not engaged in retinal screening. To illustrate, young adults 
with T2D who had never screened for DR demonstrated significantly lower 
knowledge (e.g. that all people are at risk of DR, and that individuals should 
initiate retinal screening at diabetes diagnosis), than their similar aged 
counterparts who had engaged in retinal screening. Similarly, where the in-depth 
qualitative interview study highlighted social influence and support as a key 
retinal screening facilitator for both the young adults with T2D, and their older 
adult counterparts (Section 3.5.2.1), the quantitative survey findings confirmed 
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that young adults with T2D who had previously screened were significantly more 
likely to agree that significant others (i.e. family/friends, healthcare team) would 
approve of screening (Table 12, Section  4.4.1.2.2). 
Summary of retinal screening barriers and determinants. The findings 
from the mixed-methods needs assessment studies indicated that many clinical 
and psychosocial barriers which apply to diabetes self-management (Browne et 
al., 2013a; Diabetes Australia, 2006), apply to retinal screening behaviour.  Taken 
in combination with the literature study described in Section 4.8.1, these include:  
 absence of symptoms from diabetes-related complications, which typically 
manifest 10 years post diagnosis (Dart et al., 2014; Delamater, Jacquez, & 
Patino-Fernandez, 2009);  
 added burden of multiple health comorbidities at a young age, including 
obesity which is commonly cited by young adults with T2D as their main 
health concern (Auslander et al., 2010; Dabelea et al., 2017; Nguyen et al., 
2014);  
 lack of encouragement to screen for DR from general practitioner (GP), 
potentially due to uncertainty about how to manage younger onset T2D, or 
clinician misconception that the condition is low risk (Song, 2015; Zafar, 
Stone, Davies, & Khunti, 2014);  
 time and financial constraints associated with life stage, which include 
parenting, full time work and study (Arnett, 2000; Sachdeva, Stratton, Unwin, 
Moreton, & Scanlon, 2012; Strutton, Du Chemin, Stratton, & Forster, 2016);  
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 low health literacy and low appreciation of long-term consequences of 
diabetes, exacerbated by low rates of diabetes self-management education, 
an important screening predictor (Bailey et al., 2014; MacLennan, McGwin, 
Heckemeyer, & et al., 2014);  
 disengagement with existing diabetes services and support networks, due to 
lack of perceived ‘age-appropriate’ materials and resources, and denial of 
diabetes diagnosis (Diabetes Australia, 2006);  
 fatalism about the inevitability of diabetes complications, due to family 
history of T2D (Turner et al., 2015), and  
 perception of stigma and negative judgment due to having a condition 
usually associated with older adults (Savage et al., 2009).   
Similarly, the mixed-methods needs assessment identified that many 
retinal screening determinants were psychosocial in origin (e.g. knowledge, 
attitudes, health and normative beliefs, intentions and self-efficacy), and were 
similar to those identified in studies examining the uptake of other screening 
behaviours, such as breast and cervical cancer (Burgess et al., 2008; Byrd et al., 
2012; Magai, Consedine, Neugut, & Hershman, 2007; Sadler, Albrow, Shelton, 
Kitchener, & Brabin, 2013; Vernon et al., 2008), colorectal cancer (Dharni, 
Armstrong, Chung-Faye, & Wright, 2017), hepatitis B (Van Der Veen, Van 
Empelen, & Richardus, 2012), and sexual health screening by young people 
(Newby et al., 2017; Theunissen et al., 2013; Tilson, Sanchez, Ford, & Smurzynski, 
2004; Wolfers, de Zwart, & Kok, 2012).  
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For example, although positive attitudes regarding the benefit of retinal 
screening, and expectations of a positive outcome, facilitated the behaviour, 
youth-related perceptions of invulnerability and low personal risk impeded it, 
lowering perception of need and decreasing prioritisation of retinal screening 
over competing activities (MacLennan et al., 2014). Further, although social 
normative factors, such as social support, beliefs about others’ approval, and 
awareness of the screening behaviour of similar others, facilitated retinal 
screening (as they also influence other screening behaviours), a crucial difference 
is that many young adults with T2D did not know anyone else with the condition 
and therefore, did not know whether similar others screened for DR, or whether 
others approved of the behaviour (Mulvaney et al., 2006).  
Similarly, health beliefs (e.g. unrealistic optimism, fatalism, fear of 
adverse effects, misconceptions regarding eye health as an ‘older person’s’ 
concern) were demonstrated to influence young adults’ eye health behaviour, as 
they did for cancer screening initiatives (Sadler et al., 2013; Shickle et al., 2014). 
Intention to screen for DR was high among the priority population, even for 
those who had not screened, highlighting low actual prioritisation of the 
behaviour; a similar finding for young women and breast cancer screening 
(Sadler et al., 2013). Finally, low self-efficacy represented by low confidence in 
ability to screen for DR due to competing ‘life stage’ demands, was an important 
and distinct barrier contributing to the confluence of factors impacting retinal 
screening behaviour for young adults with T2D.  
In addition to identifying salient barriers, facilitators and behavioural 
determinants, the most potent factor impeding retinal screening behaviour for 
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young adults with T2D appeared to be clustering of barriers, rather than one 
over-riding specific factor. The hypothesis that an accumulation of barriers 
impedes retinal screening was raised in earlier, qualitative work (Lindenmeyer et 
al., 2014). Thus, in contrast to the discrete focus on increasing knowledge and 
awareness, which was customary to many earlier retinal screening promotion 
interventions (Livingston et al., 1998; Zhang et al., 2007), this program of PhD 
research has highlighted the imperative of targeting and addressing a range of 
salient factors when developing retinal screening promotion interventions 
tailored to young adults with T2D.  Further, given that the TDF was used to 
identify barriers and facilitators to retinal screening, the findings from this study 
have the potential to contribute to the systematic review currently being 
conducted by Graham-Rowe et al. (2016), described in Section 2.1.2.   
In summary, the findings of the mixed methods needs assessment 
demonstrated that this priority population faces a converging range of 
psychosocial and other barriers to retinal screening, many of which distinguish 
them from their older adult counterparts. Consequently, a tailored intervention 
is warranted in order to target appropriate underlying factors, and engage this 
priority population in retinal screening. 
6.1.2 Objective 2: Develop an individual-level, theoretically-grounded, 
psycho-educational retinal screening promotion intervention, 
tailored to young adults with type 2 diabetes.  Chapter 4 
reported on the use of Intervention Mapping (IM) as a framework to develop a 
theoretically-grounded and evidence-based intervention tailored to the 
expressed needs of young adults with T2D. Using causal modelling, modifiable 
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determinants (summarised in Section 4.4.1.2.3) and non-modifiable 
determinants (e.g. socioeconomic status, cultural diversity, general and health 
literacy, life stage demands, multimorbidity and complex treatment regimen) 
were integrated to identify both pathways of problem causation (i.e. from 
personal and environmental determinants, to consequent impact on health and 
quality of life; Section 4.4.1.3), and pathways of problem rectification (i.e. from 
the intervention to program objectives and outcomes, to anticipated health and 
quality of life improvements; Section 4.4.2.2). 
 Expected cognitions, behaviour and intervention outcomes were 
identified, and more than 40 evidence-based persuasive messages were 
developed systematically and mapped to theory-based behaviour change 
techniques (BCTs, Abraham & Kools, 2012; Abraham & Michie, 2008). In 
collaboration with a multidisciplinary project planning team, the messages were 
embedded in an engaging, individual-level, print-based intervention and paired 
with cohort-appropriate imagery. The final product, entitled ‘Who is looking after 
your eyes?’, was piloted widely among stakeholders, including members of the 
priority population.  
As reported in Section 4.4.1.1, a highly engaged group of young adults 
with T2D remained with the study throughout the entire process, providing input 
and feedback on all key processes and expressing satisfaction at their 
involvement.  The benefit of involving young adults with T2D was demonstrated 
when priority population feedback prompted inclusion of more information 
about treatment options (illustrated in Table 18, Section 4.4.4.2), ensuring an 
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accurate and relevant resource, which could be used readily in real-world 
conditions.   
The process of formative research and development of empirically and 
theoretically-grounded psycho-educational materials that are culturally relevant 
and age-appropriate is consistent with UK Medical Research Council (MRC) 
guidance for developing health behaviour change interventions (Craig et al., 
2008).  However, as highlighted in Section 2.3.2, and in the broader literature 
(Abraham, Southby, Quandte, Krahé, & ven der Sluijs, 2007; Lawrenson et al., 
2016; Zwarenstein et al., 2014), many health behaviour change leaflets (including 
those that promote retinal screening uptake) are not developed in a systematic, 
evidence-based and rigorous manner; nor do they explore barriers or attempt to 
change the clearly identified, underlying modifiable determinants of health 
behaviour.  
Furthermore, lack of specificity of theory- and evidence-based content in 
previous work has impeded our understanding of the effective components of 
various interventions (Michie & Abraham, 2008), including existing interventions 
to promote retinal screening  (Graham-Rowe et al., 2016; Lawrenson et al., 2016; 
Zhang et al., 2007).  In utilising IM as an overarching intervention development 
framework, and in clearly specifying each step of intervention development, this 
program of PhD research demonstrated a rigorous approach, providing a clear, 
replicable procedure upon which future program planners can build (Hoffmann 
et al., 2014).  Further, in clearly specifying the underlying mechanisms for retinal 
screening uptake and systematically developing age- and contextually-
appropriate persuasive messaging linked to evidence-based BCT, with the active 
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participation of members of the priority population, the ‘Who is looking after 
your eyes?’ leaflet has since been used to illustrate ‘best practice’ in health 
behaviour change intervention development (Abraham, 2017).   
However, although IM was a useful framework for intervention 
development, the process was both time and resource intensive; an issue raised 
across a range of IM-based studies, (Ball, Mushquash, Keaschuk, Ambler, & 
Newton, 2017; Lloyd, Logan, Greaves, & Wyatt, 2011; Suzuki et al., 2012; Voogt, 
Poelen, Kleinjan, Lemmers, & Engels, 2014); the implications of which are 
discussed in Section 6.3.2.3 below.    
In summary, development of a high-quality, print-based retinal screening 
promotion leaflet under real-world conditions, is a novel and valuable 
contribution to provision of age-appropriate resources for this priority 
population.  
6.1.3 Objective 3: Evaluate the effectiveness of the intervention in 
increasing self-reported uptake of retinal screening and 
improving modifiable behavioural determinants.  Chapter 5 
reported the conduct and findings of an RCT evaluation to assess the 
effectiveness of the ‘Who is looking after your eyes?’ leaflet in increasing self-
reported uptake of retinal screening (primary outcome) and improving 
modifiable behavioural determinants (secondary outcomes).  Although the study 
was ultimately underpowered to detect improvement in the primary outcome, 
trends were apparent, with a slightly larger proportion of intervention group 
participants initiating screening compared to their control group counterparts 
(n=5 and n=3, respectively) in the four-week, post-intervention follow-up period. 
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In terms of secondary outcomes, the only differences between those in 
the leaflet intervention group and the control group at follow-up were that the 
former had a significant improvement in their knowledge of DR. Given that 
knowledge is a significant barrier to retinal screening, this finding is promising 
and has the potential to make a contribution to the systematic review currently 
being conducted by Lawrenson et al. (2016), described in Section 2.1.2.  Further, 
as noted in a meta-synthesis of 62 health behaviour change meta-analyses 
(Johnson, Scott-Sheldon, & Carey, 2010), health behaviour change interventions 
typically report small-to-moderate effect, and effect sizes for those that focus on 
‘Improving participation in health services’ is typically even lower. As such, the 
moderate effect size observed in the current study was an encouraging finding. 
The improvement in knowledge is consistent with a small review of print-
based information specific to screening programs (N=9), which found that the 
most common significant outcome was increase in knowledge, but not 
necessarily measurable behaviour (Fox, 2006). This is also consistent with the 
broader experience of print-based interventions focussing on young people. For 
example, a leaflet targeting uptake and determinants of sun protection 
behaviour for young women (N=97, mean age 18±2 years) reported increase in 
knowledge of skin cancer, but no change in beliefs, or increase in sun protection 
behaviour (Castle, Skinner, & Hampson, 1999).   
In similar circumstances to the RCT reported in this program of PhD 
research, an evaluation of a condom promotion leaflet designed for secondary 
school students (N=404, age range: 16-18 years), was underpowered to detect 
effect on the primary outcome (i.e. self-reported uptake of condom use with new 
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partner), with the authors suggesting that opportunity to measure effect was 
curtailed due to high attrition and limited follow-up time.  The study reported an 
increase in previously identified behavioural determinants (e.g. attitudes, beliefs, 
self-efficacy), but did not measure knowledge directly (Hill & Abraham, 2008).  
Knowledge is a crucial factor in individual health behaviour, and a key 
underlying component of health behaviour and self-management theories 
(Fisher et al., 2003; Serlachius & Sutton, 2009).  Unsurprisingly, knowledge is also 
a key factor in successful diabetes self-management (Speight & Bradley, 2001), 
including for uptake of retinal screening (Zhang et al., 2007).  As young adults 
with T2D are under-researched, and arguably one of the most challenging 
diabetes populations to reach and engage, the findings from the evaluation 
conducted in this program of PhD research are novel. Further, considering that 
studies focussing on correlates of health promoting behaviours for young people 
have found that knowledge is a weaker correlate than social cognitive 
antecedents, such as attitudes, self-efficacy, risk perception and intentions 
(Abraham, Krahe, Dominic, & Fritsche, 2002; Bengel, Belz-merk, & Farin, 1996; 
DiClemente, 1991), the identification of motivational and behavioural skills based 
factors impacting retinal screening makes an important contribution to our 
understanding of this priority population. 
As noted in Section 2.3.1, previous print-based retinal screening 
interventions have reported only moderate improvement in retinal screening 
rates with relative risk (RR) ranging from 1.02 (CI 0.94-1.10) to 1.13 (CI 1.04-
1.23), (Burnett et al., 1998; Halbert, Kwan-Moon, Nichol, & Legorreta, 1999; 
Lafata, Baker, Divine, McCarthy, & Xi, 2002; Prela, Smilie, McInerney, Harwell, & 
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Helgerson, 2000).  Importantly for this program of PhD research, all but Halbert 
et al. (1999) included people who had previously screened for DR but who were 
overdue. Further, moderation analyses reported by Prela et al. (2000), (closest in 
design to the current study), reported that the intervention was not effective for 
participants who had not screened in the previous two years.     
Thus, despite the study being underpowered and the primary outcome 
not being achieved, the finding that single presentation of an evidence-based 
leaflet can increase knowledge of DR among those who have never engaged in 
retinal screening, and who therefore may be resistant to the behaviour (Strutton 
et al., 2016; Zhang et al., 2007), is promising. 
6.1.4 Summary. In summary, this program of PhD research achieved the 
overall aim of developing and evaluating an evidence-based public health 
intervention to promote uptake of retinal screening, tailored to the needs and 
characteristics of young adults with T2D. As no previous research has explored, 
in-depth, the factors impacting retinal screening behaviour for young adults with 
T2D and no retinal screening promotion interventions have been developed to 
address the unique characteristics of the priority population, this novel program 
of PhD research makes several original empirical contributions.  
In identifying factors influencing retinal screening uptake for young adults 
with T2D, the first study (described in Chapter 3) laid the foundation for an 
evidence-based health behaviour change intervention. In utilising IM to inform 
the development of a tailored retinal screening promotion intervention, the 
second study (described in Chapter 4) not only produced a promising 
intervention that can be used to promote screening, but also provided a ‘best-
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practice’ illustration of evidence-based, tailored resource development. Finally, in 
assessing the effectiveness of the leaflet intervention in a two-arm RCT, the third 
study (described in Chapter 5), used rigorous, ‘gold standard’ methods for 
evaluation. While the RCT was ultimately underpowered (compromised by low 
recruitment and attrition), the study demonstrated that the ‘Who is looking after 
your eyes?’ leaflet can significantly increase knowledge of DR; and with trends in 
the expected direction, suggests that a well-designed, print-based intervention 
(developed with and endorsed by the target group) has the potential to improve 
key retinal screening facilitators in a priority population at high risk of vision loss 
from DR, who are traditionally considered ‘hard-to-reach’. 
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6.2 Implications for Clinical Practice and Health Policy 
I’ve been to [diabetes advocacy organisations information 
event] … this year … and I think when I went there, the one 
thing I found is that probably 95% of the room comprised of 60-
plus year olds.  So there was only a handful, literally, 10 people 
out of 300 that were my age group.  Being in that kind of 
environment felt a bit strange to me. 
ID 39, 37 years, diabetes duration 9 years 
 
Young-onset T2D has been described as a complex condition with 
heightened risk of sub-optimal long-term health outcomes (Wilmot & Idris, 
2014). Clinical practice guidelines recommend “comprehensive management 
[including] early and aggressive control of diabetes complications … to reduce 
lifetime risk of morbidity and early death” (Zeitler et al., 2014, p.41).  The needs 
assessment findings reported in this program of PhD research highlighted key 
differences in psychosocial retinal screening barriers and facilitators between 
young adults with T2D and their older-onset counterparts (for whom the 
majority of diabetes information and services are developed), and provided 
timely evidence that young adults with T2D have a lower than average retinal 
screening rate when compared to the broader Australian population (72% and 
78%, respectively; Foreman et al., 2017). These findings confirm that young 
adults with T2D represent a demographic ‘pocket’, warranting targeted and 
tailored health behaviour change intervention, to improve retinal screening rates 
and reduce the risk of vision loss from DR. 
In order to promote optimal health care, including diabetes self-
management, ‘best practice’ health behaviour change intervention development 
requires that interventions “take account of socioeconomic and cultural context 
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and strengths and skills of target groups … anticipate barriers to change [and] 
ensure that … content is evidence-based” (Abraham, Kelly, West, & Michie, 2009, 
p.3).  Although there have not been any previous retinal screening interventions 
developed specifically for young adults with T2D (print-based or other formats), 
recent reviews of other health promotion leaflets targeting young adults and 
ophthalmic information leaflets demonstrate that content often does not take 
into account the criteria noted above  (Abraham et al., 2002; Abraham et al., 
2007; Muir & Lee, 2010).  
Health education resources that do not suit the characteristics and 
literacy levels of the target group not only represent a missed opportunity for 
inclusion of key persuasive messages, and correspondence with evidence, but 
they also risk loss of engagement, unmet information needs, and lost 
opportunity to increase the reader’s motivation or skills to achieve the target 
behaviour (Abraham & Kools, 2012).  Further, they may be counterproductive, 
including information that may be misunderstood or rejected  (Doak, Doak, & 
Root, 1996) or worse, elicit feelings of stigma or shame (Parikh, Parker, Nurss, 
Baker, & Williams, 1996).  Exemplified by the quotation at the start of this section 
derived from the current study, and as noted in previous studies (Browne et al., 
2013a; Diabetes Australia, 2006; Dunning & Savage, 2013; Savage et al., 2009), 
young adults with T2D perceive a lack of age-appropriate diabetes self-
management services and resources, resulting in loss of engagement and feelings 
of isolation.  
The ‘Who is looking after your eyes?’ leaflet satisfies the criteria outlined 
by Abraham et al. (2009) and represents a crucial first step in age- and context-
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appropriate engagement of young adults with T2D in their diabetes self-
management.  The leaflet has already had a sustained impact.  Since completion 
of the RCT evaluation in mid-2015, the leaflet has been distributed statewide to 
all eligible NDSS registrants, periodically reviewed and updated, as per ‘best 
practice’ (Coulter, Entwistle, & Gilbert, 1999), and is freely available online, on 
diabetes and eye health websites (Diabetes Victoria; Vision 2020 Australia, 
2017b). Furthermore, plans are underway for inclusion of the leaflet in the NDSS 
starter pack,11 a resource which is well-accepted by young adults with T2D 
(Dunning, Savage, & Dabkowski, 2009).  
6.2.1 Implications for clinical practice. Two logical implications for 
clinical practice proceed from this work. First, given that India and China (both 
associated with increased risk of young-onset of T2D; Yeung et al., 2014), are 
represented in the top four countries of birth for Australian immigrants, and that 
Asian-born immigrants have a lower median age at immigration compared to 
their European counterparts (35 and 59 years, respectively; Australian Bureau of 
Statistics, 2016), Australia is very likely to experience increased incidence of 
young-onset T2D in coming years.   Therefore, cultural adaptation and translation 
of the leaflet resource into the most commonly spoken languages of the priority 
population is warranted.  As non-Australian born members of the priority 
population were well represented in both the in-depth qualitative and online 
                                                     
11The starter pack is a collection of diabetes self-management and support 
information sent to all people with diabetes when they are registered on the 
NDSS (typically at or soon after diagnosis) by their treating practitioner. 
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quantitative needs assessment studies (40% in-depth qualitative interviews, 42% 
quantitative online survey), it is likely that a cognitive debriefing (i.e. active ‘think 
aloud’ evaluation among members of the cultural group) would be sufficient to 
ensure comprehension, relevance and engagement for the priority population 
(Woods et al., 2000).  
Second, in addition to DR, young adults with T2D are at increased risk of 
progression of a range of micro- and macro-vascular complications, highlighting 
an imperative for the development of a range of diabetes self-management 
resources tailored to young adults with T2D, in order to engage them in other 
aspects of diabetes self-management. For example, young adults with T2D have 
higher prevalence of diabetic peripheral neuropathy compared to similar aged 
young adults with type 1 diabetes (T1D), (22% vs 7%, respectively; Jaiswal et al., 
2017), and concerns have been raised with regard to albuminuria (an indicator of 
chronic kidney disease) and cardiovascular disease (Al-Saeed et al., 2016; 
Bjornstad, Cherney, Maahs, & Nadeau, 2016; Deconinck, Mathieu, & Benhalima, 
2017; Wilmot et al., 2014).   
In summary, this program of PhD research corroborated the findings of 
earlier studies; that young adults with T2D are a heterogeneous population with 
complex and specific healthcare needs that are not being met, including for self-
management resources (Amed et al., 2014; Browne et al., 2013a; Diabetes 
Australia, 2006; Dunning et al., 2009; Twigg & Wong, 2015).  As concern for the 
burgeoning population of young adults with T2D has grown, leading clinicians 
and researchers have called for targeted psychological support and patient 
empowerment initiatives to promote behaviour change for this priority 
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population (Song, 2012; Wilmot & Idris, 2014; Zhang & Ning, 2014). The ‘Who is 
looking after your eyes?’ leaflet represents the first step in the development of 
evidence and theory-based age-appropriate resources for this priority 
population.  However, there exists a broad imperative to develop a range of self-
management resources and education programs for this emerging, 
heterogeneous population.   
6.2.2 Implications for health policy.  Retinal screening for the early 
detection of DR satisfies the criteria for a screening program outlined by the 
World Health Organisation (Scanlon, 2008; Wilson & Jungner, 1968). Despite the 
challenges associated with their establishment (Hazin, Colyer, Lum, & Barazi, 
2011; Scanlon, 2017), systematic, nationwide retinal screening programs are 
effective in increasing screening rates and decreasing the frequency of vision 
threatening DR (Forster et al., 2013; Liew, Michaelides, & Bunce, 2014). 
Furthermore, the economic case for retinal screening programs is well-
established, with systematic programs more cost-effective than opportunistic 
screening (Javitt & Aiello, 1996; Jones & Edwards, 2010; Raikou & McGuire, 
2003).  In Australia, cost per participant was considered competitive when 80% 
coverage is reached (Mitchell & Foran, 2008); in the UK, the current minimum 
acceptable level is 70%, with 80% diabetes population coverage considered 
achievable (Moreton, Stratton, Chave, Lipinski, & Scanlon, 2017). Significantly, 
the review by Raikou and McGuire (2003) singled out younger-aged people with 
T2D as the main beneficiaries, because “they had the most QALYs (Quality-
Adjusted Life Years) to gain” (p.550).  
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Australia does not currently have a nationally coordinated retinal 
screening program. However, key stakeholders (Vision 2020 Australia, Diabetes 
Australia and Centre for Eye Research Australia) have recently proposed a 
pathway for a coordinated approach, which utilises the NDSS database as a 
foundation ‘registry’ database (Australian Diabetes Blindness Prevention 
Initiative;  Vision 2020 Australia, 2017a).  Should the Australian Diabetes 
Blindness Prevention Initiative (ADBPI) receive government support, the ‘Who is 
looking after your eyes?’ leaflet has the potential to be incorporated (in its 
current format) into coordinated retinal screening promotion initiatives targeting 
all young adults with T2D who have not screened or who are overdue for DR 
screening.   
Further, the leaflet is just one means of delivering the evidence-based 
messages developed during this program of PhD research.  The identification of 
effective knowledge-based messages contained in the leaflet enables their use in 
other formats as prompts and reminders, including “emails and text messages, 
social and traditional media and channels” suggested by the ADBPI (Vision 2020 
Australia, 2017a). This strategy is concordant with the conclusions of systematic 
reviews of interventions to promote retinal screening, and of strategies to 
facilitate exposure of young adults to internet-delivered health behaviour change 
interventions, which noted that the most commonly used, effective strategies 
were a combination of tailored communication with the use of reminders and 
incentives (Crutzen et al., 2011; Zhang et al., 2007).  
  
REDUCING RISK OF VISION LOSS FOR YOUNG ADULTS WITH TYPE 2 DIABETES 
Page 383 of 470 
6.3 Future Research  
Implications for future research that relate to specific components of the 
study (e.g. mixed-methods needs assessment, leaflet development, RCT 
evaluation) have been discussed within each of the relevant chapters. The 
implications discussed below relate, more broadly, to the entire program of PhD 
research and fall into two categories: utilisation or adaptation of the ‘Who is 
looking after your eyes?’ leaflet for other populations at risk of low retinal 
screening uptake, and lessons learned from this program of PhD research. 
6.3.1 Utilisation of the ‘Who is looking after your eyes?’ leaflet as a 
foundation for other populations at risk of low retinal screening 
uptake.  With the combined benefits of low cost, broad reach, 
consistency of message and wide acceptance, health promotion leaflets and 
other printed materials are ideally placed for dissemination of public health 
messages, and are broadly assumed to represent a cost-effective health 
behaviour change strategy (Abraham et al., 2007; Fox, 2006).  There are several 
populations at risk of low retinal screening, each of which warrant targeted 
intervention.  Other at risk-populations include: young adults with T1D, those 
living in socio-economically deprived areas, and individuals from minority ethnic 
and Indigenous populations (Foreman et al., 2017; Moreton et al., 2017; Paksin-
Hall, Dent, Dong, & Ablah, 2013; Shi, Zhao, Fonseca, Krousel-Wood, & Shi, 2014). 
As the ‘Who is looking after your eyes?’ leaflet is demonstrably evidence- 
and theory-based, it has the potential to be used as a foundation for 
development of similar eye health or other diabetes-complication resources.  For 
example, considering that similar aged younger adults with T1D face the same 
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life-stage challenges as their T2D counterparts (Arnett, 2000), it is likely that this 
leaflet could be adapted to suit the young adults with T1D population.  
Intervention mapping provides clear guidance on the process required for 
adaption of evidence-based interventions for new populations and settings 
(Bartholomew Eldredge et al., 2016) and an example is available in the peer-
reviewed literature (Highfield et al., 2015). 
6.3.2 Lessons learned and recommendations for future research. The 
challenges associated with recruiting young adults with T2D to the needs 
assessment studies, and using IM to develop the ‘Who is looking after your 
eyes?’ leaflet have been discussed in earlier chapters (see Sections 3.6.3, 4.5.1 
and 5.6.2, respectively).   
This section revisits both issues from a broader perspective, to discuss 
lessons learned and suggest improvements for future program planners.  
6.3.2.1 Recruiting young adults with T2D into research. Historically, it 
has been challenging to recruit individuals with younger-onset T2D into clinical 
trials and behavioural research (Browne et al., 2014; Browne et al., 2013a; 
Nadeau et al., 2016; Nguyen et al., 2014; Walders-Abramson et al., 2016; Zeitler, 
Chou, Copeland, & Geffner, 2015). Low recruitment rate and high attrition rate 
have had considerable consequences, including inability to successfully complete 
clinical trials (Nguyen et al., 2014; Zeitler et al., 2015), lack of power to conduct 
complex statistical analyses or detect effect (Browne et al., 2014), and reduced 
generalisability of findings (Zeitler et al., 2015).   
Strategies used to boost recruitment and retention for hard-to-reach 
groups, including for this priority population, have included: leveraging social 
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media (Valdez et al., 2014); promoting the study via credible sources (Close, 
Smaldone, Fennoy, Reame, & Grey, 2013); use of monetary and material 
incentives (Nguyen et al., 2014; Walders-Abramson et al., 2016); collaborative 
partnerships with clinicians and/or communities (Vangeepuram, Townsend, 
Arniella, Goytia, & Horowitz, 2016); maintaining consistency of study personnel, 
establishing rapport with participants and prioritising flexibility of study 
participation (Leerlooijer et al., 2014; Newby et al., 2017; Nguyen et al., 2014; 
Walders-Abramson et al., 2016; Wolfers et al., 2012). 
Many of the above strategies were utilised for the in-depth qualitative 
interview study (see Section 3.4.2).  However, despite a six-month recruitment 
period, only 10 young adults with T2D participated, nine of whom responded to 
Diabetes Victoria postal invitations.  Building on this experience, a direct mail out 
in collaboration with the NDSS was utilised for the quantitative, online survey 
(see Section 4.4.1.2.2). This strategy was not without precedent, as an earlier 
study following similar procedure with the same priority population achieved a 
modest response rate for a postal survey (12%; Browne et al., 2013a). Despite 
this, only 227 (4%) eligible young adults with T2D completed the baseline survey 
and only 129 (2%) completed follow-up.  
Lessons learned in this program of PhD research reflect the experience of 
public health researchers working to promote uptake of other health behaviours 
such as sexual health checks and cancer screening among young adults. These 
studies have faced the same recruitment, attrition, and engagement challenges 
experienced in this program of PhD research. Consequently, published evaluation 
methodologies for uptake of screening or public health activities targeting young 
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adults are randomised controlled trials (cluster or stepped wedge, 
underpowered, published as pilot or feasibility studies), or pre-post design, 
without a control group (Fuller et al., 2015; Reisner et al., 2016; Town et al., 
2016; Willis et al., 2018; Wolf et al., 2017).  
Consequently, the three key recommendation for future researchers 
focus on increasing recruitment and engagement and minimising attrition among 
this priority population. First, there is no guaranteed recruitment pathway for 
young adults with T2D and the experience of this program of PhD research 
reinforced earlier findings that promotion via social media, including Facebook, 
does not necessarily represent a solution, despite wide adoption of the medium 
by the priority population (Nguyen et al., 2014; Sensis, 2017; Valdez et al., 2014).  
Importantly, previous research that identified the desire of young adults with 
T2D for credibility of information source over medium (Diabetes Australia, 2006; 
Dunning et al., 2009), appears also to be relevant for study recruitment.  As such, 
the endorsement by and involvement of diabetes advocacy organisations (in this 
case Diabetes Victoria, NDSS and Diabetes Australia) was beneficial. Inclusion of 
an introductory letter from the diabetes advocacy organisation to their 
members/registrants immediately established credibility and promoted trust 
between study participants and organisers. The only drawbacks of this strategy 
were the potential for recruitment of individuals highly engaged with such 
organisations (and therefore, potentially, in their diabetes self-management), 
and ‘study fatigue’ due to the large number of concurrent studies being 
promoted by the NDSS, which may have contributed to the lower than 
anticipated response rate (Section 5.6.2).  
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Second, efforts to maintain a good rapport with participants were 
valuable in sustaining involvement throughout the mixed-methods needs 
assessment studies.  This was also of crucial importance when involving 
members of the priority population in development of the leaflet resource. 
Although interactions with participants did not raise the issue of appropriate 
boundaries, which have been faced by other studies (Valdez et al., 2014), it was a 
time-consuming process.  Thus, it is recommended that future researchers make 
sufficient allowance for this necessary activity in their project planning. 
Third, although the use of study incentives (described in Section 4.4.1.2), 
were age-appropriate and not excessive, there was a noticeable spike in study 
withdrawals after the winners of the technology-based incentive (three iPad 
minis) were announced at the end of the recruitment period for the quantitative 
online survey.  This suggests that the order of study incentives should have been 
reversed, so that the most valuable (yet probabilistic) incentive was awarded 
upon completion of the entire study.   
6.3.2.2 Study designs for hard-to-reach populations. In a cautionary note 
on appropriate study design, the MRC framework suggests that randomisation 
may be unsuitable if “the changes are very small or take a very long time to 
appear” (Craig et al., 2006, p.11). Given the experience of this and other trials 
(Nadeau et al., 2016; Nguyen et al., 2014; Zeitler et al., 2015), there is an 
imperative to consider alternate study designs and data collection methods for 
evaluations that focus on young adults with T2D.   
Options for randomised and non-randomised study design options were 
briefly discussed in Section 5.6.3 and two are explored further here, in the 
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context of greater use of non-randomised study designs for hard-to-reach 
populations (Zhang et al., 2007). An alternate, non-randomised, qualitative 
approach is ‘think aloud’ cognitive interviewing (Willis, 2005).  The think aloud 
approach asks interviewees to verbalise their thoughts about a resource as they 
read it, allowing for detection of patterns or changes in cognitions, using a much 
smaller sample. In the current context, a think aloud study could recruit a small 
sample of the priority population who did not have DR and were ‘naïve’ (i.e. had 
not participated in) to the retinal screening process. The procedure has been 
utilised successfully to explore how participants evaluate and interpret other 
print-based screening information materials, and in diabetes self-management 
(Kelly, Brandom, & Mattick, 2015; Smith et al., 2013). Further, considering that 
young adults with T1D  are the population closest in experience to the priority 
population in this program of PhD research, this strategy could potentially 
represent a cost-effective way to evaluate the components of the ‘Who is looking 
after your eyes?’ leaflet that require adaptation to promote change in cognition 
in that population. 
A second alternate study design and data collection method could utilise 
the population-based approach adopted by Vision Initiative, which focussed 
intervention on a specific geographic location (see Section 2.1.1). Effect of a 
retinal screening promotion leaflet could then be determined via pre-/post-
assessment of medical record and ophthalmic data in that locality, which is 
considered an accurate approach (MacLennan, McGwin, Searcey, & Owsley, 
2013), or via comparison of two geographic locations, such as discrete Local 
Government Areas.  
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The former design has been used in earlier studies (Zwarenstein et al., 
2014), with the obvious benefit being that it circumvents the need to recruit a 
priority population traditionally considered hard-to-reach. However, without a 
coordinated retinal screening database, such as the one proposed in Section 
6.2.2, this procedure presents other recruitment concerns because it relies on 
study contact with all GPs and ophthalmologists in the locality.  Furthermore, this 
type of design does not allow for evaluation of the impact of an intervention on 
behavioural and psychological determinants, which are key factors in 
understanding the processes underlying health behaviour change (Craig et al., 
2008) but not typically collected in registries. 
6.3.2.3 Utility of IM in development of ‘best practice’ public health 
intervention. Interventions underpinned by an evidence base and 
theoretical constructs are both recommended (Craig et al., 2008; Department of 
Health, 2004) and overall, more efficacious than those with no explicit 
theoretical basis (Gage et al., 2004; Hampson et al., 2000). However, such 
interventions are complex and time-consuming to develop and implement, 
presenting a considerable challenge to research, clinical and community settings 
(Leventhal, Weinman, Leventhal, & Phillips, 2008; Song, 2012).  
The time and resource-intensive nature of IM (which has variously been 
described as complex, elaborate, tiresome, expensive, and time consuming; Kok, 
Peters, & Ruiter, 2017) has implications for the capacity of health services to 
develop ‘best practice’ resources. Essential yet burdensome activities included 
the iterative nature of the process, heavy emphasis on process documentation 
and wide-ranging consultative model, including formation of “at least one” 
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multidisciplinary planning team comprising a wide range of expertise, such as 
health practitioners and educators, behavioural scientists (to “link the relevant 
elements of a given problem to useful theories”, p.59), and representatives from 
potential implementation and dissemination organisations (Bartholomew 
Eldredge et al., 2016).   
The time and resources required to develop and implement health 
behaviour change interventions are crucial barriers because health services 
research is invariably conducted in resource-poor research or clinical 
environments (Dieppe & Ades, 2008). This issue is of particular relevance to 
psychosocial and behavioural studies in diabetes, which receive minimal resource 
allocation in comparison to biomedical research (Jones, Vallis, Cooke, & Pouwer, 
2016).  The current lack of published evaluations and cost-effectiveness studies 
for IM-based projects (see Section 2.4.2.2) must also be addressed if the 
framework is to remain a relevant and appropriate intervention development 
method (Garba & Gadanya, 2017).   
Prudent strategies advanced by others to assist future program planners 
wishing to maintain IM as a foundation for intervention development, include: a 
focus on general principles, processes and concepts rather than the minutiae 
(Gillison et al., 2012), and adaptation of existing, evidence-based health 
behaviour change programs into new contexts utilising a simplified version of IM, 
such as IM Adapt (Bartholomew Eldredge et al., 2016; Highfield et al., 2015).  
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6.4 Strengths and Limitations  
This program of PhD research has several strengths and limitations, many 
of which have been discussed in previous chapters because they relate to the 
specific study components (e.g. Section 3.6.3, in-depth qualitative interview 
study; Section 4.5.1, mixed-methods needs assessment and leaflet development; 
Section 5.6.2, RCT evaluation). The strengths and limitations discussed below 
relate, more broadly, to utilisation of IM and development of a health behaviour 
change intervention within a real-world context. 
6.4.1 Strengths. An important strength of this study is that the ‘Who is 
looking after your eyes?’ leaflet was developed and piloted within real-world 
conditions and with the involvement of young adults with T2D throughout, 
ensuring that the outcome is compatible with, and tailored to, the 
developmental stage and life context of the priority population (Abraham, 
Johnson, De Bruin, & Luszczynska, 2014). In pursuing a rigorous, best-practice 
development process, the study avoided commonly cited causes of limited 
effectiveness of previous health behaviour change leaflets.  
The appointment of a multi-disciplinary project planning team facilitated 
involvement of key agency stakeholders (Vision 2020 Australia, Diabetes Victoria, 
Centre for Eye Research Australia and The Australian Centre for Behavioural 
Research in Diabetes), ensuring engagement, collaboration and contextual 
insights across a range of fields (Kok et al., 2017). In-depth exploration of 
barriers, facilitators and determinants of retinal screening behaviour provided a 
thorough evidence-base by which to understand the problem and pathways of 
causation (Abraham & Kools, 2012).  
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Clear mapping of persuasive messaging to behavioural determinants and 
theory-based BCTs, ensured that the messages contained in the leaflet accurately 
targeted factors impacting the clearly-specified behaviour (Abraham et al., 2007). 
Detailed pilot and review, which included consideration of literacy demand, 
contextual and cultural appropriateness (including piloting with young adults 
with T2D), ensured that the content was engaging, easily understood, and 
relevant to both the target behaviour and the priority population (Coulter et al., 
1999; Payne, Large, Jarrett, & Turner, 2000). Finally, inclusion of fidelity checks 
for intervention delivery and/or engagement ensured that the intervention 
reached the priority population and that the evaluation was accurately 
conducted (Walton, Spector, Tombor, & Michie, 2017).  
6.4.2 Limitations 
6.4.2.1 Constraints of predetermined study components. Although there 
were considerable benefits to conducting the program of PhD research under 
real-world conditions, each of the predetermined study components (e.g. 
eligibility criteria, timeline, intervention format and delivery medium, see Section 
2.1.1) potentially impacted negatively on the ability of the study to detect effect. 
For example, strict eligibility criteria were applied (to meet the purpose of the 
suite of Vision Initiative projects), in order to reach those who were most likely to 
benefit from the intervention. However, in restricting the priority population to 
those young adults with T2D who had registered with the NDSS in the previous 
three years, and in restricting evaluation criteria to those who had not screened 
for DR, the pool of eligible participants was reduced considerably. 
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Furthermore, the strict timeline applied to all Vision Initiative projects 
potentially impacted the ability to detect change during the evaluation phase of 
the project.  By necessity, time to follow-up for the leaflet evaluation was four 
weeks, a period confirmed as suitable by a ‘dummy’ booking exercise (Section 
5.4.3.2). However, the four-week time to follow-up was far shorter than that 
reported by earlier retinal screening intervention evaluations (see Table 1, 
Section 2.3.1), and in a meta-analytic review of 57 tailored, print-based health 
behaviour change interventions (Noar, Benac, & Harris, 2007), with average 
follow-up time noted as 37 weeks and 23 weeks, respectively.   
Given that one of the most salient barriers to retinal screening and other 
health behaviours for young adults is ‘lack of time’ (Browne et al., 2013a; Burgess 
et al., 2015; Diabetes Australia, 2006; Savage et al., 2009; Wilmot & Idris, 2014), 
and that this was the only reason given by study participants for not reading the 
leaflet, longer follow-up or an additional follow-up period six months later, would 
have been beneficial. That said, it is well-established that ‘lack of time’ and other 
practical barriers are often the verbalised reasons for not undertaking an activity 
for which the individual experiences other psychological barriers. These include 
denial of risk of diabetes complications, perception of stigma and negative 
judgement from having a condition usually associated with ‘older’ adults and 
high rates of diabetes related distress (Browne et al., 2013a; Browne, Ventura, 
Mosely, & Speight, 2013b; Horigan, Davies, Findlay-White, Chaney, & Coates, 
2017; Mulvaney et al., 2006).  
Finally, the predetermined nature of both the format and delivery 
medium potentially limited intervention reach. As described in Section 2.1.1, the 
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NDSS database primarily records registrant postal addresses and consequently, 
the intervention was, by necessity, print-based in a format that could be posted 
to participants at their home address.  Although previous research into the 
education and information needs of young adults with T2D reported the 
acceptability of printed materials (Savage et al., 2009), greater flexibility of 
intervention format would have provided opportunity to broaden the reach and 
sustain message impact. This is particularly relevant for the 18-39 year age 
group, where utilisation of social media is “almost universal” in Australia (Sensis, 
2017). 
6.4.2.2 Impact of small sample size on study design and identification of 
effective change processes and techniques. Two principal elements of 
experimental research design theory are the control of known, potentially 
confounding variables, and the randomisation of study participants to 
intervention or control conditions, to determine intervention effect.  Although 
study design was initially planned to uphold both (see Section 5.8.4 for detail of 
Solomon 4-group design), the design had to be adapted due to small sample size, 
exposing the study to the potentially confounding influence of question-
behaviour effect (McCambridge, 2015). 
Small sample size, particularly of those who had never engaged in retinal 
screening, also limited the ability to evaluate whether change processes were 
impacted by the leaflet (Abraham, 2012; Moore et al., 2015). Mediation analyses 
(i.e. evaluation of whether the targeted determinants were changed by the 
intervention) were conducted in this program of PhD research via assessment of 
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secondary outcomes (Section 5.5.3.2), and established that the leaflet was 
successful in improving knowledge of DR, a key screening facilitator.   
However, moderation analyses (i.e. evaluation of whether an intervention 
is differentially successful with sub-groups within the same target population), 
were precluded by small sample size and consequent lack of power to analyse 
sub-groups. Given the heterogeneity of the priority population, sub-groups of 
interest would have been country of birth (e.g. Australian versus non-Australian 
born) and age, as the range of 18-39 years encompasses a number of life-stage, 
physical and psychological changes from ‘emerging adulthood’ (18-25 years; 
Arnett, 2000), to approaching mid-life.  A clearer understanding of whether the 
leaflet intervention was effective for key sub-groups would have contributed to 
resource planning for this priority population.   
Finally, although a limited process evaluation was conducted (see Section 
5.4.7), which confirmed that the leaflet was received and read by 86% of 
intervention group participants, and that key messages were qualitatively 
recalled (data not reported), predetermined contractual limitations meant that a 
more in-depth theory-based process evaluation was not conducted. Lack of 
detailed theory-based process evaluation, which is designed to explore the 
mechanisms through which specific behaviour change occurs, as well as identify 
implementation problems (Moore et al., 2015) impeded a deeper understanding 
of the underlying processes of retinal screening behaviour (Michie & Abraham, 
2004). 
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6.5 Conclusion 
This program of PhD research was initiated in response to a well-
articulated need for age-appropriate retinal screening promotion resources to 
reduce risk of vision loss for young adults with T2D. It is the first study to 
specifically explore factors affecting retinal screening uptake for young adults 
with T2D, and the first to develop an age-appropriate, evidence-based retinal 
screening resource tailored to this priority population.  
Utilising an approach consistent with the MRC framework on developing 
complex interventions (Craig et al., 2008), the rigorous, step-by-step intervention 
development process outlined in Chapter 4 facilitates replication, providing a 
template for development of theory-based messages for future health behaviour 
change interventions. Utilising gold-standard RCT evaluation, the leaflet was 
found to be effective in increasing knowledge of DR, a key retinal screening 
facilitator. Discussion of leaflet development constraints and limitations within a 
real-world context allows future researchers to benefit from these learnings and 
insights (Michie & Abraham, 2004).   
Preventing DR in young adults with T2D requires a broad, system-level 
approach incorporating early multidisciplinary intervention, and a nationally 
coordinated approach to retinal screening. As the product of a comprehensive, 
mixed-methods needs assessment, the evidence-based ‘Who is looking after 
your eyes?’ leaflet has the potential to be incorporated within the proposed 
nationally coordinated screening program, to enable systematic and targeted 
promotion of the program to young adults with T2D, and others who have not 
engaged in retinal screening for the early detection of DR.  
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Appendix C: In-depth interviews - Participant interview guide (Chapter 3) 
Warm up questions 
Q. Perhaps we can start with you telling me about what happened when you 
found out that you had type 2 diabetes. (Prompts: were you initially advised to 
have eyes examined? By whom? What did it mean to you?  Did you do anything 
about it at the time? Did you follow advice?) 
 
1. On a scale of 0 to 10, how much does your diabetes affect your life?  Where 0 
is ‘No affect at all’ and 10 is ‘Severely affects my life’  
 0  1 2 3 4 5 6 7 8 9 10 
 No affect at all     Severely affects my life 
Can you please tell me why you nominated____________________________? 
______________________________________________________________ 
Why did you pick x and not 0?_______________________________________ 
_______________________________________________________________ 
Why did you pick x and no 10? ______________________________________ 
_______________________________________________________________ 
 
2 On a scale of 0 to 10, where 0 is ‘Not at all confident’ and 10 is ‘Very confident’, 
how confident are you that you can take care of your diabetes in the longer 
term? 
0 1 2 3 4 5 6 7 8 9 10 
Not at all confident      Very confident 
Can you please tell me why you 
nominated_______________________________________________________ 
 
3. Thinking about diabetes in the longer term, what is it that concerns you the 
most? (prompt: complications, greatest fear?) 
__________________________________________________________________ 
 
4. I am going to list 5 possible complications of diabetes.  Please rate in order of 
concern to you: 
 Nephropathy (kidney damage)   Retinopathy (vision loss)    
 Heart disease  Amputation (due to nerve damage)  Stroke 
What was your reason for choosing____as most 
concern?__________________________________________________________ 
 
What was your reason for choosing____ as least concern (ie: 5)?____________ 
Interviewer: I would like to focus the rest of the questions on one area of long 
term care, which is care of your eyes and your vision 
Knowledge                
5. Are you aware of a connection between diabetes and eye health?  
If Y: in your own words, can you please tell me what it 
is?________________________________________________________________ 
 
Optimism          
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6. Do you think that you are likely to experience vision problems due to 
diabetes? Can you tell me 
why?_____________________________________________________________ 
 
Knowledge                   
7. Have you previously heard of diabetic 
retinopathy?__________________________If Y: in your own words, can you 
please tell me what it is? 
_________________________________________________________________ 
 
Interviewer: provide brief, simple explanation of retinopathy, if appropriate 
8. Do you know of anything that a person can do to reduce their risk of getting 
retinopathy, or of slowing its progress?       
If Y: in your own words, can you please tell me? 
__________________________________________________________________ 
 
9. I am going to list 5 things that people do, to lower the risk or slow the 
progression of diabetic retinopathy in the longer term.  Please rate in order of 
importance to you. 
 Keeping HbA1c levels in target  Keeping blood pressure in target 
 Having regular eye examination  Keeping cholesterol at target 
 Keep a regular check on blood glucose levels 
 
What was your reason for choosing___as most important (ie: 1)?___________ 
What was your reason for choosing__as least important (ie: 5)? __ 
 
Interviewer: “I would like to focus most of the rest of the questions on having 
regular eye examinations. These eye exams are usually done by putting drops in 
your eyes, which dilate your pupil. A photo is then taken of the inside of your eye, 
to look for damage to your retina.  The rest of the questions will be about this 
kind of eye exam. Some of the questions may sound repetitive, but please 
answer all questions to help us best understand your point of view. 
 
Beliefs about consequences                 
10. What are the positive benefits to having eye 
exams?___________________________________ 
Are there are any negatives or ‘down sides’ to having eye exams? Does one 
outweigh the other?   
 
Reinforcement         
11. (If previous eye exam) Did the experience of having an eye examination 
make it more or less likely that you would have another one in the future? Why? 
 
Beliefs about consequences        
12. What do you expect will happen immediately after having an eye 
examination?________ (Hypothetically) if you were diagnosed with DR, how do 
you think you would  feel?  
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13. What do you expect will happen if you don’t have regular eye 
examinations?_________  
 
Knowledge                     
14. Do you know the recommended target for blood glucose (HbA1c) to prevent 
complications like retinopathy?  
[Interviewer: HbA1c is an indicator of a patient‘s individual control over blood 
glucose levels in the past 90-120 days. [For patients with diabetes, the HbA1c 
target should be less than 7%.  Every 1% reduction in HbA1c lowered the risk of 
DR by 30–40%]  
 
15. Do you know the recommended target for blood pressure to prevent 
complications like retinopathy 
[Interviewer: the target for systolic blood pressure should be less than 130 
mmHg or 130/80 mmHg[ 
 
16. Do you know of any recommendations or guidelines that say how often 
people with diabetes should have their eyes examined? If Y: please describe. 
 
Skills, Knowledge         
17. Can you please describe how you would go about getting an eye 
examination? _______ 
 
Social/Professional Role and Identity               
18. Are you comfortable with people knowing that you have type 2 diabetes? 
How did people react when you told them? 
Is there anyone you wouldn’t want to know that you have diabetes? 
 
19. What does having eye examinations mean to you?  
(Prompt: what kind of person are they?) 
 
20. Do you belong to any diabetes support groups or forums?  
(Prompt for full list)  
 
Social Influence          
21. Have you been prompted by someone to have an eye examination? (Prompt: 
for full list)  What was your response?  
 
22. If anyone could influence your decision to have an eye examination, who 
would it be? (Prompt: for full list)__Why would their views influence you? 
 
23. Has anyone you know had an eye examination for DR?  How did that make 
you feel? 
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24. Do you know of anyone who has experienced vision problems or lost their 
vision because of diabetes or diabetic retinopathy? How does that make you 
feel?  
 
Knowledge            
25. What steps would you take if you did notice changes in your vision (spots or 
blurred vision)? 
 
Goals           
26. Considering your other priorities, on a scale of 0 to 10, with 0 being ‘not at all 
important’ 10 being ‘very important’, how important is it for you to maintain 
your current vision? 
0 1 2 3 4 5 6 7 8 9 10 
Not at all important      Very important 
(If not 10) What are higher priorities and why? 
 
Intentions          
27. Considering your other competing priorities, on a scale of 0 to 10, with 0 
being ‘not at all likely’, and 10 being ‘extremely likely’, how likely is it for you to 
have regular eye examinations when they are next due? 
0 1 2 3 4 5 6 7 8 9 10 
Not at all likely      Extremely likely 
(If not 10) What are higher priorities and why?___ 
 
[Interviewer to state: the major benefit of regular eye examinations is early 
detection of DR before people experience symptoms of vision loss.  Once DR is 
detected, treatment to slow the progression of the condition can begin.]   
 
28. Now that I have explained the benefits of eye examinations, on a scale of 0 
to10, where 0 is ‘not at all likely’ and 10 is ‘extremely likely’, how likely are you 
to have an eye examination when it is next due?     
0 1 2 3 4 5 6 7 8 9 10 
Not at all likely      Extremely likely 
If the two values are different: explore Why? (Prompt: for detail)_ 
 
Beliefs about capabilities                          
29. One a scale of 0 –10, where 0 is ‘not at all confident’ and 10 is ‘very 
confident’, how confident are you that you can talk to your GP or diabetes 
educator about eye examinations?   
0 1 2 3 4 5 6 7 8 9 10 
Not at all confident        Very confident 
What makes it easy/hard? What do you think would help you to overcome these 
problems? 
 
Emotion          
30. Can you please imagine/think back to, receiving a reminder for your regular 
eye examination, what feelings would you/did you have? 
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31. Can you please imagine/think back to when you are having an eye 
examination, what thoughts or feelings would you/did you, have?   
 
32. Please imagine the time immediately after you have an eye examination, 
what thoughts or feelings do you have?  
_______________________________________________________ 
 
33. One a scale of 0 –10, where 0 is ‘not at all concerned’ and 10 is ‘extremely 
concerned’, do thoughts of vision loss worry or concern you? 
 0 1 2 3 4 5 6 7 8 9 10 
Not at all concerned      Extremely concerned 
Interviewer to explore 
 
Behavioural regulation             
34. Eye examinations don’t have to be done as often as other diabetes self-
management tasks, such as taking medication or checking blood glucose.  If you 
want to have an eye examination, how do you think you will remember (or 
remind yourself)?(Prompt: for detail)_____________ 
 
Memory, attention and decision processes            
35. Have you ever forgotten, or delayed, an eye examination when it was due? 
If Y: do you know why? (Prompt for detail) 
 
36. Making the decision to have an eye exam: 
If previously had an eye exam: Please step me through how you made the 
decision to have an eye examination? 
If not previously had eye exam: Did you consciously decide against going for an 
eye exam? What went through your mind when you made that decision? 
(Prompt: Please step me through thought process)_ 
 
Environmental context and resources      
37. Sometimes our plans are hindered by things outside of our control.  
What things, outside of your control, could make it harder for you to have 
regular eye exams? (Prompt: list) What things could make it easier? (Prompt: 
list) 
 
38. How/where do you get information regarding diabetes management? 
(Prompt: What have you found useful? Preferred format? Suggest 
improvements) 
 
39 How/where do you get information regarding eye examinations and diabetic 
eye conditions? (Prompt: What have you found useful? Preferred format? 
Suggest improvements). 
 
Closing                                                                                              
Thank you very much for taking part in our study. Is there anything else about 
this topic that you would like to mention?  
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Appendix D: Online survey - Baseline (phase 1)  
Instructions: Please complete this short questionnaire which asks about you and 
your background.  All responses are confidential; please select the option that 
best suits your situation. 
 
1. What is your gender? 
 Woman       Man       Prefer not to say 
 
2. What age were you when you were diagnosed with type 2  
 diabetes?______________(years) 
 
3. What is your postcode? __________________ 
 
4. Were you born in Australia?      
 Yes   No, I was born overseas (please state) ______________ 
 
5. Do you identify as Aboriginal or Torres Strait Islander?      
 Yes   No 
 
6. What ethnic group do you identify with the most? 
 Australian  Other (please state) ______________ 
 
7. What is the main language you speak at home?  
 English       Other (please state) ______________ 
 
8. What is the highest qualification you have completed? 
 No formal qualifications  Trade / apprenticeship (eg. 
Hairdresser, Chef) 
 
 Primary school  
 
 Certificate / diploma 
 
 High school to Year 10 (or 
equivalent) 
 
 University degree 
 High school to Year 12 (or 
equivalent) 
 Higher University  degree 
(Grad Dip, Masters, PhD) 
 
9. Which of the following best describes your current employment? 
 Paid full-time work 
 
 Paid part-time work  
 Student 
 
 Retired  
 No paid work 
 
 Other (please state)____________ 
 
 
 
10. What is your total household income (before tax)? 
 Up to $18,200  $18,201 – $37,000 
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 $37,001-$80,000  $80,001-$180,000 
 $180,001 and over  Don’t know/prefer not to say 
 
11. Which of the following best describes your current relationship status? 
 Married/De Facto 
 
 In a steady 
relationship 
 Separated/Divorced  
 
 Widowed 
 Single 
 
 Other (please state) 
 
Instructions: This section asks about your health, your general diabetes 
knowledge and self-management activities.  Please select the option that you 
think is correct, but don’t spend too long on any question. 
 
12. How do you currently manage your diabetes? (Select all that apply) 
  Diet and physical activity (lifestyle only) 
  Blood glucose-lowering tablets (e.g. Metformin) 
  Non-insulin injectable (e.g. Byetta) 
  Insulin injections 
  Insulin pump  
  Other:   __________________________ 
 
13. The HbA1c or haemoglobin A1c test is: 
  The fasting blood glucose test that you do in the mornings 
  A measure of your average blood glucose over the last 2 - 3 months 
   The blood glucose monitoring that you do throughout the day 
   Not sure 
 
14. What is the HbA1c goal for most people with diabetes?  
 Less than or equal to 7%  
 Less than or equal to 10%  
 It doesn’t matter if you are on medication 
 Not sure 
 
15. What is the blood pressure goal for most people with diabetes? 
 As low as possible 
 130/80 or lower 
 It doesn’t matter if you are on medication 
 Not sure 
 
16. Have either of your parents, or any of your brothers or sisters  
       been diagnosed with type 2 diabetes? 
 Yes   No   Don’t know 
 
 
 
17. Do you currently have any of the following health or medical conditions? 
 Cardiovascular disease (heart disease) Cerebrovascular disease (stroke) 
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 Peripheral vascular disease (arterial 
disease) 
 Polycystic ovary syndrome 
 High blood pressure (hypertension) 
 
 Sleep apnoea 
 High cholesterol (triglycerides/lipids) 
 
 Diabetic retinopathy (eye disease) 
 
 Sexual dysfunction  Nephropathy (kidney damage) 
 Peripheral neuropathy (nerve damage)  Something else associated with  
diabetes? (please state)__________ 
 
18. Since you were diagnosed with diabetes have you had: 
Your cholesterol checked? 
Your blood pressure checked? 
Your average blood glucose (HbA1c)i  checked? 
Your kidney function checked because of your diabetes? 
Your eyes examined because of your diabetes? 
Your feet checked because of your diabetes? 
Response options for each: 
  Yes   No    Not sure 
If Yes, how long ago? ___________________________(months) 
What was the last reading (%)______________   Don’t remember 
 
Instructions: This section asks how you’re feeling in general about living with and 
managing diabetes.  There are no right or wrong answers, so please select the 
option that you think is correct and don’t spend too long on any question. 
For the following questions, please select the number that best corresponds to 
your views. 
 
19. How much does diabetes affect your life? 
0 1 2 3 4 5 6 7 8 9 10 
No affect at all         Severely affects my life 
 
20. How long do you think your diabetes will continue? 
0 1 2 3 4 5 6 7 8 9 10 
A very short time               Forever 
 
21. How much control do you feel you have over your diabetes? 
0 1 2 3 4 5 6 7 8 9 10 
Absolutely no control         Extreme amount of control 
 
22. How much do you think your treatment can help your diabetes? 
0 1 2 3 4 5 6 7 8 9 10 
Not at all              Extremely helpful 
 
23. How much do you experience symptoms from your diabetes? 
0 1 2 3 4 5 6 7 8 9 10 
i “HbA1c is a 
measure of your 
average blood 
glucose over the last 
3 months” 
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No symptoms at all          Many severe symptoms 
 
24. How concerned are you about your diabetes? 
0 1 2 3 4 5 6 7 8 9 10 
Not at all concerned       Extremely concerned 
 
25. How well do you feel you understand your diabetes? 
0 1 2 3 4 5 6 7 8 9 10 
Don’t understand at all       Understand very clearly 
 
26. How much does your diabetes affect you emotionally? (e.g. does it make 
you angry, scared, upset or depressed?) 
0 1 2 3 4 5 6 7 8 9 10 
Not at all affected emotionally              Extreme affected emotionally 
 
Instructions: Living with diabetes can sometimes be tough. There may be many 
problems and hassles concerning diabetes and they can vary greatly in severity. 
Problems may range from minor hassles to major life difficulties. Listed below are 
2 potential problem areas that people with diabetes may experience. Consider 
the degree to which each of the 2 items may have distressed or bothered you 
DURING THE PAST MONTH and select the appropriate number. 
 
Please note that we are asking you to indicate the degree to which each item 
may be bothering you in your life, NOT whether the item is merely true for you. If 
you feel that a particular item is not a bother or a problem for you, you would 
circle “1.” If it is very bothersome to you, you might circle “6.” 
 
Feeling Not a 
Problem 
Moderate 
problem 
Serious 
problem 
1. Feeling overwhelmed by the 
demands of living with diabetes. 
1 2 3 4 5 6 
2. Feeling that I am often failing with my 
diabetes regime. 
1 2 3 4 5 6 
 
Over the past 2 weeks, how often have you been bothered by any of the 
following problems? 
 Not at 
all 
Several 
days 
More 
than half 
the days 
Nearly 
every 
day 
1. Little interest or pleasure in 
doing things 
0 1 2 3 
2. Feeling down, depressed or 
hopeless 
0 1 2 3 
Thank you for completing the questionnaire.  We will contact you by email when 
the next stage is ready.  Would you like to leave a comment about any part of the 
study so far? 
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Appendix E: Online survey - Baseline (phase 2)  
Instructions: Many of the questions in this survey use of rating scales with either 
5 or 7 options.  For each question, please select the number that best describes 
your opinion or experience.         
 
As you go through the questionnaire, you may notice that some of the questions 
are similar to others; this is because we are keen to understand your diabetes 
self-management from a number of perspectives.       
 
We are going to start with some general questions about diabetes. 
 
1. Which of the following senses can be damaged by diabetes?  
    (Select all that apply) 
 Vision 
 Hearing 
 Touch 
 Taste 
 Smell 
 All of the above 
 Don't know / Not sure 
 
[Qualtrics survey flow instruction: If Vision selected] 
1a. Where did you learn that diabetes affects eye health? (Select all that apply) 
 My health professionals (e.g. doctor, diabetes nurse educator, 
endocrinologist) 
 My pharmacy or chemist (in person or via mailed catalogue) 
 Printed information (poster/leaflet) or online health information (e.g. 
Better Health Channel)  
 Social media (e.g. facebook, twitter, blogs, Pintrest, tumblr) 
 Media campaign (e.g. radio, TV, newspaper)  
 My pathology centre (where I have my blood tests done)  
 My family, friends or work colleagues  
 Diabetes organisations (e.g. Diabetes Australia), National Diabetes 
Services Scheme  
 Other (please state):  ______________________________________ 
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Instructions: The next question lists five possible complications of diabetes. Not 
everyone with diabetes develops these complications but we would like to know 
which concern you the most. 
 
2. How worried or concerned are you about each of the following possible   
   diabetes complications?  
 Not at all 
concerned 
Slightly 
concerned 
Moderately 
concerned  
Very 
concerned  
Extremely 
concerned 
Kidney 
damage 
(nephropathy) 
     
Eye damage 
(retinopathy)  
     
Heart disease      
Stroke      
Nerve damage 
(neuropathy)  
     
 
Instructions: Please note: from this point onwards, we refer to ‘diabetic 
retinopathy (DR)’ and ‘eye health checks’. The next questions are about your 
knowledge of diabetes complications, such as diabetic retinopathy (DR)i and eye 
health checks.  Please answer each question to the best of your ability (but do not 
look up any answers).   
 
iDefinition: Diabetic retinopathy is a complication of diabetes that damages blood vessels at the 
back of the eye. If untreated it can cause vision loss. An eye health check is usually done by an 
optometrist or eye specialist who will check the blood vessels at the back of your eye for signs of 
diabetes-related eye damage.  They do this by taking a photo or using a lamp and they may use 
eye drops to dilate your pupil 
 
3. Since you were diagnosed with diabetes have you been advised to have your 
eyes examined to check your eye health? 
 Yes  
 No  
 Don't know / Not sure 
 
[Qualtrics survey flow instruction: If yes selected] 
3a. Who advised you to have your eyes examined to check your eye health?  
(Select all that apply) 
 My health professionals (i.e. doctor, diabetes nurse educator,  
 endocrinologist)  
 My pharmacy or chemist (in person or via mailed catalogue)  
 My family, friends or work colleagues  
 No one advised me to have my eyes examined to check my eye health  
 Other (please state):  ____________________ 
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4.  Which health professional do you think is most likely to do an eye health    
     check for DR?   (Select one)  
 General practitioner (doctor) 
 Diabetes nurse educator 
 Optometrist 
 Endocrinologist 
 Don't know / Not sure 
 
5. When should a person with diabetes have their first eye health check for  
    DR?     (Select all that apply) 
 When they are first diagnosed with diabetes  
 Whey they notice changes or problems with their vision 
 If they regularly have blood glucose levels above the target 
recommended by their doctor 
 When they are advised by their doctor 
 Once they have had diabetes for longer than 10 years 
 When they start taking tablets to treat their diabetes  
 When they start taking insulin to treat their diabetes 
 Once they are over 40 years of age 
 All of the above  
 Don't know / Not sure  
 
6. If a previous eye health check showed their eyes to be healthy, a person  
    with diabetes should have eye health checks for DR: (Select one) 
 at least every 6 months  
 at least every 12 months  
 at least every 2 years  
 at least every 3 years  
 Don't know/ Not sure  
 
Instructions: The next set of questions asks about your knowledge of DR and 
what you can do to reduce your risk of developing the condition.   As before, we 
want to understand your current knowledge so please answer each question 
without referring to any information sources. 
 
7.  Please indicate whether you think that each of the following statements  
   about DR are True, False, or whether you're not sure. 
 True False Don't know / 
Not sure 
At least 1 in 4 people with type 2 
diabetes have DR 
   
DR can cause vision loss or 
blindness 
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DR can develop without symptoms    
DR is influenced by high blood 
pressure 
   
DR is influenced by high cholesterol    
DR is influenced by high blood 
glucose 
   
DR is treatable if detected early via 
an eye health check  
   
DR is more likely to develop the 
longer you have diabetes 
   
 
8. In the EARLY STAGES of DR, people can experience: (Select all that apply) 
 blurry vision 
 pain or discomfort in the eyes 
 blood shot eyes 
 itchy eyes 
 spots or floaters in their vision 
 loss of vision 
 no symptoms at all 
 All of the above 
 Don't know / Not sure  
 
9. What do you think is the HbA1ci target to reduce the risk of DR? (Select one) 
 Less than or equal to 7% 
 Less than or equal to 10%  
 It doesn't matter if you are on medication  
 Don't know / Not sure  
 
 
 
10. What do you think is the blood pressure goal to reduce the risk of DR? 
(Select one) 
 As low as possible  
 130/80 or lower  
 It doesn't matter if you are on medication  
 Don't know / Not sure  
 
iAn HbA1c check is a blood 
test which provides an 
overall picture of average 
blood glucose levels over 
the past 3 months 
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Instructions: The next questions are about your personal opinions on DR and eye health checks.  There are no right or wrong answers; we are 
interested in your point of view, so please don’t take too much time on any one question or look up answers as you go. Occasionally the 
questions may seem repetitive, but please answer them all because we are trying to understand you views from different perspectives. 
 
11 How much do you agree or disagree with these three statements about eye health checks for DR? 
 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Neither agree 
nor disagree 
Slightly 
agree  
Moderately 
agree  
Strongly 
agree  
I plan to attend an eye health check in 
the next four weeks OR when it is 
next due 
       
I will make an effort to have an eye 
health check in the next four weeks 
OR when it is next due 
       
I intend to have an eye health check 
in the next four weeks or when it is 
next due 
       
 
12. Who do you believe is at risk of developing DR? (Select one only) 
 Only people with type 1 diabetes  
 Only people with type 2 diabetes  
 Only people who use medications such as tablets or insulin to treat their diabetes  
 Only people who have had diabetes for more than 10 years 
 All people with diabetes  
 Don’t know / Not sure  
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13. How much do you agree or disagree with these statements about eye health checks for DR? 
 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Don’t 
know/not 
sure 
Slightly 
agree 
Moderately 
agree  
Strongly 
agree 
My family/close friends would approve of 
me attending an eye health check in the 
next 4 weeks OR when it is next due 
       
My health professionals would approve of 
me attending an eye health check in the 
next 4 weeks OR when it is next due 
       
Most people I know with diabetes have 
regular eye health checks 
       
 
14 How much do you agree or disagree with each response?   
For me to have an eye health check for DR in the next four weeks OR when it is next due would be.... 
 Strongly disagree Disagree Neither agree nor 
disagree 
Agree Strongly agree 
...a good idea      
...unpleasant      
...wise      
...difficult      
...frightening       
...unnecessary      
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14. For me to have an eye health check for DR in the next four weeks OR when it is next due would be....(Cont.) 
 Strongly disagree Disagree Neither agree nor 
disagree 
Agree Strongly agree 
...important      
...beneficial       
...comfortable       
...empowering      
 
15 How much do you agree or disagree with these statements? 
 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Neither agree 
nor disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree  
I believe I will develop DR due to my 
diabetes 
       
I believe I will develop vision 
problems due to my diabetes 
       
I expect to be diagnosed with DR at 
my next eye health check 
       
I believe I can reduce my risk of 
vision problems if I manage my 
diabetes well 
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16. How much do you agree or disagree with each response?   If I did NOT have an eye health check, I would feel..... 
 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Neither agree 
nor disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
...indifferent?        
...concerned?        
...fearful?        
...worried?         
...regretful?        
...guilty?        
 
Instructions: Next are some questions which ask about your confidence or ability to have eye health checks to check for signs of DR. As before, 
there are no right or wrong answers, so please select the option that best fits your experience / situation and don’t spend too long on any one 
question. 
    
17 How confident are you that you ... 
 Not at all 
confident  
Slightly 
confident 
Moderately 
confident 
Confident  Extremely 
confident  
....know what steps you can take to reduce the risk 
of developing DR? 
     
....can talk to your doctor about your eye health?      
....will have regular eye health checks?      
....know how to make the appointment for an eye 
check? 
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17. How confident are you that you ...(Cont.) 
 Not at all 
confident  
Slightly 
confident 
Moderately 
confident 
Confident  Extremely 
confident  
....can find the time to attend an eye health check in the 
next four weeks OR when it is next due? 
     
....will remember to have an eye health check in the next 
four weeks OR when it is next due? 
     
....will mention that you have diabetes when you make the 
eye check appointment? 
     
....will attend the eye health check that you have booked?      
....can reschedule the eye health check to a different time 
or day if needed? 
     
....can resume your normal activities immediately after the 
eye health check? 
     
....can afford to pay for the eye health check, if there is a 
charge? 
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[Qualtrics survey flow instruction: next questions are for ‘unengaged’ study 
participants only] 
18. Since you completed the last yourSAY questionnaire, have you had an eye 
health check?  
 Yes   No 
 
18a. If you haven’t had an eye check yet, can you tell us the main reasons for  
         not having one? (Select up to three reasons) 
 I didn't receive a reminder/my doctor didn’t tell me to have one 
 I couldn't afford it 
 I didn't know that regular eye checks were important 
 I forgot to make an appointment  
 I forgot to attend the appointment  
 I was concerned that there would be something wrong with my eyes 
 Eye health checks are low on my list of priorities 
 I was away (e.g. on holidays or with work) 
 I haven’t noticed any changes to my vision 
 I don’t like to think about my diabetes 
 I didn't have time  
 I felt tired or unwell  
 Other reason (please state):____________________ 
 
Instructions: This section asks about your general mood and how you feel about 
living with diabetes.  There are no right or wrong answers, so please select the 
option that best fits your experience / situation and don’t spend too long on any 
one question. Over the past two weeks, how often have you been bothered by 
any of the following problems? 
 Not at 
all  
Several 
days 
More than 
half the days 
Nearly 
every day  
1. Little interest or pleasure 
in doing things?  
    
2. Feeling down, depressed 
or hopeless?  
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Living with diabetes can sometimes be tough. There may be many problems and 
hassles concerning diabetes and they can vary greatly in severity. Problems may 
range from minor hassles to major life difficulties.  Listed below are two potential 
problem areas that people with diabetes may experience.  
Consider the degree to which each of the two items may have distressed or 
bothered you DURING THE PAST MONTH and select the appropriate number.  
Please note that we are asking you to indicate the degree to which each item 
may be bothering you in your life, NOT whether the item is merely true for you. If 
you feel that a particular item is not a bother or a problem for you, you would 
circle “1.” If it is very bothersome to you, you might circle “6.” 
 
Feeling Not a 
Problem 
Moderate 
problem 
Serious 
problem 
1. Feeling overwhelmed by the demands of 
living with diabetes. 
1 2 3 4 5 6 
2. Feeling that I am often failing with my 
diabetes regime. 
1 2 3 4 5 6 
 
Thank you for completing this questionnaire.   
[Qualtrics survey flow instruction: next statement for ‘intervention group’ study 
participants only] The information that you have provided will be used to develop 
a leaflet about diabetes self-management which we will post to you in March 
2015.   
 
[All participants] We also welcome your feedback; please write any comments 
into the box below: 
 
 
 
 
 
 
 
 
 
 
 
 
 
